<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Preprocess and Curate the 11 Gold-Standard Datasets; Also give DeepTargetâ€™s Score for each hit</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>/*! jQuery v3.6.0 | (c) OpenJS Foundation and other contributors | jquery.org/license */
!function(e,t){"use strict";"object"==typeof module&&"object"==typeof module.exports?module.exports=e.document?t(e,!0):function(e){if(!e.document)throw new Error("jQuery requires a window with a document");return t(e)}:t(e)}("undefined"!=typeof window?window:this,function(C,e){"use strict";var t=[],r=Object.getPrototypeOf,s=t.slice,g=t.flat?function(e){return t.flat.call(e)}:function(e){return t.concat.apply([],e)},u=t.push,i=t.indexOf,n={},o=n.toString,v=n.hasOwnProperty,a=v.toString,l=a.call(Object),y={},m=function(e){return"function"==typeof e&&"number"!=typeof e.nodeType&&"function"!=typeof e.item},x=function(e){return null!=e&&e===e.window},E=C.document,c={type:!0,src:!0,nonce:!0,noModule:!0};function b(e,t,n){var r,i,o=(n=n||E).createElement("script");if(o.text=e,t)for(r in c)(i=t[r]||t.getAttribute&&t.getAttribute(r))&&o.setAttribute(r,i);n.head.appendChild(o).parentNode.removeChild(o)}function w(e){return null==e?e+"":"object"==typeof e||"function"==typeof e?n[o.call(e)]||"object":typeof e}var f="3.6.0",S=function(e,t){return new S.fn.init(e,t)};function p(e){var t=!!e&&"length"in e&&e.length,n=w(e);return!m(e)&&!x(e)&&("array"===n||0===t||"number"==typeof t&&0<t&&t-1 in e)}S.fn=S.prototype={jquery:f,constructor:S,length:0,toArray:function(){return s.call(this)},get:function(e){return null==e?s.call(this):e<0?this[e+this.length]:this[e]},pushStack:function(e){var t=S.merge(this.constructor(),e);return t.prevObject=this,t},each:function(e){return S.each(this,e)},map:function(n){return this.pushStack(S.map(this,function(e,t){return n.call(e,t,e)}))},slice:function(){return this.pushStack(s.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},even:function(){return this.pushStack(S.grep(this,function(e,t){return(t+1)%2}))},odd:function(){return this.pushStack(S.grep(this,function(e,t){return t%2}))},eq:function(e){var t=this.length,n=+e+(e<0?t:0);return this.pushStack(0<=n&&n<t?[this[n]]:[])},end:function(){return this.prevObject||this.constructor()},push:u,sort:t.sort,splice:t.splice},S.extend=S.fn.extend=function(){var e,t,n,r,i,o,a=arguments[0]||{},s=1,u=arguments.length,l=!1;for("boolean"==typeof a&&(l=a,a=arguments[s]||{},s++),"object"==typeof a||m(a)||(a={}),s===u&&(a=this,s--);s<u;s++)if(null!=(e=arguments[s]))for(t in e)r=e[t],"__proto__"!==t&&a!==r&&(l&&r&&(S.isPlainObject(r)||(i=Array.isArray(r)))?(n=a[t],o=i&&!Array.isArray(n)?[]:i||S.isPlainObject(n)?n:{},i=!1,a[t]=S.extend(l,o,r)):void 0!==r&&(a[t]=r));return a},S.extend({expando:"jQuery"+(f+Math.random()).replace(/\D/g,""),isReady:!0,error:function(e){throw new Error(e)},noop:function(){},isPlainObject:function(e){var t,n;return!(!e||"[object Object]"!==o.call(e))&&(!(t=r(e))||"function"==typeof(n=v.call(t,"constructor")&&t.constructor)&&a.call(n)===l)},isEmptyObject:function(e){var t;for(t in e)return!1;return!0},globalEval:function(e,t,n){b(e,{nonce:t&&t.nonce},n)},each:function(e,t){var n,r=0;if(p(e)){for(n=e.length;r<n;r++)if(!1===t.call(e[r],r,e[r]))break}else for(r in e)if(!1===t.call(e[r],r,e[r]))break;return e},makeArray:function(e,t){var n=t||[];return null!=e&&(p(Object(e))?S.merge(n,"string"==typeof e?[e]:e):u.call(n,e)),n},inArray:function(e,t,n){return null==t?-1:i.call(t,e,n)},merge:function(e,t){for(var n=+t.length,r=0,i=e.length;r<n;r++)e[i++]=t[r];return e.length=i,e},grep:function(e,t,n){for(var r=[],i=0,o=e.length,a=!n;i<o;i++)!t(e[i],i)!==a&&r.push(e[i]);return r},map:function(e,t,n){var r,i,o=0,a=[];if(p(e))for(r=e.length;o<r;o++)null!=(i=t(e[o],o,n))&&a.push(i);else for(o in e)null!=(i=t(e[o],o,n))&&a.push(i);return g(a)},guid:1,support:y}),"function"==typeof Symbol&&(S.fn[Symbol.iterator]=t[Symbol.iterator]),S.each("Boolean Number String Function Array Date RegExp Object Error Symbol".split(" "),function(e,t){n["[object "+t+"]"]=t.toLowerCase()});var d=function(n){var e,d,b,o,i,h,f,g,w,u,l,T,C,a,E,v,s,c,y,S="sizzle"+1*new Date,p=n.document,k=0,r=0,m=ue(),x=ue(),A=ue(),N=ue(),j=function(e,t){return e===t&&(l=!0),0},D={}.hasOwnProperty,t=[],q=t.pop,L=t.push,H=t.push,O=t.slice,P=function(e,t){for(var n=0,r=e.length;n<r;n++)if(e[n]===t)return n;return-1},R="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",M="[\\x20\\t\\r\\n\\f]",I="(?:\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\[^\\r\\n\\f]|[\\w-]|[^\0-\\x7f])+",W="\\["+M+"*("+I+")(?:"+M+"*([*^$|!~]?=)"+M+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+I+"))|)"+M+"*\\]",F=":("+I+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+W+")*)|.*)\\)|)",B=new RegExp(M+"+","g"),$=new RegExp("^"+M+"+|((?:^|[^\\\\])(?:\\\\.)*)"+M+"+$","g"),_=new RegExp("^"+M+"*,"+M+"*"),z=new RegExp("^"+M+"*([>+~]|"+M+")"+M+"*"),U=new RegExp(M+"|>"),X=new RegExp(F),V=new RegExp("^"+I+"$"),G={ID:new RegExp("^#("+I+")"),CLASS:new RegExp("^\\.("+I+")"),TAG:new RegExp("^("+I+"|[*])"),ATTR:new RegExp("^"+W),PSEUDO:new RegExp("^"+F),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+M+"*(even|odd|(([+-]|)(\\d*)n|)"+M+"*(?:([+-]|)"+M+"*(\\d+)|))"+M+"*\\)|)","i"),bool:new RegExp("^(?:"+R+")$","i"),needsContext:new RegExp("^"+M+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+M+"*((?:-\\d)?\\d*)"+M+"*\\)|)(?=[^-]|$)","i")},Y=/HTML$/i,Q=/^(?:input|select|textarea|button)$/i,J=/^h\d$/i,K=/^[^{]+\{\s*\[native \w/,Z=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,ee=/[+~]/,te=new RegExp("\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\([^\\r\\n\\f])","g"),ne=function(e,t){var n="0x"+e.slice(1)-65536;return t||(n<0?String.fromCharCode(n+65536):String.fromCharCode(n>>10|55296,1023&n|56320))},re=/([\0-\x1f\x7f]|^-?\d)|^-$|[^\0-\x1f\x7f-\uFFFF\w-]/g,ie=function(e,t){return t?"\0"===e?"\ufffd":e.slice(0,-1)+"\\"+e.charCodeAt(e.length-1).toString(16)+" ":"\\"+e},oe=function(){T()},ae=be(function(e){return!0===e.disabled&&"fieldset"===e.nodeName.toLowerCase()},{dir:"parentNode",next:"legend"});try{H.apply(t=O.call(p.childNodes),p.childNodes),t[p.childNodes.length].nodeType}catch(e){H={apply:t.length?function(e,t){L.apply(e,O.call(t))}:function(e,t){var n=e.length,r=0;while(e[n++]=t[r++]);e.length=n-1}}}function se(t,e,n,r){var i,o,a,s,u,l,c,f=e&&e.ownerDocument,p=e?e.nodeType:9;if(n=n||[],"string"!=typeof t||!t||1!==p&&9!==p&&11!==p)return n;if(!r&&(T(e),e=e||C,E)){if(11!==p&&(u=Z.exec(t)))if(i=u[1]){if(9===p){if(!(a=e.getElementById(i)))return n;if(a.id===i)return n.push(a),n}else if(f&&(a=f.getElementById(i))&&y(e,a)&&a.id===i)return n.push(a),n}else{if(u[2])return H.apply(n,e.getElementsByTagName(t)),n;if((i=u[3])&&d.getElementsByClassName&&e.getElementsByClassName)return H.apply(n,e.getElementsByClassName(i)),n}if(d.qsa&&!N[t+" "]&&(!v||!v.test(t))&&(1!==p||"object"!==e.nodeName.toLowerCase())){if(c=t,f=e,1===p&&(U.test(t)||z.test(t))){(f=ee.test(t)&&ye(e.parentNode)||e)===e&&d.scope||((s=e.getAttribute("id"))?s=s.replace(re,ie):e.setAttribute("id",s=S)),o=(l=h(t)).length;while(o--)l[o]=(s?"#"+s:":scope")+" "+xe(l[o]);c=l.join(",")}try{return H.apply(n,f.querySelectorAll(c)),n}catch(e){N(t,!0)}finally{s===S&&e.removeAttribute("id")}}}return g(t.replace($,"$1"),e,n,r)}function ue(){var r=[];return function e(t,n){return r.push(t+" ")>b.cacheLength&&delete e[r.shift()],e[t+" "]=n}}function le(e){return e[S]=!0,e}function ce(e){var t=C.createElement("fieldset");try{return!!e(t)}catch(e){return!1}finally{t.parentNode&&t.parentNode.removeChild(t),t=null}}function fe(e,t){var n=e.split("|"),r=n.length;while(r--)b.attrHandle[n[r]]=t}function pe(e,t){var n=t&&e,r=n&&1===e.nodeType&&1===t.nodeType&&e.sourceIndex-t.sourceIndex;if(r)return r;if(n)while(n=n.nextSibling)if(n===t)return-1;return e?1:-1}function de(t){return function(e){return"input"===e.nodeName.toLowerCase()&&e.type===t}}function he(n){return function(e){var t=e.nodeName.toLowerCase();return("input"===t||"button"===t)&&e.type===n}}function ge(t){return function(e){return"form"in e?e.parentNode&&!1===e.disabled?"label"in e?"label"in e.parentNode?e.parentNode.disabled===t:e.disabled===t:e.isDisabled===t||e.isDisabled!==!t&&ae(e)===t:e.disabled===t:"label"in e&&e.disabled===t}}function ve(a){return le(function(o){return o=+o,le(function(e,t){var n,r=a([],e.length,o),i=r.length;while(i--)e[n=r[i]]&&(e[n]=!(t[n]=e[n]))})})}function ye(e){return e&&"undefined"!=typeof e.getElementsByTagName&&e}for(e in d=se.support={},i=se.isXML=function(e){var t=e&&e.namespaceURI,n=e&&(e.ownerDocument||e).documentElement;return!Y.test(t||n&&n.nodeName||"HTML")},T=se.setDocument=function(e){var t,n,r=e?e.ownerDocument||e:p;return r!=C&&9===r.nodeType&&r.documentElement&&(a=(C=r).documentElement,E=!i(C),p!=C&&(n=C.defaultView)&&n.top!==n&&(n.addEventListener?n.addEventListener("unload",oe,!1):n.attachEvent&&n.attachEvent("onunload",oe)),d.scope=ce(function(e){return a.appendChild(e).appendChild(C.createElement("div")),"undefined"!=typeof e.querySelectorAll&&!e.querySelectorAll(":scope fieldset div").length}),d.attributes=ce(function(e){return e.className="i",!e.getAttribute("className")}),d.getElementsByTagName=ce(function(e){return e.appendChild(C.createComment("")),!e.getElementsByTagName("*").length}),d.getElementsByClassName=K.test(C.getElementsByClassName),d.getById=ce(function(e){return a.appendChild(e).id=S,!C.getElementsByName||!C.getElementsByName(S).length}),d.getById?(b.filter.ID=function(e){var t=e.replace(te,ne);return function(e){return e.getAttribute("id")===t}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n=t.getElementById(e);return n?[n]:[]}}):(b.filter.ID=function(e){var n=e.replace(te,ne);return function(e){var t="undefined"!=typeof e.getAttributeNode&&e.getAttributeNode("id");return t&&t.value===n}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n,r,i,o=t.getElementById(e);if(o){if((n=o.getAttributeNode("id"))&&n.value===e)return[o];i=t.getElementsByName(e),r=0;while(o=i[r++])if((n=o.getAttributeNode("id"))&&n.value===e)return[o]}return[]}}),b.find.TAG=d.getElementsByTagName?function(e,t){return"undefined"!=typeof t.getElementsByTagName?t.getElementsByTagName(e):d.qsa?t.querySelectorAll(e):void 0}:function(e,t){var n,r=[],i=0,o=t.getElementsByTagName(e);if("*"===e){while(n=o[i++])1===n.nodeType&&r.push(n);return r}return o},b.find.CLASS=d.getElementsByClassName&&function(e,t){if("undefined"!=typeof t.getElementsByClassName&&E)return t.getElementsByClassName(e)},s=[],v=[],(d.qsa=K.test(C.querySelectorAll))&&(ce(function(e){var t;a.appendChild(e).innerHTML="<a id='"+S+"'></a><select id='"+S+"-\r\\' msallowcapture=''><option selected=''></option></select>",e.querySelectorAll("[msallowcapture^='']").length&&v.push("[*^$]="+M+"*(?:''|\"\")"),e.querySelectorAll("[selected]").length||v.push("\\["+M+"*(?:value|"+R+")"),e.querySelectorAll("[id~="+S+"-]").length||v.push("~="),(t=C.createElement("input")).setAttribute("name",""),e.appendChild(t),e.querySelectorAll("[name='']").length||v.push("\\["+M+"*name"+M+"*="+M+"*(?:''|\"\")"),e.querySelectorAll(":checked").length||v.push(":checked"),e.querySelectorAll("a#"+S+"+*").length||v.push(".#.+[+~]"),e.querySelectorAll("\\\f"),v.push("[\\r\\n\\f]")}),ce(function(e){e.innerHTML="<a href='' disabled='disabled'></a><select disabled='disabled'><option/></select>";var t=C.createElement("input");t.setAttribute("type","hidden"),e.appendChild(t).setAttribute("name","D"),e.querySelectorAll("[name=d]").length&&v.push("name"+M+"*[*^$|!~]?="),2!==e.querySelectorAll(":enabled").length&&v.push(":enabled",":disabled"),a.appendChild(e).disabled=!0,2!==e.querySelectorAll(":disabled").length&&v.push(":enabled",":disabled"),e.querySelectorAll("*,:x"),v.push(",.*:")})),(d.matchesSelector=K.test(c=a.matches||a.webkitMatchesSelector||a.mozMatchesSelector||a.oMatchesSelector||a.msMatchesSelector))&&ce(function(e){d.disconnectedMatch=c.call(e,"*"),c.call(e,"[s!='']:x"),s.push("!=",F)}),v=v.length&&new RegExp(v.join("|")),s=s.length&&new RegExp(s.join("|")),t=K.test(a.compareDocumentPosition),y=t||K.test(a.contains)?function(e,t){var n=9===e.nodeType?e.documentElement:e,r=t&&t.parentNode;return e===r||!(!r||1!==r.nodeType||!(n.contains?n.contains(r):e.compareDocumentPosition&&16&e.compareDocumentPosition(r)))}:function(e,t){if(t)while(t=t.parentNode)if(t===e)return!0;return!1},j=t?function(e,t){if(e===t)return l=!0,0;var n=!e.compareDocumentPosition-!t.compareDocumentPosition;return n||(1&(n=(e.ownerDocument||e)==(t.ownerDocument||t)?e.compareDocumentPosition(t):1)||!d.sortDetached&&t.compareDocumentPosition(e)===n?e==C||e.ownerDocument==p&&y(p,e)?-1:t==C||t.ownerDocument==p&&y(p,t)?1:u?P(u,e)-P(u,t):0:4&n?-1:1)}:function(e,t){if(e===t)return l=!0,0;var n,r=0,i=e.parentNode,o=t.parentNode,a=[e],s=[t];if(!i||!o)return e==C?-1:t==C?1:i?-1:o?1:u?P(u,e)-P(u,t):0;if(i===o)return pe(e,t);n=e;while(n=n.parentNode)a.unshift(n);n=t;while(n=n.parentNode)s.unshift(n);while(a[r]===s[r])r++;return r?pe(a[r],s[r]):a[r]==p?-1:s[r]==p?1:0}),C},se.matches=function(e,t){return se(e,null,null,t)},se.matchesSelector=function(e,t){if(T(e),d.matchesSelector&&E&&!N[t+" "]&&(!s||!s.test(t))&&(!v||!v.test(t)))try{var n=c.call(e,t);if(n||d.disconnectedMatch||e.document&&11!==e.document.nodeType)return n}catch(e){N(t,!0)}return 0<se(t,C,null,[e]).length},se.contains=function(e,t){return(e.ownerDocument||e)!=C&&T(e),y(e,t)},se.attr=function(e,t){(e.ownerDocument||e)!=C&&T(e);var n=b.attrHandle[t.toLowerCase()],r=n&&D.call(b.attrHandle,t.toLowerCase())?n(e,t,!E):void 0;return void 0!==r?r:d.attributes||!E?e.getAttribute(t):(r=e.getAttributeNode(t))&&r.specified?r.value:null},se.escape=function(e){return(e+"").replace(re,ie)},se.error=function(e){throw new Error("Syntax error, unrecognized expression: "+e)},se.uniqueSort=function(e){var t,n=[],r=0,i=0;if(l=!d.detectDuplicates,u=!d.sortStable&&e.slice(0),e.sort(j),l){while(t=e[i++])t===e[i]&&(r=n.push(i));while(r--)e.splice(n[r],1)}return u=null,e},o=se.getText=function(e){var t,n="",r=0,i=e.nodeType;if(i){if(1===i||9===i||11===i){if("string"==typeof e.textContent)return e.textContent;for(e=e.firstChild;e;e=e.nextSibling)n+=o(e)}else if(3===i||4===i)return e.nodeValue}else while(t=e[r++])n+=o(t);return n},(b=se.selectors={cacheLength:50,createPseudo:le,match:G,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(e){return e[1]=e[1].replace(te,ne),e[3]=(e[3]||e[4]||e[5]||"").replace(te,ne),"~="===e[2]&&(e[3]=" "+e[3]+" "),e.slice(0,4)},CHILD:function(e){return e[1]=e[1].toLowerCase(),"nth"===e[1].slice(0,3)?(e[3]||se.error(e[0]),e[4]=+(e[4]?e[5]+(e[6]||1):2*("even"===e[3]||"odd"===e[3])),e[5]=+(e[7]+e[8]||"odd"===e[3])):e[3]&&se.error(e[0]),e},PSEUDO:function(e){var t,n=!e[6]&&e[2];return G.CHILD.test(e[0])?null:(e[3]?e[2]=e[4]||e[5]||"":n&&X.test(n)&&(t=h(n,!0))&&(t=n.indexOf(")",n.length-t)-n.length)&&(e[0]=e[0].slice(0,t),e[2]=n.slice(0,t)),e.slice(0,3))}},filter:{TAG:function(e){var t=e.replace(te,ne).toLowerCase();return"*"===e?function(){return!0}:function(e){return e.nodeName&&e.nodeName.toLowerCase()===t}},CLASS:function(e){var t=m[e+" "];return t||(t=new RegExp("(^|"+M+")"+e+"("+M+"|$)"))&&m(e,function(e){return t.test("string"==typeof e.className&&e.className||"undefined"!=typeof e.getAttribute&&e.getAttribute("class")||"")})},ATTR:function(n,r,i){return function(e){var t=se.attr(e,n);return null==t?"!="===r:!r||(t+="","="===r?t===i:"!="===r?t!==i:"^="===r?i&&0===t.indexOf(i):"*="===r?i&&-1<t.indexOf(i):"$="===r?i&&t.slice(-i.length)===i:"~="===r?-1<(" "+t.replace(B," ")+" ").indexOf(i):"|="===r&&(t===i||t.slice(0,i.length+1)===i+"-"))}},CHILD:function(h,e,t,g,v){var y="nth"!==h.slice(0,3),m="last"!==h.slice(-4),x="of-type"===e;return 1===g&&0===v?function(e){return!!e.parentNode}:function(e,t,n){var r,i,o,a,s,u,l=y!==m?"nextSibling":"previousSibling",c=e.parentNode,f=x&&e.nodeName.toLowerCase(),p=!n&&!x,d=!1;if(c){if(y){while(l){a=e;while(a=a[l])if(x?a.nodeName.toLowerCase()===f:1===a.nodeType)return!1;u=l="only"===h&&!u&&"nextSibling"}return!0}if(u=[m?c.firstChild:c.lastChild],m&&p){d=(s=(r=(i=(o=(a=c)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1])&&r[2],a=s&&c.childNodes[s];while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if(1===a.nodeType&&++d&&a===e){i[h]=[k,s,d];break}}else if(p&&(d=s=(r=(i=(o=(a=e)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1]),!1===d)while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if((x?a.nodeName.toLowerCase()===f:1===a.nodeType)&&++d&&(p&&((i=(o=a[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]=[k,d]),a===e))break;return(d-=v)===g||d%g==0&&0<=d/g}}},PSEUDO:function(e,o){var t,a=b.pseudos[e]||b.setFilters[e.toLowerCase()]||se.error("unsupported pseudo: "+e);return a[S]?a(o):1<a.length?(t=[e,e,"",o],b.setFilters.hasOwnProperty(e.toLowerCase())?le(function(e,t){var n,r=a(e,o),i=r.length;while(i--)e[n=P(e,r[i])]=!(t[n]=r[i])}):function(e){return a(e,0,t)}):a}},pseudos:{not:le(function(e){var r=[],i=[],s=f(e.replace($,"$1"));return s[S]?le(function(e,t,n,r){var i,o=s(e,null,r,[]),a=e.length;while(a--)(i=o[a])&&(e[a]=!(t[a]=i))}):function(e,t,n){return r[0]=e,s(r,null,n,i),r[0]=null,!i.pop()}}),has:le(function(t){return function(e){return 0<se(t,e).length}}),contains:le(function(t){return t=t.replace(te,ne),function(e){return-1<(e.textContent||o(e)).indexOf(t)}}),lang:le(function(n){return V.test(n||"")||se.error("unsupported lang: "+n),n=n.replace(te,ne).toLowerCase(),function(e){var t;do{if(t=E?e.lang:e.getAttribute("xml:lang")||e.getAttribute("lang"))return(t=t.toLowerCase())===n||0===t.indexOf(n+"-")}while((e=e.parentNode)&&1===e.nodeType);return!1}}),target:function(e){var t=n.location&&n.location.hash;return t&&t.slice(1)===e.id},root:function(e){return e===a},focus:function(e){return e===C.activeElement&&(!C.hasFocus||C.hasFocus())&&!!(e.type||e.href||~e.tabIndex)},enabled:ge(!1),disabled:ge(!0),checked:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&!!e.checked||"option"===t&&!!e.selected},selected:function(e){return e.parentNode&&e.parentNode.selectedIndex,!0===e.selected},empty:function(e){for(e=e.firstChild;e;e=e.nextSibling)if(e.nodeType<6)return!1;return!0},parent:function(e){return!b.pseudos.empty(e)},header:function(e){return J.test(e.nodeName)},input:function(e){return Q.test(e.nodeName)},button:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&"button"===e.type||"button"===t},text:function(e){var t;return"input"===e.nodeName.toLowerCase()&&"text"===e.type&&(null==(t=e.getAttribute("type"))||"text"===t.toLowerCase())},first:ve(function(){return[0]}),last:ve(function(e,t){return[t-1]}),eq:ve(function(e,t,n){return[n<0?n+t:n]}),even:ve(function(e,t){for(var n=0;n<t;n+=2)e.push(n);return e}),odd:ve(function(e,t){for(var n=1;n<t;n+=2)e.push(n);return e}),lt:ve(function(e,t,n){for(var r=n<0?n+t:t<n?t:n;0<=--r;)e.push(r);return e}),gt:ve(function(e,t,n){for(var r=n<0?n+t:n;++r<t;)e.push(r);return e})}}).pseudos.nth=b.pseudos.eq,{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})b.pseudos[e]=de(e);for(e in{submit:!0,reset:!0})b.pseudos[e]=he(e);function me(){}function xe(e){for(var t=0,n=e.length,r="";t<n;t++)r+=e[t].value;return r}function be(s,e,t){var u=e.dir,l=e.next,c=l||u,f=t&&"parentNode"===c,p=r++;return e.first?function(e,t,n){while(e=e[u])if(1===e.nodeType||f)return s(e,t,n);return!1}:function(e,t,n){var r,i,o,a=[k,p];if(n){while(e=e[u])if((1===e.nodeType||f)&&s(e,t,n))return!0}else while(e=e[u])if(1===e.nodeType||f)if(i=(o=e[S]||(e[S]={}))[e.uniqueID]||(o[e.uniqueID]={}),l&&l===e.nodeName.toLowerCase())e=e[u]||e;else{if((r=i[c])&&r[0]===k&&r[1]===p)return a[2]=r[2];if((i[c]=a)[2]=s(e,t,n))return!0}return!1}}function we(i){return 1<i.length?function(e,t,n){var r=i.length;while(r--)if(!i[r](e,t,n))return!1;return!0}:i[0]}function Te(e,t,n,r,i){for(var o,a=[],s=0,u=e.length,l=null!=t;s<u;s++)(o=e[s])&&(n&&!n(o,r,i)||(a.push(o),l&&t.push(s)));return a}function Ce(d,h,g,v,y,e){return v&&!v[S]&&(v=Ce(v)),y&&!y[S]&&(y=Ce(y,e)),le(function(e,t,n,r){var i,o,a,s=[],u=[],l=t.length,c=e||function(e,t,n){for(var r=0,i=t.length;r<i;r++)se(e,t[r],n);return n}(h||"*",n.nodeType?[n]:n,[]),f=!d||!e&&h?c:Te(c,s,d,n,r),p=g?y||(e?d:l||v)?[]:t:f;if(g&&g(f,p,n,r),v){i=Te(p,u),v(i,[],n,r),o=i.length;while(o--)(a=i[o])&&(p[u[o]]=!(f[u[o]]=a))}if(e){if(y||d){if(y){i=[],o=p.length;while(o--)(a=p[o])&&i.push(f[o]=a);y(null,p=[],i,r)}o=p.length;while(o--)(a=p[o])&&-1<(i=y?P(e,a):s[o])&&(e[i]=!(t[i]=a))}}else p=Te(p===t?p.splice(l,p.length):p),y?y(null,t,p,r):H.apply(t,p)})}function Ee(e){for(var i,t,n,r=e.length,o=b.relative[e[0].type],a=o||b.relative[" "],s=o?1:0,u=be(function(e){return e===i},a,!0),l=be(function(e){return-1<P(i,e)},a,!0),c=[function(e,t,n){var r=!o&&(n||t!==w)||((i=t).nodeType?u(e,t,n):l(e,t,n));return i=null,r}];s<r;s++)if(t=b.relative[e[s].type])c=[be(we(c),t)];else{if((t=b.filter[e[s].type].apply(null,e[s].matches))[S]){for(n=++s;n<r;n++)if(b.relative[e[n].type])break;return Ce(1<s&&we(c),1<s&&xe(e.slice(0,s-1).concat({value:" "===e[s-2].type?"*":""})).replace($,"$1"),t,s<n&&Ee(e.slice(s,n)),n<r&&Ee(e=e.slice(n)),n<r&&xe(e))}c.push(t)}return we(c)}return me.prototype=b.filters=b.pseudos,b.setFilters=new me,h=se.tokenize=function(e,t){var n,r,i,o,a,s,u,l=x[e+" "];if(l)return t?0:l.slice(0);a=e,s=[],u=b.preFilter;while(a){for(o in n&&!(r=_.exec(a))||(r&&(a=a.slice(r[0].length)||a),s.push(i=[])),n=!1,(r=z.exec(a))&&(n=r.shift(),i.push({value:n,type:r[0].replace($," ")}),a=a.slice(n.length)),b.filter)!(r=G[o].exec(a))||u[o]&&!(r=u[o](r))||(n=r.shift(),i.push({value:n,type:o,matches:r}),a=a.slice(n.length));if(!n)break}return t?a.length:a?se.error(e):x(e,s).slice(0)},f=se.compile=function(e,t){var n,v,y,m,x,r,i=[],o=[],a=A[e+" "];if(!a){t||(t=h(e)),n=t.length;while(n--)(a=Ee(t[n]))[S]?i.push(a):o.push(a);(a=A(e,(v=o,m=0<(y=i).length,x=0<v.length,r=function(e,t,n,r,i){var o,a,s,u=0,l="0",c=e&&[],f=[],p=w,d=e||x&&b.find.TAG("*",i),h=k+=null==p?1:Math.random()||.1,g=d.length;for(i&&(w=t==C||t||i);l!==g&&null!=(o=d[l]);l++){if(x&&o){a=0,t||o.ownerDocument==C||(T(o),n=!E);while(s=v[a++])if(s(o,t||C,n)){r.push(o);break}i&&(k=h)}m&&((o=!s&&o)&&u--,e&&c.push(o))}if(u+=l,m&&l!==u){a=0;while(s=y[a++])s(c,f,t,n);if(e){if(0<u)while(l--)c[l]||f[l]||(f[l]=q.call(r));f=Te(f)}H.apply(r,f),i&&!e&&0<f.length&&1<u+y.length&&se.uniqueSort(r)}return i&&(k=h,w=p),c},m?le(r):r))).selector=e}return a},g=se.select=function(e,t,n,r){var i,o,a,s,u,l="function"==typeof e&&e,c=!r&&h(e=l.selector||e);if(n=n||[],1===c.length){if(2<(o=c[0]=c[0].slice(0)).length&&"ID"===(a=o[0]).type&&9===t.nodeType&&E&&b.relative[o[1].type]){if(!(t=(b.find.ID(a.matches[0].replace(te,ne),t)||[])[0]))return n;l&&(t=t.parentNode),e=e.slice(o.shift().value.length)}i=G.needsContext.test(e)?0:o.length;while(i--){if(a=o[i],b.relative[s=a.type])break;if((u=b.find[s])&&(r=u(a.matches[0].replace(te,ne),ee.test(o[0].type)&&ye(t.parentNode)||t))){if(o.splice(i,1),!(e=r.length&&xe(o)))return H.apply(n,r),n;break}}}return(l||f(e,c))(r,t,!E,n,!t||ee.test(e)&&ye(t.parentNode)||t),n},d.sortStable=S.split("").sort(j).join("")===S,d.detectDuplicates=!!l,T(),d.sortDetached=ce(function(e){return 1&e.compareDocumentPosition(C.createElement("fieldset"))}),ce(function(e){return e.innerHTML="<a href='#'></a>","#"===e.firstChild.getAttribute("href")})||fe("type|href|height|width",function(e,t,n){if(!n)return e.getAttribute(t,"type"===t.toLowerCase()?1:2)}),d.attributes&&ce(function(e){return e.innerHTML="<input/>",e.firstChild.setAttribute("value",""),""===e.firstChild.getAttribute("value")})||fe("value",function(e,t,n){if(!n&&"input"===e.nodeName.toLowerCase())return e.defaultValue}),ce(function(e){return null==e.getAttribute("disabled")})||fe(R,function(e,t,n){var r;if(!n)return!0===e[t]?t.toLowerCase():(r=e.getAttributeNode(t))&&r.specified?r.value:null}),se}(C);S.find=d,S.expr=d.selectors,S.expr[":"]=S.expr.pseudos,S.uniqueSort=S.unique=d.uniqueSort,S.text=d.getText,S.isXMLDoc=d.isXML,S.contains=d.contains,S.escapeSelector=d.escape;var h=function(e,t,n){var r=[],i=void 0!==n;while((e=e[t])&&9!==e.nodeType)if(1===e.nodeType){if(i&&S(e).is(n))break;r.push(e)}return r},T=function(e,t){for(var n=[];e;e=e.nextSibling)1===e.nodeType&&e!==t&&n.push(e);return n},k=S.expr.match.needsContext;function A(e,t){return e.nodeName&&e.nodeName.toLowerCase()===t.toLowerCase()}var N=/^<([a-z][^\/\0>:\x20\t\r\n\f]*)[\x20\t\r\n\f]*\/?>(?:<\/\1>|)$/i;function j(e,n,r){return m(n)?S.grep(e,function(e,t){return!!n.call(e,t,e)!==r}):n.nodeType?S.grep(e,function(e){return e===n!==r}):"string"!=typeof n?S.grep(e,function(e){return-1<i.call(n,e)!==r}):S.filter(n,e,r)}S.filter=function(e,t,n){var r=t[0];return n&&(e=":not("+e+")"),1===t.length&&1===r.nodeType?S.find.matchesSelector(r,e)?[r]:[]:S.find.matches(e,S.grep(t,function(e){return 1===e.nodeType}))},S.fn.extend({find:function(e){var t,n,r=this.length,i=this;if("string"!=typeof e)return this.pushStack(S(e).filter(function(){for(t=0;t<r;t++)if(S.contains(i[t],this))return!0}));for(n=this.pushStack([]),t=0;t<r;t++)S.find(e,i[t],n);return 1<r?S.uniqueSort(n):n},filter:function(e){return this.pushStack(j(this,e||[],!1))},not:function(e){return this.pushStack(j(this,e||[],!0))},is:function(e){return!!j(this,"string"==typeof e&&k.test(e)?S(e):e||[],!1).length}});var D,q=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]+))$/;(S.fn.init=function(e,t,n){var r,i;if(!e)return this;if(n=n||D,"string"==typeof e){if(!(r="<"===e[0]&&">"===e[e.length-1]&&3<=e.length?[null,e,null]:q.exec(e))||!r[1]&&t)return!t||t.jquery?(t||n).find(e):this.constructor(t).find(e);if(r[1]){if(t=t instanceof S?t[0]:t,S.merge(this,S.parseHTML(r[1],t&&t.nodeType?t.ownerDocument||t:E,!0)),N.test(r[1])&&S.isPlainObject(t))for(r in t)m(this[r])?this[r](t[r]):this.attr(r,t[r]);return this}return(i=E.getElementById(r[2]))&&(this[0]=i,this.length=1),this}return e.nodeType?(this[0]=e,this.length=1,this):m(e)?void 0!==n.ready?n.ready(e):e(S):S.makeArray(e,this)}).prototype=S.fn,D=S(E);var L=/^(?:parents|prev(?:Until|All))/,H={children:!0,contents:!0,next:!0,prev:!0};function O(e,t){while((e=e[t])&&1!==e.nodeType);return e}S.fn.extend({has:function(e){var t=S(e,this),n=t.length;return this.filter(function(){for(var e=0;e<n;e++)if(S.contains(this,t[e]))return!0})},closest:function(e,t){var n,r=0,i=this.length,o=[],a="string"!=typeof e&&S(e);if(!k.test(e))for(;r<i;r++)for(n=this[r];n&&n!==t;n=n.parentNode)if(n.nodeType<11&&(a?-1<a.index(n):1===n.nodeType&&S.find.matchesSelector(n,e))){o.push(n);break}return this.pushStack(1<o.length?S.uniqueSort(o):o)},index:function(e){return e?"string"==typeof e?i.call(S(e),this[0]):i.call(this,e.jquery?e[0]:e):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(e,t){return this.pushStack(S.uniqueSort(S.merge(this.get(),S(e,t))))},addBack:function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}}),S.each({parent:function(e){var t=e.parentNode;return t&&11!==t.nodeType?t:null},parents:function(e){return h(e,"parentNode")},parentsUntil:function(e,t,n){return h(e,"parentNode",n)},next:function(e){return O(e,"nextSibling")},prev:function(e){return O(e,"previousSibling")},nextAll:function(e){return h(e,"nextSibling")},prevAll:function(e){return h(e,"previousSibling")},nextUntil:function(e,t,n){return h(e,"nextSibling",n)},prevUntil:function(e,t,n){return h(e,"previousSibling",n)},siblings:function(e){return T((e.parentNode||{}).firstChild,e)},children:function(e){return T(e.firstChild)},contents:function(e){return null!=e.contentDocument&&r(e.contentDocument)?e.contentDocument:(A(e,"template")&&(e=e.content||e),S.merge([],e.childNodes))}},function(r,i){S.fn[r]=function(e,t){var n=S.map(this,i,e);return"Until"!==r.slice(-5)&&(t=e),t&&"string"==typeof t&&(n=S.filter(t,n)),1<this.length&&(H[r]||S.uniqueSort(n),L.test(r)&&n.reverse()),this.pushStack(n)}});var P=/[^\x20\t\r\n\f]+/g;function R(e){return e}function M(e){throw e}function I(e,t,n,r){var i;try{e&&m(i=e.promise)?i.call(e).done(t).fail(n):e&&m(i=e.then)?i.call(e,t,n):t.apply(void 0,[e].slice(r))}catch(e){n.apply(void 0,[e])}}S.Callbacks=function(r){var e,n;r="string"==typeof r?(e=r,n={},S.each(e.match(P)||[],function(e,t){n[t]=!0}),n):S.extend({},r);var i,t,o,a,s=[],u=[],l=-1,c=function(){for(a=a||r.once,o=i=!0;u.length;l=-1){t=u.shift();while(++l<s.length)!1===s[l].apply(t[0],t[1])&&r.stopOnFalse&&(l=s.length,t=!1)}r.memory||(t=!1),i=!1,a&&(s=t?[]:"")},f={add:function(){return s&&(t&&!i&&(l=s.length-1,u.push(t)),function n(e){S.each(e,function(e,t){m(t)?r.unique&&f.has(t)||s.push(t):t&&t.length&&"string"!==w(t)&&n(t)})}(arguments),t&&!i&&c()),this},remove:function(){return S.each(arguments,function(e,t){var n;while(-1<(n=S.inArray(t,s,n)))s.splice(n,1),n<=l&&l--}),this},has:function(e){return e?-1<S.inArray(e,s):0<s.length},empty:function(){return s&&(s=[]),this},disable:function(){return a=u=[],s=t="",this},disabled:function(){return!s},lock:function(){return a=u=[],t||i||(s=t=""),this},locked:function(){return!!a},fireWith:function(e,t){return a||(t=[e,(t=t||[]).slice?t.slice():t],u.push(t),i||c()),this},fire:function(){return f.fireWith(this,arguments),this},fired:function(){return!!o}};return f},S.extend({Deferred:function(e){var o=[["notify","progress",S.Callbacks("memory"),S.Callbacks("memory"),2],["resolve","done",S.Callbacks("once memory"),S.Callbacks("once memory"),0,"resolved"],["reject","fail",S.Callbacks("once memory"),S.Callbacks("once memory"),1,"rejected"]],i="pending",a={state:function(){return i},always:function(){return s.done(arguments).fail(arguments),this},"catch":function(e){return a.then(null,e)},pipe:function(){var i=arguments;return S.Deferred(function(r){S.each(o,function(e,t){var n=m(i[t[4]])&&i[t[4]];s[t[1]](function(){var e=n&&n.apply(this,arguments);e&&m(e.promise)?e.promise().progress(r.notify).done(r.resolve).fail(r.reject):r[t[0]+"With"](this,n?[e]:arguments)})}),i=null}).promise()},then:function(t,n,r){var u=0;function l(i,o,a,s){return function(){var n=this,r=arguments,e=function(){var e,t;if(!(i<u)){if((e=a.apply(n,r))===o.promise())throw new TypeError("Thenable self-resolution");t=e&&("object"==typeof e||"function"==typeof e)&&e.then,m(t)?s?t.call(e,l(u,o,R,s),l(u,o,M,s)):(u++,t.call(e,l(u,o,R,s),l(u,o,M,s),l(u,o,R,o.notifyWith))):(a!==R&&(n=void 0,r=[e]),(s||o.resolveWith)(n,r))}},t=s?e:function(){try{e()}catch(e){S.Deferred.exceptionHook&&S.Deferred.exceptionHook(e,t.stackTrace),u<=i+1&&(a!==M&&(n=void 0,r=[e]),o.rejectWith(n,r))}};i?t():(S.Deferred.getStackHook&&(t.stackTrace=S.Deferred.getStackHook()),C.setTimeout(t))}}return S.Deferred(function(e){o[0][3].add(l(0,e,m(r)?r:R,e.notifyWith)),o[1][3].add(l(0,e,m(t)?t:R)),o[2][3].add(l(0,e,m(n)?n:M))}).promise()},promise:function(e){return null!=e?S.extend(e,a):a}},s={};return S.each(o,function(e,t){var n=t[2],r=t[5];a[t[1]]=n.add,r&&n.add(function(){i=r},o[3-e][2].disable,o[3-e][3].disable,o[0][2].lock,o[0][3].lock),n.add(t[3].fire),s[t[0]]=function(){return s[t[0]+"With"](this===s?void 0:this,arguments),this},s[t[0]+"With"]=n.fireWith}),a.promise(s),e&&e.call(s,s),s},when:function(e){var n=arguments.length,t=n,r=Array(t),i=s.call(arguments),o=S.Deferred(),a=function(t){return function(e){r[t]=this,i[t]=1<arguments.length?s.call(arguments):e,--n||o.resolveWith(r,i)}};if(n<=1&&(I(e,o.done(a(t)).resolve,o.reject,!n),"pending"===o.state()||m(i[t]&&i[t].then)))return o.then();while(t--)I(i[t],a(t),o.reject);return o.promise()}});var W=/^(Eval|Internal|Range|Reference|Syntax|Type|URI)Error$/;S.Deferred.exceptionHook=function(e,t){C.console&&C.console.warn&&e&&W.test(e.name)&&C.console.warn("jQuery.Deferred exception: "+e.message,e.stack,t)},S.readyException=function(e){C.setTimeout(function(){throw e})};var F=S.Deferred();function B(){E.removeEventListener("DOMContentLoaded",B),C.removeEventListener("load",B),S.ready()}S.fn.ready=function(e){return F.then(e)["catch"](function(e){S.readyException(e)}),this},S.extend({isReady:!1,readyWait:1,ready:function(e){(!0===e?--S.readyWait:S.isReady)||(S.isReady=!0)!==e&&0<--S.readyWait||F.resolveWith(E,[S])}}),S.ready.then=F.then,"complete"===E.readyState||"loading"!==E.readyState&&!E.documentElement.doScroll?C.setTimeout(S.ready):(E.addEventListener("DOMContentLoaded",B),C.addEventListener("load",B));var $=function(e,t,n,r,i,o,a){var s=0,u=e.length,l=null==n;if("object"===w(n))for(s in i=!0,n)$(e,t,s,n[s],!0,o,a);else if(void 0!==r&&(i=!0,m(r)||(a=!0),l&&(a?(t.call(e,r),t=null):(l=t,t=function(e,t,n){return l.call(S(e),n)})),t))for(;s<u;s++)t(e[s],n,a?r:r.call(e[s],s,t(e[s],n)));return i?e:l?t.call(e):u?t(e[0],n):o},_=/^-ms-/,z=/-([a-z])/g;function U(e,t){return t.toUpperCase()}function X(e){return e.replace(_,"ms-").replace(z,U)}var V=function(e){return 1===e.nodeType||9===e.nodeType||!+e.nodeType};function G(){this.expando=S.expando+G.uid++}G.uid=1,G.prototype={cache:function(e){var t=e[this.expando];return t||(t={},V(e)&&(e.nodeType?e[this.expando]=t:Object.defineProperty(e,this.expando,{value:t,configurable:!0}))),t},set:function(e,t,n){var r,i=this.cache(e);if("string"==typeof t)i[X(t)]=n;else for(r in t)i[X(r)]=t[r];return i},get:function(e,t){return void 0===t?this.cache(e):e[this.expando]&&e[this.expando][X(t)]},access:function(e,t,n){return void 0===t||t&&"string"==typeof t&&void 0===n?this.get(e,t):(this.set(e,t,n),void 0!==n?n:t)},remove:function(e,t){var n,r=e[this.expando];if(void 0!==r){if(void 0!==t){n=(t=Array.isArray(t)?t.map(X):(t=X(t))in r?[t]:t.match(P)||[]).length;while(n--)delete r[t[n]]}(void 0===t||S.isEmptyObject(r))&&(e.nodeType?e[this.expando]=void 0:delete e[this.expando])}},hasData:function(e){var t=e[this.expando];return void 0!==t&&!S.isEmptyObject(t)}};var Y=new G,Q=new G,J=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,K=/[A-Z]/g;function Z(e,t,n){var r,i;if(void 0===n&&1===e.nodeType)if(r="data-"+t.replace(K,"-$&").toLowerCase(),"string"==typeof(n=e.getAttribute(r))){try{n="true"===(i=n)||"false"!==i&&("null"===i?null:i===+i+""?+i:J.test(i)?JSON.parse(i):i)}catch(e){}Q.set(e,t,n)}else n=void 0;return n}S.extend({hasData:function(e){return Q.hasData(e)||Y.hasData(e)},data:function(e,t,n){return Q.access(e,t,n)},removeData:function(e,t){Q.remove(e,t)},_data:function(e,t,n){return Y.access(e,t,n)},_removeData:function(e,t){Y.remove(e,t)}}),S.fn.extend({data:function(n,e){var t,r,i,o=this[0],a=o&&o.attributes;if(void 0===n){if(this.length&&(i=Q.get(o),1===o.nodeType&&!Y.get(o,"hasDataAttrs"))){t=a.length;while(t--)a[t]&&0===(r=a[t].name).indexOf("data-")&&(r=X(r.slice(5)),Z(o,r,i[r]));Y.set(o,"hasDataAttrs",!0)}return i}return"object"==typeof n?this.each(function(){Q.set(this,n)}):$(this,function(e){var t;if(o&&void 0===e)return void 0!==(t=Q.get(o,n))?t:void 0!==(t=Z(o,n))?t:void 0;this.each(function(){Q.set(this,n,e)})},null,e,1<arguments.length,null,!0)},removeData:function(e){return this.each(function(){Q.remove(this,e)})}}),S.extend({queue:function(e,t,n){var r;if(e)return t=(t||"fx")+"queue",r=Y.get(e,t),n&&(!r||Array.isArray(n)?r=Y.access(e,t,S.makeArray(n)):r.push(n)),r||[]},dequeue:function(e,t){t=t||"fx";var n=S.queue(e,t),r=n.length,i=n.shift(),o=S._queueHooks(e,t);"inprogress"===i&&(i=n.shift(),r--),i&&("fx"===t&&n.unshift("inprogress"),delete o.stop,i.call(e,function(){S.dequeue(e,t)},o)),!r&&o&&o.empty.fire()},_queueHooks:function(e,t){var n=t+"queueHooks";return Y.get(e,n)||Y.access(e,n,{empty:S.Callbacks("once memory").add(function(){Y.remove(e,[t+"queue",n])})})}}),S.fn.extend({queue:function(t,n){var e=2;return"string"!=typeof t&&(n=t,t="fx",e--),arguments.length<e?S.queue(this[0],t):void 0===n?this:this.each(function(){var e=S.queue(this,t,n);S._queueHooks(this,t),"fx"===t&&"inprogress"!==e[0]&&S.dequeue(this,t)})},dequeue:function(e){return this.each(function(){S.dequeue(this,e)})},clearQueue:function(e){return this.queue(e||"fx",[])},promise:function(e,t){var n,r=1,i=S.Deferred(),o=this,a=this.length,s=function(){--r||i.resolveWith(o,[o])};"string"!=typeof e&&(t=e,e=void 0),e=e||"fx";while(a--)(n=Y.get(o[a],e+"queueHooks"))&&n.empty&&(r++,n.empty.add(s));return s(),i.promise(t)}});var ee=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,te=new RegExp("^(?:([+-])=|)("+ee+")([a-z%]*)$","i"),ne=["Top","Right","Bottom","Left"],re=E.documentElement,ie=function(e){return S.contains(e.ownerDocument,e)},oe={composed:!0};re.getRootNode&&(ie=function(e){return S.contains(e.ownerDocument,e)||e.getRootNode(oe)===e.ownerDocument});var ae=function(e,t){return"none"===(e=t||e).style.display||""===e.style.display&&ie(e)&&"none"===S.css(e,"display")};function se(e,t,n,r){var i,o,a=20,s=r?function(){return r.cur()}:function(){return S.css(e,t,"")},u=s(),l=n&&n[3]||(S.cssNumber[t]?"":"px"),c=e.nodeType&&(S.cssNumber[t]||"px"!==l&&+u)&&te.exec(S.css(e,t));if(c&&c[3]!==l){u/=2,l=l||c[3],c=+u||1;while(a--)S.style(e,t,c+l),(1-o)*(1-(o=s()/u||.5))<=0&&(a=0),c/=o;c*=2,S.style(e,t,c+l),n=n||[]}return n&&(c=+c||+u||0,i=n[1]?c+(n[1]+1)*n[2]:+n[2],r&&(r.unit=l,r.start=c,r.end=i)),i}var ue={};function le(e,t){for(var n,r,i,o,a,s,u,l=[],c=0,f=e.length;c<f;c++)(r=e[c]).style&&(n=r.style.display,t?("none"===n&&(l[c]=Y.get(r,"display")||null,l[c]||(r.style.display="")),""===r.style.display&&ae(r)&&(l[c]=(u=a=o=void 0,a=(i=r).ownerDocument,s=i.nodeName,(u=ue[s])||(o=a.body.appendChild(a.createElement(s)),u=S.css(o,"display"),o.parentNode.removeChild(o),"none"===u&&(u="block"),ue[s]=u)))):"none"!==n&&(l[c]="none",Y.set(r,"display",n)));for(c=0;c<f;c++)null!=l[c]&&(e[c].style.display=l[c]);return e}S.fn.extend({show:function(){return le(this,!0)},hide:function(){return le(this)},toggle:function(e){return"boolean"==typeof e?e?this.show():this.hide():this.each(function(){ae(this)?S(this).show():S(this).hide()})}});var ce,fe,pe=/^(?:checkbox|radio)$/i,de=/<([a-z][^\/\0>\x20\t\r\n\f]*)/i,he=/^$|^module$|\/(?:java|ecma)script/i;ce=E.createDocumentFragment().appendChild(E.createElement("div")),(fe=E.createElement("input")).setAttribute("type","radio"),fe.setAttribute("checked","checked"),fe.setAttribute("name","t"),ce.appendChild(fe),y.checkClone=ce.cloneNode(!0).cloneNode(!0).lastChild.checked,ce.innerHTML="<textarea>x</textarea>",y.noCloneChecked=!!ce.cloneNode(!0).lastChild.defaultValue,ce.innerHTML="<option></option>",y.option=!!ce.lastChild;var ge={thead:[1,"<table>","</table>"],col:[2,"<table><colgroup>","</colgroup></table>"],tr:[2,"<table><tbody>","</tbody></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:[0,"",""]};function ve(e,t){var n;return n="undefined"!=typeof e.getElementsByTagName?e.getElementsByTagName(t||"*"):"undefined"!=typeof e.querySelectorAll?e.querySelectorAll(t||"*"):[],void 0===t||t&&A(e,t)?S.merge([e],n):n}function ye(e,t){for(var n=0,r=e.length;n<r;n++)Y.set(e[n],"globalEval",!t||Y.get(t[n],"globalEval"))}ge.tbody=ge.tfoot=ge.colgroup=ge.caption=ge.thead,ge.th=ge.td,y.option||(ge.optgroup=ge.option=[1,"<select multiple='multiple'>","</select>"]);var me=/<|&#?\w+;/;function xe(e,t,n,r,i){for(var o,a,s,u,l,c,f=t.createDocumentFragment(),p=[],d=0,h=e.length;d<h;d++)if((o=e[d])||0===o)if("object"===w(o))S.merge(p,o.nodeType?[o]:o);else if(me.test(o)){a=a||f.appendChild(t.createElement("div")),s=(de.exec(o)||["",""])[1].toLowerCase(),u=ge[s]||ge._default,a.innerHTML=u[1]+S.htmlPrefilter(o)+u[2],c=u[0];while(c--)a=a.lastChild;S.merge(p,a.childNodes),(a=f.firstChild).textContent=""}else p.push(t.createTextNode(o));f.textContent="",d=0;while(o=p[d++])if(r&&-1<S.inArray(o,r))i&&i.push(o);else if(l=ie(o),a=ve(f.appendChild(o),"script"),l&&ye(a),n){c=0;while(o=a[c++])he.test(o.type||"")&&n.push(o)}return f}var be=/^([^.]*)(?:\.(.+)|)/;function we(){return!0}function Te(){return!1}function Ce(e,t){return e===function(){try{return E.activeElement}catch(e){}}()==("focus"===t)}function Ee(e,t,n,r,i,o){var a,s;if("object"==typeof t){for(s in"string"!=typeof n&&(r=r||n,n=void 0),t)Ee(e,s,n,r,t[s],o);return e}if(null==r&&null==i?(i=n,r=n=void 0):null==i&&("string"==typeof n?(i=r,r=void 0):(i=r,r=n,n=void 0)),!1===i)i=Te;else if(!i)return e;return 1===o&&(a=i,(i=function(e){return S().off(e),a.apply(this,arguments)}).guid=a.guid||(a.guid=S.guid++)),e.each(function(){S.event.add(this,t,i,r,n)})}function Se(e,i,o){o?(Y.set(e,i,!1),S.event.add(e,i,{namespace:!1,handler:function(e){var t,n,r=Y.get(this,i);if(1&e.isTrigger&&this[i]){if(r.length)(S.event.special[i]||{}).delegateType&&e.stopPropagation();else if(r=s.call(arguments),Y.set(this,i,r),t=o(this,i),this[i](),r!==(n=Y.get(this,i))||t?Y.set(this,i,!1):n={},r!==n)return e.stopImmediatePropagation(),e.preventDefault(),n&&n.value}else r.length&&(Y.set(this,i,{value:S.event.trigger(S.extend(r[0],S.Event.prototype),r.slice(1),this)}),e.stopImmediatePropagation())}})):void 0===Y.get(e,i)&&S.event.add(e,i,we)}S.event={global:{},add:function(t,e,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.get(t);if(V(t)){n.handler&&(n=(o=n).handler,i=o.selector),i&&S.find.matchesSelector(re,i),n.guid||(n.guid=S.guid++),(u=v.events)||(u=v.events=Object.create(null)),(a=v.handle)||(a=v.handle=function(e){return"undefined"!=typeof S&&S.event.triggered!==e.type?S.event.dispatch.apply(t,arguments):void 0}),l=(e=(e||"").match(P)||[""]).length;while(l--)d=g=(s=be.exec(e[l])||[])[1],h=(s[2]||"").split(".").sort(),d&&(f=S.event.special[d]||{},d=(i?f.delegateType:f.bindType)||d,f=S.event.special[d]||{},c=S.extend({type:d,origType:g,data:r,handler:n,guid:n.guid,selector:i,needsContext:i&&S.expr.match.needsContext.test(i),namespace:h.join(".")},o),(p=u[d])||((p=u[d]=[]).delegateCount=0,f.setup&&!1!==f.setup.call(t,r,h,a)||t.addEventListener&&t.addEventListener(d,a)),f.add&&(f.add.call(t,c),c.handler.guid||(c.handler.guid=n.guid)),i?p.splice(p.delegateCount++,0,c):p.push(c),S.event.global[d]=!0)}},remove:function(e,t,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.hasData(e)&&Y.get(e);if(v&&(u=v.events)){l=(t=(t||"").match(P)||[""]).length;while(l--)if(d=g=(s=be.exec(t[l])||[])[1],h=(s[2]||"").split(".").sort(),d){f=S.event.special[d]||{},p=u[d=(r?f.delegateType:f.bindType)||d]||[],s=s[2]&&new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"),a=o=p.length;while(o--)c=p[o],!i&&g!==c.origType||n&&n.guid!==c.guid||s&&!s.test(c.namespace)||r&&r!==c.selector&&("**"!==r||!c.selector)||(p.splice(o,1),c.selector&&p.delegateCount--,f.remove&&f.remove.call(e,c));a&&!p.length&&(f.teardown&&!1!==f.teardown.call(e,h,v.handle)||S.removeEvent(e,d,v.handle),delete u[d])}else for(d in u)S.event.remove(e,d+t[l],n,r,!0);S.isEmptyObject(u)&&Y.remove(e,"handle events")}},dispatch:function(e){var t,n,r,i,o,a,s=new Array(arguments.length),u=S.event.fix(e),l=(Y.get(this,"events")||Object.create(null))[u.type]||[],c=S.event.special[u.type]||{};for(s[0]=u,t=1;t<arguments.length;t++)s[t]=arguments[t];if(u.delegateTarget=this,!c.preDispatch||!1!==c.preDispatch.call(this,u)){a=S.event.handlers.call(this,u,l),t=0;while((i=a[t++])&&!u.isPropagationStopped()){u.currentTarget=i.elem,n=0;while((o=i.handlers[n++])&&!u.isImmediatePropagationStopped())u.rnamespace&&!1!==o.namespace&&!u.rnamespace.test(o.namespace)||(u.handleObj=o,u.data=o.data,void 0!==(r=((S.event.special[o.origType]||{}).handle||o.handler).apply(i.elem,s))&&!1===(u.result=r)&&(u.preventDefault(),u.stopPropagation()))}return c.postDispatch&&c.postDispatch.call(this,u),u.result}},handlers:function(e,t){var n,r,i,o,a,s=[],u=t.delegateCount,l=e.target;if(u&&l.nodeType&&!("click"===e.type&&1<=e.button))for(;l!==this;l=l.parentNode||this)if(1===l.nodeType&&("click"!==e.type||!0!==l.disabled)){for(o=[],a={},n=0;n<u;n++)void 0===a[i=(r=t[n]).selector+" "]&&(a[i]=r.needsContext?-1<S(i,this).index(l):S.find(i,this,null,[l]).length),a[i]&&o.push(r);o.length&&s.push({elem:l,handlers:o})}return l=this,u<t.length&&s.push({elem:l,handlers:t.slice(u)}),s},addProp:function(t,e){Object.defineProperty(S.Event.prototype,t,{enumerable:!0,configurable:!0,get:m(e)?function(){if(this.originalEvent)return e(this.originalEvent)}:function(){if(this.originalEvent)return this.originalEvent[t]},set:function(e){Object.defineProperty(this,t,{enumerable:!0,configurable:!0,writable:!0,value:e})}})},fix:function(e){return e[S.expando]?e:new S.Event(e)},special:{load:{noBubble:!0},click:{setup:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click",we),!1},trigger:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click"),!0},_default:function(e){var t=e.target;return pe.test(t.type)&&t.click&&A(t,"input")&&Y.get(t,"click")||A(t,"a")}},beforeunload:{postDispatch:function(e){void 0!==e.result&&e.originalEvent&&(e.originalEvent.returnValue=e.result)}}}},S.removeEvent=function(e,t,n){e.removeEventListener&&e.removeEventListener(t,n)},S.Event=function(e,t){if(!(this instanceof S.Event))return new S.Event(e,t);e&&e.type?(this.originalEvent=e,this.type=e.type,this.isDefaultPrevented=e.defaultPrevented||void 0===e.defaultPrevented&&!1===e.returnValue?we:Te,this.target=e.target&&3===e.target.nodeType?e.target.parentNode:e.target,this.currentTarget=e.currentTarget,this.relatedTarget=e.relatedTarget):this.type=e,t&&S.extend(this,t),this.timeStamp=e&&e.timeStamp||Date.now(),this[S.expando]=!0},S.Event.prototype={constructor:S.Event,isDefaultPrevented:Te,isPropagationStopped:Te,isImmediatePropagationStopped:Te,isSimulated:!1,preventDefault:function(){var e=this.originalEvent;this.isDefaultPrevented=we,e&&!this.isSimulated&&e.preventDefault()},stopPropagation:function(){var e=this.originalEvent;this.isPropagationStopped=we,e&&!this.isSimulated&&e.stopPropagation()},stopImmediatePropagation:function(){var e=this.originalEvent;this.isImmediatePropagationStopped=we,e&&!this.isSimulated&&e.stopImmediatePropagation(),this.stopPropagation()}},S.each({altKey:!0,bubbles:!0,cancelable:!0,changedTouches:!0,ctrlKey:!0,detail:!0,eventPhase:!0,metaKey:!0,pageX:!0,pageY:!0,shiftKey:!0,view:!0,"char":!0,code:!0,charCode:!0,key:!0,keyCode:!0,button:!0,buttons:!0,clientX:!0,clientY:!0,offsetX:!0,offsetY:!0,pointerId:!0,pointerType:!0,screenX:!0,screenY:!0,targetTouches:!0,toElement:!0,touches:!0,which:!0},S.event.addProp),S.each({focus:"focusin",blur:"focusout"},function(e,t){S.event.special[e]={setup:function(){return Se(this,e,Ce),!1},trigger:function(){return Se(this,e),!0},_default:function(){return!0},delegateType:t}}),S.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(e,i){S.event.special[e]={delegateType:i,bindType:i,handle:function(e){var t,n=e.relatedTarget,r=e.handleObj;return n&&(n===this||S.contains(this,n))||(e.type=r.origType,t=r.handler.apply(this,arguments),e.type=i),t}}}),S.fn.extend({on:function(e,t,n,r){return Ee(this,e,t,n,r)},one:function(e,t,n,r){return Ee(this,e,t,n,r,1)},off:function(e,t,n){var r,i;if(e&&e.preventDefault&&e.handleObj)return r=e.handleObj,S(e.delegateTarget).off(r.namespace?r.origType+"."+r.namespace:r.origType,r.selector,r.handler),this;if("object"==typeof e){for(i in e)this.off(i,t,e[i]);return this}return!1!==t&&"function"!=typeof t||(n=t,t=void 0),!1===n&&(n=Te),this.each(function(){S.event.remove(this,e,n,t)})}});var ke=/<script|<style|<link/i,Ae=/checked\s*(?:[^=]|=\s*.checked.)/i,Ne=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g;function je(e,t){return A(e,"table")&&A(11!==t.nodeType?t:t.firstChild,"tr")&&S(e).children("tbody")[0]||e}function De(e){return e.type=(null!==e.getAttribute("type"))+"/"+e.type,e}function qe(e){return"true/"===(e.type||"").slice(0,5)?e.type=e.type.slice(5):e.removeAttribute("type"),e}function Le(e,t){var n,r,i,o,a,s;if(1===t.nodeType){if(Y.hasData(e)&&(s=Y.get(e).events))for(i in Y.remove(t,"handle events"),s)for(n=0,r=s[i].length;n<r;n++)S.event.add(t,i,s[i][n]);Q.hasData(e)&&(o=Q.access(e),a=S.extend({},o),Q.set(t,a))}}function He(n,r,i,o){r=g(r);var e,t,a,s,u,l,c=0,f=n.length,p=f-1,d=r[0],h=m(d);if(h||1<f&&"string"==typeof d&&!y.checkClone&&Ae.test(d))return n.each(function(e){var t=n.eq(e);h&&(r[0]=d.call(this,e,t.html())),He(t,r,i,o)});if(f&&(t=(e=xe(r,n[0].ownerDocument,!1,n,o)).firstChild,1===e.childNodes.length&&(e=t),t||o)){for(s=(a=S.map(ve(e,"script"),De)).length;c<f;c++)u=e,c!==p&&(u=S.clone(u,!0,!0),s&&S.merge(a,ve(u,"script"))),i.call(n[c],u,c);if(s)for(l=a[a.length-1].ownerDocument,S.map(a,qe),c=0;c<s;c++)u=a[c],he.test(u.type||"")&&!Y.access(u,"globalEval")&&S.contains(l,u)&&(u.src&&"module"!==(u.type||"").toLowerCase()?S._evalUrl&&!u.noModule&&S._evalUrl(u.src,{nonce:u.nonce||u.getAttribute("nonce")},l):b(u.textContent.replace(Ne,""),u,l))}return n}function Oe(e,t,n){for(var r,i=t?S.filter(t,e):e,o=0;null!=(r=i[o]);o++)n||1!==r.nodeType||S.cleanData(ve(r)),r.parentNode&&(n&&ie(r)&&ye(ve(r,"script")),r.parentNode.removeChild(r));return e}S.extend({htmlPrefilter:function(e){return e},clone:function(e,t,n){var r,i,o,a,s,u,l,c=e.cloneNode(!0),f=ie(e);if(!(y.noCloneChecked||1!==e.nodeType&&11!==e.nodeType||S.isXMLDoc(e)))for(a=ve(c),r=0,i=(o=ve(e)).length;r<i;r++)s=o[r],u=a[r],void 0,"input"===(l=u.nodeName.toLowerCase())&&pe.test(s.type)?u.checked=s.checked:"input"!==l&&"textarea"!==l||(u.defaultValue=s.defaultValue);if(t)if(n)for(o=o||ve(e),a=a||ve(c),r=0,i=o.length;r<i;r++)Le(o[r],a[r]);else Le(e,c);return 0<(a=ve(c,"script")).length&&ye(a,!f&&ve(e,"script")),c},cleanData:function(e){for(var t,n,r,i=S.event.special,o=0;void 0!==(n=e[o]);o++)if(V(n)){if(t=n[Y.expando]){if(t.events)for(r in t.events)i[r]?S.event.remove(n,r):S.removeEvent(n,r,t.handle);n[Y.expando]=void 0}n[Q.expando]&&(n[Q.expando]=void 0)}}}),S.fn.extend({detach:function(e){return Oe(this,e,!0)},remove:function(e){return Oe(this,e)},text:function(e){return $(this,function(e){return void 0===e?S.text(this):this.empty().each(function(){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||(this.textContent=e)})},null,e,arguments.length)},append:function(){return He(this,arguments,function(e){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||je(this,e).appendChild(e)})},prepend:function(){return He(this,arguments,function(e){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var t=je(this,e);t.insertBefore(e,t.firstChild)}})},before:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this)})},after:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this.nextSibling)})},empty:function(){for(var e,t=0;null!=(e=this[t]);t++)1===e.nodeType&&(S.cleanData(ve(e,!1)),e.textContent="");return this},clone:function(e,t){return e=null!=e&&e,t=null==t?e:t,this.map(function(){return S.clone(this,e,t)})},html:function(e){return $(this,function(e){var t=this[0]||{},n=0,r=this.length;if(void 0===e&&1===t.nodeType)return t.innerHTML;if("string"==typeof e&&!ke.test(e)&&!ge[(de.exec(e)||["",""])[1].toLowerCase()]){e=S.htmlPrefilter(e);try{for(;n<r;n++)1===(t=this[n]||{}).nodeType&&(S.cleanData(ve(t,!1)),t.innerHTML=e);t=0}catch(e){}}t&&this.empty().append(e)},null,e,arguments.length)},replaceWith:function(){var n=[];return He(this,arguments,function(e){var t=this.parentNode;S.inArray(this,n)<0&&(S.cleanData(ve(this)),t&&t.replaceChild(e,this))},n)}}),S.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(e,a){S.fn[e]=function(e){for(var t,n=[],r=S(e),i=r.length-1,o=0;o<=i;o++)t=o===i?this:this.clone(!0),S(r[o])[a](t),u.apply(n,t.get());return this.pushStack(n)}});var Pe=new RegExp("^("+ee+")(?!px)[a-z%]+$","i"),Re=function(e){var t=e.ownerDocument.defaultView;return t&&t.opener||(t=C),t.getComputedStyle(e)},Me=function(e,t,n){var r,i,o={};for(i in t)o[i]=e.style[i],e.style[i]=t[i];for(i in r=n.call(e),t)e.style[i]=o[i];return r},Ie=new RegExp(ne.join("|"),"i");function We(e,t,n){var r,i,o,a,s=e.style;return(n=n||Re(e))&&(""!==(a=n.getPropertyValue(t)||n[t])||ie(e)||(a=S.style(e,t)),!y.pixelBoxStyles()&&Pe.test(a)&&Ie.test(t)&&(r=s.width,i=s.minWidth,o=s.maxWidth,s.minWidth=s.maxWidth=s.width=a,a=n.width,s.width=r,s.minWidth=i,s.maxWidth=o)),void 0!==a?a+"":a}function Fe(e,t){return{get:function(){if(!e())return(this.get=t).apply(this,arguments);delete this.get}}}!function(){function e(){if(l){u.style.cssText="position:absolute;left:-11111px;width:60px;margin-top:1px;padding:0;border:0",l.style.cssText="position:relative;display:block;box-sizing:border-box;overflow:scroll;margin:auto;border:1px;padding:1px;width:60%;top:1%",re.appendChild(u).appendChild(l);var e=C.getComputedStyle(l);n="1%"!==e.top,s=12===t(e.marginLeft),l.style.right="60%",o=36===t(e.right),r=36===t(e.width),l.style.position="absolute",i=12===t(l.offsetWidth/3),re.removeChild(u),l=null}}function t(e){return Math.round(parseFloat(e))}var n,r,i,o,a,s,u=E.createElement("div"),l=E.createElement("div");l.style&&(l.style.backgroundClip="content-box",l.cloneNode(!0).style.backgroundClip="",y.clearCloneStyle="content-box"===l.style.backgroundClip,S.extend(y,{boxSizingReliable:function(){return e(),r},pixelBoxStyles:function(){return e(),o},pixelPosition:function(){return e(),n},reliableMarginLeft:function(){return e(),s},scrollboxSize:function(){return e(),i},reliableTrDimensions:function(){var e,t,n,r;return null==a&&(e=E.createElement("table"),t=E.createElement("tr"),n=E.createElement("div"),e.style.cssText="position:absolute;left:-11111px;border-collapse:separate",t.style.cssText="border:1px solid",t.style.height="1px",n.style.height="9px",n.style.display="block",re.appendChild(e).appendChild(t).appendChild(n),r=C.getComputedStyle(t),a=parseInt(r.height,10)+parseInt(r.borderTopWidth,10)+parseInt(r.borderBottomWidth,10)===t.offsetHeight,re.removeChild(e)),a}}))}();var Be=["Webkit","Moz","ms"],$e=E.createElement("div").style,_e={};function ze(e){var t=S.cssProps[e]||_e[e];return t||(e in $e?e:_e[e]=function(e){var t=e[0].toUpperCase()+e.slice(1),n=Be.length;while(n--)if((e=Be[n]+t)in $e)return e}(e)||e)}var Ue=/^(none|table(?!-c[ea]).+)/,Xe=/^--/,Ve={position:"absolute",visibility:"hidden",display:"block"},Ge={letterSpacing:"0",fontWeight:"400"};function Ye(e,t,n){var r=te.exec(t);return r?Math.max(0,r[2]-(n||0))+(r[3]||"px"):t}function Qe(e,t,n,r,i,o){var a="width"===t?1:0,s=0,u=0;if(n===(r?"border":"content"))return 0;for(;a<4;a+=2)"margin"===n&&(u+=S.css(e,n+ne[a],!0,i)),r?("content"===n&&(u-=S.css(e,"padding"+ne[a],!0,i)),"margin"!==n&&(u-=S.css(e,"border"+ne[a]+"Width",!0,i))):(u+=S.css(e,"padding"+ne[a],!0,i),"padding"!==n?u+=S.css(e,"border"+ne[a]+"Width",!0,i):s+=S.css(e,"border"+ne[a]+"Width",!0,i));return!r&&0<=o&&(u+=Math.max(0,Math.ceil(e["offset"+t[0].toUpperCase()+t.slice(1)]-o-u-s-.5))||0),u}function Je(e,t,n){var r=Re(e),i=(!y.boxSizingReliable()||n)&&"border-box"===S.css(e,"boxSizing",!1,r),o=i,a=We(e,t,r),s="offset"+t[0].toUpperCase()+t.slice(1);if(Pe.test(a)){if(!n)return a;a="auto"}return(!y.boxSizingReliable()&&i||!y.reliableTrDimensions()&&A(e,"tr")||"auto"===a||!parseFloat(a)&&"inline"===S.css(e,"display",!1,r))&&e.getClientRects().length&&(i="border-box"===S.css(e,"boxSizing",!1,r),(o=s in e)&&(a=e[s])),(a=parseFloat(a)||0)+Qe(e,t,n||(i?"border":"content"),o,r,a)+"px"}function Ke(e,t,n,r,i){return new Ke.prototype.init(e,t,n,r,i)}S.extend({cssHooks:{opacity:{get:function(e,t){if(t){var n=We(e,"opacity");return""===n?"1":n}}}},cssNumber:{animationIterationCount:!0,columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,gridArea:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnStart:!0,gridRow:!0,gridRowEnd:!0,gridRowStart:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{},style:function(e,t,n,r){if(e&&3!==e.nodeType&&8!==e.nodeType&&e.style){var i,o,a,s=X(t),u=Xe.test(t),l=e.style;if(u||(t=ze(s)),a=S.cssHooks[t]||S.cssHooks[s],void 0===n)return a&&"get"in a&&void 0!==(i=a.get(e,!1,r))?i:l[t];"string"===(o=typeof n)&&(i=te.exec(n))&&i[1]&&(n=se(e,t,i),o="number"),null!=n&&n==n&&("number"!==o||u||(n+=i&&i[3]||(S.cssNumber[s]?"":"px")),y.clearCloneStyle||""!==n||0!==t.indexOf("background")||(l[t]="inherit"),a&&"set"in a&&void 0===(n=a.set(e,n,r))||(u?l.setProperty(t,n):l[t]=n))}},css:function(e,t,n,r){var i,o,a,s=X(t);return Xe.test(t)||(t=ze(s)),(a=S.cssHooks[t]||S.cssHooks[s])&&"get"in a&&(i=a.get(e,!0,n)),void 0===i&&(i=We(e,t,r)),"normal"===i&&t in Ge&&(i=Ge[t]),""===n||n?(o=parseFloat(i),!0===n||isFinite(o)?o||0:i):i}}),S.each(["height","width"],function(e,u){S.cssHooks[u]={get:function(e,t,n){if(t)return!Ue.test(S.css(e,"display"))||e.getClientRects().length&&e.getBoundingClientRect().width?Je(e,u,n):Me(e,Ve,function(){return Je(e,u,n)})},set:function(e,t,n){var r,i=Re(e),o=!y.scrollboxSize()&&"absolute"===i.position,a=(o||n)&&"border-box"===S.css(e,"boxSizing",!1,i),s=n?Qe(e,u,n,a,i):0;return a&&o&&(s-=Math.ceil(e["offset"+u[0].toUpperCase()+u.slice(1)]-parseFloat(i[u])-Qe(e,u,"border",!1,i)-.5)),s&&(r=te.exec(t))&&"px"!==(r[3]||"px")&&(e.style[u]=t,t=S.css(e,u)),Ye(0,t,s)}}}),S.cssHooks.marginLeft=Fe(y.reliableMarginLeft,function(e,t){if(t)return(parseFloat(We(e,"marginLeft"))||e.getBoundingClientRect().left-Me(e,{marginLeft:0},function(){return e.getBoundingClientRect().left}))+"px"}),S.each({margin:"",padding:"",border:"Width"},function(i,o){S.cssHooks[i+o]={expand:function(e){for(var t=0,n={},r="string"==typeof e?e.split(" "):[e];t<4;t++)n[i+ne[t]+o]=r[t]||r[t-2]||r[0];return n}},"margin"!==i&&(S.cssHooks[i+o].set=Ye)}),S.fn.extend({css:function(e,t){return $(this,function(e,t,n){var r,i,o={},a=0;if(Array.isArray(t)){for(r=Re(e),i=t.length;a<i;a++)o[t[a]]=S.css(e,t[a],!1,r);return o}return void 0!==n?S.style(e,t,n):S.css(e,t)},e,t,1<arguments.length)}}),((S.Tween=Ke).prototype={constructor:Ke,init:function(e,t,n,r,i,o){this.elem=e,this.prop=n,this.easing=i||S.easing._default,this.options=t,this.start=this.now=this.cur(),this.end=r,this.unit=o||(S.cssNumber[n]?"":"px")},cur:function(){var e=Ke.propHooks[this.prop];return e&&e.get?e.get(this):Ke.propHooks._default.get(this)},run:function(e){var t,n=Ke.propHooks[this.prop];return this.options.duration?this.pos=t=S.easing[this.easing](e,this.options.duration*e,0,1,this.options.duration):this.pos=t=e,this.now=(this.end-this.start)*t+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),n&&n.set?n.set(this):Ke.propHooks._default.set(this),this}}).init.prototype=Ke.prototype,(Ke.propHooks={_default:{get:function(e){var t;return 1!==e.elem.nodeType||null!=e.elem[e.prop]&&null==e.elem.style[e.prop]?e.elem[e.prop]:(t=S.css(e.elem,e.prop,""))&&"auto"!==t?t:0},set:function(e){S.fx.step[e.prop]?S.fx.step[e.prop](e):1!==e.elem.nodeType||!S.cssHooks[e.prop]&&null==e.elem.style[ze(e.prop)]?e.elem[e.prop]=e.now:S.style(e.elem,e.prop,e.now+e.unit)}}}).scrollTop=Ke.propHooks.scrollLeft={set:function(e){e.elem.nodeType&&e.elem.parentNode&&(e.elem[e.prop]=e.now)}},S.easing={linear:function(e){return e},swing:function(e){return.5-Math.cos(e*Math.PI)/2},_default:"swing"},S.fx=Ke.prototype.init,S.fx.step={};var Ze,et,tt,nt,rt=/^(?:toggle|show|hide)$/,it=/queueHooks$/;function ot(){et&&(!1===E.hidden&&C.requestAnimationFrame?C.requestAnimationFrame(ot):C.setTimeout(ot,S.fx.interval),S.fx.tick())}function at(){return C.setTimeout(function(){Ze=void 0}),Ze=Date.now()}function st(e,t){var n,r=0,i={height:e};for(t=t?1:0;r<4;r+=2-t)i["margin"+(n=ne[r])]=i["padding"+n]=e;return t&&(i.opacity=i.width=e),i}function ut(e,t,n){for(var r,i=(lt.tweeners[t]||[]).concat(lt.tweeners["*"]),o=0,a=i.length;o<a;o++)if(r=i[o].call(n,t,e))return r}function lt(o,e,t){var n,a,r=0,i=lt.prefilters.length,s=S.Deferred().always(function(){delete u.elem}),u=function(){if(a)return!1;for(var e=Ze||at(),t=Math.max(0,l.startTime+l.duration-e),n=1-(t/l.duration||0),r=0,i=l.tweens.length;r<i;r++)l.tweens[r].run(n);return s.notifyWith(o,[l,n,t]),n<1&&i?t:(i||s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l]),!1)},l=s.promise({elem:o,props:S.extend({},e),opts:S.extend(!0,{specialEasing:{},easing:S.easing._default},t),originalProperties:e,originalOptions:t,startTime:Ze||at(),duration:t.duration,tweens:[],createTween:function(e,t){var n=S.Tween(o,l.opts,e,t,l.opts.specialEasing[e]||l.opts.easing);return l.tweens.push(n),n},stop:function(e){var t=0,n=e?l.tweens.length:0;if(a)return this;for(a=!0;t<n;t++)l.tweens[t].run(1);return e?(s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l,e])):s.rejectWith(o,[l,e]),this}}),c=l.props;for(!function(e,t){var n,r,i,o,a;for(n in e)if(i=t[r=X(n)],o=e[n],Array.isArray(o)&&(i=o[1],o=e[n]=o[0]),n!==r&&(e[r]=o,delete e[n]),(a=S.cssHooks[r])&&"expand"in a)for(n in o=a.expand(o),delete e[r],o)n in e||(e[n]=o[n],t[n]=i);else t[r]=i}(c,l.opts.specialEasing);r<i;r++)if(n=lt.prefilters[r].call(l,o,c,l.opts))return m(n.stop)&&(S._queueHooks(l.elem,l.opts.queue).stop=n.stop.bind(n)),n;return S.map(c,ut,l),m(l.opts.start)&&l.opts.start.call(o,l),l.progress(l.opts.progress).done(l.opts.done,l.opts.complete).fail(l.opts.fail).always(l.opts.always),S.fx.timer(S.extend(u,{elem:o,anim:l,queue:l.opts.queue})),l}S.Animation=S.extend(lt,{tweeners:{"*":[function(e,t){var n=this.createTween(e,t);return se(n.elem,e,te.exec(t),n),n}]},tweener:function(e,t){m(e)?(t=e,e=["*"]):e=e.match(P);for(var n,r=0,i=e.length;r<i;r++)n=e[r],lt.tweeners[n]=lt.tweeners[n]||[],lt.tweeners[n].unshift(t)},prefilters:[function(e,t,n){var r,i,o,a,s,u,l,c,f="width"in t||"height"in t,p=this,d={},h=e.style,g=e.nodeType&&ae(e),v=Y.get(e,"fxshow");for(r in n.queue||(null==(a=S._queueHooks(e,"fx")).unqueued&&(a.unqueued=0,s=a.empty.fire,a.empty.fire=function(){a.unqueued||s()}),a.unqueued++,p.always(function(){p.always(function(){a.unqueued--,S.queue(e,"fx").length||a.empty.fire()})})),t)if(i=t[r],rt.test(i)){if(delete t[r],o=o||"toggle"===i,i===(g?"hide":"show")){if("show"!==i||!v||void 0===v[r])continue;g=!0}d[r]=v&&v[r]||S.style(e,r)}if((u=!S.isEmptyObject(t))||!S.isEmptyObject(d))for(r in f&&1===e.nodeType&&(n.overflow=[h.overflow,h.overflowX,h.overflowY],null==(l=v&&v.display)&&(l=Y.get(e,"display")),"none"===(c=S.css(e,"display"))&&(l?c=l:(le([e],!0),l=e.style.display||l,c=S.css(e,"display"),le([e]))),("inline"===c||"inline-block"===c&&null!=l)&&"none"===S.css(e,"float")&&(u||(p.done(function(){h.display=l}),null==l&&(c=h.display,l="none"===c?"":c)),h.display="inline-block")),n.overflow&&(h.overflow="hidden",p.always(function(){h.overflow=n.overflow[0],h.overflowX=n.overflow[1],h.overflowY=n.overflow[2]})),u=!1,d)u||(v?"hidden"in v&&(g=v.hidden):v=Y.access(e,"fxshow",{display:l}),o&&(v.hidden=!g),g&&le([e],!0),p.done(function(){for(r in g||le([e]),Y.remove(e,"fxshow"),d)S.style(e,r,d[r])})),u=ut(g?v[r]:0,r,p),r in v||(v[r]=u.start,g&&(u.end=u.start,u.start=0))}],prefilter:function(e,t){t?lt.prefilters.unshift(e):lt.prefilters.push(e)}}),S.speed=function(e,t,n){var r=e&&"object"==typeof e?S.extend({},e):{complete:n||!n&&t||m(e)&&e,duration:e,easing:n&&t||t&&!m(t)&&t};return S.fx.off?r.duration=0:"number"!=typeof r.duration&&(r.duration in S.fx.speeds?r.duration=S.fx.speeds[r.duration]:r.duration=S.fx.speeds._default),null!=r.queue&&!0!==r.queue||(r.queue="fx"),r.old=r.complete,r.complete=function(){m(r.old)&&r.old.call(this),r.queue&&S.dequeue(this,r.queue)},r},S.fn.extend({fadeTo:function(e,t,n,r){return this.filter(ae).css("opacity",0).show().end().animate({opacity:t},e,n,r)},animate:function(t,e,n,r){var i=S.isEmptyObject(t),o=S.speed(e,n,r),a=function(){var e=lt(this,S.extend({},t),o);(i||Y.get(this,"finish"))&&e.stop(!0)};return a.finish=a,i||!1===o.queue?this.each(a):this.queue(o.queue,a)},stop:function(i,e,o){var a=function(e){var t=e.stop;delete e.stop,t(o)};return"string"!=typeof i&&(o=e,e=i,i=void 0),e&&this.queue(i||"fx",[]),this.each(function(){var e=!0,t=null!=i&&i+"queueHooks",n=S.timers,r=Y.get(this);if(t)r[t]&&r[t].stop&&a(r[t]);else for(t in r)r[t]&&r[t].stop&&it.test(t)&&a(r[t]);for(t=n.length;t--;)n[t].elem!==this||null!=i&&n[t].queue!==i||(n[t].anim.stop(o),e=!1,n.splice(t,1));!e&&o||S.dequeue(this,i)})},finish:function(a){return!1!==a&&(a=a||"fx"),this.each(function(){var e,t=Y.get(this),n=t[a+"queue"],r=t[a+"queueHooks"],i=S.timers,o=n?n.length:0;for(t.finish=!0,S.queue(this,a,[]),r&&r.stop&&r.stop.call(this,!0),e=i.length;e--;)i[e].elem===this&&i[e].queue===a&&(i[e].anim.stop(!0),i.splice(e,1));for(e=0;e<o;e++)n[e]&&n[e].finish&&n[e].finish.call(this);delete t.finish})}}),S.each(["toggle","show","hide"],function(e,r){var i=S.fn[r];S.fn[r]=function(e,t,n){return null==e||"boolean"==typeof e?i.apply(this,arguments):this.animate(st(r,!0),e,t,n)}}),S.each({slideDown:st("show"),slideUp:st("hide"),slideToggle:st("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(e,r){S.fn[e]=function(e,t,n){return this.animate(r,e,t,n)}}),S.timers=[],S.fx.tick=function(){var e,t=0,n=S.timers;for(Ze=Date.now();t<n.length;t++)(e=n[t])()||n[t]!==e||n.splice(t--,1);n.length||S.fx.stop(),Ze=void 0},S.fx.timer=function(e){S.timers.push(e),S.fx.start()},S.fx.interval=13,S.fx.start=function(){et||(et=!0,ot())},S.fx.stop=function(){et=null},S.fx.speeds={slow:600,fast:200,_default:400},S.fn.delay=function(r,e){return r=S.fx&&S.fx.speeds[r]||r,e=e||"fx",this.queue(e,function(e,t){var n=C.setTimeout(e,r);t.stop=function(){C.clearTimeout(n)}})},tt=E.createElement("input"),nt=E.createElement("select").appendChild(E.createElement("option")),tt.type="checkbox",y.checkOn=""!==tt.value,y.optSelected=nt.selected,(tt=E.createElement("input")).value="t",tt.type="radio",y.radioValue="t"===tt.value;var ct,ft=S.expr.attrHandle;S.fn.extend({attr:function(e,t){return $(this,S.attr,e,t,1<arguments.length)},removeAttr:function(e){return this.each(function(){S.removeAttr(this,e)})}}),S.extend({attr:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return"undefined"==typeof e.getAttribute?S.prop(e,t,n):(1===o&&S.isXMLDoc(e)||(i=S.attrHooks[t.toLowerCase()]||(S.expr.match.bool.test(t)?ct:void 0)),void 0!==n?null===n?void S.removeAttr(e,t):i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:(e.setAttribute(t,n+""),n):i&&"get"in i&&null!==(r=i.get(e,t))?r:null==(r=S.find.attr(e,t))?void 0:r)},attrHooks:{type:{set:function(e,t){if(!y.radioValue&&"radio"===t&&A(e,"input")){var n=e.value;return e.setAttribute("type",t),n&&(e.value=n),t}}}},removeAttr:function(e,t){var n,r=0,i=t&&t.match(P);if(i&&1===e.nodeType)while(n=i[r++])e.removeAttribute(n)}}),ct={set:function(e,t,n){return!1===t?S.removeAttr(e,n):e.setAttribute(n,n),n}},S.each(S.expr.match.bool.source.match(/\w+/g),function(e,t){var a=ft[t]||S.find.attr;ft[t]=function(e,t,n){var r,i,o=t.toLowerCase();return n||(i=ft[o],ft[o]=r,r=null!=a(e,t,n)?o:null,ft[o]=i),r}});var pt=/^(?:input|select|textarea|button)$/i,dt=/^(?:a|area)$/i;function ht(e){return(e.match(P)||[]).join(" ")}function gt(e){return e.getAttribute&&e.getAttribute("class")||""}function vt(e){return Array.isArray(e)?e:"string"==typeof e&&e.match(P)||[]}S.fn.extend({prop:function(e,t){return $(this,S.prop,e,t,1<arguments.length)},removeProp:function(e){return this.each(function(){delete this[S.propFix[e]||e]})}}),S.extend({prop:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return 1===o&&S.isXMLDoc(e)||(t=S.propFix[t]||t,i=S.propHooks[t]),void 0!==n?i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:e[t]=n:i&&"get"in i&&null!==(r=i.get(e,t))?r:e[t]},propHooks:{tabIndex:{get:function(e){var t=S.find.attr(e,"tabindex");return t?parseInt(t,10):pt.test(e.nodeName)||dt.test(e.nodeName)&&e.href?0:-1}}},propFix:{"for":"htmlFor","class":"className"}}),y.optSelected||(S.propHooks.selected={get:function(e){var t=e.parentNode;return t&&t.parentNode&&t.parentNode.selectedIndex,null},set:function(e){var t=e.parentNode;t&&(t.selectedIndex,t.parentNode&&t.parentNode.selectedIndex)}}),S.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){S.propFix[this.toLowerCase()]=this}),S.fn.extend({addClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).addClass(t.call(this,e,gt(this)))});if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])r.indexOf(" "+o+" ")<0&&(r+=o+" ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},removeClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).removeClass(t.call(this,e,gt(this)))});if(!arguments.length)return this.attr("class","");if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])while(-1<r.indexOf(" "+o+" "))r=r.replace(" "+o+" "," ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},toggleClass:function(i,t){var o=typeof i,a="string"===o||Array.isArray(i);return"boolean"==typeof t&&a?t?this.addClass(i):this.removeClass(i):m(i)?this.each(function(e){S(this).toggleClass(i.call(this,e,gt(this),t),t)}):this.each(function(){var e,t,n,r;if(a){t=0,n=S(this),r=vt(i);while(e=r[t++])n.hasClass(e)?n.removeClass(e):n.addClass(e)}else void 0!==i&&"boolean"!==o||((e=gt(this))&&Y.set(this,"__className__",e),this.setAttribute&&this.setAttribute("class",e||!1===i?"":Y.get(this,"__className__")||""))})},hasClass:function(e){var t,n,r=0;t=" "+e+" ";while(n=this[r++])if(1===n.nodeType&&-1<(" "+ht(gt(n))+" ").indexOf(t))return!0;return!1}});var yt=/\r/g;S.fn.extend({val:function(n){var r,e,i,t=this[0];return arguments.length?(i=m(n),this.each(function(e){var t;1===this.nodeType&&(null==(t=i?n.call(this,e,S(this).val()):n)?t="":"number"==typeof t?t+="":Array.isArray(t)&&(t=S.map(t,function(e){return null==e?"":e+""})),(r=S.valHooks[this.type]||S.valHooks[this.nodeName.toLowerCase()])&&"set"in r&&void 0!==r.set(this,t,"value")||(this.value=t))})):t?(r=S.valHooks[t.type]||S.valHooks[t.nodeName.toLowerCase()])&&"get"in r&&void 0!==(e=r.get(t,"value"))?e:"string"==typeof(e=t.value)?e.replace(yt,""):null==e?"":e:void 0}}),S.extend({valHooks:{option:{get:function(e){var t=S.find.attr(e,"value");return null!=t?t:ht(S.text(e))}},select:{get:function(e){var t,n,r,i=e.options,o=e.selectedIndex,a="select-one"===e.type,s=a?null:[],u=a?o+1:i.length;for(r=o<0?u:a?o:0;r<u;r++)if(((n=i[r]).selected||r===o)&&!n.disabled&&(!n.parentNode.disabled||!A(n.parentNode,"optgroup"))){if(t=S(n).val(),a)return t;s.push(t)}return s},set:function(e,t){var n,r,i=e.options,o=S.makeArray(t),a=i.length;while(a--)((r=i[a]).selected=-1<S.inArray(S.valHooks.option.get(r),o))&&(n=!0);return n||(e.selectedIndex=-1),o}}}}),S.each(["radio","checkbox"],function(){S.valHooks[this]={set:function(e,t){if(Array.isArray(t))return e.checked=-1<S.inArray(S(e).val(),t)}},y.checkOn||(S.valHooks[this].get=function(e){return null===e.getAttribute("value")?"on":e.value})}),y.focusin="onfocusin"in C;var mt=/^(?:focusinfocus|focusoutblur)$/,xt=function(e){e.stopPropagation()};S.extend(S.event,{trigger:function(e,t,n,r){var i,o,a,s,u,l,c,f,p=[n||E],d=v.call(e,"type")?e.type:e,h=v.call(e,"namespace")?e.namespace.split("."):[];if(o=f=a=n=n||E,3!==n.nodeType&&8!==n.nodeType&&!mt.test(d+S.event.triggered)&&(-1<d.indexOf(".")&&(d=(h=d.split(".")).shift(),h.sort()),u=d.indexOf(":")<0&&"on"+d,(e=e[S.expando]?e:new S.Event(d,"object"==typeof e&&e)).isTrigger=r?2:3,e.namespace=h.join("."),e.rnamespace=e.namespace?new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,e.result=void 0,e.target||(e.target=n),t=null==t?[e]:S.makeArray(t,[e]),c=S.event.special[d]||{},r||!c.trigger||!1!==c.trigger.apply(n,t))){if(!r&&!c.noBubble&&!x(n)){for(s=c.delegateType||d,mt.test(s+d)||(o=o.parentNode);o;o=o.parentNode)p.push(o),a=o;a===(n.ownerDocument||E)&&p.push(a.defaultView||a.parentWindow||C)}i=0;while((o=p[i++])&&!e.isPropagationStopped())f=o,e.type=1<i?s:c.bindType||d,(l=(Y.get(o,"events")||Object.create(null))[e.type]&&Y.get(o,"handle"))&&l.apply(o,t),(l=u&&o[u])&&l.apply&&V(o)&&(e.result=l.apply(o,t),!1===e.result&&e.preventDefault());return e.type=d,r||e.isDefaultPrevented()||c._default&&!1!==c._default.apply(p.pop(),t)||!V(n)||u&&m(n[d])&&!x(n)&&((a=n[u])&&(n[u]=null),S.event.triggered=d,e.isPropagationStopped()&&f.addEventListener(d,xt),n[d](),e.isPropagationStopped()&&f.removeEventListener(d,xt),S.event.triggered=void 0,a&&(n[u]=a)),e.result}},simulate:function(e,t,n){var r=S.extend(new S.Event,n,{type:e,isSimulated:!0});S.event.trigger(r,null,t)}}),S.fn.extend({trigger:function(e,t){return this.each(function(){S.event.trigger(e,t,this)})},triggerHandler:function(e,t){var n=this[0];if(n)return S.event.trigger(e,t,n,!0)}}),y.focusin||S.each({focus:"focusin",blur:"focusout"},function(n,r){var i=function(e){S.event.simulate(r,e.target,S.event.fix(e))};S.event.special[r]={setup:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r);t||e.addEventListener(n,i,!0),Y.access(e,r,(t||0)+1)},teardown:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r)-1;t?Y.access(e,r,t):(e.removeEventListener(n,i,!0),Y.remove(e,r))}}});var bt=C.location,wt={guid:Date.now()},Tt=/\?/;S.parseXML=function(e){var t,n;if(!e||"string"!=typeof e)return null;try{t=(new C.DOMParser).parseFromString(e,"text/xml")}catch(e){}return n=t&&t.getElementsByTagName("parsererror")[0],t&&!n||S.error("Invalid XML: "+(n?S.map(n.childNodes,function(e){return e.textContent}).join("\n"):e)),t};var Ct=/\[\]$/,Et=/\r?\n/g,St=/^(?:submit|button|image|reset|file)$/i,kt=/^(?:input|select|textarea|keygen)/i;function At(n,e,r,i){var t;if(Array.isArray(e))S.each(e,function(e,t){r||Ct.test(n)?i(n,t):At(n+"["+("object"==typeof t&&null!=t?e:"")+"]",t,r,i)});else if(r||"object"!==w(e))i(n,e);else for(t in e)At(n+"["+t+"]",e[t],r,i)}S.param=function(e,t){var n,r=[],i=function(e,t){var n=m(t)?t():t;r[r.length]=encodeURIComponent(e)+"="+encodeURIComponent(null==n?"":n)};if(null==e)return"";if(Array.isArray(e)||e.jquery&&!S.isPlainObject(e))S.each(e,function(){i(this.name,this.value)});else for(n in e)At(n,e[n],t,i);return r.join("&")},S.fn.extend({serialize:function(){return S.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var e=S.prop(this,"elements");return e?S.makeArray(e):this}).filter(function(){var e=this.type;return this.name&&!S(this).is(":disabled")&&kt.test(this.nodeName)&&!St.test(e)&&(this.checked||!pe.test(e))}).map(function(e,t){var n=S(this).val();return null==n?null:Array.isArray(n)?S.map(n,function(e){return{name:t.name,value:e.replace(Et,"\r\n")}}):{name:t.name,value:n.replace(Et,"\r\n")}}).get()}});var Nt=/%20/g,jt=/#.*$/,Dt=/([?&])_=[^&]*/,qt=/^(.*?):[ \t]*([^\r\n]*)$/gm,Lt=/^(?:GET|HEAD)$/,Ht=/^\/\//,Ot={},Pt={},Rt="*/".concat("*"),Mt=E.createElement("a");function It(o){return function(e,t){"string"!=typeof e&&(t=e,e="*");var n,r=0,i=e.toLowerCase().match(P)||[];if(m(t))while(n=i[r++])"+"===n[0]?(n=n.slice(1)||"*",(o[n]=o[n]||[]).unshift(t)):(o[n]=o[n]||[]).push(t)}}function Wt(t,i,o,a){var s={},u=t===Pt;function l(e){var r;return s[e]=!0,S.each(t[e]||[],function(e,t){var n=t(i,o,a);return"string"!=typeof n||u||s[n]?u?!(r=n):void 0:(i.dataTypes.unshift(n),l(n),!1)}),r}return l(i.dataTypes[0])||!s["*"]&&l("*")}function Ft(e,t){var n,r,i=S.ajaxSettings.flatOptions||{};for(n in t)void 0!==t[n]&&((i[n]?e:r||(r={}))[n]=t[n]);return r&&S.extend(!0,e,r),e}Mt.href=bt.href,S.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:bt.href,type:"GET",isLocal:/^(?:about|app|app-storage|.+-extension|file|res|widget):$/.test(bt.protocol),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Rt,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/\bxml\b/,html:/\bhtml/,json:/\bjson\b/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":JSON.parse,"text xml":S.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(e,t){return t?Ft(Ft(e,S.ajaxSettings),t):Ft(S.ajaxSettings,e)},ajaxPrefilter:It(Ot),ajaxTransport:It(Pt),ajax:function(e,t){"object"==typeof e&&(t=e,e=void 0),t=t||{};var c,f,p,n,d,r,h,g,i,o,v=S.ajaxSetup({},t),y=v.context||v,m=v.context&&(y.nodeType||y.jquery)?S(y):S.event,x=S.Deferred(),b=S.Callbacks("once memory"),w=v.statusCode||{},a={},s={},u="canceled",T={readyState:0,getResponseHeader:function(e){var t;if(h){if(!n){n={};while(t=qt.exec(p))n[t[1].toLowerCase()+" "]=(n[t[1].toLowerCase()+" "]||[]).concat(t[2])}t=n[e.toLowerCase()+" "]}return null==t?null:t.join(", ")},getAllResponseHeaders:function(){return h?p:null},setRequestHeader:function(e,t){return null==h&&(e=s[e.toLowerCase()]=s[e.toLowerCase()]||e,a[e]=t),this},overrideMimeType:function(e){return null==h&&(v.mimeType=e),this},statusCode:function(e){var t;if(e)if(h)T.always(e[T.status]);else for(t in e)w[t]=[w[t],e[t]];return this},abort:function(e){var t=e||u;return c&&c.abort(t),l(0,t),this}};if(x.promise(T),v.url=((e||v.url||bt.href)+"").replace(Ht,bt.protocol+"//"),v.type=t.method||t.type||v.method||v.type,v.dataTypes=(v.dataType||"*").toLowerCase().match(P)||[""],null==v.crossDomain){r=E.createElement("a");try{r.href=v.url,r.href=r.href,v.crossDomain=Mt.protocol+"//"+Mt.host!=r.protocol+"//"+r.host}catch(e){v.crossDomain=!0}}if(v.data&&v.processData&&"string"!=typeof v.data&&(v.data=S.param(v.data,v.traditional)),Wt(Ot,v,t,T),h)return T;for(i in(g=S.event&&v.global)&&0==S.active++&&S.event.trigger("ajaxStart"),v.type=v.type.toUpperCase(),v.hasContent=!Lt.test(v.type),f=v.url.replace(jt,""),v.hasContent?v.data&&v.processData&&0===(v.contentType||"").indexOf("application/x-www-form-urlencoded")&&(v.data=v.data.replace(Nt,"+")):(o=v.url.slice(f.length),v.data&&(v.processData||"string"==typeof v.data)&&(f+=(Tt.test(f)?"&":"?")+v.data,delete v.data),!1===v.cache&&(f=f.replace(Dt,"$1"),o=(Tt.test(f)?"&":"?")+"_="+wt.guid+++o),v.url=f+o),v.ifModified&&(S.lastModified[f]&&T.setRequestHeader("If-Modified-Since",S.lastModified[f]),S.etag[f]&&T.setRequestHeader("If-None-Match",S.etag[f])),(v.data&&v.hasContent&&!1!==v.contentType||t.contentType)&&T.setRequestHeader("Content-Type",v.contentType),T.setRequestHeader("Accept",v.dataTypes[0]&&v.accepts[v.dataTypes[0]]?v.accepts[v.dataTypes[0]]+("*"!==v.dataTypes[0]?", "+Rt+"; q=0.01":""):v.accepts["*"]),v.headers)T.setRequestHeader(i,v.headers[i]);if(v.beforeSend&&(!1===v.beforeSend.call(y,T,v)||h))return T.abort();if(u="abort",b.add(v.complete),T.done(v.success),T.fail(v.error),c=Wt(Pt,v,t,T)){if(T.readyState=1,g&&m.trigger("ajaxSend",[T,v]),h)return T;v.async&&0<v.timeout&&(d=C.setTimeout(function(){T.abort("timeout")},v.timeout));try{h=!1,c.send(a,l)}catch(e){if(h)throw e;l(-1,e)}}else l(-1,"No Transport");function l(e,t,n,r){var i,o,a,s,u,l=t;h||(h=!0,d&&C.clearTimeout(d),c=void 0,p=r||"",T.readyState=0<e?4:0,i=200<=e&&e<300||304===e,n&&(s=function(e,t,n){var r,i,o,a,s=e.contents,u=e.dataTypes;while("*"===u[0])u.shift(),void 0===r&&(r=e.mimeType||t.getResponseHeader("Content-Type"));if(r)for(i in s)if(s[i]&&s[i].test(r)){u.unshift(i);break}if(u[0]in n)o=u[0];else{for(i in n){if(!u[0]||e.converters[i+" "+u[0]]){o=i;break}a||(a=i)}o=o||a}if(o)return o!==u[0]&&u.unshift(o),n[o]}(v,T,n)),!i&&-1<S.inArray("script",v.dataTypes)&&S.inArray("json",v.dataTypes)<0&&(v.converters["text script"]=function(){}),s=function(e,t,n,r){var i,o,a,s,u,l={},c=e.dataTypes.slice();if(c[1])for(a in e.converters)l[a.toLowerCase()]=e.converters[a];o=c.shift();while(o)if(e.responseFields[o]&&(n[e.responseFields[o]]=t),!u&&r&&e.dataFilter&&(t=e.dataFilter(t,e.dataType)),u=o,o=c.shift())if("*"===o)o=u;else if("*"!==u&&u!==o){if(!(a=l[u+" "+o]||l["* "+o]))for(i in l)if((s=i.split(" "))[1]===o&&(a=l[u+" "+s[0]]||l["* "+s[0]])){!0===a?a=l[i]:!0!==l[i]&&(o=s[0],c.unshift(s[1]));break}if(!0!==a)if(a&&e["throws"])t=a(t);else try{t=a(t)}catch(e){return{state:"parsererror",error:a?e:"No conversion from "+u+" to "+o}}}return{state:"success",data:t}}(v,s,T,i),i?(v.ifModified&&((u=T.getResponseHeader("Last-Modified"))&&(S.lastModified[f]=u),(u=T.getResponseHeader("etag"))&&(S.etag[f]=u)),204===e||"HEAD"===v.type?l="nocontent":304===e?l="notmodified":(l=s.state,o=s.data,i=!(a=s.error))):(a=l,!e&&l||(l="error",e<0&&(e=0))),T.status=e,T.statusText=(t||l)+"",i?x.resolveWith(y,[o,l,T]):x.rejectWith(y,[T,l,a]),T.statusCode(w),w=void 0,g&&m.trigger(i?"ajaxSuccess":"ajaxError",[T,v,i?o:a]),b.fireWith(y,[T,l]),g&&(m.trigger("ajaxComplete",[T,v]),--S.active||S.event.trigger("ajaxStop")))}return T},getJSON:function(e,t,n){return S.get(e,t,n,"json")},getScript:function(e,t){return S.get(e,void 0,t,"script")}}),S.each(["get","post"],function(e,i){S[i]=function(e,t,n,r){return m(t)&&(r=r||n,n=t,t=void 0),S.ajax(S.extend({url:e,type:i,dataType:r,data:t,success:n},S.isPlainObject(e)&&e))}}),S.ajaxPrefilter(function(e){var t;for(t in e.headers)"content-type"===t.toLowerCase()&&(e.contentType=e.headers[t]||"")}),S._evalUrl=function(e,t,n){return S.ajax({url:e,type:"GET",dataType:"script",cache:!0,async:!1,global:!1,converters:{"text script":function(){}},dataFilter:function(e){S.globalEval(e,t,n)}})},S.fn.extend({wrapAll:function(e){var t;return this[0]&&(m(e)&&(e=e.call(this[0])),t=S(e,this[0].ownerDocument).eq(0).clone(!0),this[0].parentNode&&t.insertBefore(this[0]),t.map(function(){var e=this;while(e.firstElementChild)e=e.firstElementChild;return e}).append(this)),this},wrapInner:function(n){return m(n)?this.each(function(e){S(this).wrapInner(n.call(this,e))}):this.each(function(){var e=S(this),t=e.contents();t.length?t.wrapAll(n):e.append(n)})},wrap:function(t){var n=m(t);return this.each(function(e){S(this).wrapAll(n?t.call(this,e):t)})},unwrap:function(e){return this.parent(e).not("body").each(function(){S(this).replaceWith(this.childNodes)}),this}}),S.expr.pseudos.hidden=function(e){return!S.expr.pseudos.visible(e)},S.expr.pseudos.visible=function(e){return!!(e.offsetWidth||e.offsetHeight||e.getClientRects().length)},S.ajaxSettings.xhr=function(){try{return new C.XMLHttpRequest}catch(e){}};var Bt={0:200,1223:204},$t=S.ajaxSettings.xhr();y.cors=!!$t&&"withCredentials"in $t,y.ajax=$t=!!$t,S.ajaxTransport(function(i){var o,a;if(y.cors||$t&&!i.crossDomain)return{send:function(e,t){var n,r=i.xhr();if(r.open(i.type,i.url,i.async,i.username,i.password),i.xhrFields)for(n in i.xhrFields)r[n]=i.xhrFields[n];for(n in i.mimeType&&r.overrideMimeType&&r.overrideMimeType(i.mimeType),i.crossDomain||e["X-Requested-With"]||(e["X-Requested-With"]="XMLHttpRequest"),e)r.setRequestHeader(n,e[n]);o=function(e){return function(){o&&(o=a=r.onload=r.onerror=r.onabort=r.ontimeout=r.onreadystatechange=null,"abort"===e?r.abort():"error"===e?"number"!=typeof r.status?t(0,"error"):t(r.status,r.statusText):t(Bt[r.status]||r.status,r.statusText,"text"!==(r.responseType||"text")||"string"!=typeof r.responseText?{binary:r.response}:{text:r.responseText},r.getAllResponseHeaders()))}},r.onload=o(),a=r.onerror=r.ontimeout=o("error"),void 0!==r.onabort?r.onabort=a:r.onreadystatechange=function(){4===r.readyState&&C.setTimeout(function(){o&&a()})},o=o("abort");try{r.send(i.hasContent&&i.data||null)}catch(e){if(o)throw e}},abort:function(){o&&o()}}}),S.ajaxPrefilter(function(e){e.crossDomain&&(e.contents.script=!1)}),S.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/\b(?:java|ecma)script\b/},converters:{"text script":function(e){return S.globalEval(e),e}}}),S.ajaxPrefilter("script",function(e){void 0===e.cache&&(e.cache=!1),e.crossDomain&&(e.type="GET")}),S.ajaxTransport("script",function(n){var r,i;if(n.crossDomain||n.scriptAttrs)return{send:function(e,t){r=S("<script>").attr(n.scriptAttrs||{}).prop({charset:n.scriptCharset,src:n.url}).on("load error",i=function(e){r.remove(),i=null,e&&t("error"===e.type?404:200,e.type)}),E.head.appendChild(r[0])},abort:function(){i&&i()}}});var _t,zt=[],Ut=/(=)\?(?=&|$)|\?\?/;S.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var e=zt.pop()||S.expando+"_"+wt.guid++;return this[e]=!0,e}}),S.ajaxPrefilter("json jsonp",function(e,t,n){var r,i,o,a=!1!==e.jsonp&&(Ut.test(e.url)?"url":"string"==typeof e.data&&0===(e.contentType||"").indexOf("application/x-www-form-urlencoded")&&Ut.test(e.data)&&"data");if(a||"jsonp"===e.dataTypes[0])return r=e.jsonpCallback=m(e.jsonpCallback)?e.jsonpCallback():e.jsonpCallback,a?e[a]=e[a].replace(Ut,"$1"+r):!1!==e.jsonp&&(e.url+=(Tt.test(e.url)?"&":"?")+e.jsonp+"="+r),e.converters["script json"]=function(){return o||S.error(r+" was not called"),o[0]},e.dataTypes[0]="json",i=C[r],C[r]=function(){o=arguments},n.always(function(){void 0===i?S(C).removeProp(r):C[r]=i,e[r]&&(e.jsonpCallback=t.jsonpCallback,zt.push(r)),o&&m(i)&&i(o[0]),o=i=void 0}),"script"}),y.createHTMLDocument=((_t=E.implementation.createHTMLDocument("").body).innerHTML="<form></form><form></form>",2===_t.childNodes.length),S.parseHTML=function(e,t,n){return"string"!=typeof e?[]:("boolean"==typeof t&&(n=t,t=!1),t||(y.createHTMLDocument?((r=(t=E.implementation.createHTMLDocument("")).createElement("base")).href=E.location.href,t.head.appendChild(r)):t=E),o=!n&&[],(i=N.exec(e))?[t.createElement(i[1])]:(i=xe([e],t,o),o&&o.length&&S(o).remove(),S.merge([],i.childNodes)));var r,i,o},S.fn.load=function(e,t,n){var r,i,o,a=this,s=e.indexOf(" ");return-1<s&&(r=ht(e.slice(s)),e=e.slice(0,s)),m(t)?(n=t,t=void 0):t&&"object"==typeof t&&(i="POST"),0<a.length&&S.ajax({url:e,type:i||"GET",dataType:"html",data:t}).done(function(e){o=arguments,a.html(r?S("<div>").append(S.parseHTML(e)).find(r):e)}).always(n&&function(e,t){a.each(function(){n.apply(this,o||[e.responseText,t,e])})}),this},S.expr.pseudos.animated=function(t){return S.grep(S.timers,function(e){return t===e.elem}).length},S.offset={setOffset:function(e,t,n){var r,i,o,a,s,u,l=S.css(e,"position"),c=S(e),f={};"static"===l&&(e.style.position="relative"),s=c.offset(),o=S.css(e,"top"),u=S.css(e,"left"),("absolute"===l||"fixed"===l)&&-1<(o+u).indexOf("auto")?(a=(r=c.position()).top,i=r.left):(a=parseFloat(o)||0,i=parseFloat(u)||0),m(t)&&(t=t.call(e,n,S.extend({},s))),null!=t.top&&(f.top=t.top-s.top+a),null!=t.left&&(f.left=t.left-s.left+i),"using"in t?t.using.call(e,f):c.css(f)}},S.fn.extend({offset:function(t){if(arguments.length)return void 0===t?this:this.each(function(e){S.offset.setOffset(this,t,e)});var e,n,r=this[0];return r?r.getClientRects().length?(e=r.getBoundingClientRect(),n=r.ownerDocument.defaultView,{top:e.top+n.pageYOffset,left:e.left+n.pageXOffset}):{top:0,left:0}:void 0},position:function(){if(this[0]){var e,t,n,r=this[0],i={top:0,left:0};if("fixed"===S.css(r,"position"))t=r.getBoundingClientRect();else{t=this.offset(),n=r.ownerDocument,e=r.offsetParent||n.documentElement;while(e&&(e===n.body||e===n.documentElement)&&"static"===S.css(e,"position"))e=e.parentNode;e&&e!==r&&1===e.nodeType&&((i=S(e).offset()).top+=S.css(e,"borderTopWidth",!0),i.left+=S.css(e,"borderLeftWidth",!0))}return{top:t.top-i.top-S.css(r,"marginTop",!0),left:t.left-i.left-S.css(r,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var e=this.offsetParent;while(e&&"static"===S.css(e,"position"))e=e.offsetParent;return e||re})}}),S.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(t,i){var o="pageYOffset"===i;S.fn[t]=function(e){return $(this,function(e,t,n){var r;if(x(e)?r=e:9===e.nodeType&&(r=e.defaultView),void 0===n)return r?r[i]:e[t];r?r.scrollTo(o?r.pageXOffset:n,o?n:r.pageYOffset):e[t]=n},t,e,arguments.length)}}),S.each(["top","left"],function(e,n){S.cssHooks[n]=Fe(y.pixelPosition,function(e,t){if(t)return t=We(e,n),Pe.test(t)?S(e).position()[n]+"px":t})}),S.each({Height:"height",Width:"width"},function(a,s){S.each({padding:"inner"+a,content:s,"":"outer"+a},function(r,o){S.fn[o]=function(e,t){var n=arguments.length&&(r||"boolean"!=typeof e),i=r||(!0===e||!0===t?"margin":"border");return $(this,function(e,t,n){var r;return x(e)?0===o.indexOf("outer")?e["inner"+a]:e.document.documentElement["client"+a]:9===e.nodeType?(r=e.documentElement,Math.max(e.body["scroll"+a],r["scroll"+a],e.body["offset"+a],r["offset"+a],r["client"+a])):void 0===n?S.css(e,t,i):S.style(e,t,n,i)},s,n?e:void 0,n)}})}),S.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(e,t){S.fn[t]=function(e){return this.on(t,e)}}),S.fn.extend({bind:function(e,t,n){return this.on(e,null,t,n)},unbind:function(e,t){return this.off(e,null,t)},delegate:function(e,t,n,r){return this.on(t,e,n,r)},undelegate:function(e,t,n){return 1===arguments.length?this.off(e,"**"):this.off(t,e||"**",n)},hover:function(e,t){return this.mouseenter(e).mouseleave(t||e)}}),S.each("blur focus focusin focusout resize scroll click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup contextmenu".split(" "),function(e,n){S.fn[n]=function(e,t){return 0<arguments.length?this.on(n,null,e,t):this.trigger(n)}});var Xt=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g;S.proxy=function(e,t){var n,r,i;if("string"==typeof t&&(n=e[t],t=e,e=n),m(e))return r=s.call(arguments,2),(i=function(){return e.apply(t||this,r.concat(s.call(arguments)))}).guid=e.guid=e.guid||S.guid++,i},S.holdReady=function(e){e?S.readyWait++:S.ready(!0)},S.isArray=Array.isArray,S.parseJSON=JSON.parse,S.nodeName=A,S.isFunction=m,S.isWindow=x,S.camelCase=X,S.type=w,S.now=Date.now,S.isNumeric=function(e){var t=S.type(e);return("number"===t||"string"===t)&&!isNaN(e-parseFloat(e))},S.trim=function(e){return null==e?"":(e+"").replace(Xt,"")},"function"==typeof define&&define.amd&&define("jquery",[],function(){return S});var Vt=C.jQuery,Gt=C.$;return S.noConflict=function(e){return C.$===S&&(C.$=Gt),e&&C.jQuery===S&&(C.jQuery=Vt),S},"undefined"==typeof e&&(C.jQuery=C.$=S),S});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:700}dfn{font-style:italic}h1{margin:.67em 0;font-size:2em}mark{color:#000;background:#ff0}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sup{top:-.5em}sub{bottom:-.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{height:0;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace,monospace;font-size:1em}button,input,optgroup,select,textarea{margin:0;font:inherit;color:inherit}button{overflow:visible}button,select{text-transform:none}button,html input[type=button],input[type=reset],input[type=submit]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{padding:0;border:0}input{line-height:normal}input[type=checkbox],input[type=radio]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type=number]::-webkit-inner-spin-button,input[type=number]::-webkit-outer-spin-button{height:auto}input[type=search]{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-appearance:textfield}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration{-webkit-appearance:none}fieldset{padding:.35em .625em .75em;margin:0 2px;border:1px solid silver}legend{padding:0;border:0}textarea{overflow:auto}optgroup{font-weight:700}table{border-spacing:0;border-collapse:collapse}td,th{padding:0}@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="javascript:"]:after,a[href^="#"]:after{content:""}blockquote,pre{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000!important}.label{border:1px solid #000}.table{border-collapse:collapse!important}.table td,.table th{background-color:#fff!important}.table-bordered td,.table-bordered th{border:1px solid #ddd!important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:application/font-woff;base64,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) format('woff'),url(data:application/font-sfnt;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:400;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\2a"}.glyphicon-plus:before{content:"\2b"}.glyphicon-eur:before,.glyphicon-euro:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}button,input,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.carousel-inner>.item>a>img,.carousel-inner>.item>img,.img-responsive,.thumbnail a>img,.thumbnail>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:6px}.img-thumbnail{display:inline-block;max-width:100%;height:auto;padding:4px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.img-circle{border-radius:50%}hr{margin-top:20px;margin-bottom:20px;border:0;border-top:1px solid #eee}.sr-only{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role=button]{cursor:pointer}.h1,.h2,.h3,.h4,.h5,.h6,h1,h2,h3,h4,h5,h6{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-weight:400;line-height:1;color:#777}.h1,.h2,.h3,h1,h2,h3{margin-top:20px;margin-bottom:10px}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small{font-size:65%}.h4,.h5,.h6,h4,h5,h6{margin-top:10px;margin-bottom:10px}.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-size:75%}.h1,h1{font-size:36px}.h2,h2{font-size:30px}.h3,h3{font-size:24px}.h4,h4{font-size:18px}.h5,h5{font-size:14px}.h6,h6{font-size:12px}p{margin:0 0 10px}.lead{margin-bottom:20px;font-size:16px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:21px}}.small,small{font-size:85%}.mark,mark{padding:.2em;background-color:#fcf8e3}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#777}.text-primary{color:#337ab7}a.text-primary:focus,a.text-primary:hover{color:#286090}.text-success{color:#3c763d}a.text-success:focus,a.text-success:hover{color:#2b542c}.text-info{color:#31708f}a.text-info:focus,a.text-info:hover{color:#245269}.text-warning{color:#8a6d3b}a.text-warning:focus,a.text-warning:hover{color:#66512c}.text-danger{color:#a94442}a.text-danger:focus,a.text-danger:hover{color:#843534}.bg-primary{color:#fff;background-color:#337ab7}a.bg-primary:focus,a.bg-primary:hover{background-color:#286090}.bg-success{background-color:#dff0d8}a.bg-success:focus,a.bg-success:hover{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:focus,a.bg-info:hover{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:focus,a.bg-warning:hover{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:focus,a.bg-danger:hover{background-color:#e4b9b9}.page-header{padding-bottom:9px;margin:40px 0 20px;border-bottom:1px solid #eee}ol,ul{margin-top:0;margin-bottom:10px}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;margin-left:-5px;list-style:none}.list-inline>li{display:inline-block;padding-right:5px;padding-left:5px}dl{margin-top:0;margin-bottom:20px}dd,dt{line-height:1.42857143}dt{font-weight:700}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;overflow:hidden;clear:left;text-align:right;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[data-original-title],abbr[title]{cursor:help;border-bottom:1px dotted #777}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10px 20px;margin:0 0 20px;font-size:17.5px;border-left:5px solid #eee}blockquote ol:last-child,blockquote p:last-child,blockquote ul:last-child{margin-bottom:0}blockquote .small,blockquote footer,blockquote small{display:block;font-size:80%;line-height:1.42857143;color:#777}blockquote .small:before,blockquote footer:before,blockquote small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;text-align:right;border-right:5px solid #eee;border-left:0}.blockquote-reverse .small:before,.blockquote-reverse footer:before,.blockquote-reverse small:before,blockquote.pull-right .small:before,blockquote.pull-right footer:before,blockquote.pull-right small:before{content:''}.blockquote-reverse .small:after,.blockquote-reverse footer:after,.blockquote-reverse small:after,blockquote.pull-right .small:after,blockquote.pull-right footer:after,blockquote.pull-right small:after{content:'\00A0 \2014'}address{margin-bottom:20px;font-style:normal;line-height:1.42857143}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:4px}kbd{padding:2px 4px;font-size:90%;color:#fff;background-color:#333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,.25)}kbd kbd{padding:0;font-size:100%;font-weight:700;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:9.5px;margin:0 0 10px;font-size:13px;line-height:1.42857143;color:#333;word-break:break-all;word-wrap:break-word;background-color:#f5f5f5;border:1px solid #ccc;border-radius:4px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0}@media (min-width:768px){.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0}}@media (min-width:992px){.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0}}@media (min-width:1200px){.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#777;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:20px}.table>tbody>tr>td,.table>tbody>tr>th,.table>tfoot>tr>td,.table>tfoot>tr>th,.table>thead>tr>td,.table>thead>tr>th{padding:8px;line-height:1.42857143;vertical-align:top;border-top:1px solid #ddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #ddd}.table>caption+thead>tr:first-child>td,.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>td,.table>thead:first-child>tr:first-child>th{border-top:0}.table>tbody+tbody{border-top:2px solid #ddd}.table .table{background-color:#fff}.table-condensed>tbody>tr>td,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>td,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>thead>tr>th{padding:5px}.table-bordered{border:1px solid #ddd}.table-bordered>tbody>tr>td,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>td,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border:1px solid #ddd}.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*=col-]{position:static;display:table-column;float:none}table td[class*=col-],table th[class*=col-]{position:static;display:table-cell;float:none}.table>tbody>tr.active>td,.table>tbody>tr.active>th,.table>tbody>tr>td.active,.table>tbody>tr>th.active,.table>tfoot>tr.active>td,.table>tfoot>tr.active>th,.table>tfoot>tr>td.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>thead>tr.active>th,.table>thead>tr>td.active,.table>thead>tr>th.active{background-color:#f5f5f5}.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr.active:hover>th,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover{background-color:#e8e8e8}.table>tbody>tr.success>td,.table>tbody>tr.success>th,.table>tbody>tr>td.success,.table>tbody>tr>th.success,.table>tfoot>tr.success>td,.table>tfoot>tr.success>th,.table>tfoot>tr>td.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>thead>tr.success>th,.table>thead>tr>td.success,.table>thead>tr>th.success{background-color:#dff0d8}.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr.success:hover>th,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover{background-color:#d0e9c6}.table>tbody>tr.info>td,.table>tbody>tr.info>th,.table>tbody>tr>td.info,.table>tbody>tr>th.info,.table>tfoot>tr.info>td,.table>tfoot>tr.info>th,.table>tfoot>tr>td.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>thead>tr.info>th,.table>thead>tr>td.info,.table>thead>tr>th.info{background-color:#d9edf7}.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr.info:hover>th,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover{background-color:#c4e3f3}.table>tbody>tr.warning>td,.table>tbody>tr.warning>th,.table>tbody>tr>td.warning,.table>tbody>tr>th.warning,.table>tfoot>tr.warning>td,.table>tfoot>tr.warning>th,.table>tfoot>tr>td.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>thead>tr.warning>th,.table>thead>tr>td.warning,.table>thead>tr>th.warning{background-color:#fcf8e3}.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr.warning:hover>th,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover{background-color:#faf2cc}.table>tbody>tr.danger>td,.table>tbody>tr.danger>th,.table>tbody>tr>td.danger,.table>tbody>tr>th.danger,.table>tfoot>tr.danger>td,.table>tfoot>tr.danger>th,.table>tfoot>tr>td.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>thead>tr.danger>th,.table>thead>tr>td.danger,.table>thead>tr>th.danger{background-color:#f2dede}.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr.danger:hover>th,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover{background-color:#ebcccc}.table-responsive{min-height:.01%;overflow-x:auto}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #ddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>td,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>thead>tr>th{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;padding:0;margin-bottom:20px;font-size:21px;line-height:inherit;color:#333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:700}input[type=search]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type=checkbox],input[type=radio]{margin:4px 0 0;margin-top:1px\9;line-height:normal}input[type=file]{display:block}input[type=range]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type=file]:focus,input[type=checkbox]:focus,input[type=radio]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:14px;line-height:1.42857143;color:#555}.form-control{display:block;width:100%;height:34px;padding:6px 12px;font-size:14px;line-height:1.42857143;color:#555;background-color:#fff;background-image:none;border:1px solid #ccc;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6);box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6)}.form-control::-moz-placeholder{color:#999;opacity:1}.form-control:-ms-input-placeholder{color:#999}.form-control::-webkit-input-placeholder{color:#999}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type=search]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type=date].form-control,input[type=time].form-control,input[type=datetime-local].form-control,input[type=month].form-control{line-height:34px}.input-group-sm input[type=date],.input-group-sm input[type=time],.input-group-sm input[type=datetime-local],.input-group-sm input[type=month],input[type=date].input-sm,input[type=time].input-sm,input[type=datetime-local].input-sm,input[type=month].input-sm{line-height:30px}.input-group-lg input[type=date],.input-group-lg input[type=time],.input-group-lg input[type=datetime-local],.input-group-lg input[type=month],input[type=date].input-lg,input[type=time].input-lg,input[type=datetime-local].input-lg,input[type=month].input-lg{line-height:46px}}.form-group{margin-bottom:15px}.checkbox,.radio{position:relative;display:block;margin-top:10px;margin-bottom:10px}.checkbox label,.radio label{min-height:20px;padding-left:20px;margin-bottom:0;font-weight:400;cursor:pointer}.checkbox input[type=checkbox],.checkbox-inline input[type=checkbox],.radio input[type=radio],.radio-inline input[type=radio]{position:absolute;margin-top:4px\9;margin-left:-20px}.checkbox+.checkbox,.radio+.radio{margin-top:-5px}.checkbox-inline,.radio-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;font-weight:400;vertical-align:middle;cursor:pointer}.checkbox-inline+.checkbox-inline,.radio-inline+.radio-inline{margin-top:0;margin-left:10px}fieldset[disabled] input[type=checkbox],fieldset[disabled] input[type=radio],input[type=checkbox].disabled,input[type=checkbox][disabled],input[type=radio].disabled,input[type=radio][disabled]{cursor:not-allowed}.checkbox-inline.disabled,.radio-inline.disabled,fieldset[disabled] .checkbox-inline,fieldset[disabled] .radio-inline{cursor:not-allowed}.checkbox.disabled label,.radio.disabled label,fieldset[disabled] .checkbox label,fieldset[disabled] .radio label{cursor:not-allowed}.form-control-static{min-height:34px;padding-top:7px;padding-bottom:7px;margin-bottom:0}.form-control-static.input-lg,.form-control-static.input-sm{padding-right:0;padding-left:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}select[multiple].input-sm,textarea.input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm select[multiple].form-control,.form-group-sm textarea.form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:32px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-lg{height:46px;line-height:46px}select[multiple].input-lg,textarea.input-lg{height:auto}.form-group-lg .form-control{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.form-group-lg select.form-control{height:46px;line-height:46px}.form-group-lg select[multiple].form-control,.form-group-lg textarea.form-control{height:auto}.form-group-lg .form-control-static{height:46px;min-height:38px;padding:11px 16px;font-size:18px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:42.5px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:34px;height:34px;line-height:34px;text-align:center;pointer-events:none}.form-group-lg .form-control+.form-control-feedback,.input-group-lg+.form-control-feedback,.input-lg+.form-control-feedback{width:46px;height:46px;line-height:46px}.form-group-sm .form-control+.form-control-feedback,.input-group-sm+.form-control-feedback,.input-sm+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .checkbox,.has-success .checkbox-inline,.has-success .control-label,.has-success .help-block,.has-success .radio,.has-success .radio-inline,.has-success.checkbox label,.has-success.checkbox-inline label,.has-success.radio label,.has-success.radio-inline label{color:#3c763d}.has-success .form-control{border-color:#3c763d;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-success .form-control:focus{border-color:#2b542c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168}.has-success .input-group-addon{color:#3c763d;background-color:#dff0d8;border-color:#3c763d}.has-success .form-control-feedback{color:#3c763d}.has-warning .checkbox,.has-warning .checkbox-inline,.has-warning .control-label,.has-warning .help-block,.has-warning .radio,.has-warning .radio-inline,.has-warning.checkbox label,.has-warning.checkbox-inline label,.has-warning.radio label,.has-warning.radio-inline label{color:#8a6d3b}.has-warning .form-control{border-color:#8a6d3b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-warning .form-control:focus{border-color:#66512c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b}.has-warning .input-group-addon{color:#8a6d3b;background-color:#fcf8e3;border-color:#8a6d3b}.has-warning .form-control-feedback{color:#8a6d3b}.has-error .checkbox,.has-error .checkbox-inline,.has-error .control-label,.has-error .help-block,.has-error .radio,.has-error .radio-inline,.has-error.checkbox label,.has-error.checkbox-inline label,.has-error.radio label,.has-error.radio-inline label{color:#a94442}.has-error .form-control{border-color:#a94442;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-error .form-control:focus{border-color:#843534;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483}.has-error .input-group-addon{color:#a94442;background-color:#f2dede;border-color:#a94442}.has-error .form-control-feedback{color:#a94442}.has-feedback label~.form-control-feedback{top:25px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#737373}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .form-control,.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .checkbox,.form-inline .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .checkbox label,.form-inline .radio label{padding-left:0}.form-inline .checkbox input[type=checkbox],.form-inline .radio input[type=radio]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .checkbox,.form-horizontal .checkbox-inline,.form-horizontal .radio,.form-horizontal .radio-inline{padding-top:7px;margin-top:0;margin-bottom:0}.form-horizontal .checkbox,.form-horizontal .radio{min-height:27px}.form-horizontal .form-group{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.form-horizontal .control-label{padding-top:7px;margin-bottom:0;text-align:right}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:14.33px;font-size:18px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;padding:6px 12px;margin-bottom:0;font-size:14px;font-weight:400;line-height:1.42857143;text-align:center;white-space:nowrap;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;background-image:none;border:1px solid transparent;border-radius:4px}.btn.active.focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn:active:focus,.btn:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn.focus,.btn:focus,.btn:hover{color:#333;text-decoration:none}.btn.active,.btn:active{background-image:none;outline:0;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none;opacity:.65}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333;background-color:#fff;border-color:#ccc}.btn-default.focus,.btn-default:focus{color:#333;background-color:#e6e6e6;border-color:#8c8c8c}.btn-default:hover{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active.focus,.btn-default.active:focus,.btn-default.active:hover,.btn-default:active.focus,.btn-default:active:focus,.btn-default:active:hover,.open>.dropdown-toggle.btn-default.focus,.open>.dropdown-toggle.btn-default:focus,.open>.dropdown-toggle.btn-default:hover{color:#333;background-color:#d4d4d4;border-color:#8c8c8c}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled,.btn-default.disabled.active,.btn-default.disabled.focus,.btn-default.disabled:active,.btn-default.disabled:focus,.btn-default.disabled:hover,.btn-default[disabled],.btn-default[disabled].active,.btn-default[disabled].focus,.btn-default[disabled]:active,.btn-default[disabled]:focus,.btn-default[disabled]:hover,fieldset[disabled] .btn-default,fieldset[disabled] .btn-default.active,fieldset[disabled] .btn-default.focus,fieldset[disabled] .btn-default:active,fieldset[disabled] .btn-default:focus,fieldset[disabled] .btn-default:hover{background-color:#fff;border-color:#ccc}.btn-default .badge{color:#fff;background-color:#333}.btn-primary{color:#fff;background-color:#337ab7;border-color:#2e6da4}.btn-primary.focus,.btn-primary:focus{color:#fff;background-color:#286090;border-color:#122b40}.btn-primary:hover{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active.focus,.btn-primary.active:focus,.btn-primary.active:hover,.btn-primary:active.focus,.btn-primary:active:focus,.btn-primary:active:hover,.open>.dropdown-toggle.btn-primary.focus,.open>.dropdown-toggle.btn-primary:focus,.open>.dropdown-toggle.btn-primary:hover{color:#fff;background-color:#204d74;border-color:#122b40}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled,.btn-primary.disabled.active,.btn-primary.disabled.focus,.btn-primary.disabled:active,.btn-primary.disabled:focus,.btn-primary.disabled:hover,.btn-primary[disabled],.btn-primary[disabled].active,.btn-primary[disabled].focus,.btn-primary[disabled]:active,.btn-primary[disabled]:focus,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary,fieldset[disabled] .btn-primary.active,fieldset[disabled] .btn-primary.focus,fieldset[disabled] .btn-primary:active,fieldset[disabled] .btn-primary:focus,fieldset[disabled] .btn-primary:hover{background-color:#337ab7;border-color:#2e6da4}.btn-primary .badge{color:#337ab7;background-color:#fff}.btn-success{color:#fff;background-color:#5cb85c;border-color:#4cae4c}.btn-success.focus,.btn-success:focus{color:#fff;background-color:#449d44;border-color:#255625}.btn-success:hover{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active.focus,.btn-success.active:focus,.btn-success.active:hover,.btn-success:active.focus,.btn-success:active:focus,.btn-success:active:hover,.open>.dropdown-toggle.btn-success.focus,.open>.dropdown-toggle.btn-success:focus,.open>.dropdown-toggle.btn-success:hover{color:#fff;background-color:#398439;border-color:#255625}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled,.btn-success.disabled.active,.btn-success.disabled.focus,.btn-success.disabled:active,.btn-success.disabled:focus,.btn-success.disabled:hover,.btn-success[disabled],.btn-success[disabled].active,.btn-success[disabled].focus,.btn-success[disabled]:active,.btn-success[disabled]:focus,.btn-success[disabled]:hover,fieldset[disabled] .btn-success,fieldset[disabled] .btn-success.active,fieldset[disabled] .btn-success.focus,fieldset[disabled] .btn-success:active,fieldset[disabled] .btn-success:focus,fieldset[disabled] .btn-success:hover{background-color:#5cb85c;border-color:#4cae4c}.btn-success .badge{color:#5cb85c;background-color:#fff}.btn-info{color:#fff;background-color:#5bc0de;border-color:#46b8da}.btn-info.focus,.btn-info:focus{color:#fff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active.focus,.btn-info.active:focus,.btn-info.active:hover,.btn-info:active.focus,.btn-info:active:focus,.btn-info:active:hover,.open>.dropdown-toggle.btn-info.focus,.open>.dropdown-toggle.btn-info:focus,.open>.dropdown-toggle.btn-info:hover{color:#fff;background-color:#269abc;border-color:#1b6d85}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled,.btn-info.disabled.active,.btn-info.disabled.focus,.btn-info.disabled:active,.btn-info.disabled:focus,.btn-info.disabled:hover,.btn-info[disabled],.btn-info[disabled].active,.btn-info[disabled].focus,.btn-info[disabled]:active,.btn-info[disabled]:focus,.btn-info[disabled]:hover,fieldset[disabled] .btn-info,fieldset[disabled] .btn-info.active,fieldset[disabled] .btn-info.focus,fieldset[disabled] .btn-info:active,fieldset[disabled] .btn-info:focus,fieldset[disabled] .btn-info:hover{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#fff}.btn-warning{color:#fff;background-color:#f0ad4e;border-color:#eea236}.btn-warning.focus,.btn-warning:focus{color:#fff;background-color:#ec971f;border-color:#985f0d}.btn-warning:hover{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active.focus,.btn-warning.active:focus,.btn-warning.active:hover,.btn-warning:active.focus,.btn-warning:active:focus,.btn-warning:active:hover,.open>.dropdown-toggle.btn-warning.focus,.open>.dropdown-toggle.btn-warning:focus,.open>.dropdown-toggle.btn-warning:hover{color:#fff;background-color:#d58512;border-color:#985f0d}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled,.btn-warning.disabled.active,.btn-warning.disabled.focus,.btn-warning.disabled:active,.btn-warning.disabled:focus,.btn-warning.disabled:hover,.btn-warning[disabled],.btn-warning[disabled].active,.btn-warning[disabled].focus,.btn-warning[disabled]:active,.btn-warning[disabled]:focus,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning,fieldset[disabled] .btn-warning.active,fieldset[disabled] .btn-warning.focus,fieldset[disabled] .btn-warning:active,fieldset[disabled] .btn-warning:focus,fieldset[disabled] .btn-warning:hover{background-color:#f0ad4e;border-color:#eea236}.btn-warning .badge{color:#f0ad4e;background-color:#fff}.btn-danger{color:#fff;background-color:#d9534f;border-color:#d43f3a}.btn-danger.focus,.btn-danger:focus{color:#fff;background-color:#c9302c;border-color:#761c19}.btn-danger:hover{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active.focus,.btn-danger.active:focus,.btn-danger.active:hover,.btn-danger:active.focus,.btn-danger:active:focus,.btn-danger:active:hover,.open>.dropdown-toggle.btn-danger.focus,.open>.dropdown-toggle.btn-danger:focus,.open>.dropdown-toggle.btn-danger:hover{color:#fff;background-color:#ac2925;border-color:#761c19}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled,.btn-danger.disabled.active,.btn-danger.disabled.focus,.btn-danger.disabled:active,.btn-danger.disabled:focus,.btn-danger.disabled:hover,.btn-danger[disabled],.btn-danger[disabled].active,.btn-danger[disabled].focus,.btn-danger[disabled]:active,.btn-danger[disabled]:focus,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger,fieldset[disabled] .btn-danger.active,fieldset[disabled] .btn-danger.focus,fieldset[disabled] .btn-danger:active,fieldset[disabled] .btn-danger:focus,fieldset[disabled] .btn-danger:hover{background-color:#d9534f;border-color:#d43f3a}.btn-danger .badge{color:#d9534f;background-color:#fff}.btn-link{font-weight:400;color:#337ab7;border-radius:0}.btn-link,.btn-link.active,.btn-link:active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:active,.btn-link:focus,.btn-link:hover{border-color:transparent}.btn-link:focus,.btn-link:hover{color:#23527c;text-decoration:underline;background-color:transparent}.btn-link[disabled]:focus,.btn-link[disabled]:hover,fieldset[disabled] .btn-link:focus,fieldset[disabled] .btn-link:hover{color:#777;text-decoration:none}.btn-group-lg>.btn,.btn-lg{padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.btn-group-sm>.btn,.btn-sm{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-group-xs>.btn,.btn-xs{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type=button].btn-block,input[type=reset].btn-block,input[type=submit].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity .15s linear;-o-transition:opacity .15s linear;transition:opacity .15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease;-webkit-transition-duration:.35s;-o-transition-duration:.35s;transition-duration:.35s;-webkit-transition-property:height,visibility;-o-transition-property:height,visibility;transition-property:height,visibility}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid\9;border-right:4px solid transparent;border-left:4px solid transparent}.dropdown,.dropup{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;font-size:14px;text-align:left;list-style:none;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.15);border-radius:4px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,.175);box-shadow:0 6px 12px rgba(0,0,0,.175)}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:400;line-height:1.42857143;color:#333;white-space:nowrap}.dropdown-menu>li>a:focus,.dropdown-menu>li>a:hover{color:#262626;text-decoration:none;background-color:#f5f5f5}.dropdown-menu>.active>a,.dropdown-menu>.active>a:focus,.dropdown-menu>.active>a:hover{color:#fff;text-decoration:none;background-color:#337ab7;outline:0}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{color:#777}.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{text-decoration:none;cursor:not-allowed;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false)}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{right:0;left:auto}.dropdown-menu-left{right:auto;left:0}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.42857143;color:#777;white-space:nowrap}.dropdown-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{content:"";border-top:0;border-bottom:4px dashed;border-bottom:4px solid\9}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{right:0;left:auto}.navbar-right .dropdown-menu-left{right:auto;left:0}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group-vertical>.btn,.btn-group>.btn{position:relative;float:left}.btn-group-vertical>.btn.active,.btn-group-vertical>.btn:active,.btn-group-vertical>.btn:focus,.btn-group-vertical>.btn:hover,.btn-group>.btn.active,.btn-group>.btn:active,.btn-group>.btn:focus,.btn-group>.btn:hover{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-top-left-radius:0;border-bottom-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-bottom-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-right:8px;padding-left:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-right:12px;padding-left:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-left-radius:0;border-top-right-radius:0;border-bottom-left-radius:4px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-top-right-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{display:table-cell;float:none;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle=buttons]>.btn input[type=checkbox],[data-toggle=buttons]>.btn input[type=radio],[data-toggle=buttons]>.btn-group>.btn input[type=checkbox],[data-toggle=buttons]>.btn-group>.btn input[type=radio]{position:absolute;clip:rect(0,0,0,0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*=col-]{float:none;padding-right:0;padding-left:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:46px;line-height:46px}select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn,textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn,textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn{height:auto}.input-group .form-control,.input-group-addon,.input-group-btn{display:table-cell}.input-group .form-control:not(:first-child):not(:last-child),.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 12px;font-size:14px;font-weight:400;line-height:1;color:#555;text-align:center;background-color:#eee;border:1px solid #ccc;border-radius:4px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:18px;border-radius:6px}.input-group-addon input[type=checkbox],.input-group-addon input[type=radio]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn-group:not(:last-child)>.btn,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:first-child>.btn-group:not(:first-child)>.btn,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle{border-top-left-radius:0;border-bottom-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:active,.input-group-btn>.btn:focus,.input-group-btn>.btn:hover{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.nav>li.disabled>a{color:#777}.nav>li.disabled>a:focus,.nav>li.disabled>a:hover{color:#777;text-decoration:none;cursor:not-allowed;background-color:transparent}.nav .open>a,.nav .open>a:focus,.nav .open>a:hover{background-color:#eee;border-color:#337ab7}.nav .nav-divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #ddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.42857143;border:1px solid transparent;border-radius:4px 4px 0 0}.nav-tabs>li>a:hover{border-color:#eee #eee #ddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus,.nav-tabs>li.active>a:hover{color:#555;cursor:default;background-color:#fff;border:1px solid #ddd;border-bottom-color:transparent}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border-bottom-color:#fff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:4px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:focus,.nav-pills>li.active>a:hover{color:#fff;background-color:#337ab7}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border-bottom-color:#fff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-left-radius:0;border-top-right-radius:0}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse{padding-right:0;padding-left:0}}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:200px}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-bottom,.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-bottom,.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;padding:9px 10px;margin-top:8px;margin-right:15px;margin-bottom:8px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:4px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu .dropdown-header,.navbar-nav .open .dropdown-menu>li>a{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:20px}.navbar-nav .open .dropdown-menu>li>a:focus,.navbar-nav .open .dropdown-menu>li>a:hover{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}.navbar-form{padding:10px 15px;margin-top:8px;margin-right:-15px;margin-bottom:8px;margin-left:-15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .form-control,.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .checkbox,.navbar-form .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .checkbox label,.navbar-form .radio label{padding-left:0}.navbar-form .checkbox input[type=checkbox],.navbar-form .radio input[type=radio]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;padding-top:0;padding-bottom:0;margin-right:0;margin-left:0;border:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-left-radius:0;border-top-right-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:8px;margin-bottom:8px}.navbar-btn.btn-sm{margin-top:10px;margin-bottom:10px}.navbar-btn.btn-xs{margin-top:14px;margin-bottom:14px}.navbar-text{margin-top:15px;margin-bottom:15px}@media (min-width:768px){.navbar-text{float:left;margin-right:15px;margin-left:15px}}@media (min-width:768px){.navbar-left{float:left!important}.navbar-right{float:right!important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-text{color:#777}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:focus,.navbar-default .navbar-nav>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:focus,.navbar-default .navbar-nav>.disabled>a:hover{color:#ccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:#ddd}.navbar-default .navbar-toggle:focus,.navbar-default .navbar-toggle:hover{background-color:#ddd}.navbar-default .navbar-toggle .icon-bar{background-color:#888}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#e7e7e7}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:focus,.navbar-default .navbar-nav>.open>a:hover{color:#555;background-color:#e7e7e7}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#777}.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#ccc;background-color:transparent}}.navbar-default .navbar-link{color:#777}.navbar-default .navbar-link:hover{color:#333}.navbar-default .btn-link{color:#777}.navbar-default .btn-link:focus,.navbar-default .btn-link:hover{color:#333}.navbar-default .btn-link[disabled]:focus,.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:focus,fieldset[disabled] .navbar-default .btn-link:hover{color:#ccc}.navbar-inverse{background-color:#222;border-color:#080808}.navbar-inverse .navbar-brand{color:#9d9d9d}.navbar-inverse .navbar-brand:focus,.navbar-inverse .navbar-brand:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-text{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a:focus,.navbar-inverse .navbar-nav>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:focus,.navbar-inverse .navbar-nav>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:focus,.navbar-inverse .navbar-nav>.disabled>a:hover{color:#444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:#333}.navbar-inverse .navbar-toggle:focus,.navbar-inverse .navbar-toggle:hover{background-color:#333}.navbar-inverse .navbar-toggle .icon-bar{background-color:#fff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#101010}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:focus,.navbar-inverse .navbar-nav>.open>a:hover{color:#fff;background-color:#080808}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#444;background-color:transparent}}.navbar-inverse .navbar-link{color:#9d9d9d}.navbar-inverse .navbar-link:hover{color:#fff}.navbar-inverse .btn-link{color:#9d9d9d}.navbar-inverse .btn-link:focus,.navbar-inverse .btn-link:hover{color:#fff}.navbar-inverse .btn-link[disabled]:focus,.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:focus,fieldset[disabled] .navbar-inverse .btn-link:hover{color:#444}.breadcrumb{padding:8px 15px;margin-bottom:20px;list-style:none;background-color:#f5f5f5;border-radius:4px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{padding:0 5px;color:#ccc;content:"/\00a0"}.breadcrumb>.active{color:#777}.pagination{display:inline-block;padding-left:0;margin:20px 0;border-radius:4px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 12px;margin-left:-1px;line-height:1.42857143;color:#337ab7;text-decoration:none;background-color:#fff;border:1px solid #ddd}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-top-left-radius:4px;border-bottom-left-radius:4px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-top-right-radius:4px;border-bottom-right-radius:4px}.pagination>li>a:focus,.pagination>li>a:hover,.pagination>li>span:focus,.pagination>li>span:hover{z-index:3;color:#23527c;background-color:#eee;border-color:#ddd}.pagination>.active>a,.pagination>.active>a:focus,.pagination>.active>a:hover,.pagination>.active>span,.pagination>.active>span:focus,.pagination>.active>span:hover{z-index:2;color:#fff;cursor:default;background-color:#337ab7;border-color:#337ab7}.pagination>.disabled>a,.pagination>.disabled>a:focus,.pagination>.disabled>a:hover,.pagination>.disabled>span,.pagination>.disabled>span:focus,.pagination>.disabled>span:hover{color:#777;cursor:not-allowed;background-color:#fff;border-color:#ddd}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:18px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-top-left-radius:6px;border-bottom-left-radius:6px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-top-right-radius:6px;border-bottom-right-radius:6px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-top-left-radius:3px;border-bottom-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-top-right-radius:3px;border-bottom-right-radius:3px}.pager{padding-left:0;margin:20px 0;text-align:center;list-style:none}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#fff;border:1px solid #ddd;border-radius:15px}.pager li>a:focus,.pager li>a:hover{text-decoration:none;background-color:#eee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:focus,.pager .disabled>a:hover,.pager .disabled>span{color:#777;cursor:not-allowed;background-color:#fff}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:focus,a.label:hover{color:#fff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#777}.label-default[href]:focus,.label-default[href]:hover{background-color:#5e5e5e}.label-primary{background-color:#337ab7}.label-primary[href]:focus,.label-primary[href]:hover{background-color:#286090}.label-success{background-color:#5cb85c}.label-success[href]:focus,.label-success[href]:hover{background-color:#449d44}.label-info{background-color:#5bc0de}.label-info[href]:focus,.label-info[href]:hover{background-color:#31b0d5}.label-warning{background-color:#f0ad4e}.label-warning[href]:focus,.label-warning[href]:hover{background-color:#ec971f}.label-danger{background-color:#d9534f}.label-danger[href]:focus,.label-danger[href]:hover{background-color:#c9302c}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:middle;background-color:#777;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-group-xs>.btn .badge,.btn-xs .badge{top:0;padding:1px 5px}a.badge:focus,a.badge:hover{color:#fff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#337ab7;background-color:#fff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#eee}.jumbotron .h1,.jumbotron h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:21px;font-weight:200}.jumbotron>hr{border-top-color:#d5d5d5}.container .jumbotron,.container-fluid .jumbotron{border-radius:6px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-right:60px;padding-left:60px}.jumbotron .h1,.jumbotron h1{font-size:63px}}.thumbnail{display:block;padding:4px;margin-bottom:20px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail a>img,.thumbnail>img{margin-right:auto;margin-left:auto}a.thumbnail.active,a.thumbnail:focus,a.thumbnail:hover{border-color:#337ab7}.thumbnail .caption{padding:9px;color:#333}.alert{padding:15px;margin-bottom:20px;border:1px solid transparent;border-radius:4px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:700}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#2b542c}.alert-info{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.alert-info hr{border-top-color:#a6e1ec}.alert-info .alert-link{color:#245269}.alert-warning{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.alert-warning hr{border-top-color:#f7e1b5}.alert-warning .alert-link{color:#66512c}.alert-danger{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.alert-danger hr{border-top-color:#e4b9c0}.alert-danger .alert-link{color:#843534}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{height:20px;margin-bottom:20px;overflow:hidden;background-color:#f5f5f5;border-radius:4px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,.1);box-shadow:inset 0 1px 2px rgba(0,0,0,.1)}.progress-bar{float:left;width:0;height:100%;font-size:12px;line-height:20px;color:#fff;text-align:center;background-color:#337ab7;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);-webkit-transition:width .6s ease;-o-transition:width .6s ease;transition:width .6s ease}.progress-bar-striped,.progress-striped .progress-bar{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress-bar.active,.progress.active .progress-bar{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#5cb85c}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-warning{background-color:#f0ad4e}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-danger{background-color:#d9534f}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{overflow:hidden;zoom:1}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-body,.media-left,.media-right{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{padding-left:0;margin-bottom:20px}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#fff;border:1px solid #ddd}.list-group-item:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:4px;border-bottom-left-radius:4px}a.list-group-item,button.list-group-item{color:#555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333}a.list-group-item:focus,a.list-group-item:hover,button.list-group-item:focus,button.list-group-item:hover{color:#555;text-decoration:none;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:focus,.list-group-item.disabled:hover{color:#777;cursor:not-allowed;background-color:#eee}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text{color:#777}.list-group-item.active,.list-group-item.active:focus,.list-group-item.active:hover{z-index:2;color:#fff;background-color:#337ab7;border-color:#337ab7}.list-group-item.active .list-group-item-heading,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:focus .list-group-item-text,.list-group-item.active:hover .list-group-item-text{color:#c7ddef}.list-group-item-success{color:#3c763d;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#3c763d}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:focus,a.list-group-item-success:hover,button.list-group-item-success:focus,button.list-group-item-success:hover{color:#3c763d;background-color:#d0e9c6}a.list-group-item-success.active,a.list-group-item-success.active:focus,a.list-group-item-success.active:hover,button.list-group-item-success.active,button.list-group-item-success.active:focus,button.list-group-item-success.active:hover{color:#fff;background-color:#3c763d;border-color:#3c763d}.list-group-item-info{color:#31708f;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#31708f}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:focus,a.list-group-item-info:hover,button.list-group-item-info:focus,button.list-group-item-info:hover{color:#31708f;background-color:#c4e3f3}a.list-group-item-info.active,a.list-group-item-info.active:focus,a.list-group-item-info.active:hover,button.list-group-item-info.active,button.list-group-item-info.active:focus,button.list-group-item-info.active:hover{color:#fff;background-color:#31708f;border-color:#31708f}.list-group-item-warning{color:#8a6d3b;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#8a6d3b}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:focus,a.list-group-item-warning:hover,button.list-group-item-warning:focus,button.list-group-item-warning:hover{color:#8a6d3b;background-color:#faf2cc}a.list-group-item-warning.active,a.list-group-item-warning.active:focus,a.list-group-item-warning.active:hover,button.list-group-item-warning.active,button.list-group-item-warning.active:focus,button.list-group-item-warning.active:hover{color:#fff;background-color:#8a6d3b;border-color:#8a6d3b}.list-group-item-danger{color:#a94442;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#a94442}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:focus,a.list-group-item-danger:hover,button.list-group-item-danger:focus,button.list-group-item-danger:hover{color:#a94442;background-color:#ebcccc}a.list-group-item-danger.active,a.list-group-item-danger.active:focus,a.list-group-item-danger.active:hover,button.list-group-item-danger.active,button.list-group-item-danger.active:focus,button.list-group-item-danger.active:hover{color:#fff;background-color:#a94442;border-color:#a94442}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:20px;background-color:#fff;border:1px solid transparent;border-radius:4px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,.05);box-shadow:0 1px 1px rgba(0,0,0,.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-left-radius:3px;border-top-right-radius:3px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:16px;color:inherit}.panel-title>.small,.panel-title>.small>a,.panel-title>a,.panel-title>small,.panel-title>small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #ddd;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-left-radius:3px;border-top-right-radius:3px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-left-radius:0;border-top-right-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.panel-collapse>.table,.panel>.table,.panel>.table-responsive>.table{margin-bottom:0}.panel>.panel-collapse>.table caption,.panel>.table caption,.panel>.table-responsive>.table caption{padding-right:15px;padding-left:15px}.panel>.table-responsive:first-child>.table:first-child,.panel>.table:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table:first-child>thead:first-child>tr:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child{border-top-left-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child{border-top-right-radius:3px}.panel>.table-responsive:last-child>.table:last-child,.panel>.table:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:3px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #ddd}.panel>.table>tbody:first-child>tr:first-child td,.panel>.table>tbody:first-child>tr:first-child th{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{margin-bottom:0;border:0}.panel-group{margin-bottom:20px}.panel-group .panel{margin-bottom:0;border-radius:4px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.list-group,.panel-group .panel-heading+.panel-collapse>.panel-body{border-top:1px solid #ddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #ddd}.panel-default{border-color:#ddd}.panel-default>.panel-heading{color:#333;background-color:#f5f5f5;border-color:#ddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ddd}.panel-primary{border-color:#337ab7}.panel-primary>.panel-heading{color:#fff;background-color:#337ab7;border-color:#337ab7}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#337ab7}.panel-primary>.panel-heading .badge{color:#337ab7;background-color:#fff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#337ab7}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#dff0d8;background-color:#3c763d}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#bce8f1}.panel-info>.panel-heading{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#bce8f1}.panel-info>.panel-heading .badge{color:#d9edf7;background-color:#31708f}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#bce8f1}.panel-warning{border-color:#faebcc}.panel-warning>.panel-heading{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#faebcc}.panel-warning>.panel-heading .badge{color:#fcf8e3;background-color:#8a6d3b}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#faebcc}.panel-danger{border-color:#ebccd1}.panel-danger>.panel-heading{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ebccd1}.panel-danger>.panel-heading .badge{color:#f2dede;background-color:#a94442}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ebccd1}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive embed,.embed-responsive iframe,.embed-responsive object,.embed-responsive video{position:absolute;top:0;bottom:0;left:0;width:100%;height:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f5f5f5;border:1px solid #e3e3e3;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.05);box-shadow:inset 0 1px 1px rgba(0,0,0,.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,.15)}.well-lg{padding:24px;border-radius:6px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:21px;font-weight:700;line-height:1;color:#000;text-shadow:0 1px 0 #fff;filter:alpha(opacity=20);opacity:.2}.close:focus,.close:hover{color:#000;text-decoration:none;cursor:pointer;filter:alpha(opacity=50);opacity:.5}button.close{-webkit-appearance:none;padding:0;cursor:pointer;background:0 0;border:0}.modal-open{overflow:hidden}.modal{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;display:none;overflow:hidden;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out;-webkit-transform:translate(0,-25%);-ms-transform:translate(0,-25%);-o-transform:translate(0,-25%);transform:translate(0,-25%)}.modal.in .modal-dialog{-webkit-transform:translate(0,0);-ms-transform:translate(0,0);-o-transform:translate(0,0);transform:translate(0,0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #999;border:1px solid rgba(0,0,0,.2);border-radius:6px;outline:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,.5);box-shadow:0 3px 9px rgba(0,0,0,.5)}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000}.modal-backdrop.fade{filter:alpha(opacity=0);opacity:0}.modal-backdrop.in{filter:alpha(opacity=50);opacity:.5}.modal-header{min-height:16.43px;padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.42857143}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-bottom:0;margin-left:5px}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,.5);box-shadow:0 5px 15px rgba(0,0,0,.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:12px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;filter:alpha(opacity=0);opacity:0;line-break:auto}.tooltip.in{filter:alpha(opacity=90);opacity:.9}.tooltip.top{padding:5px 0;margin-top:-3px}.tooltip.right{padding:0 5px;margin-left:3px}.tooltip.bottom{padding:5px 0;margin-top:3px}.tooltip.left{padding:0 5px;margin-left:-3px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#fff;text-align:center;background-color:#000;border-radius:4px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-left .tooltip-arrow{right:5px;bottom:0;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#000}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#000}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.2);border-radius:6px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,.2);box-shadow:0 5px 10px rgba(0,0,0,.2);line-break:auto}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{padding:8px 14px;margin:0;font-size:14px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:5px 5px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{content:"";border-width:10px}.popover.top>.arrow{bottom:-11px;left:50%;margin-left:-11px;border-top-color:#999;border-top-color:rgba(0,0,0,.25);border-bottom-width:0}.popover.top>.arrow:after{bottom:1px;margin-left:-10px;content:" ";border-top-color:#fff;border-bottom-width:0}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-right-color:#999;border-right-color:rgba(0,0,0,.25);border-left-width:0}.popover.right>.arrow:after{bottom:-10px;left:1px;content:" ";border-right-color:#fff;border-left-width:0}.popover.bottom>.arrow{top:-11px;left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#999;border-bottom-color:rgba(0,0,0,.25)}.popover.bottom>.arrow:after{top:1px;margin-left:-10px;content:" ";border-top-width:0;border-bottom-color:#fff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#999;border-left-color:rgba(0,0,0,.25)}.popover.left>.arrow:after{right:1px;bottom:-10px;content:" ";border-right-width:0;border-left-color:#fff}.carousel{position:relative}.carousel-inner{position:relative;width:100%;overflow:hidden}.carousel-inner>.item{position:relative;display:none;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>a>img,.carousel-inner>.item>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.active.right,.carousel-inner>.item.next{left:0;-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.carousel-inner>.item.active.left,.carousel-inner>.item.prev{left:0;-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}.carousel-inner>.item.active,.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right{left:0;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;bottom:0;left:0;width:15%;font-size:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6);filter:alpha(opacity=50);opacity:.5}.carousel-control.left{background-image:-webkit-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.5)),to(rgba(0,0,0,.0001)));background-image:linear-gradient(to right,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);background-repeat:repeat-x}.carousel-control.right{right:0;left:auto;background-image:-webkit-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.0001)),to(rgba(0,0,0,.5)));background-image:linear-gradient(to right,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);background-repeat:repeat-x}.carousel-control:focus,.carousel-control:hover{color:#fff;text-decoration:none;filter:alpha(opacity=90);outline:0;opacity:.9}.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{position:absolute;top:50%;z-index:5;display:inline-block;margin-top:-10px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{left:50%;margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{right:50%;margin-right:-10px}.carousel-control .icon-next,.carousel-control .icon-prev{width:20px;height:20px;font-family:serif;line-height:1}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;padding-left:0;margin-left:-30%;text-align:center;list-style:none}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;cursor:pointer;background-color:#000\9;background-color:rgba(0,0,0,0);border:1px solid #fff;border-radius:10px}.carousel-indicators .active{width:12px;height:12px;margin:0;background-color:#fff}.carousel-caption{position:absolute;right:15%;bottom:20px;left:15%;z-index:10;padding-top:20px;padding-bottom:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{width:30px;height:30px;margin-top:-15px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-15px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-15px}.carousel-caption{right:20%;left:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.btn-group-vertical>.btn-group:after,.btn-group-vertical>.btn-group:before,.btn-toolbar:after,.btn-toolbar:before,.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.dl-horizontal dd:after,.dl-horizontal dd:before,.form-horizontal .form-group:after,.form-horizontal .form-group:before,.modal-footer:after,.modal-footer:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.pager:after,.pager:before,.panel-body:after,.panel-body:before,.row:after,.row:before{display:table;content:" "}.btn-group-vertical>.btn-group:after,.btn-toolbar:after,.clearfix:after,.container-fluid:after,.container:after,.dl-horizontal dd:after,.form-horizontal .form-group:after,.modal-footer:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.pager:after,.panel-body:after,.row:after{clear:both}.center-block{display:block;margin-right:auto;margin-left:auto}.pull-right{float:right!important}.pull-left{float:left!important}.hide{display:none!important}.show{display:block!important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none!important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-lg,.visible-md,.visible-sm,.visible-xs{display:none!important}.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block{display:none!important}@media (max-width:767px){.visible-xs{display:block!important}table.visible-xs{display:table!important}tr.visible-xs{display:table-row!important}td.visible-xs,th.visible-xs{display:table-cell!important}}@media (max-width:767px){.visible-xs-block{display:block!important}}@media (max-width:767px){.visible-xs-inline{display:inline!important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block!important}table.visible-sm{display:table!important}tr.visible-sm{display:table-row!important}td.visible-sm,th.visible-sm{display:table-cell!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block!important}table.visible-md{display:table!important}tr.visible-md{display:table-row!important}td.visible-md,th.visible-md{display:table-cell!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block!important}}@media (min-width:1200px){.visible-lg{display:block!important}table.visible-lg{display:table!important}tr.visible-lg{display:table-row!important}td.visible-lg,th.visible-lg{display:table-cell!important}}@media (min-width:1200px){.visible-lg-block{display:block!important}}@media (min-width:1200px){.visible-lg-inline{display:inline!important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block!important}}@media (max-width:767px){.hidden-xs{display:none!important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none!important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none!important}}@media (min-width:1200px){.hidden-lg{display:none!important}}.visible-print{display:none!important}@media print{.visible-print{display:block!important}table.visible-print{display:table!important}tr.visible-print{display:table-row!important}td.visible-print,th.visible-print{display:table-cell!important}}.visible-print-block{display:none!important}@media print{.visible-print-block{display:block!important}}.visible-print-inline{display:none!important}@media print{.visible-print-inline{display:inline!important}}.visible-print-inline-block{display:none!important}@media print{.visible-print-inline-block{display:inline-block!important}}@media print{.hidden-print{display:none!important}}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<style type="text/css">.pagedtable {
overflow: auto;
padding-left: 8px;
padding-right: 8px;
}
.pagedtable-wrapper {
border: 1px solid #ccc;
border-radius: 4px;
margin-bottom: 10px;
}
.pagedtable table {
width: 100%;
max-width: 100%;
margin: 0;
}
.pagedtable th {
padding: 0 5px 0 5px;
border: none;
border-bottom: 2px solid #dddddd;
min-width: 45px;
}
.pagedtable-empty th {
display: none;
}
.pagedtable td {
padding: 0 4px 0 4px;
}
.pagedtable .even {
background-color: rgba(140, 140, 140, 0.1);
}
.pagedtable-padding-col {
display: none;
}
.pagedtable a {
-webkit-touch-callout: none;
-webkit-user-select: none;
-khtml-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.pagedtable-index-nav {
cursor: pointer;
padding: 0 5px 0 5px;
float: right;
border: 0;
}
.pagedtable-index-nav-disabled {
cursor: default;
text-decoration: none;
color: #999;
}
a.pagedtable-index-nav-disabled:hover {
text-decoration: none;
color: #999;
}
.pagedtable-indexes {
cursor: pointer;
float: right;
border: 0;
}
.pagedtable-index-current {
cursor: default;
text-decoration: none;
font-weight: bold;
color: #333;
border: 0;
}
a.pagedtable-index-current:hover {
text-decoration: none;
font-weight: bold;
color: #333;
}
.pagedtable-index {
width: 30px;
display: inline-block;
text-align: center;
border: 0;
}
.pagedtable-index-separator-left {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 0 0 0;
cursor: default;
}
.pagedtable-index-separator-right {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 4px 0 0;
cursor: default;
}
.pagedtable-footer {
padding-top: 4px;
padding-bottom: 5px;
}
.pagedtable-not-empty .pagedtable-footer {
border-top: 2px solid #dddddd;
}
.pagedtable-info {
overflow: hidden;
color: #999;
white-space: nowrap;
text-overflow: ellipsis;
}
.pagedtable-header-name {
overflow: hidden;
text-overflow: ellipsis;
}
.pagedtable-header-type {
color: #999;
font-weight: 400;
}
.pagedtable-na-cell {
font-style: italic;
opacity: 0.3;
}
</style>
<script>// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = Math.max(
          column.label.toString().length,
          column.type.toString().length
        );

        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    function retryFit() {
      if (tableDiv.clientWidth <= 0) {
        setTimeout(retryFit, 100);
      } else {
        me.render();
        triggerOnChange();
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<script>
window.initializeCodeFolding = function(show) {

  // handlers for show-all and hide all
  $("#rmd-show-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('show');
    });
  });
  $("#rmd-hide-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('hide');
    });
  });

  // index for unique code element ids
  var currentIndex = 1;

  // select all R code blocks
  var rCodeBlocks = $('pre.r, pre.python, pre.bash, pre.sql, pre.cpp, pre.stan, pre.julia, pre.foldable');
  rCodeBlocks.each(function() {
    // skip if the block has fold-none class
    if ($(this).hasClass('fold-none')) return;

    // create a collapsable div to wrap the code in
    var div = $('<div class="collapse r-code-collapse"></div>');
    var showThis = (show || $(this).hasClass('fold-show')) && !$(this).hasClass('fold-hide');
    var id = 'rcode-643E0F36' + currentIndex++;
    div.attr('id', id);
    $(this).before(div);
    $(this).detach().appendTo(div);

    // add a show code button right above
    var showCodeText = $('<span>' + (showThis ? 'Hide' : 'Code') + '</span>');
    var showCodeButton = $('<button type="button" class="btn btn-default btn-xs btn-secondary btn-sm code-folding-btn pull-right float-right"></button>');
    showCodeButton.append(showCodeText);
    showCodeButton
        .attr('data-toggle', 'collapse')
        .attr('data-bs-toggle', 'collapse') // BS5
        .attr('data-target', '#' + id)
        .attr('data-bs-target', '#' + id)   // BS5
        .attr('aria-expanded', showThis)
        .attr('aria-controls', id);

    var buttonRow = $('<div class="row"></div>');
    var buttonCol = $('<div class="col-md-12"></div>');

    buttonCol.append(showCodeButton);
    buttonRow.append(buttonCol);

    div.before(buttonRow);

    // show the div if necessary
    if (showThis) div.collapse('show');

    // update state of button on show/hide
    //   * Change text
    //   * add a class for intermediate states styling
    div.on('hide.bs.collapse', function () {
      showCodeText.text('Code');
      showCodeButton.addClass('btn-collapsing');
    });
    div.on('hidden.bs.collapse', function () {
      showCodeButton.removeClass('btn-collapsing');
    });
    div.on('show.bs.collapse', function () {
      showCodeText.text('Hide');
      showCodeButton.addClass('btn-expanding');
    });
    div.on('shown.bs.collapse', function () {
      showCodeButton.removeClass('btn-expanding');
    });

  });

}
</script>
<script>
window.initializeSourceEmbed = function(filename) {
  $("#rmd-download-source").click(function() {
    var src = $("#rmd-source-code").html();
    var a = document.createElement('a');
    a.href = "data:text/x-r-markdown;base64," + src;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    document.body.removeChild(a);
  });
};
</script>
<style type="text/css">.hljs-literal {
color: rgb(88, 72, 246);
}
.hljs-number {
color: rgb(0, 0, 205);
}
.hljs-comment {
color: rgb(76, 136, 107);
}
.hljs-keyword {
color: rgb(0, 0, 255);
}
.hljs-string {
color: rgb(3, 106, 7);
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>




<style type="text/css">
#rmd-source-code {
  display: none;
}
</style>





<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>

<style type="text/css">
.kable-table {
  border: 1px solid #ccc;
  border-radius: 4px;
  overflow: auto;
  padding-left: 8px;
  padding-right: 8px;
  margin-bottom: 20px;
  max-height: 350px;
}

.kable-table table {
  margin-bottom: 0px;
}

.kable-table table>thead>tr>th {
  border: none;
  border-bottom: 2px solid #dddddd;
}

.kable-table table>thead {
  background-color: #fff;
}
</style>


<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "î‰™";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "î‰˜";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "î‰™";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>




</head>

<body>


<div class="container-fluid main-container">




<div id="header">

<div class="btn-group pull-right float-right">
<button type="button" class="btn btn-default btn-xs btn-secondary btn-sm dropdown-toggle" data-toggle="dropdown" data-bs-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu dropdown-menu-right" style="min-width: 50px;">
<li><a id="rmd-show-all-code" href="#">Show All Code</a></li>
<li><a id="rmd-hide-all-code" href="#">Hide All Code</a></li>
<li role="separator" class="divider"></li>
<li><a id="rmd-download-source" href="#">Download Rmd</a></li>
</ul>
</div>



<h1 class="title toc-ignore">Preprocess and Curate the 11 Gold-Standard
Datasets; Also give DeepTargetâ€™s Score for each hit</h1>

</div>


<!-- rnb-text-begin -->
<!-- Here, we will Curate and preprocess 11 gold-standard datasets -->
<!-- Validation of Step 1: Primary target identification -->
<!-- Set the working Directory -->
<!-- rnb-text-end -->
<!-- rnb-text-begin -->
<!-- Uncomment this chunk to run this script independently -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxud29ya2luZ19kaXJlY3Rvcnk9Jy9Vc2Vycy9zaW5oYXM4L1Byb2plY3RfVHJ1ZVRhcmdldC8nXG5rbml0cjo6b3B0c19rbml0JHNldChyb290LmRpciA9IHdvcmtpbmdfZGlyZWN0b3J5KVxuYGBgIn0= -->
<pre class="r"><code>working_directory=&#39;/Users/sinhas8/Project_TrueTarget/&#39;
knitr::opts_knit$set(root.dir = working_directory)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 1: Drug-Target pairs with multiple independent reports (>3) as per BioGrid (Biogrid Highly Cited, N=28).We Curate this from BioGrid Chemical Interaction database. -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 2: Drug-Target pairs, where drugs are inhibitors & target have a pharmacologically active status from DrugBank-->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>load(&#39;Data/drugs2targets.RData&#39;)
numberOfTargets=table(drugs2targets$drug.name)
drugs2targets$numberOfTargets=numberOfTargets[match(drugs2targets$drug.name, names(numberOfTargets))]
active_drugs2targets=drugs2targets[which(drugs2targets$pharmaco.active==&#39;yes&#39; &amp; 
                                           drugs2targets$action.simp.strict==&#39;inhibition&#39;),]
numberOfActiveTargets=table(as.character(active_drugs2targets$drug.name))
active_drugs2targets$numberOfActiveTargets=numberOfActiveTargets[match(active_drugs2targets$drug.name, names(numberOfActiveTargets))]
matched_gs3=active_drugs2targets[stripall2match(active_drugs2targets$drug.name) %in%
                                    KnownTarget_predictions$drugName_stripall,]
matched_gs3=na.omit(matched_gs3)
# Seed for creating shuffled Negative labels
seedNumber=1
#Filtering Criteria and conditions;
numberOfActiveTargets_Thr=2;numberOfTargets_Thr=2; drug_type=&#39;inhibitor&#39;
cond1=matched_gs3$numberOfActiveTargets&lt;numberOfActiveTargets_Thr
cond2=matched_gs3$numberOfTargets&lt;numberOfTargets_Thr
cond3=matched_gs3$action==drug_type
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=matched_gs3$protein.gene.symbol[cond1 &amp; cond2 &amp; cond3], 
                                               Chemical.Name=matched_gs3$drug.name[cond1 &amp; cond2 &amp; cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)

Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))

Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset2=data.frame(Complete_Set, Source=&#39;DrugBank Active Inhibitors&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 3: Repeating the above but focusing on Antagonists instead of Inhibitors-->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>load(&#39;Data/drugs2targets.RData&#39;)
numberOfTargets=table(drugs2targets$drug.name)
drugs2targets$numberOfTargets=numberOfTargets[match(drugs2targets$drug.name, names(numberOfTargets))]
active_drugs2targets=drugs2targets[which(drugs2targets$pharmaco.active==&#39;yes&#39; &amp; 
                                           drugs2targets$action.simp.strict==&#39;inhibition&#39;),]
numberOfActiveTargets=table(as.character(active_drugs2targets$drug.name))
active_drugs2targets$numberOfActiveTargets=numberOfActiveTargets[match(active_drugs2targets$drug.name, names(numberOfActiveTargets))]
matched_gs3=active_drugs2targets[stripall2match(active_drugs2targets$drug.name) %in%
                                    KnownTarget_predictions$drugName_stripall,]
matched_gs3=na.omit(matched_gs3)
# Seed for creating shuffled Negative labels
seedNumber=1
#Filtering Criteria and conditions;
numberOfActiveTargets_Thr=2;numberOfTargets_Thr=2; drug_type=&#39;inhibitor&#39;
cond1=matched_gs3$numberOfActiveTargets&lt;numberOfActiveTargets_Thr
cond2=matched_gs3$numberOfTargets&lt;numberOfTargets_Thr
cond3=matched_gs3$action==drug_type
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=matched_gs3$protein.gene.symbol[cond1 &amp; cond2 &amp; cond3], 
                                               Chemical.Name=matched_gs3$drug.name[cond1 &amp; cond2 &amp; cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)

Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))

Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset2=data.frame(Complete_Set, Source=&#39;DrugBank Active Inhibitors&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 4: Drug-Target pairs from ChemicalProbes.org Scientific Advisory Board recommendation score   -->
<!-- Note: if we increase our stringency, our prediction power increases -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>seedNumber=1
#Filtering Criteria and conditions;
numberOfActiveTargets_Thr=2;numberOfTargets_Thr=3; drug_type=&#39;antagonist&#39;
cond1=matched_gs3$numberOfActiveTargets&lt;numberOfActiveTargets_Thr
cond2=matched_gs3$numberOfTargets&lt;numberOfTargets_Thr
cond3=matched_gs3$action==drug_type
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=matched_gs3$protein.gene.symbol[cond1 &amp; cond2 &amp; cond3], 
                                               Chemical.Name=matched_gs3$drug.name[cond1 &amp; cond2 &amp; cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)

Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))

Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset3=data.frame(Complete_Set, Source=&#39;DrugBank Active antagonists&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 5: Drug Target pairs where, a mutation in the target gene causes clinical resistance to the drug; from COSMIC (COSMIC resistance, N=16) (COSMICv91 Drug Resistance file) -->
<!-- Note: if we increase our stringency, our prediction power increases -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-frame-begin 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 -->
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["Probe Name"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Protein target"],"name":[2],"type":["chr"],"align":["left"]},{"label":["Target class"],"name":[3],"type":["chr"],"align":["left"]},{"label":["Subclass"],"name":[4],"type":["chr"],"align":["left"]},{"label":["Number of SAB Reviews"],"name":[5],"type":["dbl"],"align":["right"]},{"label":["Avg Rating (in cells)"],"name":[6],"type":["dbl"],"align":["right"]}],"data":[{"1":"afatinib","2":"EGFR, ERBB2","3":"Protein kinase","4":"Tyrosine Kinase","5":"3","6":"2.6667"}],"options":{"columns":{"min":{},"max":[10],"total":[6]},"rows":{"min":[10],"max":[10],"total":[1]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 6: Drug Target pairs where, a mutation in the target gene causes clinical resistance to the drug; from onkoKB -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>CosmicResistanceMutations=read.table(&#39;Data/CosmicResistanceMutations.tsv&#39;, sep=&#39;\t&#39;)
colnames(CosmicResistanceMutations)=as.character(unlist(CosmicResistanceMutations[1,]))
CosmicResistanceMutations=CosmicResistanceMutations[-1,]
CosmicResistanceMutations=CosmicResistanceMutations[-1,]
CosmicResistanceMutations[CosmicResistanceMutations$`Drug Name`==&#39;Ibrutinib&#39;,]</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["data.frame"],"nrow":144,"ncol":27,"summary":{"Description":["df [144 × 27]"]}},"rdf":"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"} -->
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":[""],"name":["_rn_"],"type":[""],"align":["left"]},{"label":["Sample Name"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Sample ID"],"name":[2],"type":["chr"],"align":["left"]},{"label":["Gene Name"],"name":[3],"type":["chr"],"align":["left"]},{"label":["Transcript"],"name":[4],"type":["chr"],"align":["left"]},{"label":["Census Gene"],"name":[5],"type":["chr"],"align":["left"]},{"label":["Drug Name"],"name":[6],"type":["chr"],"align":["left"]},{"label":["MUTATION_ID"],"name":[7],"type":["chr"],"align":["left"]},{"label":["GENOMIC_MUTATION_ID"],"name":[8],"type":["chr"],"align":["left"]},{"label":["LEGACY_MUTATION_ID"],"name":[9],"type":["chr"],"align":["left"]},{"label":["AA Mutation"],"name":[10],"type":["chr"],"align":["left"]},{"label":["CDS Mutation"],"name":[11],"type":["chr"],"align":["left"]},{"label":["Primary Tissue"],"name":[12],"type":["chr"],"align":["left"]},{"label":["Tissue Subtype 1"],"name":[13],"type":["chr"],"align":["left"]},{"label":["Tissue Subtype 2"],"name":[14],"type":["chr"],"align":["left"]},{"label":["Histology"],"name":[15],"type":["chr"],"align":["left"]},{"label":["Histology Subtype 1"],"name":[16],"type":["chr"],"align":["left"]},{"label":["Histology Subtype 2"],"name":[17],"type":["chr"],"align":["left"]},{"label":["Pubmed Id"],"name":[18],"type":["chr"],"align":["left"]},{"label":["CGP Study"],"name":[19],"type":["chr"],"align":["left"]},{"label":["Somatic Status"],"name":[20],"type":["chr"],"align":["left"]},{"label":["Sample Type"],"name":[21],"type":["chr"],"align":["left"]},{"label":["Zygosity"],"name":[22],"type":["chr"],"align":["left"]},{"label":["Genome Coordinates (GRCh38)"],"name":[23],"type":["chr"],"align":["left"]},{"label":["Tier"],"name":[24],"type":["chr"],"align":["left"]},{"label":["HGVSP"],"name":[25],"type":["chr"],"align":["left"]},{"label":["HGVSC"],"name":[26],"type":["chr"],"align":["left"]},{"label":["HGVSG"],"name":[27],"type":["chr"],"align":["left"]}],"data":[{"1":"2616286","2":"2616286","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"39"},{"1":"2621340","2":"2621340","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"40"},{"1":"2623674","2":"2623674","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"155910767","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000479125.1:p.Thr316Ala","26":"ENST00000618050.4:c.946A>G","27":"X:g.101358645T>C","_rn_":"41"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901244","8":"COSV58122597","9":"COSM6053939","10":"p.?","11":"c.1039-1482G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>A","27":"X:g.101356176C>T","_rn_":"154"},{"1":"2616284","2":"2616284","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171659105","8":"","9":"COSM6188650","10":"p.C481F","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Phe","26":"","27":"","_rn_":"155"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449353","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1441T>A","27":"X:g.101356177A>T","_rn_":"207"},{"1":"2616260","2":"2616260","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"210"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901581","8":"COSV58117871","9":"COSM6053937","10":"p.?","11":"c.1039-1483T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>A","27":"X:g.101356177A>T","_rn_":"264"},{"1":"2623673","2":"2623673","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"154988865","8":"COSV58118015","9":"COSM6191212","10":"p.T350A","11":"c.1048A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"1","25":"ENSP00000483570.1:p.Thr350Ala","26":"ENST00000621635.4:c.1048A>G","27":"X:g.101358645T>C","_rn_":"265"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901581","8":"COSV58117871","9":"COSM6053937","10":"p.?","11":"c.1039-1483T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>A","27":"X:g.101356177A>T","_rn_":"322"},{"1":"2609319","2":"2609319","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"323"},{"1":"2616267","2":"2616267","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"117599033","8":"COSV58122516","9":"COSM6191211","10":"p.?","11":"c.1039-1482G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>T","27":"X:g.101356176C>A","_rn_":"324"},{"1":"2616294","2":"2616294","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"325"},{"1":"2621340","2":"2621340","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"374"},{"1":"2621349","2":"2621349","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"375"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"474"},{"1":"2608498","2":"2608498","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"475"},{"1":"2628607","2":"2628607","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039310","8":"COSV58119120","9":"COSM6196566","10":"p.C515S","11":"c.1544_1545delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544_1545delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"476"},{"1":"2608492","2":"2608492","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039506","8":"COSV58117871","9":"COSM6053937","10":"p.C515S","11":"c.1543T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1543T>A","27":"X:g.101356177A>T","_rn_":"538"},{"1":"2621495","2":"2621495","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449353","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1441T>A","27":"X:g.101356177A>T","_rn_":"539"},{"1":"2628609","2":"2628609","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"647"},{"1":"2616260","2":"2616260","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"698"},{"1":"2621333","2":"2621333","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"699"},{"1":"2621495","2":"2621495","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901581","8":"COSV58117871","9":"COSM6053937","10":"p.?","11":"c.1039-1483T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>A","27":"X:g.101356177A>T","_rn_":"700"},{"1":"2628609","2":"2628609","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"701"},{"1":"2608492","2":"2608492","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"761"},{"1":"2621496","2":"2621496","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039506","8":"COSV58117871","9":"COSM6053937","10":"p.C515S","11":"c.1543T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1543T>A","27":"X:g.101356177A>T","_rn_":"763"},{"1":"2621496","2":"2621496","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901581","8":"COSV58117871","9":"COSM6053937","10":"p.?","11":"c.1039-1483T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>A","27":"X:g.101356177A>T","_rn_":"764"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"823"},{"1":"2616262","2":"2616262","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"824"},{"1":"2619738","2":"2619738","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"27199251","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"825"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449353","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1441T>A","27":"X:g.101356177A>T","_rn_":"882"},{"1":"2621349","2":"2621349","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"883"},{"1":"2608492","2":"2608492","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039514","8":"COSV58117643","9":"COSM6053936","10":"p.C515R","11":"c.1543T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Arg","26":"ENST00000621635.4:c.1543T>C","27":"X:g.101356177A>G","_rn_":"985"},{"1":"2609319","2":"2609319","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"986"},{"1":"2616262","2":"2616262","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"987"},{"1":"2616264","2":"2616264","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"988"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883241","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Arg","26":"ENST00000308731.7:c.1441T>C","27":"X:g.101356177A>G","_rn_":"1031"},{"1":"2609321","2":"2609321","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"1032"},{"1":"2616262","2":"2616262","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1033"},{"1":"2616298","2":"2616298","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"1034"},{"1":"2621336","2":"2621336","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1035"},{"1":"2616300","2":"2616300","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"1088"},{"1":"2616304","2":"2616304","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171659664","8":"","9":"COSM6188655","10":"p.C481R","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Arg","26":"","27":"","_rn_":"1089"},{"1":"2621287","2":"2621287","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039506","8":"COSV58117871","9":"COSM6053937","10":"p.C515S","11":"c.1543T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1543T>A","27":"X:g.101356177A>T","_rn_":"1090"},{"1":"2628609","2":"2628609","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1091"},{"1":"2608498","2":"2608498","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"1137"},{"1":"2619738","2":"2619738","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"27199251","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1138"},{"1":"2621496","2":"2621496","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449353","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1441T>A","27":"X:g.101356177A>T","_rn_":"1139"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901581","8":"COSV58117871","9":"COSM6053937","10":"p.?","11":"c.1039-1483T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>A","27":"X:g.101356177A>T","_rn_":"1191"},{"1":"2621284","2":"2621284","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1193"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901590","8":"COSV58117643","9":"COSM6053936","10":"p.?","11":"c.1039-1483T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>C","27":"X:g.101356177A>G","_rn_":"1194"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94882774","8":"COSV58122597","9":"COSM6053939","10":"p.C481Y","11":"c.1442G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Tyr","26":"ENST00000308731.7:c.1442G>A","27":"X:g.101356176C>T","_rn_":"1258"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901590","8":"COSV58117643","9":"COSM6053936","10":"p.?","11":"c.1039-1483T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>C","27":"X:g.101356177A>G","_rn_":"1259"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449353","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1441T>A","27":"X:g.101356177A>T","_rn_":"1310"},{"1":"2621495","2":"2621495","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883232","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1441T>A","27":"X:g.101356177A>T","_rn_":"1361"},{"1":"2608487","2":"2608487","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039506","8":"COSV58117871","9":"COSM6053937","10":"p.C515S","11":"c.1543T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1543T>A","27":"X:g.101356177A>T","_rn_":"1420"},{"1":"2621333","2":"2621333","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1422"},{"1":"2621274","2":"2621274","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1486"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"1487"},{"1":"2621284","2":"2621284","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"1538"},{"1":"2621333","2":"2621333","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"1539"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883241","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Arg","26":"ENST00000308731.7:c.1441T>C","27":"X:g.101356177A>G","_rn_":"1586"},{"1":"2608492","2":"2608492","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039204","8":"COSV58122597","9":"COSM6053939","10":"p.C515Y","11":"c.1544G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Tyr","26":"ENST00000621635.4:c.1544G>A","27":"X:g.101356176C>T","_rn_":"1587"},{"1":"2621274","2":"2621274","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1647"},{"1":"2628606","2":"2628606","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901345","8":"COSV58119120","9":"COSM6196566","10":"p.?","11":"c.1039-1482_1039-1481delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482_1039-1481delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"1648"},{"1":"2616262","2":"2616262","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1705"},{"1":"2616264","2":"2616264","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"1768"},{"1":"2608487","2":"2608487","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1824"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901590","8":"COSV58117643","9":"COSM6053936","10":"p.?","11":"c.1039-1483T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"","26":"ENST00000372880.5:c.1039-1483T>C","27":"X:g.101356177A>G","_rn_":"1825"},{"1":"2616264","2":"2616264","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"1826"},{"1":"2608487","2":"2608487","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039204","8":"COSV58122597","9":"COSM6053939","10":"p.C515Y","11":"c.1544G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Tyr","26":"ENST00000621635.4:c.1544G>A","27":"X:g.101356176C>T","_rn_":"1877"},{"1":"2623673","2":"2623673","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"163913542","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000308176.7:p.Thr316Ala","26":"ENST00000308731.7:c.946A>G","27":"X:g.101358645T>C","_rn_":"1878"},{"1":"2616266","2":"2616266","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"163908170","8":"COSV58122516","9":"COSM6191211","10":"p.C481F","11":"c.1442G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Phe","26":"ENST00000308731.7:c.1442G>T","27":"X:g.101356176C>A","_rn_":"1979"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883241","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Arg","26":"ENST00000308731.7:c.1441T>C","27":"X:g.101356177A>G","_rn_":"1980"},{"1":"2628607","2":"2628607","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449078","8":"COSV58119120","9":"COSM6196566","10":"p.C481S","11":"c.1442_1443delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442_1443delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"2091"},{"1":"2616267","2":"2616267","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"154985935","8":"COSV58122516","9":"COSM6191211","10":"p.C515F","11":"c.1544G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Phe","26":"ENST00000621635.4:c.1544G>T","27":"X:g.101356176C>A","_rn_":"2145"},{"1":"2616296","2":"2616296","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"2146"},{"1":"2621336","2":"2621336","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2147"},{"1":"2621336","2":"2621336","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"2148"},{"1":"2616260","2":"2616260","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2215"},{"1":"2616266","2":"2616266","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"155907011","8":"COSV58122516","9":"COSM6191211","10":"p.C481F","11":"c.1442G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Phe","26":"ENST00000618050.4:c.1442G>T","27":"X:g.101356176C>A","_rn_":"2441"},{"1":"2621496","2":"2621496","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883232","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1441T>A","27":"X:g.101356177A>T","_rn_":"2442"},{"1":"2623673","2":"2623673","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"155910767","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000479125.1:p.Thr316Ala","26":"ENST00000618050.4:c.946A>G","27":"X:g.101358645T>C","_rn_":"2443"},{"1":"2623674","2":"2623674","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"117603008","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000361971.1:p.Thr316Ala","26":"ENST00000372880.5:c.946A>G","27":"X:g.101358645T>C","_rn_":"2444"},{"1":"2628606","2":"2628606","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94882946","8":"COSV58119120","9":"COSM6196566","10":"p.C481S","11":"c.1442_1443delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442_1443delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"2445"},{"1":"2616267","2":"2616267","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"163908170","8":"COSV58122516","9":"COSM6191211","10":"p.C481F","11":"c.1442G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Phe","26":"ENST00000308731.7:c.1442G>T","27":"X:g.101356176C>A","_rn_":"2507"},{"1":"2616290","2":"2616290","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"2508"},{"1":"2621284","2":"2621284","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2509"},{"1":"2621287","2":"2621287","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2510"},{"1":"2621336","2":"2621336","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2511"},{"1":"2609319","2":"2609319","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2561"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883232","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1441T>A","27":"X:g.101356177A>T","_rn_":"2609"},{"1":"2616304","2":"2616304","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171659663","8":"","9":"COSM6188654","10":"p.C481Y","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Tyr","26":"","27":"","_rn_":"2610"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"2611"},{"1":"2621340","2":"2621340","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"2612"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2664"},{"1":"2621274","2":"2621274","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"2665"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2666"},{"1":"2621349","2":"2621349","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2667"},{"1":"2628607","2":"2628607","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901345","8":"COSV58119120","9":"COSM6196566","10":"p.?","11":"c.1039-1482_1039-1481delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482_1039-1481delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"2669"},{"1":"2608487","2":"2608487","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039514","8":"COSV58117643","9":"COSM6053936","10":"p.C515R","11":"c.1543T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Arg","26":"ENST00000621635.4:c.1543T>C","27":"X:g.101356177A>G","_rn_":"2718"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883232","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1441T>A","27":"X:g.101356177A>T","_rn_":"2719"},{"1":"2619738","2":"2619738","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"27199251","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2771"},{"1":"2628606","2":"2628606","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039310","8":"COSV58119120","9":"COSM6196566","10":"p.C515S","11":"c.1544_1545delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544_1545delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"2772"},{"1":"2628609","2":"2628609","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2773"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111448970","8":"COSV58122597","9":"COSM6053939","10":"p.C481Y","11":"c.1442G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Tyr","26":"ENST00000618050.4:c.1442G>A","27":"X:g.101356176C>T","_rn_":"2837"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111448970","8":"COSV58122597","9":"COSM6053939","10":"p.C481Y","11":"c.1442G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Tyr","26":"ENST00000618050.4:c.1442G>A","27":"X:g.101356176C>T","_rn_":"2838"},{"1":"2623674","2":"2623674","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"154988865","8":"COSV58118015","9":"COSM6191212","10":"p.T350A","11":"c.1048A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"1","25":"ENSP00000483570.1:p.Thr350Ala","26":"ENST00000621635.4:c.1048A>G","27":"X:g.101358645T>C","_rn_":"2839"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"2889"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449362","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Arg","26":"ENST00000618050.4:c.1441T>C","27":"X:g.101356177A>G","_rn_":"2890"},{"1":"2621333","2":"2621333","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2891"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2949"},{"1":"2608498","2":"2608498","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"2950"},{"1":"2609321","2":"2609321","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2951"},{"1":"2616267","2":"2616267","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"155907011","8":"COSV58122516","9":"COSM6191211","10":"p.C481F","11":"c.1442G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Phe","26":"ENST00000618050.4:c.1442G>T","27":"X:g.101356176C>A","_rn_":"2952"},{"1":"2621340","2":"2621340","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"2953"},{"1":"2623674","2":"2623674","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"163913542","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000308176.7:p.Thr316Ala","26":"ENST00000308731.7:c.946A>G","27":"X:g.101358645T>C","_rn_":"2954"},{"1":"2628607","2":"2628607","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94882946","8":"COSV58119120","9":"COSM6196566","10":"p.C481S","11":"c.1442_1443delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442_1443delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"2955"},{"1":"2616266","2":"2616266","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"154985935","8":"COSV58122516","9":"COSM6191211","10":"p.C515F","11":"c.1544G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Phe","26":"ENST00000621635.4:c.1544G>T","27":"X:g.101356176C>A","_rn_":"3006"},{"1":"2628606","2":"2628606","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449078","8":"COSV58119120","9":"COSM6196566","10":"p.C481S","11":"c.1442_1443delinsCT","12":"haematopoietic_and_lymphoid_tissue","13":"lymph_node","14":"NS","15":"lymphoid_neoplasm","16":"mantle_cell_lymphoma","17":"NS","18":"25082755","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356175..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442_1443delinsCT","27":"X:g.101356175_101356176delinsAG","_rn_":"3007"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449362","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Arg","26":"ENST00000618050.4:c.1441T>C","27":"X:g.101356177A>G","_rn_":"3070"},{"1":"2616288","2":"2616288","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"3071"},{"1":"2616302","2":"2616302","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"3072"},{"1":"2621274","2":"2621274","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3073"},{"1":"2621287","2":"2621287","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039514","8":"COSV58117643","9":"COSM6053936","10":"p.C515R","11":"c.1543T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Arg","26":"ENST00000621635.4:c.1543T>C","27":"X:g.101356177A>G","_rn_":"3113"},{"1":"2621495","2":"2621495","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112039506","8":"COSV58117871","9":"COSM6053937","10":"p.C515S","11":"c.1543T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869597","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1543T>A","27":"X:g.101356177A>T","_rn_":"3114"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96901244","8":"COSV58122597","9":"COSM6053939","10":"p.?","11":"c.1039-1482G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>A","27":"X:g.101356176C>T","_rn_":"3172"},{"1":"2608487","2":"2608487","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94882774","8":"COSV58122597","9":"COSM6053939","10":"p.C481Y","11":"c.1442G>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Tyr","26":"ENST00000308731.7:c.1442G>A","27":"X:g.101356176C>T","_rn_":"3225"},{"1":"2621284","2":"2621284","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3226"},{"1":"2621287","2":"2621287","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111449362","8":"COSV58117643","9":"COSM6053936","10":"p.C481R","11":"c.1441T>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Homozygous","23":"X:101356177..101356177","24":"","25":"ENSP00000479125.1:p.Cys481Arg","26":"ENST00000618050.4:c.1441T>C","27":"X:g.101356177A>G","_rn_":"3227"},{"1":"2623673","2":"2623673","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"117603008","8":"COSV58118015","9":"COSM6191212","10":"p.T316A","11":"c.946A>G","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"Richter_transformation","18":"27626698","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101358645..101358645","24":"","25":"ENSP00000361971.1:p.Thr316Ala","26":"ENST00000372880.5:c.946A>G","27":"X:g.101358645T>C","_rn_":"3228"},{"1":"2609321","2":"2609321","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"3289"},{"1":"2609319","2":"2609319","3":"BTK","4":"ENST00000621635.4","5":"Yes","6":"Ibrutinib","7":"112038657","8":"COSV58117136","9":"COSM6053938","10":"p.C515S","11":"c.1544G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"1","25":"ENSP00000483570.1:p.Cys515Ser","26":"ENST00000621635.4:c.1544G>C","27":"X:g.101356176C>G","_rn_":"3344"},{"1":"2616266","2":"2616266","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"117599033","8":"COSV58122516","9":"COSM6191211","10":"p.?","11":"c.1039-1482G>T","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Heterozygous","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>T","27":"X:g.101356176C>A","_rn_":"3345"},{"1":"2621349","2":"2621349","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"28049639","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"3346"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94883232","8":"COSV58117871","9":"COSM6053937","10":"p.C481S","11":"c.1441T>A","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356177..101356177","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1441T>A","27":"X:g.101356177A>T","_rn_":"3402"},{"1":"2609321","2":"2609321","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3403"},{"1":"2619738","2":"2619738","3":"BTK_ENST00000372880","4":"ENST00000372880.5","5":"No","6":"Ibrutinib","7":"96900340","8":"COSV58117136","9":"COSM6053938","10":"p.?","11":"c.1039-1482G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"27199251","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"","26":"ENST00000372880.5:c.1039-1482G>C","27":"X:g.101356176C>G","_rn_":"3405"},{"1":"2616264","2":"2616264","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3460"},{"1":"2608498","2":"2608498","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3514"},{"1":"2616260","2":"2616260","3":"BTK_ENST00000618050","4":"ENST00000618050.4","5":"No","6":"Ibrutinib","7":"111447953","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"24869598","19":"","20":"Previously Reported","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000479125.1:p.Cys481Ser","26":"ENST00000618050.4:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3515"},{"1":"2608492","2":"2608492","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"94881679","8":"COSV58117136","9":"COSM6053938","10":"p.C481S","11":"c.1442G>C","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"lymphoplasmacytic_lymphoma","17":"NS","18":"28235842","19":"","20":"Confirmed Somatic","21":"Tumour Sample","22":"Unknown","23":"X:101356176..101356176","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"ENST00000308731.7:c.1442G>C","27":"X:g.101356176C>G","_rn_":"3575"},{"1":"2616292","2":"2616292","3":"BTK_ENST00000308731","4":"ENST00000308731.7","5":"No","6":"Ibrutinib","7":"171656714","8":"","9":"COSM6188651","10":"p.C481S","11":"c.?","12":"haematopoietic_and_lymphoid_tissue","13":"NS","14":"NS","15":"lymphoid_neoplasm","16":"chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma","17":"NS","18":"26182309","19":"","20":"Variant of unknown origin","21":"Tumour Sample","22":"Unknown","23":"","24":"","25":"ENSP00000308176.7:p.Cys481Ser","26":"","27":"","_rn_":"3577"}],"options":{"columns":{"min":{},"max":[10],"total":[27]},"rows":{"min":[10],"max":[10],"total":[144]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuQ29zbWljUmVzaXN0YW5jZU11dGF0aW9ucyR0cmltbWVkX2dlbmVOYW1lPSBzYXBwbHkoQ29zbWljUmVzaXN0YW5jZU11dGF0aW9ucyRgR2VuZSBOYW1lYCxmdW5jdGlvbih4KSBzdHJzcGxpdChhcy5jaGFyYWN0ZXIoeCksICdfJylbWzFdXVsxXSlcbkRydWdUYXJnZXRQYWlyPSBkYXRhLmZyYW1lKGRydWduYW1lPUNvc21pY1Jlc2lzdGFuY2VNdXRhdGlvbnMkYERydWcgTmFtZWAsIEdlbmVOYW1lPUNvc21pY1Jlc2lzdGFuY2VNdXRhdGlvbnMkdHJpbW1lZF9nZW5lTmFtZSlcbkV2aWRlbmNlX1N0cmVuZ3RoPXRhYmxlKHBhc3RlKERydWdUYXJnZXRQYWlyJGRydWduYW1lLCBEcnVnVGFyZ2V0UGFpciRHZW5lTmFtZSkpXG5EcnVnVGFyZ2V0UGFpcj11bmlxdWUoRHJ1Z1RhcmdldFBhaXIpXG5EcnVnVGFyZ2V0UGFpciRkcnVnTmFtZV9nZW5lTmFtZT1wYXN0ZShEcnVnVGFyZ2V0UGFpciRkcnVnbmFtZSwgRHJ1Z1RhcmdldFBhaXIkR2VuZU5hbWUpXG5EcnVnVGFyZ2V0UGFpcj1jYmluZChEcnVnVGFyZ2V0UGFpcixcbiAgICAgICAgICAgICAgICAgICAgIEV2aWRlbmNlX1N0cmVuZ3RoPWFzLm51bWVyaWMoRXZpZGVuY2VfU3RyZW5ndGhbXG4gICAgICAgICAgICAgICAgICAgICAgIG1hdGNoKERydWdUYXJnZXRQYWlyJGRydWdOYW1lX2dlbmVOYW1lLCBuYW1lcyhFdmlkZW5jZV9TdHJlbmd0aCkpXSkpXG5udW1iZXJvZlRhcmdldHM9dGFibGUoRHJ1Z1RhcmdldFBhaXIkZHJ1Z25hbWUpXG5EcnVnVGFyZ2V0UGFpciRudW1iZXJvZlRhcmdldHM9bnVtYmVyb2ZUYXJnZXRzW21hdGNoKERydWdUYXJnZXRQYWlyJGRydWduYW1lLCBuYW1lcyhudW1iZXJvZlRhcmdldHMpKV1cblxuRHJ1Z1RhcmdldFBhaXIka25vd25fdGFyZ2V0PW9uVGFyZ2V0JGRydWdDYXRlZ29yeSR0YXJnZXRbXG4gIG1hdGNoKHN0cmlwYWxsMm1hdGNoKERydWdUYXJnZXRQYWlyJGRydWduYW1lKSxcbiAgICAgICAgc3RyaXBhbGwybWF0Y2gob25UYXJnZXQkZHJ1Z0NhdGVnb3J5JG5hbWUpKV1cbkRydWdUYXJnZXRQYWlyJGlzLnRhcmdldD1hcHBseShEcnVnVGFyZ2V0UGFpciwgMSwgZnVuY3Rpb24oeCkgZ3JlcGwoeFsyXSwgeFs2XSkgKVxuIyBGaWx0ZXIgY3JpdGVyaWFcbnNlZWROdW1iZXI9MTsgbnVtYmVyT2ZUYXJnZXRzX1Rocj01OyBFdmlkZW5jZV9TdHJlbmd0aF90aHI9NTBcbmNvbmQxPURydWdUYXJnZXRQYWlyJG51bWJlcm9mVGFyZ2V0czxudW1iZXJPZlRhcmdldHNfVGhyXG5jb25kMj1EcnVnVGFyZ2V0UGFpciRFdmlkZW5jZV9TdHJlbmd0aD4gRXZpZGVuY2VfU3RyZW5ndGhfdGhyXG5jb25kMz1EcnVnVGFyZ2V0UGFpciRpcy50YXJnZXRcblBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycz1uYS5vbWl0KGRhdGEuZnJhbWUoXG4gIERydWdiYW5rX0dlbmU9YXMuY2hhcmFjdGVyKERydWdUYXJnZXRQYWlyJEdlbmVOYW1lKVtjb25kMSAmIGNvbmQyICYgY29uZDNdLFxuICBDaGVtaWNhbC5OYW1lPWFzLmNoYXJhY3RlcihEcnVnVGFyZ2V0UGFpciRkcnVnbmFtZSlbY29uZDEgJiBjb25kMiAmIGNvbmQzXSkpXG5cblBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycz11bmlxdWUoUG9zaXRpdmVfU2V0X0RydWdHZW5lX1BhaXJzKVxuUG9zaXRpdmVfU2V0X0RydWdHZW5lX1BhaXJzPVBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlyc1tQb3NpdGl2ZV9TZXRfRHJ1Z0dlbmVfUGFpcnMkRHJ1Z2JhbmtfR2VuZSAlaW4lXG4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgcm93bmFtZXMoY29yck1hdCksXVxuUG9zaXRpdmVfU2V0X0RydWdHZW5lX1BhaXJzPVBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlyc1t0b2xvd2VyKFBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycyRDaGVtaWNhbC5OYW1lKSAgJWluJVxuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHRvbG93ZXIob25UYXJnZXQkZHJ1Z0NhdGVnb3J5JG5hbWUpLF1cbnNldC5zZWVkKHNlZWROdW1iZXIpXG5OZWdhdGl2ZV9TZXRfRHJ1Z0dlbmVfUGFpcnM9cmFuZG9taXplX0RGX3dpdGhfdW5pcXVlX1BhaXJzX1YyKFBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycylcblBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycyRMYWJlbD0xXG5OZWdhdGl2ZV9TZXRfRHJ1Z0dlbmVfUGFpcnMkTGFiZWw9MFxuQ29tcGxldGVfU2V0PXJiaW5kKFBvc2l0aXZlX1NldF9EcnVnR2VuZV9QYWlycywgTmVnYXRpdmVfU2V0X0RydWdHZW5lX1BhaXJzKVxuQ29tcGxldGVfU2V0JExhYmVsPSBmYWN0b3IoQ29tcGxldGVfU2V0JExhYmVsLCBsYWJlbHMgPSBjKCdOZWdhdGl2ZScsICdQb3NpdGl2ZScpKVxuQ29tcGxldGVfU2V0JGRydWdfQnJvYWRJRD1vblRhcmdldCRkcnVnQ2F0ZWdvcnkkYnJvYWRfaWRfdHJpbW1lZFtcbiAgbWF0Y2godG9sb3dlcihDb21wbGV0ZV9TZXQkQ2hlbWljYWwuTmFtZSksIHRvbG93ZXIob25UYXJnZXQkZHJ1Z0NhdGVnb3J5JG5hbWUpKV1cbkNvbXBsZXRlX1NldCRjcmlzcHJfY29ycj1zYXBwbHkoMTpucm93KENvbXBsZXRlX1NldCksIGZ1bmN0aW9uKHgpXG4gIGVycl9oYW5kbGUoY29yck1hdFthcy5jaGFyYWN0ZXIoQ29tcGxldGVfU2V0JERydWdiYW5rX0dlbmUpW3hdLCBhcy5jaGFyYWN0ZXIoQ29tcGxldGVfU2V0JGRydWdfQnJvYWRJRClbeF1dKSlcbkNvbXBsZXRlX1NldD1uYS5vbWl0KENvbXBsZXRlX1NldClcbkdvbGRfU3RhbmRhcmRfRGF0YXNldDU9ZGF0YS5mcmFtZShDb21wbGV0ZV9TZXQsIFNvdXJjZT0nQ09TTUlDIHJlc2lzdGFuY2UnKVxuIyBBcmVhIHVuZGVyIHRoZSBjdXJ2ZTogMC45Mzc1ICNzaXplPThcbiMgQXJlYSB1bmRlciB0aGUgY3VydmU6IDAuOCAjc2l6ZT0xNFxuYGBgIn0= -->
<pre class="r"><code>CosmicResistanceMutations$trimmed_geneName= sapply(CosmicResistanceMutations$`Gene Name`,function(x) strsplit(as.character(x), &#39;_&#39;)[[1]][1])
DrugTargetPair= data.frame(drugname=CosmicResistanceMutations$`Drug Name`, GeneName=CosmicResistanceMutations$trimmed_geneName)
Evidence_Strength=table(paste(DrugTargetPair$drugname, DrugTargetPair$GeneName))
DrugTargetPair=unique(DrugTargetPair)
DrugTargetPair$drugName_geneName=paste(DrugTargetPair$drugname, DrugTargetPair$GeneName)
DrugTargetPair=cbind(DrugTargetPair,
                     Evidence_Strength=as.numeric(Evidence_Strength[
                       match(DrugTargetPair$drugName_geneName, names(Evidence_Strength))]))
numberofTargets=table(DrugTargetPair$drugname)
DrugTargetPair$numberofTargets=numberofTargets[match(DrugTargetPair$drugname, names(numberofTargets))]

DrugTargetPair$known_target=onTarget$drugCategory$target[
  match(stripall2match(DrugTargetPair$drugname),
        stripall2match(onTarget$drugCategory$name))]
DrugTargetPair$is.target=apply(DrugTargetPair, 1, function(x) grepl(x[2], x[6]) )
# Filter criteria
seedNumber=1; numberOfTargets_Thr=5; Evidence_Strength_thr=50
cond1=DrugTargetPair$numberofTargets&lt;numberOfTargets_Thr
cond2=DrugTargetPair$Evidence_Strength&gt; Evidence_Strength_thr
cond3=DrugTargetPair$is.target
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(DrugTargetPair$GeneName)[cond1 &amp; cond2 &amp; cond3],
  Chemical.Name=as.character(DrugTargetPair$drugname)[cond1 &amp; cond2 &amp; cond3]))

Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[tolower(Positive_Set_DrugGene_Pairs$Chemical.Name)  %in%
                                                          tolower(onTarget$drugCategory$name),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs_V2(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset5=data.frame(Complete_Set, Source=&#39;COSMIC resistance&#39;)
# Area under the curve: 0.9375 #size=8
# Area under the curve: 0.8 #size=14</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 7: Drug Target pairs where, there is an FDA approval for treatment in patients with a mutation in target gene; from onkoKB -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Dataset 8: Hihgly Selective inhibitors based on their binding profile; SelleckChem -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>oncokb_approved=read.csv(&#39;Data/oncokb_biomarker_drug_associations_approved.tsv&#39;, sep=&#39;\t&#39;)
# Preprocessing
split_drugnames=strsplit(oncokb_approved$Drugs..for.therapeutic.implications.only., &#39;, &#39;)
oncokb_approved_expanded=lapply(1:nrow(oncokb_approved), function(x)
  cbind(oncokb_approved[x,],split_drugnames=split_drugnames[[x]]) )
oncokb_approved_expanded=do.call(rbind, oncokb_approved_expanded)

# remove ceratin biomarker types are are not application
to_remove_categories=c(&#39;Amp&#39;, &#39;Wildtype&#39;,&#39;High&#39;, &#39;Deletion&#39;, &#39;Duplication&#39;)
maybe_categories=c(&#39;Fusion&#39;, &#39;Truncating&#39;,  &#39;Oncogenic Mutations&#39;)
to_remove_categories_id=unique(unlist(sapply(to_remove_categories, function(x) 
  grep(x,oncokb_approved_expanded$Alterations) )))
oncokb_approved_expanded=oncokb_approved_expanded[-to_remove_categories_id,]
#remove combinations
oncokb_approved_expanded=oncokb_approved_expanded[
  -grep(&#39;\\+&#39;,oncokb_approved_expanded$split_drugnames),]
oncokb_approved_expanded=oncokb_approved_expanded[!is.na(match_stripall(oncokb_approved_expanded$split_drugnames, onTarget$drugCategory$name)),]

oncokb_approved_expanded$known_target=onTarget$drugCategory$target[match_stripall(oncokb_approved_expanded$split_drugnames, onTarget$drugCategory$name)]
oncokb_approved_expanded$count_target=sapply(strsplit(as.character(oncokb_approved_expanded$known_target), &#39;, &#39;), length)
#whether the biomarker is a target or not
oncokb_approved_expanded$is.target=apply(oncokb_approved_expanded, 1, function(x) grepl(x[2], x[7]))
#Filtering Criteria
seedNumber=1; numberOfTargets_Thr=10; which_level = c(1:4)
cond1=oncokb_approved_expanded$count_target&lt;numberOfTargets_Thr
cond2=oncokb_approved_expanded$is.target
cond3= oncokb_approved_expanded$Level %in% which_level
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(oncokb_approved_expanded$Gene)[cond1 &amp; cond2 &amp; cond3],
  Chemical.Name=as.character(oncokb_approved_expanded$split_drugnames)[cond1 &amp; cond2 &amp; cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[
  Positive_Set_DrugGene_Pairs$Drugbank_Gene %in% rownames(corrMat),]
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
print(dim(Positive_Set_DrugGene_Pairs))</code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin eyJkYXRhIjoiWzFdIDQzICAyXG4ifQ== -->
<pre><code>[1] 43  2</code></pre>
<!-- rnb-output-end -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset7=data.frame(Complete_Set, Source=&#39;oncoKB resistance&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- Intergarte the above 8 datasets for testing the performance of DeepTarget for primary Target prediction  -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code># Preprocessing
highly_selective_inhibitor=readxl::read_xlsx(&#39;Data/Updated_20220419-L3500-Highly-Selective-Inhibitor-Library-96-well.xlsx&#39;, sheet = 2)
highly_selective_inhibitor$known_target=onTarget$drugCategory$target[
  match_stripall(highly_selective_inhibitor$Name, onTarget$drugCategory$name)]
highly_selective_inhibitor$count_target=sapply(strsplit(as.character(highly_selective_inhibitor$known_target), &#39;, &#39;), length)
highly_selective_inhibitor$known_target_single=KnownTarget_predictions$MaxTargetName[
  match_stripall(highly_selective_inhibitor$Name, KnownTarget_predictions$drugName)]
highly_selective_inhibitor</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["tbl_df","tbl","data.frame"],"nrow":474,"ncol":27,"summary":{"A tibble":["474 × 27"]}},"rdf":"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"} -->
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["Cat"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Name"],"name":[2],"type":["chr"],"align":["left"]},{"label":["Plate Location"],"name":[3],"type":["chr"],"align":["left"]},{"label":["Rack Number"],"name":[4],"type":["chr"],"align":["left"]},{"label":["Formulation"],"name":[5],"type":["chr"],"align":["left"]},{"label":["Target"],"name":[6],"type":["chr"],"align":["left"]},{"label":["Pathway"],"name":[7],"type":["chr"],"align":["left"]},{"label":["Information"],"name":[8],"type":["chr"],"align":["left"]},{"label":["M.w."],"name":[9],"type":["dbl"],"align":["right"]},{"label":["CAS Number"],"name":[10],"type":["chr"],"align":["left"]},{"label":["DMSO (mg/mL)Max Solubility"],"name":[11],"type":["chr"],"align":["left"]},{"label":["DMSO (mM)Max Solubility"],"name":[12],"type":["dbl"],"align":["right"]},{"label":["Water (mg/mL)Max Solubility"],"name":[13],"type":["chr"],"align":["left"]},{"label":["Water (mM)Max Solubility"],"name":[14],"type":["dbl"],"align":["right"]},{"label":["URL"],"name":[15],"type":["chr"],"align":["left"]},{"label":["Formula"],"name":[16],"type":["chr"],"align":["left"]},{"label":["Form"],"name":[17],"type":["chr"],"align":["left"]},{"label":["Synonyms"],"name":[18],"type":["chr"],"align":["left"]},{"label":["SMILES"],"name":[19],"type":["chr"],"align":["left"]},{"label":["ALogP"],"name":[20],"type":["dbl"],"align":["right"]},{"label":["HBA_Count"],"name":[21],"type":["dbl"],"align":["right"]},{"label":["HBD_Count"],"name":[22],"type":["dbl"],"align":["right"]},{"label":["RotatableBond"],"name":[23],"type":["dbl"],"align":["right"]},{"label":["Diffential_binding"],"name":[24],"type":["chr"],"align":["left"]},{"label":["known_target"],"name":[25],"type":["fctr"],"align":["left"]},{"label":["count_target"],"name":[26],"type":["int"],"align":["right"]},{"label":["known_target_single"],"name":[27],"type":["chr"],"align":["left"]}],"data":[{"1":"S1004","2":"Veliparib (ABT-888)","3":"a2","4":"L3500-01","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM in cell-free assays, respectively. It is inactive to SIRT2. Phase 3.","9":"244.29","10":"912444-00-9","11":"17","12":"69.59","13":"<1","14":"NA","15":"http://selleckchem.com/products/ABT-888.html","16":"C13H16N4O","17":"free base","18":"NSC 737664","19":"CC1(CCCN1)C2=NC3=C(C=CC=C3[NH]2)C(N)=O","20":"0.986","21":"2","22":"3","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1008","2":"Selumetinib (AZD6244)","3":"b2","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"Selumetinib (AZD6244) is a potent, highly selective MEK inhibitor with IC50 of 14 nM for MEK1 and Kd value of 530 nM for MEK2. It  also inhibits ERK1/2 phosphorylation with IC50 of 10 nM, no inhibition to p38Î±, MKK6, EGFR, ErbB2, ERK2, B-Raf, etc. Phase 3.","9":"457.68","10":"606143-52-6","11":"91","12":"198.83","13":"<1","14":"NA","15":"http://selleckchem.com/products/AZD6244.html","16":"C17H15BrClFN4O3","17":"free base","18":"ARRY-142886","19":"C[N]1C=NC2=C(F)C(=C(C=C12)C(=O)NOCCO)NC3=CC=C(Br)C=C3Cl","20":"3.234","21":"3","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1011","2":"Afatinib (BIBW2992)","3":"c2","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"Afatinib (BIBW2992) inhibits EGFR/ErbB irreversibly in vitro with IC50 of 0.5, 0.4, 10, 14, 1 nM for EGFRwt, EGFR L858R , EGFR L858R/T790M ErbB2 (HER2) and ErbB4 (HER4), respectively.","9":"485.94","10":"439081-18-2","11":"97","12":"199.61","13":"<1","14":"NA","15":"http://selleckchem.com/products/BIBW2992.html","16":"C24H25ClFN5O3","17":"Free Base","18":"N/A","19":"CN(C)C/C=C/C(=O)NC1=CC2=C(NC3=CC=C(F)C(=C3)Cl)N=CN=C2C=C1OC4CCOC4","20":"3.917","21":"5","22":"2","23":"8","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S1020","2":"PD184352 (CI-1040)","3":"d2","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"PD184352 (CI-1040) is an ATP non-competitive MEK1/2 inhibitor with IC50 of 17 nM in cell-based assays, 100-fold more selective for MEK1/2 than MEK5. Phase 2.","9":"478.67","10":"212631-79-3","11":"96","12":"200.56","13":"<1","14":"NA","15":"http://selleckchem.com/products/CI-1040-(PD184352).html","16":"C17H14ClF2IN2O2","17":"free base","18":"N/A","19":"FC1=CC=C(C(=O)NOCC2CC2)C(=C1F)NC3=CC=C(I)C=C3Cl","20":"4.907","21":"2","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1036","2":"PD0325901","3":"e2","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"PD0325901 is a selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM in cell-free assays, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 2.","9":"482.19","10":"391210-10-9","11":"96","12":"199.09","13":"<1","14":"NA","15":"http://selleckchem.com/products/PD-0325901.html","16":"C16H14F3IN2O4","17":"free base","18":"N/A","19":"OCC(O)CONC(=O)C1=C(NC2=CC=C(I)C=C2F)C(=C(F)C=C1)F","20":"2.578","21":"2","22":"4","23":"7","24":"NA","25":"MAP2K1","26":"1","27":"MAP2K1"},{"1":"S1048","2":"Tozasertib (VX-680, MK-0457)","3":"f2","4":"L3500-01","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"Tozasertib (VX-680, MK-0457) is a pan-Aurora inhibitor, mostly against Aurora A with Kiapp of 0.6 nM in a cell-free assay, less potent towards Aurora B/Aurora C and 100-fold more selective for Aurora A than 55 other kinases. Phase 2.","9":"464.59","10":"639089-54-6","11":"93","12":"200.18","13":"<1","14":"NA","15":"http://selleckchem.com/products/VX-680(MK-0457).html","16":"C23H28N8OS","17":"free base","18":"N/A","19":"CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)SC4=CC=C(NC(=O)C5CC5)C=C4","20":"4.445","21":"4","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1049","2":"Y-27632 2HCl","3":"g2","4":"L3500-01","5":"in 10mM DMSO","6":"Autophagy,ROCK","7":"Cell Cycle","8":"Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.","9":"320.26","10":"129830-38-2","11":"64","12":"199.84","13":"14","14":"43.71","15":"http://selleckchem.com/products/Y-27632.html","16":"C14H23Cl2N3O","17":"Dihydrochloride","18":"N/A","19":"Cl.Cl.CC(N)C1CCC(CC1)C(=O)NC2=CC=NC=C2","20":"1.871","21":"2","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1060","2":"Olaparib (AZD2281, Ku-0059436)","3":"h2","4":"L3500-01","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"Olaparib (AZD2281, KU0059436) is a selective inhibitor of PARP1/2 with IC50 of 5 nM/1 nM in cell-free assays, 300-times less effective against tankyrase-1.","9":"434.46","10":"763113-22-0","11":"86","12":"197.95","13":"NA","14":"NA","15":"http://selleckchem.com/products/AZD2281(Olaparib).html","16":"C24H23FN4O3","17":"free base","18":"N/A","19":"FC1=C(C=C(CC2=NNC(=O)C3=C2C=CC=C3)C=C1)C(=O)N4CCN(CC4)C(=O)C5CC5","20":"2.127","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1066","2":"SL-327","3":"a3","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 Î¼M/ 0.22 Î¼M, no activity towards Erk1, MKK3, MKK4, c-JUN, PKC, PKA, or CamKIIcapable of transport through the blood-brain barrier.","9":"335.35","10":"305350-87-2","11":"67","12":"199.79","13":"<1","14":"NA","15":"http://selleckchem.com/products/SL327.html","16":"C16H12F3N3S","17":"free base","18":"N/A","19":"NC(\\\\SC1=CC=C(N)C=C1)=C(C#N)/C2=C(C=CC=C2)C(F)(F)F","20":"3.705","21":"0","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1067","2":"SB431542","3":"b3","4":"L3500-01","5":"in 10mM DMSO","6":"TGF-beta/Smad","7":"TGF-beta/Smad","8":"SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases.","9":"384.39","10":"301836-41-9","11":"76","12":"197.72","13":"<1","14":"NA","15":"http://selleckchem.com/products/SB-431542.html","16":"C22H16N4O3","17":"free base","18":"N/A","19":"NC(=O)C1=CC=C(C=C1)C2=NC(=C([NH]2)C3=NC=CC=C3)C4=CC5=C(OCO5)C=C4","20":"3.447","21":"5","22":"2","23":"4","24":"NA","25":"ACVR1C, TGFBR1","26":"2","27":"ACVR1C"},{"1":"S1078","2":"MK-2206 2HCl","3":"c3","4":"L3500-01","5":"in 10mM DMSO","6":"Akt","7":"PI3K/Akt/mTOR","8":"MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM in cell-free assays, respectively no inhibitory activities against 250 other protein kinases observed. Phase 2.","9":"480.39","10":"1032350-13-2","11":"14","12":"29.14","13":"<1","14":"NA","15":"http://selleckchem.com/products/MK-2206.html","16":"C25H23Cl2N5O","17":"Dihydrochloride","18":"N/A","19":"Cl.Cl.NC1(CCC1)C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C(=O)NN=C45)C6=CC=CC=C6","20":"4.183","21":"3","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1089","2":"Refametinib (RDEA119, Bay 86-9766)","3":"d3","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"Refametinib (RDEA119, Bay 86-9766) is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.","9":"572.34","10":"923032-37-5","11":"100","12":"174.72","13":"<1","14":"NA","15":"http://selleckchem.com/products/refametinib-rdea119-bay86-9766.html","16":"C19H20F3IN2O5S","17":"free base","18":"BAY 869766","19":"COC1=C(N[S](=O)(=O)C2(CC2)CC(O)CO)C(=C(F)C(=C1)F)NC3=CC=C(I)C=C3F","20":"2.827","21":"3","22":"4","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1092","2":"KU-55933 (ATM Kinase Inhibitor)","3":"e3","4":"L3500-01","5":"in 10mM DMSO","6":"ATM/ATR","7":"DNA Damage","8":"KU-55933 (ATM Kinase Inhibitor) is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM in cell-free assays, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.","9":"395.49","10":"587871-26-9","11":"33","12":"83.44","13":"<1","14":"NA","15":"http://selleckchem.com/products/KU-55933.html","16":"C21H17NO3S2","17":"free base","18":"N/A","19":"O=C1C=C(OC(=C1)C2=CC=CC3=C2SC4=CC=CC=C4S3)N5CCOCC5","20":"4.393","21":"3","22":"0","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1093","2":"GSK1904529A","3":"f3","4":"L3500-01","5":"in 10mM DMSO","6":"IGF-1R","7":"Protein Tyrosine Kinase","8":"GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM in cell-free assays, >100-fold more selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.","9":"851.96","10":"1089283-49-7","11":"124","12":"145.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/GSK1904529A.html","16":"C44H47F2N9O5S","17":"free base","18":"GSK 4529","19":"CCC1=CC(=C(OC)C=C1N2CCC(CC2)N3CCN(CC3)[S](C)(=O)=O)NC4=NC(=CC=N4)C5=C(N=C6C=CC=C[N]56)C7=CC(=C(OC)C=C7)C(=O)NC8=C(F)C=CC=C8F","20":"6.571","21":"8","22":"2","23":"12","24":"NA","25":"IGF1R, INSR","26":"2","27":"INSR"},{"1":"S1094","2":"PF-04217903","3":"g3","4":"L3500-01","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM in A549 cell line, susceptible to oncogenic mutations (no activity to Y1230C mutant). Phase 1.","9":"372.38","10":"956905-27-4","11":"5","12":"13.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/PF-04217903.html","16":"C19H16N8O","17":"free base","18":"N/A","19":"OCC[N]1C=C(C=N1)C2=NC3=C(N=C2)N=N[N]3CC4=CC5=CC=CN=C5C=C4","20":"1.561","21":"6","22":"1","23":"5","24":"NA","25":"MET","26":"1","27":"MET"},{"1":"S1102","2":"U0126-EtOH","3":"h3","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"U0126-EtOH is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 Î¼M/0.06 Î¼M in cell-free assays, 100-fold higher affinity for Î”N3-S218E/S222D MEK than PD98059.","9":"426.56","10":"1173097-76-1","11":"85","12":"199.27","13":"<1","14":"NA","15":"http://selleckchem.com/products/U0126.html","16":"C20H22N6OS2","17":"Ethanolate","18":"N/A","19":"CCO.N\\\\C(SC1=CC=CC=C1N)=C(C#N)\\\\C(C#N)=C(N)/SC2=CC=CC=C2N","20":"2.169","21":"0","22":"5","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1109","2":"BI 2536","3":"a4","4":"L3500-01","5":"in 10mM DMSO","6":"PLK","7":"Cell Cycle","8":"BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM in a cell-free assay. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.","9":"521.66","10":"755038-02-9","11":"21","12":"40.26","13":"<1","14":"NA","15":"http://selleckchem.com/products/BI-2536.html","16":"C28H39N7O3","17":"free base","18":"N/A","19":"CCC1N(C2CCCC2)C3=NC(=NC=C3N(C)C1=O)NC4=CC=C(C=C4OC)C(=O)NC5CCN(C)CC5","20":"3.548","21":"5","22":"2","23":"7","24":"NA","25":"BRD4, PLK1, PLK2, PLK3","26":"4","27":"PLK3"},{"1":"S1114","2":"JNJ-38877605","3":"b4","4":"L3500-01","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"JNJ-38877605 is an ATP-competitive inhibitor of c-Met with IC50 of 4 nM, 600-fold selective for c-Met than 200 other tyrosine and serine-threonine kinases. Phase 1.","9":"377.35","10":"943540-75-8","11":"37","12":"98.05","13":"<1","14":"NA","15":"http://selleckchem.com/products/JNJ-38877605.html","16":"C19H13F2N7","17":"free base","18":"N/A","19":"C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C(F)(F)C4=CC5=C(C=C4)N=CC=C5)C=C2","20":"3.052","21":"5","22":"0","23":"3","24":"NA","25":"MET","26":"1","27":"NA"},{"1":"S1115","2":"Odanacatib (MK-0822)","3":"c4","4":"L3500-01","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"Odanacatib (MK 0822) is a potent, selective, and neutral inhibitor of cathepsin K (human/rabbit) with IC50 of 0.2 nM/1 nM, and demonstrated high selectivity versus off-target cathepsin B, L, S. Phase 3.","9":"525.56","10":"603139-19-1","11":"100","12":"190.27","13":"<1","14":"NA","15":"http://selleckchem.com/products/Odanacatib-(MK0822).html","16":"C25H27F4N3O3S","17":"free base","18":"N/A","19":"CC(C)(F)CC(NC(C1=CC=C(C=C1)C2=CC=C(C=C2)[S](C)(=O)=O)C(F)(F)F)C(=O)NC3(CC3)C#N","20":"3.978","21":"3","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1129","2":"SRT1720 HCl","3":"d4","4":"L3500-01","5":"in 10mM DMSO","6":"Sirtuin","7":"Epigenetics","8":"SRT1720 HCl is a selective SIRT1 activator with EC50 of 0.16 Î¼M in a cell-free assay, but is >230-fold less potent for SIRT2 and SIRT3.","9":"506.02","10":"1001645-58-4","11":"38","12":"75.10","13":"<1","14":"NA","15":"http://selleckchem.com/products/SRT1720.html","16":"C25H24ClN7OS","17":"Hydrochloride","18":"N/A","19":"Cl.O=C(NC1=CC=CC=C1C2=C[N]3C(=CSC3=N2)CN4CCNCC4)C5=NC6=CC=CC=C6N=C5","20":"3.018","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1133","2":"Alisertib (MLN8237)","3":"e4","4":"L3500-01","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Phase 3.","9":"518.92","10":"1028486-01-2","11":"27","12":"52.03","13":"<1","14":"NA","15":"http://selleckchem.com/products/MLN8237.html","16":"C27H20ClFN4O4","17":"free base","18":"N/A","19":"COC1=C(C(=CC=C1)F)C2=NCC3=C(N=C(NC4=CC(=C(C=C4)C(O)=O)OC)N=C3)C5=C2C=C(Cl)C=C5","20":"5.954","21":"6","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1141","2":"Tanespimycin (17-AAG)","3":"f4","4":"L3500-01","5":"in 10mM DMSO","6":"HSP (e.g. HSP90)","7":"Cytoskeletal Signaling","8":"Tanespimycin (17-AAG) is a potent HSP90 inhibitor with IC50 of 5 nM in a cell-free assay, having a 100-fold higher binding affinity for HSP90 derived from tumour cells than HSP90 from normal cells. Phase 2.","9":"585.69","10":"75747-14-7","11":"100","12":"170.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/17-AAG(Geldanamycin).html","16":"C31H43N3O8","17":"free base","18":"CP127374,NSC-330507, KOS 953","19":"COC1CC(C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(=C\\\\C=C/C(OC)C(OC(N)=O)/C(=C/C(C)C1O)C)\\\\C)C2=O","20":"2.524","21":"7","22":"4","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1147","2":"Barasertib (AZD1152-HQPA)","3":"g4","4":"L3500-01","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"Barasertib (AZD1152-HQPA) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM in a cell-free assay, ~3700 fold more selective for Aurora B over Aurora A. Phase 1.","9":"507.56","10":"722544-51-6","11":"102","12":"200.96","13":"<1","14":"NA","15":"http://selleckchem.com/products/AZD1152-HQPA.html","16":"C26H30FN7O3","17":"free base","18":"INH 34","19":"CCN(CCO)CCCOC1=CC=C2C(=NC=NC2=C1)NC3=CC(=N[NH]3)CC(=O)NC4=CC=CC(=C4)F","20":"3.493","21":"5","22":"4","23":"13","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1167","2":"CP-724714","3":"h4","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"CP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, >640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met etc in cell-free assays. Phase 2.","9":"469.53","10":"537705-08-1","11":"94","12":"200.20","13":"<1","14":"NA","15":"http://selleckchem.com/products/CP-724714.html","16":"C27H27N5O3","17":"free base","18":"N/A","19":"COCC(=O)NC/C=C/C1=CC=C2N=CN=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(=C3)C)C2=C1","20":"3.987","21":"6","22":"2","23":"9","24":"NA","25":"ERBB2","26":"1","27":"ERBB2"},{"1":"S1169","2":"TGX-221","3":"a5","4":"L3500-01","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"TGX-221 is a p110Î²-specific inhibitor with IC50 of 5 nM in a cell-free assay, 1000-fold more selective for p110Î² than p110Î±.","9":"364.44","10":"663619-89-4","11":"12","12":"32.93","13":"<1","14":"NA","15":"http://selleckchem.com/products/TGX-221.html","16":"C21H24N4O2","17":"free base","18":"N/A","19":"CC(NC1=CC=CC=C1)C2=CC(=CN3C(=O)C=C(N=C23)N4CCOCC4)C","20":"2.373","21":"3","22":"1","23":"4","24":"NA","25":"PIK3CB, PIK3CD","26":"2","27":"NA"},{"1":"S1170","2":"WZ3146","3":"b5","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM does not inhibit ERBB2 phosphorylation (T798I).","9":"464.95","10":"1214265-56-1","11":"93","12":"200.02","13":"<1","14":"NA","15":"http://selleckchem.com/products/WZ3146.html","16":"C24H25ClN6O2","17":"free base","18":"N/A","19":"CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)OC4=CC(=CC=C4)NC(=O)C=C)C=C2","20":"4.823","21":"4","22":"2","23":"7","24":"1","25":"EGFR","26":"1","27":"EGFR"},{"1":"S1173","2":"WZ4002","3":"c5","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM in BaF3 cell line does not inhibit ERBB2 phosphorylation (T798I).","9":"494.18","10":"1213269-23-8","11":"13","12":"26.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/WZ4002.html","16":"C25H27ClN6O3","17":"free base","18":"N/A","19":"COC1=C(NC2=NC=C(Cl)C(=N2)OC3=CC(=CC=C3)NC(=O)C=C)C=CC(=C1)N4CCN(C)CC4","20":"4.807","21":"5","22":"2","23":"8","24":"1","25":"EGFR, ERBB2","26":"2","27":"EGFR"},{"1":"S1179","2":"WZ8040","3":"d5","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).","9":"481.01","10":"1214265-57-2","11":"96","12":"199.58","13":"<1","14":"NA","15":"http://selleckchem.com/products/WZ8040.html","16":"C24H25ClN6OS","17":"free base","18":"N/A","19":"CN1CCN(CC1)C2=CC=C(NC3=NC=C(Cl)C(=N3)SC4=CC(=CC=C4)NC(=O)C=C)C=C2","20":"5.381","21":"3","22":"2","23":"7","24":"1","25":"EGFR","26":"1","27":"EGFR"},{"1":"S1186","2":"BIBR 1532","3":"e5","4":"L3500-01","5":"in 10mM DMSO","6":"Telomerase","7":"DNA Damage","8":"BIBR 1532 is a potent, selective, non-competitive telomerase inhibitor with IC50 of 100 nM in a cell-free assay. No inhibition of DNA and RNA polymerases, including HIV reverse transcriptase were observed at concentrations vastly exceeding the IC50 for telomerase.","9":"331.36","10":"321674-73-1","11":"66","12":"199.18","13":"<1","14":"NA","15":"http://selleckchem.com/products/BIBR1532.html","16":"C21H17NO3","17":"free base","18":"N/A","19":"CC(=C\\\\C(=O)NC1=C(C=CC=C1)C(O)=O)/C2=CC3=CC=CC=C3C=C2","20":"4.067","21":"2","22":"1","23":"4","24":"NA","25":"TERT","26":"1","27":"TERT"},{"1":"S1188","2":"Anastrozole","3":"f5","4":"L3500-01","5":"in 10mM DMSO","6":"Aromatase","7":"Endocrinology & Hormones","8":"Anastrozole is a third-generation nonsteroidal selective aromatase inhibitor. It may offer greater selectivity compared with other aromatase inhibitors, being without any intrinsic endocrine effects and with no apparent effect on the synthesis of adrenal steroids.","9":"293.37","10":"120511-73-1","11":"59","12":"201.11","13":"<1","14":"NA","15":"http://selleckchem.com/products/Anastrozole.html","16":"C17H19N5","17":"free base","18":"ZD-1033","19":"CC(C)(C#N)C1=CC(=CC(=C1)C[N]2C=NC=N2)C(C)(C)C#N","20":"2.965","21":"2","22":"0","23":"4","24":"NA","25":"CYP19A1","26":"1","27":"CYP19A1"},{"1":"S1189","2":"Aprepitant","3":"g5","4":"L3500-01","5":"in 10mM DMSO","6":"Substance P","7":"Others","8":"Aprepitant is a potent and selective neurokinin-1 receptor antagonist with IC50 of 0.1 nM.","9":"534.43","10":"170729-80-3","11":"107","12":"200.21","13":"<1","14":"NA","15":"http://selleckchem.com/products/Aprepitant.html","16":"C23H21F7N4O3","17":"free base","18":"MK-0869, L-754030","19":"CC(OC1OCCN(CC2=NNC(=O)N2)C1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F","20":"4.635","21":"4","22":"2","23":"8","24":"NA","25":"TACR1","26":"1","27":"NA"},{"1":"S1195","2":"TAK-700 (Orteronel)","3":"h5","4":"L3500-01","5":"in 10mM DMSO","6":"P450 (e.g. CYP17)","7":"Metabolism","8":"TAK-700 (Orteronel) is a potent and highly selective human 17,20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.","9":"307.35","10":"426219-18-3","11":"61","12":"198.47","13":"<1","14":"NA","15":"http://selleckchem.com/products/TAK-700.html","16":"C18H17N3O2","17":"free base","18":"N/A","19":"CNC(=O)C1=CC=C2C=C(C=CC2=C1)C3(O)CC[N]4C=NC=C34","20":"1.075","21":"2","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1216","2":"PFI-1 (PF-6405761)","3":"a6","4":"L3500-01","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"PFI-1 is a highly selective BET (bromodomain-containing protein) inhibitor for BRD4 with IC50 of 0.22 Î¼M and for BRD2 with IC50 of 98 nM in a cell-free assay.","9":"347.39","10":"1403764-72-6","11":"69","12":"198.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/pfl-1.html","16":"C16H17N3O4S","17":"free base","18":"N/A","19":"COC1=C(C=CC=C1)[S](=O)(=O)NC2=CC=C3NC(=O)N(C)CC3=C2","20":"1.376","21":"4","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1226","2":"KU-0063794","3":"b6","4":"L3500-01","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM in cell-free assays no effect on PI3Ks.","9":"465.54","10":"938440-64-3","11":"16","12":"34.37","13":"<1","14":"NA","15":"http://selleckchem.com/products/KU-0063794.html","16":"C25H31N5O4","17":"free base","18":"N/A","19":"COC1=C(CO)C=C(C=C1)C2=NC3=NC(=NC(=C3C=C2)N4CCOCC4)N5CC(C)OC(C)C5","20":"3.274","21":"6","22":"1","23":"5","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S1263","2":"CHIR-99021 (CT99021)","3":"c6","4":"L3500-01","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"CHIR-99021 (CT99021) is a GSK-3Î± and GSK-3Î² inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3Î² compared to CDKs.","9":"465.34","10":"252917-06-9","11":"10","12":"21.49","13":"<1","14":"NA","15":"http://selleckchem.com/products/CHIR-99021.html","16":"C22H18Cl2N8","17":"free base","18":"N/A","19":"CC1=C[NH]C(=N1)C2=CN=C(NCCNC3=CC=C(C=N3)C#N)N=C2C4=CC=C(Cl)C=C4Cl","20":"4.476","21":"4","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1264","2":"PD173074","3":"d6","4":"L3500-01","5":"in 10mM DMSO","6":"FGFR,VEGFR","7":"Angiogenesis","8":"PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.","9":"523.67","10":"219580-11-7","11":"100","12":"190.96","13":"<1","14":"NA","15":"http://selleckchem.com/products/PD-173074.html","16":"C28H41N7O3","17":"free base","18":"N/A","19":"CCN(CC)CCCCNC1=NC=C2C=C(C(=NC2=N1)NC(=O)NC(C)(C)C)C3=CC(=CC(=C3)OC)OC","20":"4.313","21":"6","22":"3","23":"13","24":"NA","25":"FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","26":"9","27":"FGFR1"},{"1":"S1266","2":"WYE-354","3":"e6","4":"L3500-01","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) not P-AKT(T308), selective for mTOR than PI3KÎ± (>100-fold) and PI3KÎ³ (>500-fold).","9":"495.53","10":"1062169-56-5","11":"99","12":"199.79","13":"<1","14":"NA","15":"http://selleckchem.com/products/WYE-354.html","16":"C24H29N7O5","17":"free base","18":"N/A","19":"COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=N[N]3C4CCN(CC4)C(=O)OC)C(=N2)N5CCOCC5","20":"1.886","21":"8","22":"1","23":"6","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S1267","2":"Vemurafenib (PLX4032, RG7204)","3":"f6","4":"L3500-01","5":"in 10mM DMSO","6":"Raf","7":"MAPK","8":"Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM in cell-free assay. 10-fold selective for B-RafV600E over wild-type B-Raf in enzymatic assays and the cellular selectivity can exceed 100-fold.","9":"489.92","10":"918504-65-1","11":"97","12":"197.99","13":"<1","14":"NA","15":"http://selleckchem.com/products/PLX-4032.html","16":"C23H18ClF2N3O3S","17":"free base","18":"RO5185426","19":"CCC[S](=O)(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CC=C(Cl)C=C4","20":"4.953","21":"4","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1274","2":"BX-795","3":"g6","4":"L3500-01","5":"in 10mM DMSO","6":"IÎºB/IKK,PDK","7":"PI3K/Akt/mTOR","8":"BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM, 140- and 1600-fold more selective for PDK1 than PKA and PKC in cell-free assays, respectively. Meanwhile, in comparison to GSK3Î² more than 100-fold selectivity observed for PDK1.","9":"591.47","10":"702675-74-9","11":"100","12":"169.07","13":"<1","14":"NA","15":"http://selleckchem.com/products/bx-795.html","16":"C23H26IN7O2S","17":"free base","18":"N/A","19":"IC1=CN=C(NC2=CC(=CC=C2)NC(=O)N3CCCC3)N=C1NCCCNC(=O)C4=CC=CS4","20":"3.704","21":"4","22":"4","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1275","2":"BX-912","3":"h6","4":"L3500-01","5":"in 10mM DMSO","6":"PDK","7":"PI3K/Akt/mTOR","8":"BX912 is a potent and specific PDK1 inhibitor with IC50 of 12 nM, 9- and 105- fold greater selectivity for PDK1 than PKA and PKC in cell-free assays, respectively. In comparison to GSK3Î², selectivity for PDK1 is 600-fold.","9":"471.35","10":"702674-56-4","11":"94","12":"199.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/bx-912.html","16":"C20H23BrN8O","17":"free base","18":"N/A","19":"BrC1=CN=C(NC2=CC(=CC=C2)NC(=O)N3CCCC3)N=C1NCCC4=CN=C[NH]4","20":"2.798","21":"4","22":"4","23":"7","24":"NA","25":"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1","26":"6","27":"PDK1"},{"1":"S1352","2":"TG100-115","3":"a7","4":"L3500-01","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"TG100-115 is a PI3KÎ³/Î´ inhibitor with IC50 of 83 nM/235 nM, with little effect on PI3KÎ±/Î². Phase 1/2.","9":"346.34","10":"677297-51-7","11":"9","12":"25.99","13":"<1","14":"NA","15":"http://selleckchem.com/products/TG100-115.html","16":"C18H14N6O2","17":"free base","18":"N/A","19":"NC1=NC2=NC(=C(N=C2C(=N1)N)C3=CC(=CC=C3)O)C4=CC=CC(=C4)O","20":"2.687","21":"4","22":"4","23":"2","24":"NA","25":"PIK3CA, PIK3CB, PIK3CD, PIK3CG","26":"4","27":"PIK3CG"},{"1":"S1392","2":"Pelitinib (EKB-569)","3":"b7","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM. Phase2.","9":"467.92","10":"257933-82-7","11":"13","12":"27.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/Pelitinib.html","16":"C24H23ClFN5O2","17":"free base","18":"N/A","19":"CCOC1=C(NC(=O)\\\\C=C\\\\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC(=C(F)C=C3)Cl)C#N","20":"4.455","21":"3","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1451","2":"Aurora A Inhibitor I","3":"c7","4":"L3500-01","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A with IC50 of 3.4 nM in a cell-free assay. It is 1000-fold more selective for Aurora A than Aurora B.","9":"588.07","10":"1158838-45-9","11":"118","12":"200.66","13":"<1","14":"NA","15":"http://selleckchem.com/products/Aurora-A-Inhibitor-I.html","16":"C31H31ClFN7O2","17":"free base","18":"N/A","19":"CCN1CCN(CC1)C(=O)CC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=C(C=C4)C(=O)NC5=CC=CC=C5Cl)C=C2","20":"5.621","21":"4","22":"3","23":"9","24":"NA","25":"AURKA","26":"1","27":"AURKA"},{"1":"S1452","2":"Ispinesib (SB-715992)","3":"d7","4":"L3500-01","5":"in 10mM DMSO","6":"Kinesin","7":"Cytoskeletal Signaling","8":"Ispinesib (SB-715992) is a potent, specific and reversible inhibitor of kinesin spindle protein (KSP) with Ki app of 1.7 nM in a cell-free assay, no inhibition to CENP-E, RabK6, MCAK, MKLP1, KHC or Kif1A. Phase 2.","9":"517.06","10":"336113-53-2","11":"103","12":"199.20","13":"<1","14":"NA","15":"http://selleckchem.com/products/Ispinesib-mesilate(SB-715992).html","16":"C30H33ClN4O2","17":"free base","18":"CK0238273","19":"CC(C)C(N(CCCN)C(=O)C1=CC=C(C)C=C1)C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4","20":"5.259","21":"3","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1456","2":"Zibotentan (ZD4054)","3":"e7","4":"L3500-01","5":"in 10mM DMSO","6":"Endothelin Receptor","7":"GPCR & G Protein","8":"Zibotentan (ZD4054) is a specific Endothelin (ET)A antagonist with IC50 of 21 nM, exhibiting no activity at ETB. Phase 3.","9":"424.43","10":"186497-07-4","11":"24","12":"56.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/Zibotentan(ZD4054).html","16":"C19H16N6O4S","17":"free base","18":"N/A","19":"COC1=NC(=CN=C1N[S](=O)(=O)C2=CC=CN=C2C3=CC=C(C=C3)C4=NN=CO4)C","20":"1.456","21":"9","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1472","2":"Safinamide Mesylate","3":"f7","4":"L3500-01","5":"in 10mM DMSO","6":"MAO","7":"Metabolism","8":"Safinamide Mesylate is mesylate salt of Safinamide, selectively and reversibly inhibits MAO-B with IC50 of 98 nM, exhibits 5918-fold selectivity against MAO-A. Phase 3.","9":"398.45","10":"202825-46-5","11":"80","12":"200.78","13":"80","14":"200.78","15":"http://selleckchem.com/products/Safinamide-mesilate.html","16":"C18H23FN2O5S","17":"Mesylate","18":"PNU-151774E,FCE28073","19":"CC(NCC1=CC=C(OCC2=CC(=CC=C2)F)C=C1)C(N)=O.C[S](O)(=O)=O","20":"2.064","21":"2","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1474","2":"GSK429286A","3":"g7","4":"L3500-01","5":"in 10mM DMSO","6":"ROCK","7":"Cell Cycle","8":"GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.","9":"432.37","10":"864082-47-3","11":"87","12":"201.22","13":"<1","14":"NA","15":"http://selleckchem.com/products/GSK429286A.html","16":"C21H16F4N4O2","17":"free base","18":"RHO-15","19":"CC1=C(C(CC(=O)N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=C(F)C=C4[NH]N=CC4=C3","20":"3.033","21":"3","22":"3","23":"4","24":"NA","25":"ROCK1","26":"1","27":"ROCK1"},{"1":"S1475","2":"Pimasertib (AS-703026)","3":"h7","4":"L3500-01","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"Pimasertib (AS-703026) is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 Î¼M in MM cell lines. Phase 2.","9":"431.20","10":"1236699-92-5","11":"86","12":"199.44","13":"<1","14":"NA","15":"http://selleckchem.com/products/AS703026.html","16":"C15H15FIN3O3","17":"free base","18":"MSC1936369B, SAR 245509","19":"OCC(O)CNC(=O)C1=CC=NC=C1NC2=C(F)C=C(I)C=C2","20":"1.171","21":"2","22":"4","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1482","2":"Daclatasvir (BMS-790052)","3":"a8","4":"L3500-01","5":"in 10mM DMSO","6":"HCV Protease","7":"Proteases","8":"Daclatasvir (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Phase 3.","9":"738.88","10":"1009119-64-5","11":"148","12":"200.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/BMS-790052.html","16":"C40H50N8O6","17":"free base","18":"EBP883","19":"COC(=O)NC(C(C)C)C(=O)N1CCCC1C2=NC=C([NH]2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C([NH]5)C6CCCN6C(=O)C(NC(=O)OC)C(C)C","20":"5.048","21":"8","22":"4","23":"13","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1512","2":"Tadalafil","3":"b8","4":"L3500-01","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM in a cell-free assay. Tadalafil is at least 9000 times more selective for PDE5 than most of the other families of PDEs, with the exception of PDE11. It can partial inhibits PDE11","9":"389.40","10":"171596-29-5","11":"78","12":"200.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/Tadalafil(Cialis).html","16":"C22H19N3O4","17":"free base","18":"IC351","19":"CN1CC(=O)N2C(CC3=C([NH]C4=C3C=CC=C4)C2C5=CC=C6OCOC6=C5)C1=O","20":"2.183","21":"4","22":"1","23":"1","24":"NA","25":"PDE11A, PDE5A","26":"2","27":"NA"},{"1":"S1525","2":"Adavosertib ï¼ˆMK-1775ï¼‰","3":"c8","4":"L3500-01","5":"in 10mM DMSO","6":"Wee1","7":"Cell Cycle","8":"MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM in a cell-free assay hinders G2 DNA damage checkpoint. Phase 2.","9":"500.60","10":"955365-80-7","11":"80","12":"159.81","13":"NA","14":"NA","15":"http://selleckchem.com/products/MK-1775.html","16":"C27H32N8O2","17":"free base","18":"N/A","19":"CN1CCN(CC1)C2=CC=C(NC3=NC4=C(C=N3)C(=O)N(CC=C)N4C5=NC(=CC=C5)C(C)(C)O)C=C2","20":"4.158","21":"4","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1536","2":"CP-673451","3":"d8","4":"L3500-01","5":"in 10mM DMSO","6":"PDGFR","7":"Protein Tyrosine Kinase","8":"CP-673451 is a selective inhibitor of PDGFRÎ±/Î² with IC50 of 10 nM/1 nM in cell-free assays, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.","9":"417.50","10":"343787-29-1","11":"28","12":"67.07","13":"<1","14":"NA","15":"http://selleckchem.com/products/CP-673451.html","16":"C24H27N5O2","17":"free base","18":"N/A","19":"COCCOC1=CC=C2[N](C=NC2=C1)C3=NC4=C(C=CC=C4C=C3)N5CCC(N)CC5","20":"3.011","21":"4","22":"1","23":"6","24":"NA","25":"KIT, PDGFRA, PDGFRB","26":"3","27":"PDGFRA"},{"1":"S1540","2":"Saxagliptin","3":"e8","4":"L3500-01","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.","9":"315.41","10":"361442-04-8","11":"63","12":"199.74","13":"63","14":"199.74","15":"http://selleckchem.com/products/Saxagliptin(Onglyza).html","16":"C18H25N3O2","17":"Free Base","18":"BMS-477118","19":"NC(C(=O)N1C(CC2CC12)C#N)[C]34CC5[CH2]C(C[C](O)(C5)C3)C4","20":"0.275","21":"1","22":"1","23":"2","24":"NA","25":"DPP4","26":"1","27":"DPP4"},{"1":"S1541","2":"Selisistat (EX 527)","3":"f8","4":"L3500-01","5":"in 10mM DMSO","6":"Sirtuin","7":"Epigenetics","8":"Selisistat (EX 527) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM in a cell-free assay, exhibits >200-fold selectivity against SIRT2 and SIRT3. Phase 2.","9":"248.71","10":"49843-98-3","11":"49","12":"197.02","13":"<1","14":"NA","15":"http://selleckchem.com/products/EX-527.html","16":"C13H13ClN2O","17":"free base","18":"SEN0014196","19":"NC(=O)C1CCCC2=C1[NH]C3=C2C=C(Cl)C=C3","20":"3.149","21":"1","22":"2","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1548","2":"Dapagliflozin","3":"g8","4":"L3500-01","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4.","9":"408.87","10":"461432-26-8","11":"82","12":"200.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/Dapagliflozin.html","16":"C21H25ClO6","17":"free base","18":"BMS-512148","19":"CCOC1=CC=C(CC2=CC(=CC=C2Cl)C3OC(CO)C(O)C(O)C3O)C=C1","20":"2.409","21":"2","22":"4","23":"6","24":"NA","25":"SLC5A1, SLC5A2","26":"2","27":"NA"},{"1":"S1549","2":"Nebivolol HCl","3":"h8","4":"L3500-01","5":"in 10mM DMSO","6":"Adrenergic Receptor","7":"Neuronal Signaling","8":"Nebivolol HCl selectively inhibits Î²1-adrenoceptor with IC50 of 0.8 nM.","9":"441.90","10":"152520-56-4","11":"88","12":"199.14","13":"<1","14":"NA","15":"http://selleckchem.com/products/Nebivolol(Bystolic).html","16":"C22H26ClF2NO4","17":"Hydrochloride","18":"R-65824","19":"Cl.OC(CNCC(O)C1CCC2=C(O1)C=CC(=C2)F)C3CCC4=CC(=CC=C4O3)F","20":"3.939","21":"2","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1550","2":"Pimobendan","3":"a9","4":"L3500-01","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"Pimobendan is a selective inhibitor of PDE3 with IC50 of 0.32 Î¼M.","9":"334.37","10":"74150-27-9","11":"67","12":"200.38","13":"<1","14":"NA","15":"http://selleckchem.com/products/Pimobendan(Vetmedin).html","16":"C19H18N4O2","17":"free base","18":"UD-CG 115 BS","19":"COC1=CC=C(C=C1)C2=NC3=CC(=CC=C3[NH]2)C4=NNC(=O)CC4C","20":"2.936","21":"4","22":"2","23":"3","24":"NA","25":"PDE3A","26":"1","27":"NA"},{"1":"S1555","2":"AZD8055","3":"b9","4":"L3500-01","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM in MDA-MB-468 cells with excellent selectivity (?1,000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.","9":"465.54","10":"1009298-09-2","11":"50","12":"107.40","13":"<1","14":"NA","15":"http://selleckchem.com/products/AZD8055.html","16":"C25H31N5O4","17":"free base","18":"N/A","19":"COC1=C(CO)C=C(C=C1)C2=NC3=C(C=C2)C(=NC(=N3)N4CCOCC4C)N5CCOCC5C","20":"3.274","21":"6","22":"1","23":"5","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S1570","2":"KU-60019","3":"c9","4":"L3500-01","5":"in 10mM DMSO","6":"ATM/ATR","7":"DNA Damage","8":"KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM in cell-free assays, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.","9":"547.67","10":"925701-49-1","11":"18","12":"32.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/KU-60019.html","16":"C30H33N3O5S","17":"free base","18":"N/A","19":"CC1CN(CC(C)O1)CC(=O)NC2=CC3=C(SC4=C(C3)C=CC=C4C5=CC(=O)C=C(O5)N6CCOCC6)C=C2","20":"3.818","21":"5","22":"1","23":"5","24":"NA","25":"ATM","26":"1","27":"NA"},{"1":"S1577","2":"Tie2 kinase inhibitor","3":"d9","4":"L3500-01","5":"in 10mM DMSO","6":"Tie-2","7":"Protein Tyrosine Kinase","8":"Tie2 kinase inhibitor is an optimized compound of SB-203580, selective to Tie2 with IC50 of 0.25 Î¼M, 200-fold more potent than p38.","9":"439.53","10":"948557-43-5","11":"35","12":"79.63","13":"<1","14":"NA","15":"http://selleckchem.com/products/Tie2-kinase-inhibitor.html","16":"C26H21N3O2S","17":"free base","18":"N/A","19":"COC1=CC2=C(C=C1)C=C(C=C2)C3=C(N=C([NH]3)C4=CC=C(C=C4)[S](C)=O)C5=CC=NC=C5","20":"4.570","21":"4","22":"1","23":"5","24":"NA","25":"KDR, MAPK14","26":"2","27":"NA"},{"1":"S1593","2":"Apixaban","3":"e9","4":"L3500-01","5":"in 10mM DMSO","6":"Factor Xa","7":"Metabolism","8":"Apixaban is a highly selective, reversible inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively.","9":"459.50","10":"503612-47-3","11":"18","12":"39.17","13":"<1","14":"NA","15":"http://selleckchem.com/products/Apixaban(BMS-562247-01).html","16":"C25H25N5O4","17":"free base","18":"BMS 562247-01","19":"COC1=CC=C(C=C1)[N]2N=C(C(N)=O)C3=C2C(=O)N(CC3)C4=CC=C(C=C4)N5CCCCC5=O","20":"2.865","21":"5","22":"1","23":"5","24":"NA","25":"F10","26":"1","27":"NA"},{"1":"S1629","2":"Orlistat","3":"f9","4":"L3500-01","5":"in 10mM DMSO","6":"Lipase,Fatty Acid Synthase","7":"Metabolism","8":"Orlistat is a general lipase inhibitor with IC50 of 122 ng/ml for PL from human duodenal juice.","9":"495.73","10":"96829-58-2","11":"99","12":"199.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/Orlistat(Alli).html","16":"C29H53NO5","17":"free base","18":"Ro 18-0647, Tetrahydrolipstatin","19":"CCCCCCCCCCCC(CC1OC(=O)C1CCCCCC)OC(=O)C(CC(C)C)NC=O","20":"8.333","21":"5","22":"1","23":"23","24":"NA","25":"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP","26":"6","27":"NA"},{"1":"S1789","2":"Tetrabenazine (Xenazine)","3":"g9","4":"L3500-01","5":"in 10mM DMSO","6":"Dopamine Receptor","7":"Neuronal Signaling","8":"Tetrabenazine(Nitoman, Xenazine) acts primarily as a reversible high-affinity inhibitor of mono-amine uptake into granular vesicles of presynaptic neurons by binding selectively to VMAT-2 Also blocks dopamine D2 receptors, but this affinity is 1,000-fold lower than its affinity for VMAT-2.","9":"317.42","10":"58-46-8","11":"58","12":"182.72","13":"<1","14":"NA","15":"http://selleckchem.com/products/Tetrabenazine(Nitoman).html","16":"C19H27NO3","17":"free base","18":"N/A","19":"COC1=CC2=C(C=C1OC)C3CC(=O)C(CC(C)C)CN3CC2","20":"3.365","21":"3","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2005","2":"Raltegravir (MK-0518)","3":"h9","4":"L3500-01","5":"in 10mM DMSO","6":"Integrase","7":"Microbiology","8":"Raltegravir (MK-0518) is a potent integrase (IN) inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays, respectively. It shows greater than 1000-fold selectivity for HIV-1 IN over several related Mg2+-dependent enzyme such as HCV polymerase, HIV reverse transcriptase, HIV RNaseH and human Î±-, Î²-, Î³-polymerases.","9":"444.42","10":"518048-05-0","11":"88","12":"198.01","13":"<1","14":"NA","15":"http://selleckchem.com/products/Raltegravir-(MK-0518).html","16":"C20H21FN6O5","17":"free base","18":"N/A","19":"CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)O","20":"-0.291","21":"7","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2012","2":"PCI-34051","3":"a10","4":"L3500-01","5":"in 10mM DMSO","6":"HDAC","7":"Epigenetics","8":"PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM in a cell-free assay. It has greater than 200-fold selectivity over HDAC1 and 6, more than 1000-fold selectivity over HDAC2, 3, and 10.","9":"296.32","10":"950762-95-5","11":"59","12":"199.11","13":"<1","14":"NA","15":"http://selleckchem.com/products/pci-34051.html","16":"C17H16N2O3","17":"free base","18":"N/A","19":"COC1=CC=C(C[N]2C=CC3=C2C=C(C=C3)C(=O)NO)C=C1","20":"2.911","21":"2","22":"1","23":"4","24":"NA","25":"HDAC1, HDAC10, HDAC6, HDAC8","26":"4","27":"NA"},{"1":"S2097","2":"Ambrisentan","3":"b10","4":"L3500-01","5":"in 10mM DMSO","6":"Endothelin Receptor","7":"GPCR & G Protein","8":"Ambrisentan is a highly selective antagonist of the endothelin-1 type A receptor, used in the treatment of pulmonary arterial hypertension (PAH).","9":"378.42","10":"177036-94-1","11":"76","12":"200.84","13":"<1","14":"NA","15":"http://selleckchem.com/products/ambrisentan.html","16":"C22H22N2O4","17":"free base","18":"LU-208075,BSF-208075","19":"COC(C(OC1=NC(=CC(=N1)C)C)C(O)=O)(C2=CC=CC=C2)C3=CC=CC=C3","20":"3.659","21":"5","22":"0","23":"7","24":"NA","25":"EDNRA, EDNRB","26":"2","27":"NA"},{"1":"S2105","2":"Pantoprazole","3":"c10","4":"L3500-01","5":"in 10mM DMSO","6":"Proton Pump","7":"Transmembrane Transporters","8":"Pantoprazole is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.","9":"383.37","10":"102625-70-7","11":"76","12":"198.24","13":"<1","14":"NA","15":"http://selleckchem.com/products/pantoprazole-protonix.html","16":"C16H15F2N3O4S","17":"free base","18":"N/A","19":"COC1=C(OC)C(=NC=C1)C[S](=O)C2=NC3=CC=C(OC(F)F)C=C3[NH]2","20":"2.737","21":"6","22":"1","23":"7","24":"NA","25":"ATP4A","26":"1","27":"NA"},{"1":"S2178","2":"AG-14361","3":"d10","4":"L3500-01","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM in a cell-free assay. It is at least 1000-fold more potent than the benzamides.","9":"320.39","10":"328543-09-5","11":"12","12":"37.45","13":"<1","14":"NA","15":"http://selleckchem.com/products/AG14361.html","16":"C19H20N4O","17":"free base","18":"N/A","19":"CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3[N]2CCNC4=O","20":"2.576","21":"2","22":"1","23":"3","24":"NA","25":"PARP1","26":"1","27":"PARP1"},{"1":"S2182","2":"SB743921 HCl","3":"e10","4":"L3500-01","5":"in 10mM DMSO","6":"Kinesin","7":"Cytoskeletal Signaling","8":"SB743921 is a kinesin spindle protein (KSP) inhibitor with Ki of 0.1 nM, almost no affinity to MKLP1, Kin2, Kif1A, Kif15, KHC, Kif4 and CENP-E. Phase 1/2.","9":"553.52","10":"940929-33-9","11":"111","12":"200.53","13":"22","14":"39.75","15":"http://selleckchem.com/products/SB-743921.html","16":"C31H34Cl2N2O3","17":"Hydrochloride","18":"N/A","19":"Cl.CC(C)C(N(CCCN)C(=O)C1=CC=C(C)C=C1)C2=C(CC3=CC=CC=C3)C(=O)C4=C(O2)C=C(Cl)C=C4","20":"6.536","21":"3","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2185","2":"AST-1306","3":"f10","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R, more potent to ErbB2-overexpressing cells, 3000-fold selective for ErbB family than other kinases.","9":"621.08","10":"1050500-29-2","11":"124","12":"199.65","13":"<1","14":"NA","15":"http://selleckchem.com/products/ast-1306.html","16":"C31H26ClFN4O5S","17":"Mesylate","18":"AST-6","19":"CC1=CC=C(C=C1)[S](O)(=O)=O.FC2=CC(=CC=C2)COC3=CC=C(NC4=C5C=C(NC(=O)C=C)C=CC5=NC=N4)C=C3Cl","20":"7.381","21":"4","22":"2","23":"8","24":"NA","25":"EGFR, ERBB2","26":"2","27":"EGFR"},{"1":"S2192","2":"Sapitinib (AZD8931)","3":"g10","4":"L3500-01","5":"in 10mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"Sapitinib (AZD8931) is a reversible, ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4 nM, 3 nM and 4 nM in cell-free assays, more potent than Gefitinib or Lapatinib against NSCLC cell, 100-fold more selective for the ErbB family than MNK1 and Flt. Phase 2.","9":"473.93","10":"848942-61-0","11":"40","12":"84.40","13":"<1","14":"NA","15":"http://selleckchem.com/products/AZD8931.html","16":"C23H25ClFN5O3","17":"free base","18":"N/A","19":"CNC(=O)CN1CCC(CC1)OC2=C(OC)C=C3N=CN=C(NC4=C(F)C(=CC=C4)Cl)C3=C2","20":"3.485","21":"5","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2193","2":"GSK461364","3":"h10","4":"L3500-01","5":"in 10mM DMSO","6":"PLK","7":"Cell Cycle","8":"GSK461364 inhibits purified Plk1 with Ki of 2.2 nM in a cell-free assay. It is more than 1000-fold selective against Plk2/3. Phase 1.","9":"543.60","10":"929095-18-1","11":"10","12":"18.40","13":"<1","14":"NA","15":"http://selleckchem.com/products/GSK461364.html","16":"C27H28F3N5O2S","17":"free base","18":"N/A","19":"CC(OC1=C(SC(=C1)[N]2C=NC3=C2C=C(CN4CCN(C)CC4)C=C3)C(N)=O)C5=CC=CC=C5C(F)(F)F","20":"5.125","21":"3","22":"1","23":"8","24":"NA","25":"PLK1","26":"1","27":"PLK1"},{"1":"S2216","2":"Mubritinib (TAK 165)","3":"a11","4":"L3500-01","5":"in 10mM DMSO","6":"HER2","7":"Protein Tyrosine Kinase","8":"Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM in BT-474 cell no activity to EGFR, FGFR, PDGFR, JAK1, Src and Blk in BT-474 cell line. Phase 1.","9":"468.47","10":"366017-09-6","11":"13","12":"27.75","13":"<1","14":"NA","15":"http://selleckchem.com/products/Mubritinib-TAK-165.html","16":"C25H23F3N4O2","17":"free base","18":"N/A","19":"FC(F)(F)C1=CC=C(\\\\C=C\\\\C2=NC(=CO2)COC3=CC=C(CCCC[N]4C=CN=N4)C=C3)C=C1","20":"5.844","21":"5","22":"0","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2224","2":"UK 383367","3":"b11","4":"L3500-01","5":"in 10mM DMSO","6":"Procollagen C Proteinase","7":"Metabolism","8":"UK-383367 is a procollagen C-proteinase inhibitor with IC50 of 44 nM, has excellent selectivity over MMPs.","9":"324.38","10":"348622-88-8","11":"65","12":"200.38","13":"<1","14":"NA","15":"http://selleckchem.com/products/UK-383367.html","16":"C15H24N4O4","17":"free base","18":"N/A","19":"NC(=O)C1=NOC(=N1)C(CCCC2CCCCC2)CC(=O)NO","20":"1.731","21":"5","22":"2","23":"8","24":"NA","25":"BMP1","26":"1","27":"BMP1"},{"1":"S2285","2":"Cryptotanshinone","3":"c11","4":"L3500-01","5":"in 10mM DMSO","6":"STAT","7":"JAK/STAT","8":"Cryptotanshinone is a STAT3 inhibitor with IC50 of 4.6 Î¼M in a cell-free assay, strongly inhibits phosphorylation of STAT3 Tyr705, with a small effect on STAT3 Ser727, but none against STAT1 nor STAT5.","9":"296.36","10":"35825-57-1","11":"5","12":"16.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/Cryptotanshinone.html","16":"C19H20O3","17":"free base","18":"N/A","19":"CC1COC2=C1C(=O)C(=O)C3=C4CCCC(C)(C)C4=CC=C23","20":"3.761","21":"3","22":"0","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2289","2":"Daidzin","3":"d11","4":"L3500-01","5":"in 10mM DMSO","6":"Dehydrogenase","7":"Metabolism","8":"Daidzin, a natural organic compound in the class of phytochemicals known as isoflavones, is a potent and selective inhibitor of human mitochondrial aldehyde dehydrogenase and inhibits ALDH-I selectively (Ki=20 nM) at least 500 times less effective against ALDH-â…¡, the cytosolic isozyme (Ki=10 Î¼M).","9":"416.38","10":"552-66-9","11":"83","12":"199.34","13":"<1","14":"NA","15":"http://selleckchem.com/products/Daidzin.html","16":"C21H20O9","17":"Free Base","18":"Daidzoside, Daidzein 7-O-glucoside, Daidzein 7-glucoside, Daidzein-7-glucoside","19":"OCC1OC(OC2=CC3=C(C=C2)C(=O)C(=CO3)C4=CC=C(O)C=C4)C(O)C(O)C1O","20":"0.452","21":"4","22":"5","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2312","2":"Icariin","3":"e11","4":"L3500-01","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"Icariin is a cGMP-specific PDE5 inhibitor with IC50 of 0.432 Î¼M, 167-fold more selective for PDE5 than PDE4.","9":"676.66","10":"489-32-7","11":"50","12":"73.89","13":"<1","14":"NA","15":"http://selleckchem.com/products/Icariin.html","16":"C33H40O15","17":"free base","18":"N/A","19":"COC1=CC=C(C=C1)C2=C(OC3OC(C)C(O)C(O)C3O)C(=O)C4=C(O2)C(=C(OC5OC(CO)C(O)C(O)C5O)C=C4O)CC=C(C)C","20":"0.983","21":"7","22":"8","23":"9","24":"NA","25":"PDE5A","26":"1","27":"NA"},{"1":"S2499","2":"Phenoxybenzamine HCl","3":"f11","4":"L3500-01","5":"in 10mM DMSO","6":"Adrenergic Receptor","7":"GPCR & G Protein","8":"Phenoxybenzamine HCl is a non-specific, irreversible alpha antagonist with an IC50 of 550 nM.","9":"340.30","10":"63-92-3","11":"68","12":"199.82","13":"17","14":"49.96","15":"http://selleckchem.com/products/Phenoxybenzamine-hydrochloride.html","16":"C18H23Cl2NO","17":"HCl","18":"NSC 37448, NCI-c01661","19":"Cl.CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2","20":"4.960","21":"1","22":"0","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2551","2":"Sulbactam sodium","3":"g11","4":"L3500-01","5":"in 10mM DMSO","6":"Anti-infection","7":"Microbiology","8":"Sulbactam sodium (Unasyn) is an irreversible Î²-lactamase inhibitor.","9":"255.22","10":"69388-84-7","11":"3","12":"11.75","13":"51","14":"199.83","15":"http://selleckchem.com/products/sulbactam-sodium-unasyn.html","16":"C8H10NNaO5S","17":"Sodium  salt","18":"CP-45899-2","19":"[Na+].CC1(C)C(N2C(CC2=O)[S]1(=O)=O)C([O-])=O","20":"-2.145","21":"3","22":"0","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2586","2":"Dimethyl Fumarate","3":"h11","4":"L3500-01","5":"in 10mM DMSO","6":"Others","7":"Others","8":"Dimethyl fumarate is the methyl ester of fumaric acid, used to treat people with relapsing forms of multiple sclerosis.","9":"144.13","10":"624-49-7","11":"29","12":"201.21","13":"<1","14":"NA","15":"http://selleckchem.com/products/dimethyl-Fumarate.html","16":"C6H8O4","17":"free base","18":"N/A","19":"COC(=O)\\\\C=C\\\\C(=O)OC","20":"0.490","21":"4","22":"0","23":"4","24":"NA","25":"KEAP1","26":"1","27":"NA"},{"1":"S2624","2":"OSI-027","3":"a2","4":"L3500-02","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"OSI-027 is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM in cell-free assays, and more than 100-fold selectivity observed for mTOR than PI3KÎ±, PI3KÎ², PI3KÎ³ or DNA-PK. Phase 1.","9":"406.44","10":"936890-98-1","11":"18","12":"44.29","13":"<1","14":"NA","15":"http://selleckchem.com/products/OSI027.html","16":"C21H22N6O3","17":"free base","18":"ASP4786","19":"COC1=CC=CC2=C1[NH]C(=C2)C3=C4[N](N=CN=C4N)C(=N3)C5CCC(CC5)C(O)=O","20":"3.376","21":"5","22":"2","23":"4","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S2626","2":"Rabusertib (LY2603618)","3":"b2","4":"L3500-02","5":"in 10mM DMSO","6":"Chk","7":"Cell Cycle","8":"Rabusertib (LY2603618) is a highly selective Chk1 inhibitor with potential anti-tumor activity in a cell-free assay. IC50=7 nM, showing approximately 100-fold more potent against Chk1 than against any of the other protein kinases evaluated.","9":"436.30","10":"911222-45-2","11":"13","12":"29.80","13":"<1","14":"NA","15":"http://selleckchem.com/products/LY2603618-IC-83.html","16":"C18H22BrN5O3","17":"free base","18":"IC-83","19":"CC1=NC=C(NC(=O)NC2=C(OCC3CNCCO3)C=C(C)C(=C2)Br)N=C1","20":"1.580","21":"5","22":"3","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2631","2":"URB597","3":"c2","4":"L3500-02","5":"in 10mM DMSO","6":"FAAH","7":"Metabolism","8":"URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. Phase 1.","9":"338.40","10":"546141-08-6","11":"68","12":"200.95","13":"<1","14":"NA","15":"http://selleckchem.com/products/urb597.html","16":"C20H22N2O3","17":"free base","18":"KDS-4103","19":"NC(=O)C1=CC(=CC=C1)C2=CC=CC(=C2)OC(=O)NC3CCCCC3","20":"3.972","21":"3","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2636","2":"A66","3":"d2","4":"L3500-02","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"A66 is a potent and specific p110Î± inhibitor with IC50 of 32 nM in a cell-free assay, >100 fold selectivity for p110Î± over other class-I PI3K isoforms.","9":"393.53","10":"1166227-08-2","11":"79","12":"200.75","13":"<1","14":"NA","15":"http://selleckchem.com/products/a66.html","16":"C17H23N5O2S2","17":"free base","18":"N/A","19":"CC1=C(SC(=N1)NC(=O)N2CCCC2C(N)=O)C3=CSC(=N3)C(C)(C)C","20":"2.383","21":"4","22":"2","23":"4","24":"NA","25":"PIK3CA","26":"1","27":"NA"},{"1":"S2662","2":"ICG-001","3":"e2","4":"L3500-02","5":"in 10mM DMSO","6":"Wnt/beta-catenin","7":"Stem Cells &  Wnt","8":"ICG-001 antagonizes Wnt/Î²-catenin/TCF-mediated transcription and specifically binds to CREB-binding protein (CBP) with IC50 of 3 Î¼M, but is not the related transcriptional coactivator p300.","9":"548.63","10":"780757-88-2","11":"100","12":"182.27","13":"<1","14":"NA","15":"http://selleckchem.com/products/icg-001.html","16":"C33H32N4O4","17":"free base","18":"N/A","19":"OC1=CC=C(CC2N3C(CN(CC4=CC=CC5=C4C=CC=C5)C2=O)N(CCC3=O)C(=O)NCC6=CC=CC=C6)C=C1","20":"4.065","21":"3","22":"2","23":"6","24":"NA","25":"CTNNB1","26":"1","27":"CTNNB1"},{"1":"S2666","2":"PF-3845","3":"f2","4":"L3500-02","5":"in 10mM DMSO","6":"FAAH","7":"Metabolism","8":"PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.","9":"456.46","10":"1196109-52-0","11":"91","12":"199.36","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf-3845.html","16":"C24H23F3N4O2","17":"free base","18":"N/A","19":"FC(F)(F)C1=CN=C(OC2=CC(=CC=C2)CC3CCN(CC3)C(=O)NC4=CN=CC=C4)C=C1","20":"4.550","21":"4","22":"1","23":"6","24":"NA","25":"FAAH","26":"1","27":"FAAH"},{"1":"S2673","2":"Trametinib (GSK1120212)","3":"g2","4":"L3500-02","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assays, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2.","9":"615.39","10":"871700-17-3","11":"22","12":"35.75","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk1120212-jtp-74057.html","16":"C26H23FIN5O4","17":"free base","18":"JTP-74057","19":"CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC4=CC=C(I)C=C4F)C5=CC(=CC=C5)NC(C)=O)C","20":"3.176","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2680","2":"Ibrutinib (PCI-32765)","3":"h2","4":"L3500-02","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase (Btk) inhibitor with IC50 of 0.5 nM in cell-free assays, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.","9":"440.50","10":"936563-96-1","11":"88","12":"199.77","13":"<1","14":"NA","15":"http://selleckchem.com/products/pci-32765.html","16":"C25H24N6O2","17":"free base","18":"N/A","19":"NC1=C2C(=NC=N1)[N](N=C2C3=CC=C(OC4=CC=CC=C4)C=C3)C5CCCN(C5)C(=O)C=C","20":"3.985","21":"5","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2683","2":"CHIR-124","3":"a3","4":"L3500-02","5":"in 10mM DMSO","6":"Chk","7":"Cell Cycle","8":"CHIR-124 is a novel and potent Chk1 inhibitor with IC50 of 0.3 nM in a cell-free assay. It shows 2,000-fold selectivity against Chk2, 500- to 5,000-fold less activity against CDK2/4 and Cdc2.","9":"419.91","10":"405168-58-3","11":"7","12":"16.67","13":"<1","14":"NA","15":"http://selleckchem.com/products/chir-124.html","16":"C23H22ClN5O","17":"free base","18":"N/A","19":"ClC1=CC2=C(NC(=O)C(=C2NC3CN4CCC3CC4)C5=NC6=C([NH]5)C=CC=C6)C=C1","20":"3.089","21":"2","22":"3","23":"3","24":"NA","25":"CHEK1","26":"1","27":"CHEK1"},{"1":"S2687","2":"Mardepodect (PF-2545920)","3":"b3","4":"L3500-02","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE.","9":"392.45","10":"1292799-56-4","11":"78","12":"198.75","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf-2545920.html","16":"C25H20N4O","17":"free base","18":"N/A","19":"C[N]1C=C(C2=CC=NC=C2)C(=N1)C3=CC=C(OCC4=NC5=CC=CC=C5C=C4)C=C3","20":"4.763","21":"4","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2689","2":"WAY-600","3":"c3","4":"L3500-02","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308) selective for mTOR than PI3KÎ± (>100-fold) and PI3KÎ³ (>500-fold).","9":"494.59","10":"1062159-35-6","11":"22","12":"44.48","13":"<1","14":"NA","15":"http://selleckchem.com/products/way-600.html","16":"C28H30N8O","17":"free base","18":"N/A","19":"C1CN(CCO1)C2=NC(=NC3=C2C=N[N]3C4CCN(CC4)CC5=CC=CN=C5)C6=CC7=C([NH]C=C7)C=C6","20":"2.946","21":"5","22":"1","23":"5","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S2695","2":"Nepicastat (SYN-117) HCl","3":"d3","4":"L3500-02","5":"in 10mM DMSO","6":"Hydroxylase","7":"Metabolism","8":"Nepicastat (SYN-117) HCl is a potent and selective inhibitor of both bovine and human dopamine-Î²-hydroxylase with IC50 of 8.5 nM and 9 nM, with negligible affinity for twelve other enzymes and thirteen neurotransmitter receptors. Phase 2.","9":"331.81","10":"170151-24-3","11":"66","12":"198.91","13":"<1","14":"NA","15":"http://selleckchem.com/products/nepicastat-hydrochloride.html","16":"C14H16ClF2N3S","17":"Hydrochloride","18":"N/A","19":"Cl.NCC1=CNC(=S)N1C2CCC3=C(F)C=C(F)C=C3C2","20":"3.008","21":"0","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2698","2":"RS-127445","3":"e3","4":"L3500-02","5":"in 10mM DMSO","6":"5-HT Receptor","7":"Neuronal Signaling","8":"RS-127445 is a selective 5-HT2B receptor antagonist with pKi of 9.5 and pIC50 of 10.4, exhibits >1000-fold selectivity against other 5-HT receptors.","9":"281.33","10":"199864-87-4","11":"56","12":"199.05","13":"<1","14":"NA","15":"http://selleckchem.com/products/rs-127445.html","16":"C17H16FN3","17":"free base","18":"MT500","19":"CC(C)C1=NC(=NC(=C1)C2=C3C=CC=CC3=C(F)C=C2)N","20":"4.298","21":"2","22":"1","23":"2","24":"NA","25":"HTR2A, HTR2B, HTR2C","26":"3","27":"NA"},{"1":"S2717","2":"CP-91149","3":"f3","4":"L3500-02","5":"in 10mM DMSO","6":"Phosphorylase","7":"Metabolism","8":"CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 Î¼M in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.","9":"399.87","10":"186392-40-5","11":"80","12":"200.07","13":"<1","14":"NA","15":"http://selleckchem.com/products/cp-91149.html","16":"C21H22ClN3O3","17":"free base","18":"N/A","19":"CN(C)C(=O)C(O)C(CC1=CC=CC=C1)NC(=O)C2=CC3=CC(=CC=C3[NH]2)Cl","20":"3.082","21":"2","22":"3","23":"6","24":"NA","25":"PYGL","26":"1","27":"NA"},{"1":"S2727","2":"Dacomitinib (PF299804, PF299)","3":"g3","4":"L3500-02","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Dacomitinib (PF299804, PF299) is a potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM in a cell-free assay, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the EGFR T790M mutation. Phase 2.","9":"469.94","10":"1110813-31-4","11":"19","12":"40.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf299804.html","16":"C24H25ClFN5O2","17":"free base","18":"N/A","19":"COC1=C(NC(=O)/C=C/CN2CCCCC2)C=C3C(=NC=NC3=C1)NC4=CC(=C(F)C=C4)Cl","20":"5.055","21":"4","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2729","2":"SB415286","3":"h3","4":"L3500-02","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"SB415286 is a potent GSK3Î± inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3Î².","9":"359.72","10":"264218-23-7","11":"72","12":"200.16","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb-415286.html","16":"C16H10ClN3O5","17":"free base","18":"N/A","19":"OC1=C(Cl)C=C(NC2=C(C(=O)NC2=O)C3=C(C=CC=C3)[N+]([O-])=O)C=C1","20":"2.490","21":"2","22":"3","23":"4","24":"NA","25":"GSK3A, GSK3B, RPS6KB1","26":"3","27":"NA"},{"1":"S2730","2":"Crenolanib (CP-868596)","3":"a4","4":"L3500-02","5":"in 10mM DMSO","6":"PDGFR","7":"Protein Tyrosine Kinase","8":"Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFRÎ±/Î² with Kd of 2.1 nM/3.2 nM in CHO cells, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src.","9":"443.54","10":"670220-88-9","11":"88","12":"198.40","13":"<1","14":"NA","15":"http://selleckchem.com/products/crenolanib-cp-868596.html","16":"C26H29N5O2","17":"free base","18":"ARO 002","19":"CC1(COC1)COC2=CC3=C(C=C2)[N](C=N3)C4=NC5=C(C=CC=C5C=C4)N6CCC(N)CC6","20":"3.192","21":"4","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2740","2":"GSK1070916","3":"b4","4":"L3500-02","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1.","9":"507.63","10":"942918-07-2","11":"93","12":"183.20","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk1070916.html","16":"C30H33N7O","17":"free base","18":"N/A","19":"CC[N]1C=C(C2=C3C=C([NH]C3=NC=C2)C4=CC=CC(=C4)CN(C)C)C(=N1)C5=CC=C(NC(=O)N(C)C)C=C5","20":"4.841","21":"3","22":"2","23":"7","24":"NA","25":"AURKA, AURKB, AURKC, CYP2D6, CYP3A4","26":"5","27":"AURKC"},{"1":"S2741","2":"Niraparib (MK-4827)","3":"c4","4":"L3500-02","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"Niraparib (MK-4827) is a selective inhibitor of PARP1/2 with IC50 of 3.8 nM/2.1 nM, with great activity in cancer cells with mutant BRCA-1 and BRCA-2. It is >330-fold selective against PARP3, V-PARP and Tank1. Phase 3.","9":"320.39","10":"1038915-60-4","11":"64","12":"199.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/mk-4827.html","16":"C19H20N4O","17":"Free Base","18":"NA","19":"NC(=O)C1=CC=CC2=C[N](N=C12)C3=CC=C(C=C3)C4CCCNC4","20":"2.618","21":"2","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2745","2":"CHIR-98014","3":"d4","4":"L3500-02","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"CHIR-98014 is a potent GSK-3Î±/Î² inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.","9":"486.31","10":"252935-94-7","11":"8","12":"16.45","13":"<1","14":"NA","15":"http://selleckchem.com/products/chir-98014.html","16":"C20H17Cl2N9O2","17":"free base","18":"CT98014","19":"NC1=NC(=CC=C1[N+]([O-])=O)NCCNC2=NC=C([N]3C=CN=C3)C(=N2)C4=CC=C(Cl)C=C4Cl","20":"3.859","21":"4","22":"3","23":"8","24":"NA","25":"GSK3A, GSK3B","26":"2","27":"GSK3A"},{"1":"S2747","2":"AMG-458","3":"e4","4":"L3500-02","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"AMG 458 is a potent c-Met inhibitor with Ki of 1.2 nM, ~350-fold selectivity for c-Met than VEGFR2 in cells.","9":"539.58","10":"913376-83-7","11":"21","12":"38.92","13":"<1","14":"NA","15":"http://selleckchem.com/products/amg458.html","16":"C30H29N5O5","17":"free base","18":"N/A","19":"COC1=CC2=NC=CC(=C2C=C1)OC3=CN=C(NC(=O)C4=C(C)N(CC(C)(C)O)N(C4=O)C5=CC=CC=C5)C=C3","20":"3.125","21":"6","22":"1","23":"8","24":"NA","25":"MET","26":"1","27":"MET"},{"1":"S2752","2":"HER2-Inhibitor-1","3":"f4","4":"L3500-02","5":"in 10mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"HER2-Inhibitor-1 is an analog of ARRY-380. ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.","9":"569.63","10":"937265-83-3","11":"100","12":"175.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/her2-inhibitor-1.html","16":"C29H27N7O4S","17":"free base","18":"N/A","19":"CC1=CC(=CC=C1OC2=CC3=NC=N[N]3C=C2)NC4=C5C=C(C=CC5=NC=N4)C6=CC=C(CNCC[S](C)(=O)=O)O6","20":"4.446","21":"8","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2753","2":"Tivantinib (ARQ 197)","3":"g4","4":"L3500-02","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"Tivantinib (ARQ 197) is the first non-ATP-competitive c-Met inhibitor with Ki of 0.355 Î¼M in a cell-free assay, little activity to Ron, and no inhibition to EGFR, InsR, PDGFRÎ± or FGFR1/4. Phase 3.","9":"369.42","10":"905854-02-6","11":"73","12":"197.61","13":"<1","14":"NA","15":"http://selleckchem.com/products/arq-197.html","16":"C23H19N3O2","17":"free base","18":"N/A","19":"O=C1NC(=O)C(C1C2=C[NH]C3=C2C=CC=C3)C4=C[N]5CCCC6=CC=CC4=C56","20":"3.520","21":"2","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2760","2":"Canagliflozin","3":"h4","4":"L3500-02","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Canagliflozin is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM in a cell-free assay, exhibits 413-fold selectivity over hSGLT1.","9":"444.52","10":"842133-18-0","11":"88","12":"197.97","13":"<1","14":"NA","15":"http://selleckchem.com/products/canagliflozin.html","16":"C24H25FO5S","17":"free base","18":"TA 7284, JNJ 28431754","19":"CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)C4OC(CO)C(O)C(O)C4O","20":"3.446","21":"1","22":"4","23":"5","24":"NA","25":"SLC5A1, SLC5A2","26":"2","27":"NA"},{"1":"S2761","2":"NVP-BVU972","3":"a5","4":"L3500-02","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM.","9":"340.38","10":"1185763-69-2","11":"68","12":"199.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/nvp-bvu972.html","16":"C20H16N6","17":"free base","18":"N/A","19":"C[N]1C=C(C=N1)C2=N[N]3C(=CN=C3C=C2)CC4=CC=C5N=CC=CC5=C4","20":"2.867","21":"4","22":"0","23":"3","24":"NA","25":"MET","26":"1","27":"MET"},{"1":"S2770","2":"MK-5108 (VX-689)","3":"b5","4":"L3500-02","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"MK-5108 (VX-689) is a highly selective Aurora A inhibitor with IC50 of 0.064 nM in a cell-free assay and is 220- and 190-fold more selective for Aurora A than Aurora B/C, while it inhibits TrkA with less than 100-fold selectivity. Phase 1.","9":"461.94","10":"1010085-13-8","11":"92","12":"199.16","13":"<1","14":"NA","15":"http://selleckchem.com/products/mk-5108-vx-689.html","16":"C22H21ClFN3O3S","17":"free base","18":"N/A","19":"OC(=O)C1(CCC(CC1)OC2=C(F)C(=CC=C2)Cl)CC3=CC=CC(=N3)NC4=NC=CS4","20":"5.574","21":"4","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2773","2":"SB705498","3":"c5","4":"L3500-02","5":"in 10mM DMSO","6":"TRPV","7":"Others","8":"SB705498 is a TRPV1 antagonist for hTRPV1, antagonizes capsaicin, acid, and heat activation of TRPV1 with IC50 of 3 nM, 0.1 nM and 6 nM, shows a degree of voltage dependence, exhibits >100-fold selectivity for TRPV1 over TRPM8. Phase 2.","9":"429.23","10":"501951-42-4","11":"86","12":"200.36","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb705498.html","16":"C17H16BrF3N4O","17":"free base","18":"N/A","19":"FC(F)(F)C1=CN=C(C=C1)N2CCC(C2)NC(=O)NC3=CC=CC=C3Br","20":"3.745","21":"2","22":"2","23":"4","24":"NA","25":"TRPV1","26":"1","27":"NA"},{"1":"S2778","2":"GW842166X","3":"d5","4":"L3500-02","5":"in 10mM DMSO","6":"Cannabinoid Receptor","7":"GPCR & G Protein","8":"GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.","9":"449.25","10":"666260-75-9","11":"20","12":"44.52","13":"<1","14":"NA","15":"http://selleckchem.com/products/gw-842166x.html","16":"C18H17Cl2F3N4O2","17":"free base","18":"N/A","19":"FC(F)(F)C1=NC(=NC=C1C(=O)NCC2CCOCC2)NC3=CC=C(Cl)C=C3Cl","20":"4.449","21":"4","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2783","2":"Vistusertib (AZD2014)","3":"e5","4":"L3500-02","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"Vistusertib (AZD2014) is a novel mTOR inhibitor with IC50 of 2.8 nM in a cell-free assay highly selective against multiple PI3K isoforms (Î±/Î²/Î³/Î´). AZD2014 showed no or weak binding to the majority of kinases when tested at 1 Î¼M.","9":"462.54","10":"1009298-59-2","11":"38","12":"82.16","13":"<1","14":"NA","15":"http://selleckchem.com/products/azd2014.html","16":"C25H30N6O3","17":"free base","18":"N/A","19":"CNC(=O)C1=CC=CC(=C1)C2=CC=C3C(=N2)N=C(N=C3N4CCOCC4C)N5CCOCC5C","20":"3.103","21":"6","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2785","2":"A-803467","3":"f5","4":"L3500-02","5":"in 10mM DMSO","6":"Sodium Channel","7":"Transmembrane Transporters","8":"A-803467 is a selective NaV1.8 channel blocker with IC50 of 8 nM, blocks tetrodotoxin-resistant currents, exhibits >100-fold selectivity against human NaV1.2, NaV1.3, NaV1.5, and NaV1.7.","9":"357.79","10":"944261-79-4","11":"72","12":"201.24","13":"<1","14":"NA","15":"http://selleckchem.com/products/a-803467.html","16":"C19H16ClNO4","17":"free base","18":"N/A","19":"COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(Cl)C=C3)OC","20":"4.451","21":"4","22":"1","23":"5","24":"NA","25":"SCN10A","26":"1","27":"SCN10A"},{"1":"S2804","2":"Sirtinol","3":"g5","4":"L3500-02","5":"in 10mM DMSO","6":"Sirtuin","7":"Epigenetics","8":"Sirtinol is a specific SIRT1 and SIRT2 inhibitor with IC50 of 131 Î¼M and 38 Î¼M in cell-free assays, respectively.","9":"394.47","10":"410536-97-9","11":"23","12":"58.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/sirtinol.html","16":"C26H22N2O2","17":"free base","18":"N/A","19":"CC(NC(=O)C1=CC=CC=C1N=CC2=C3C=CC=CC3=CC=C2O)C4=CC=CC=C4","20":"5.262","21":"2","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2808","2":"Ipatasertib (GDC-0068)","3":"h5","4":"L3500-02","5":"in 10mM DMSO","6":"Akt","7":"PI3K/Akt/mTOR","8":"Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.","9":"458.00","10":"1001264-89-6","11":"92","12":"200.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/gdc-0068.html","16":"C24H32ClN5O2","17":"free base","18":"RG7440","19":"CC(C)NCC(C(=O)N1CCN(CC1)C2=C3C(C)CC(O)C3=NC=N2)C4=CC=C(Cl)C=C4","20":"3.102","21":"3","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2811","2":"Sapanisertib (INK 128, MLN0128)","3":"a6","4":"L3500-02","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"Sapanisertib (INK 128, MLN0128) is a potent and selective mTOR inhibitor with IC50 of 1 nM in cell-free assays >200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes (vs Rapamycin). Phase 1.","9":"309.33","10":"1224844-38-5","11":"62","12":"200.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/ink128.html","16":"C15H15N7O","17":"free base","18":"N/A","19":"CC(C)[N]1N=C(C2=CC3=C(OC(=N3)N)C=C2)C4=C(N)N=CN=C14","20":"1.886","21":"5","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2816","2":"Tyrphostin AG 879","3":"b6","4":"L3500-02","5":"in 10mM DMSO","6":"HER2","7":"Protein Tyrosine Kinase","8":"Tyrphostin AG 879 potently inhibits HER2/ErbB2 with IC50 of 1 Î¼M, 100- and 500-fold higher selective to ErbB2 than PDGFR and EGFR.","9":"316.46","10":"148741-30-4","11":"36","12":"113.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/tyrphostin-ag-879-ag-879.html","16":"C18H24N2OS","17":"free base","18":"AG 879","19":"CC(C)(C)C1=C(O)C(=CC(=C1)/C=C(C#N)/C(N)=S)C(C)(C)C","20":"4.565","21":"0","22":"2","23":"4","24":"NA","25":"ERBB2, KDR, NTRK1","26":"3","27":"NA"},{"1":"S2817","2":"Torin 2","3":"c6","4":"L3500-02","5":"in 10mM DMSO","6":"ATM/ATR,mTOR","7":"PI3K/Akt/mTOR","8":"Torin 2 is a potent and selective mTOR inhibitor with IC50 of 0.25 nM in p53?/? MEFs cell line 800-fold greater selectivity for mTOR than PI3K and improved pharmacokinetic properties. Inhibition of ATM/ATR/DNA-PK with EC50 of 28 nM/35 nM/118 nM,in PC3 cell lines respectively.","9":"432.40","10":"1223001-51-1","11":"20","12":"46.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/torin-2.html","16":"C24H15F3N4O","17":"free base","18":"N/A","19":"NC1=CC=C(C=N1)C2=CC=C3N=CC4=C(N(C(=O)C=C4)C5=CC=CC(=C5)C(F)(F)F)C3=C2","20":"4.323","21":"3","22":"1","23":"3","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S2823","2":"Tideglusib","3":"d6","4":"L3500-02","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"Tideglusib is an irreversible, non ATP-competitive GSK-3Î² inhibitor with IC50 of 60 nM in a cell-free assay fails to inhibit kinases with a Cys homologous to Cys-199 located in the active site. Phase 2.","9":"334.39","10":"865854-05-3","11":"8","12":"23.92","13":"<1","14":"NA","15":"http://selleckchem.com/products/tideglusib.html","16":"C19H14N2O2S","17":"free base","18":"NP031112, NP-12","19":"O=C1SN(C(=O)N1CC2=CC=CC=C2)C3=C4C=CC=CC4=CC=C3","20":"4.630","21":"2","22":"0","23":"3","24":"NA","25":"GSK3B","26":"1","27":"GSK3B"},{"1":"S2828","2":"JNJ-1661010","3":"e6","4":"L3500-02","5":"in 10mM DMSO","6":"FAAH","7":"Metabolism","8":"JNJ-1661010 is a potent and selective FAAH inhibitor with IC50 of 10 nM (rat) and 12 nM (human), exhibits >100-fold selectivity for FAAH-1 when compared to FAAH-2.","9":"365.45","10":"681136-29-8","11":"36","12":"98.51","13":"<1","14":"NA","15":"http://selleckchem.com/products/jnj-1661010.html","16":"C19H19N5OS","17":"Free Base","18":"Takeda-25","19":"O=C(NC1=CC=CC=C1)N2CCN(CC2)C3=NC(=NS3)C4=CC=CC=C4","20":"3.271","21":"3","22":"1","23":"3","24":"NA","25":"FAAH","26":"1","27":"NA"},{"1":"S2853","2":"Carfilzomib (PR-171)","3":"f6","4":"L3500-02","5":"in 10mM DMSO","6":"Proteasome","7":"Proteases","8":"Carfilzomib (PR-171) is an irreversible proteasome inhibitor with IC50 of <5 nM in ANBL-6 cells, displayed preferential in vitro inhibitory potency against the ChT-L activity in the Î²5 subunit, but little or no effect on the PGPH and T-L activities.","9":"719.91","10":"868540-17-4","11":"50","12":"69.45","13":"<1","14":"NA","15":"http://selleckchem.com/products/carfilzomib-pr-171.html","16":"C40H57N5O7","17":"free base","18":"N/A","19":"CC(C)CC(NC(=O)C(CCC1=CC=CC=C1)NC(=O)CN2CCOCC2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC(C)C)C(=O)C4(C)CO4","20":"3.799","21":"7","22":"4","23":"20","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2856","2":"SB 271046 hydrochloride","3":"g6","4":"L3500-02","5":"in 10mM DMSO","6":"5-HT Receptor","7":"Neuronal Signaling","8":"SB 271046 hydrochloride is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.","9":"488.45","10":"209481-24-3","11":"40","12":"81.89","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb-271046.html","16":"C20H23Cl2N3O3S2","17":"hydrochloride","18":"N/A","19":"COC1=CC=C(N[S](=O)(=O)C2=C(C)C3=CC(=CC=C3S2)Cl)C=C1N4CCNCC4","20":"4.403","21":"3","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2861","2":"CTEP (RO4956371)","3":"h6","4":"L3500-02","5":"in 10mM DMSO","6":"GluR","7":"Neuronal Signaling","8":"CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors.","9":"391.77","10":"871362-31-1","11":"78","12":"199.10","13":"<1","14":"NA","15":"http://selleckchem.com/products/ctep.html","16":"C19H13ClF3N3O","17":"free base","18":"N/A","19":"CC1=NC(=C(C)[N]1C2=CC=C(OC(F)(F)F)C=C2)C#CC3=CC=NC(=C3)Cl","20":"6.286","21":"3","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2868","2":"Alogliptinï¼ˆSYK-322ï¼‰benzoate","3":"a7","4":"L3500-02","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.","9":"461.51","10":"850649-62-6","11":"68","12":"147.34","13":"2","14":"4.33","15":"http://selleckchem.com/products/alogliptin-syr-322.html","16":"C18H21N5O2","17":"free base","18":"SYR-322","19":"CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC=CC=C3C#N)C1=O","20":"1.271","21":"2","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2871","2":"T0070907","3":"b7","4":"L3500-02","5":"in 10mM DMSO","6":"PPAR","7":"DNA Damage","8":"T0070907 is a potent and selective PPARÎ³ inhibitor with IC50 of 1 nM in a cell-free assay, with a >800-fold selectivity over PPARÎ± and PPARÎ´.","9":"277.66","10":"313516-66-4","11":"26","12":"93.64","13":"<1","14":"NA","15":"http://selleckchem.com/products/t0070907.html","16":"C12H8ClN3O3","17":"free base","18":"N/A","19":"[O-][N+](=O)C1=CC=C(Cl)C(=C1)C(=O)NC2=CC=NC=C2","20":"2.022","21":"2","22":"1","23":"3","24":"NA","25":"PPARG","26":"1","27":"NA"},{"1":"S2875","2":"Prucalopride","3":"c7","4":"L3500-02","5":"in 10mM DMSO","6":"5-HT Receptor","7":"Neuronal Signaling","8":"Prucalopride is a selective, high affinity 5-HT receptor agonist for 5-HT4A and 5-HT4B receptor with Ki of 2.5 nM and 8 nM, respectively, exhibits >290-fold selectivity against other 5-HT receptor subtypes.","9":"367.87","10":"179474-81-8","11":"60","12":"163.10","13":"<1","14":"NA","15":"http://selleckchem.com/products/prucalopride.html","16":"C18H26ClN3O3","17":"Free Base","18":"R-93877","19":"COCCCN1CCC(CC1)NC(=O)C2=CC(=C(N)C3=C2OCC3)Cl","20":"1.056","21":"3","22":"2","23":"6","24":"NA","25":"HTR4","26":"1","27":"NA"},{"1":"S2891","2":"GW441756","3":"d7","4":"L3500-02","5":"in 10mM DMSO","6":"Trk receptor","7":"Protein Tyrosine Kinase","8":"GW441756 is a potent, selective inhibitor of TrkA with IC50 of 2 nM, with very little activity to c-Raf1 and CDK2.","9":"275.30","10":"504433-23-2","11":"25","12":"90.81","13":"<1","14":"NA","15":"http://selleckchem.com/products/gw-441756.html","16":"C17H13N3O","17":"free base","18":"N/A","19":"C[N]1C=C(C=C2C(=O)NC3=CC=CN=C23)C4=C1C=CC=C4","20":"2.508","21":"2","22":"1","23":"1","24":"NA","25":"NTRK1","26":"1","27":"NTRK1"},{"1":"S2894","2":"SB742457","3":"e7","4":"L3500-02","5":"in 10mM DMSO","6":"5-HT Receptor","7":"Neuronal Signaling","8":"SB742457 is a highly selective 5-HT6 receptor antagonist with pKi of 9.63, exhibits >100-fold selectivity over other receptors. Phase 2.","9":"353.44","10":"607742-69-8","11":"78","12":"220.69","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb-742457.html","16":"C19H19N3O2S","17":"free base","18":"GSK 742457","19":"O=[S](=O)(C1=CC=CC=C1)C2=CC3=C(N=C2)C(=CC=C3)N4CCNCC4","20":"2.702","21":"3","22":"1","23":"3","24":"NA","25":"HTR6","26":"1","27":"NA"},{"1":"S2896","2":"ZM 323881 HCl","3":"f7","4":"L3500-02","5":"in 10mM DMSO","6":"VEGFR","7":"Protein Tyrosine Kinase","8":"ZM 323881 is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almost no activity on VEGFR1, PDGFRÎ², FGFR1, EGFR and ErbB2.","9":"411.86","10":"193000-39-4","11":"10","12":"24.28","13":"<1","14":"NA","15":"http://selleckchem.com/products/zm-323881-hcl.html","16":"C22H19ClFN3O2","17":"Hydrochloride","18":"N/A","19":"Cl.CC1=CC(=C(NC2=C3C=CC(=CC3=NC=N2)OCC4=CC=CC=C4)C=C1O)F","20":"5.876","21":"3","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2899","2":"GNF-2","3":"g7","4":"L3500-02","5":"in 10mM DMSO","6":"Bcr-Abl","7":"Angiogenesis","8":"GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.","9":"374.32","10":"778270-11-4","11":"74","12":"197.69","13":"<1","14":"NA","15":"http://selleckchem.com/products/gnf-2.html","16":"C18H13F3N4O2","17":"free base","18":"N/A","19":"NC(=O)C1=CC=CC(=C1)C2=NC=NC(=C2)NC3=CC=C(OC(F)(F)F)C=C3","20":"5.209","21":"4","22":"2","23":"6","24":"NA","25":"ABL1, BCR","26":"2","27":"NA"},{"1":"S2903","2":"Lumiracoxib","3":"h7","4":"L3500-02","5":"in 10mM DMSO","6":"COX","7":"Neuronal Signaling","8":"Lumiracoxib is a novel, selective COX-2 inhibitor with Ki of  0.06 Î¼M. It also inhibits COX1 with Ki of 3 Î¼M.","9":"293.72","10":"220991-20-8","11":"59","12":"200.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/lumiracoxib-cox-189.html","16":"C15H13ClFNO2","17":"free base","18":"COX-189","19":"CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(=C1)CC(O)=O","20":"4.400","21":"1","22":"1","23":"4","24":"NA","25":"PTGS1, PTGS2","26":"2","27":"NA"},{"1":"S2905","2":"JNJ-7777120","3":"a8","4":"L3500-02","5":"in 10mM DMSO","6":"Histamine Receptor","7":"Neuronal Signaling","8":"JNJ-7777120 is the first potent and selective non-imidazole histamine H4 receptor antagonist with Ki of 4.5 nM, exhibits >1000-fold selectivity over the other histamin receptors.","9":"277.75","10":"459168-41-3","11":"56","12":"201.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/jnj-7777120.html","16":"C14H16ClN3O","17":"free base","18":"N/A","19":"CN1CCN(CC1)C(=O)C2=CC3=CC(=CC=C3[NH]2)Cl","20":"2.450","21":"1","22":"1","23":"1","24":"NA","25":"HRH4","26":"1","27":"NA"},{"1":"S2919","2":"IOX2","3":"b8","4":"L3500-02","5":"in 10mM DMSO","6":"HIF","7":"Angiogenesis","8":"IOX2 is a potent inhibitor of HIF-1Î± prolyl hydroxylase-2 (PHD2) with IC50 of 21 nM in a cell-free assay, >100-fold selectivity over JMJD2A, JMJD2C, JMJD2E, JMJD3, or the 2OG oxygenase FIH.","9":"352.34","10":"931398-72-0","11":"7","12":"19.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/iox2.html","16":"C19H16N2O5","17":"free base","18":"JICL38","19":"OC(=O)CNC(=O)C1=C(O)C2=C(C=CC=C2)N(CC3=CC=CC=C3)C1=O","20":"1.153","21":"3","22":"2","23":"5","24":"NA","25":"EGLN1, KDM2A, KDM5C","26":"3","27":"NA"},{"1":"S2921","2":"PF-4981517","3":"c8","4":"L3500-02","5":"in 10mM DMSO","6":"P450 (e.g. CYP17)","7":"Metabolism","8":"PF-4981517 is a potent and selective inhibitor of CYP3A4 (P450) with IC50 of 0.03 Î¼M, exhibits >500-fold selectivity over CYP3A5 and CYP3A7.","9":"456.59","10":"1390637-82-7","11":"91","12":"199.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf-4981517.html","16":"C26H32N8","17":"free base","18":"CYP3cide, PF-04981517","19":"C[N]1N=CC(=C1C2=CC=C(C)C=C2)C3=N[N](C)C4=NC=NC(=C34)N5CCC(C5)N6CCCCC6","20":"4.659","21":"4","22":"0","23":"4","24":"NA","25":"CYP3A4","26":"1","27":"CYP3A4"},{"1":"S2924","2":"CHIR-99021 (CT99021) HCl","3":"d8","4":"L3500-02","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"CHIR-99021 HCl (CT99021) is hydrochloride of CHIR-99021, which is a GSK-3Î±/Î² inhibitor with IC50 of 10 nM/6.7 nM CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs Cdc2 and ERK2.","9":"501.80","10":"1797989-42-4","11":"93","12":"185.33","13":"<1","14":"NA","15":"http://selleckchem.com/products/chir-99021-ct99021-hcl.html","16":"C22H19Cl3N8","17":"Hydrochloride","18":"N/A","19":"Cl.CC1=C[NH]C(=N1)C2=CN=C(NCCNC3=NC=C(C=C3)C#N)N=C2C4=CC=C(Cl)C=C4Cl","20":"4.858","21":"4","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3002","2":"Rivaroxaban","3":"e8","4":"L3500-02","5":"in 10mM DMSO","6":"Factor Xa","7":"Metabolism","8":"Rivaroxaban is a direct inhibitor of Factor Xa with Ki and IC50 of 0.4 nM and 0.7 nM in cell-free assays, respectively. It is selective for human factor Xa, for which it has >10 000-fold greater selectivity than for other biologically relevant serine proteases (IC50 >20 Î¼M).","9":"435.88","10":"366789-02-8","11":"87","12":"199.60","13":"<1","14":"NA","15":"http://selleckchem.com/products/Rivaroxaban.html","16":"C19H18ClN3O5S","17":"free base","18":"BAY 59-7939","19":"ClC1=CC=C(S1)C(=O)NCC2CN(C(=O)O2)C3=CC=C(C=C3)N4CCOCC4=O","20":"1.797","21":"5","22":"1","23":"5","24":"NA","25":"F10","26":"1","27":"NA"},{"1":"S3017","2":"Aspirin","3":"f8","4":"L3500-02","5":"in 10mM DMSO","6":"COX","7":"Metabolism","8":"Aspirin is a salicylate, and irreversible COX1 and COX2 inhibitor, used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication.","9":"180.16","10":"50-78-2","11":"36","12":"199.82","13":"<1","14":"NA","15":"http://selleckchem.com/products/aspirin-acetylsalicylic-acid.html","16":"C9H8O4","17":"free base","18":"Acetylsalicylic acid","19":"CC(=O)OC1=C(C=CC=C1)C(O)=O","20":"1.227","21":"3","22":"0","23":"3","24":"NA","25":"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53","26":"19","27":"PRKAB1"},{"1":"S3025","2":"PMSF","3":"g8","4":"L3500-02","5":"in 10mM DMSO","6":"Serine Protease,Cysteine Protease","7":"Proteases","8":"PMSF is an irreversible serine/cysteine protease inhibitor.","9":"174.19","10":"329-98-6","11":"35","12":"200.93","13":"<1","14":"NA","15":"http://selleckchem.com/products/pmsf-phenylmethylsulfonyl-fluoride.html","16":"C7H7FO2S","17":"free base","18":"Phenylmethylsulfonyl Fluoride","19":"F[S](=O)(=O)CC1=CC=CC=C1","20":"1.459","21":"2","22":"0","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3031","2":"Linagliptin","3":"h8","4":"L3500-02","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM and exhibits a 10,000-fold higher selectivity for DPP-4 than for other dipeptidyl peptidases such as DPP-2, DPP-8, and DPP-9.","9":"472.54","10":"668270-12-0","11":"17","12":"35.98","13":"<1","14":"NA","15":"http://selleckchem.com/products/linagliptin-bi-1356.html","16":"C25H28N8O2","17":"free base","18":"BI-1356","19":"CC#CC[N]1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(=N3)C)C(=O)N2C)N5CCCC(N)C5","20":"2.718","21":"5","22":"1","23":"5","24":"NA","25":"DPP4","26":"1","27":"NA"},{"1":"S3033","2":"Vildagliptin (LAF-237)","3":"a9","4":"L3500-02","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Vildagliptin (LAF-237) inhibits DPP?4 with IC50 of 2.3 nM.","9":"303.40","10":"274901-16-5","11":"60","12":"197.76","13":"60","14":"197.76","15":"http://selleckchem.com/products/vildagliptin-laf-237.html","16":"C17H25N3O2","17":"free base","18":"N/A","19":"O[C]12CC3[CH2]C(C1)C[C](C3)(C2)NCC(=O)N4CCCC4C#N","20":"0.179","21":"1","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3057","2":"Azilsartan Medoxomil","3":"b9","4":"L3500-02","5":"in 10mM DMSO","6":"RAAS","7":"Endocrinology & Hormones","8":"Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist, inhibits the RAAS, with an IC50 of 2.6 nM, exhibits >10,000-fold selectivity over AT2.","9":"568.53","10":"863031-21-4","11":"114","12":"200.52","13":"<1","14":"NA","15":"http://selleckchem.com/products/azilsartan-medoxomil-tak-491.html","16":"C30H24N4O8","17":"free base","18":"TAK-491","19":"CCOC1=NC2=CC=CC(=C2[N]1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(C)OC(=O)O6","20":"5.270","21":"10","22":"1","23":"10","24":"NA","25":"AGTR1, AGTR2","26":"2","27":"NA"},{"1":"S3060","2":"Medetomidine HCl","3":"c9","4":"L3500-02","5":"in 10mM DMSO","6":"Adrenergic Receptor","7":"Neuronal Signaling","8":"Medetomidine is a selective Î±2-adrenoceptor agonist, with Ki of 1.08 nM, exhibts 1620-fold selectivity over Î±1-adrenoceptor.","9":"236.74","10":"86347-15-1","11":"12","12":"50.69","13":"47","14":"198.53","15":"http://selleckchem.com/products/medetomidine-hcl.html","16":"C13H17ClN2","17":"HCl","18":"N/A","19":"Cl.CC(C1=C[NH]C=N1)C2=C(C)C(=CC=C2)C","20":"3.515","21":"1","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3200","2":"Triflusal","3":"d9","4":"L3500-02","5":"in 10mM DMSO","6":"Thrombin","7":"Others","8":"Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.","9":"248.16","10":"322-79-2","11":"50","12":"201.48","13":"<1","14":"NA","15":"http://selleckchem.com/products/triflusal.html","16":"C10H7F3O4","17":"free base","18":"UR1501","19":"CC(=O)OC1=CC(=CC=C1C(O)=O)C(F)(F)F","20":"2.169","21":"3","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3673","2":"Sulfaphenazole","3":"e9","4":"L3500-02","5":"in 10mM DMSO","6":"P450 (e.g. CYP17)","7":"Metabolism","8":"Sulfaphenazole is an inhibitor of CYP2C9 with Ki value of 0.3 Î¼M and demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki values of 63 and 29 Î¼M for CYP2C8 and CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19).","9":"314.36","10":"526-08-9","11":"62","12":"197.23","13":"<1","14":"NA","15":"http://selleckchem.com/products/sulfaphenazole.html","16":"C15H14N4O2S","17":"free base","18":"Depocid, Depotsulfonamide, Plisulfan, Raziosulfa","19":"NC1=CC=C(C=C1)[S](=O)(=O)NC2=CC=N[N]2C3=CC=CC=C3","20":"1.922","21":"3","22":"2","23":"4","24":"NA","25":"DHPS","26":"1","27":"NA"},{"1":"S3678","2":"PTP Inhibitor II","3":"f9","4":"L3500-02","5":"in 10mM DMSO","6":"phosphatase","7":"Others","8":"PTP Inhibitor II is a cell-permeable protein tyrosine phosphatase (PTP) inhibitor that covalently binds the catalytic domain of the Src homology region 2 domain-containing phosphatase (SHP-1(Î”SH2)) with Ki value of 128 Î¼M.","9":"229.07","10":"2632-13-5","11":"45","12":"196.45","13":"<1","14":"NA","15":"http://selleckchem.com/products/ptp-inhibitor-2.html","16":"C9H9BrO2","17":"free base","18":"NSC 129010, 4-(Bromoacetyl)anisole","19":"COC1=CC=C(C=C1)C(=O)CBr","20":"2.230","21":"2","22":"0","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3692","2":"N-Ethylmaleimide (NEM)","3":"g9","4":"L3500-02","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"N-Ethylmaleimide (NEM) is an organic compound that is derived from maleic acid. It is an irreversible inhibitor of all cysteine peptidases, with alkylation occurring at the active site thiol group.","9":"125.13","10":"128-53-0","11":"25","12":"199.79","13":"25","14":"199.79","15":"http://selleckchem.com/products/n-ethylmaleimide-nem.html","16":"C6H7NO2","17":"free base","18":"N/A","19":"CCN1C(=O)C=CC1=O","20":"0.160","21":"2","22":"0","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S3732","2":"Avibactam sodium","3":"h9","4":"L3500-02","5":"in 10mM DMSO","6":"Anti-infection","7":"Microbiology","8":"Avibactam is a covalent, reversible, non-Î²-lactam Î²-lactamase inhibitor with IC50 values of 8, 80, and 38 nM for TEM-1, P99, and KPC-2 Î²-lactamases, respectively.","9":"287.23","10":"1192491-61-4","11":"57","12":"198.45","13":"57","14":"198.45","15":"http://selleckchem.com/products/avibactam-sodium.html","16":"C7H10N3NaO6S","17":"sodium salt","18":"AVE-1330A, NXL104","19":"[Na+].NC(=O)C1CCC2CN1C(=O)N2O[S]([O-])(=O)=O","20":"-3.785","21":"3","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4002","2":"Sitagliptin phosphate monohydrate","3":"a10","4":"L3500-02","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Sitagliptin phosphate monohydrate is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts.","9":"523.32","10":"654671-77-9","11":"100","12":"191.09","13":"41","14":"78.35","15":"http://selleckchem.com/products/Sitagliptin.html","16":"C16H20F6N5O6P","17":"phosphate &monohydrate","18":"MK-0431","19":"O.NC(CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F.O[P](O)(O)=O","20":"1.254","21":"3","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4019","2":"Avanafil","3":"b10","4":"L3500-02","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"Avanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >121-fold selectivity over other PDEs.","9":"483.95","10":"330784-47-9","11":"97","12":"200.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/avanafil.html","16":"C23H26ClN7O3","17":"free base","18":"N/A","19":"COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N3CCCC3CO)C(=O)NCC4=NC=CC=N4)C=C1","20":"2.165","21":"6","22":"3","23":"9","24":"NA","25":"PDE5A","26":"1","27":"PDE5A"},{"1":"S4102","2":"Eprosartan Mesylate","3":"c10","4":"L3500-02","5":"in 10mM DMSO","6":"RAAS","7":"Endocrinology & Hormones","8":"Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells.","9":"520.62","10":"144143-96-4","11":"104","12":"199.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/eprosartan-mesylate.html","16":"C24H28N2O7S2","17":"Mesylate","18":"N/A","19":"CCCCC1=NC=C(\\\\C=C(CC2=CC=CS2)\\\\C(O)=O)[N]1CC3=CC=C(C=C3)C(O)=O.C[S](O)(=O)=O","20":"4.418","21":"3","22":"0","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4136","2":"Carprofen","3":"d10","4":"L3500-02","5":"in 10mM DMSO","6":"COX","7":"Neuronal Signaling","8":"Carprofen inhibits canine COX2 with IC50 of 30 nM.","9":"273.71","10":"53716-49-7","11":"55","12":"200.94","13":"<1","14":"NA","15":"http://selleckchem.com/products/carprofen.html","16":"C15H12ClNO2","17":"free base","18":"N/A","19":"CC(C(O)=O)C1=CC2=C(C=C1)C3=C([NH]2)C=CC(=C3)Cl","20":"4.114","21":"1","22":"1","23":"2","24":"NA","25":"PTGS1, PTGS2","26":"2","27":"NA"},{"1":"S4246","2":"Tranylcypromine (2-PCPA) HCl","3":"e10","4":"L3500-02","5":"in 10mM DMSO","6":"MAO","7":"Metabolism","8":"Tranylcypromine is a monoamine oxidase inhibitor, which inhibits CYP2A6 with Ki of 0.08 Î¼M and 0.2 Î¼M in cDNA-expressing microsomes and Human Liver Microsomes, respectively.","9":"169.65","10":"1986-47-6","11":"33","12":"194.52","13":"33","14":"194.52","15":"http://selleckchem.com/products/tranylcypromine-2-pcpa-hcl.html","16":"C9H12ClNR","17":"Hydrochloride","18":"SKF-385 HCl","19":"Cl.NC1CC1C2=CC=CC=C2","20":"2.309","21":"0","22":"1","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4586","2":"4-Chloro-DL-phenylalanine","3":"f10","4":"L3500-02","5":"in 10mM DMSO","6":"Hydroxylase","7":"Metabolism","8":"4-Chloro-DL-phenylalanine is a selective and irreversible inhibitor of tryptophan hydroxylase,  a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). 4-Chloro-DL-phenylalanine acts pharmacologically to deplete endogenous levels of serotonin.","9":"199.63","10":"7424-00-2","11":"2","12":"10.02","13":"<1","14":"NA","15":"http://selleckchem.com/products/4-chloro-dl-phenylalanine.html","16":"C9H10ClNO2","17":"Free Base","18":"Fenclonine, PCPA, CP-10188","19":"NC(CC1=CC=C(Cl)C=C1)C(O)=O","20":"-0.941","21":"1","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4610","2":"Mebendazole","3":"g10","4":"L3500-02","5":"in 10mM DMSO","6":"Anti-infection","7":"Microbiology","8":"Mebendazole is a synthetic benzimidazole derivate and anthelmintic agent. Mebendazole interferes with the reproduction and survival of helminths by inhibiting the formation of their cytoplasmic microtubules, thereby selectively and irreversibly blocking glucose uptake.","9":"295.29","10":"31431-39-7","11":"6","12":"20.32","13":"<1","14":"NA","15":"http://selleckchem.com/products/mebendazole.html","16":"C16H13N3O3","17":"free base","18":"Vermox, Telmin, Pantelmin, Mebenvet","19":"COC(=O)NC1=NC2=C([NH]1)C=CC(=C2)C(=O)C3=CC=CC=C3","20":"3.055","21":"4","22":"2","23":"4","24":"NA","25":"TUBA1A, TUBB, TUBB4B","26":"3","27":"TUBA1A"},{"1":"S4697","2":"Saxagliptin hydrate","3":"h10","4":"L3500-02","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Saxagliptin H2O is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.","9":"333.43","10":"945667-22-1","11":"66","12":"197.94","13":"1","14":"3.00","15":"http://selleckchem.com/products/saxagliptin-hydrate.html","16":"C18H27N3O3","17":"hydrate","18":"BMS-477118 hydrate, Onglyza hydrate, BMS 477118 hydrate, BMS477118 hydrate","19":"O.NC(C(=O)N1C(CC2CC12)C#N)[C]34CC5[CH2]C(C[C](O)(C5)C3)C4","20":"0.068","21":"1","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4800","2":"Daminozide","3":"a11","4":"L3500-02","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"Daminozide, a plant growth regulator, selectively inhibits the KDM2/7 JmjC subfamily with IC50 of 1.5Â±0.7 Î¼M for KDM2A. It is at least 100-fold selective as an inhibitor of the KDM2/7 subfamily over the other demethylase subfamily members tested, with IC50s of 2 Î¼M or less against KDM2A, PHF8, and KIAA1718 and IC50s of 127 Î¼M for KDM3A or greater (mM range) against other demethylases.","9":"160.17","10":"1596-84-5","11":"32","12":"199.79","13":"NA","14":"NA","15":"http://selleckchem.com/products/daminozide.html","16":"C6H12N2O3","17":"free base","18":"Aminozide, Succinic Acid","19":"CN(C)NC(=O)CCC(O)=O","20":"0.000","21":"0","22":"0","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4854","2":"Bedaquiline fumarate","3":"b11","4":"L3500-02","5":"in 10mM DMSO","6":"Anti-infection","7":"Microbiology","8":"Bedaquiline fumarate, an oral diarylquinoline,  is a bactericidal antimycobacterial drug. It is a proton-translocating ATP synthetase inhibitor.","9":"671.58","10":"845533-86-0","11":"100","12":"148.90","13":"<1","14":"NA","15":"http://selleckchem.com/products/bedaquiline-fumarate.html","16":"C36H35BrN2O6","17":"fumarate","18":"TMC-207","19":"COC1=C(C=C2C=C(Br)C=CC2=N1)C(C3=CC=CC=C3)C(O)(CCN(C)C)C4=C5C=CC=CC5=CC=C4.OC(=O)\\\\C=C\\\\C(O)=O","20":"3.937","21":"4","22":"0","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4856","2":"Iproniazid","3":"c11","4":"L3500-02","5":"in 10mM DMSO","6":"MAO","7":"Metabolism","8":"Iproniazid is a non-selective, irreversible monoamine oxidase (MAO) inhibitor (MAOI) that is used as an antidepressive agent.","9":"179.22","10":"54-92-2","11":"35","12":"195.29","13":"35","14":"195.29","15":"http://selleckchem.com/products/Iproniazid.html","16":"C9H13N3O","17":"free base","18":"Marsilid, Iprazid","19":"CC(C)NNC(=O)C1=CC=NC=C1","20":"0.121","21":"2","22":"2","23":"3","24":"NA","25":"MAOA, MAOB","26":"2","27":"MAOA"},{"1":"S4901","2":"JNK-IN-8","3":"d11","4":"L3500-02","5":"in 10mM DMSO","6":"JNK","7":"MAPK","8":"JNK-IN-8 is the first irreversible JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 4.7 nM, 18.7 nM and 1 nM, >10-fold selectivity against MNK2, Fms and no inhibition to c-Kit, Met, PDGFRÎ²in A375 cell line.","9":"507.59","10":"1410880-22-6","11":"100","12":"197.01","13":"<1","14":"NA","15":"http://selleckchem.com/products/jnk-in-8.html","16":"C29H29N7O2","17":"free base","18":"N/A","19":"CN(C)C/C=C/C(=O)NC1=CC(=CC=C1)C(=O)NC2=CC=C(NC3=NC=CC(=N3)C4=CC=CN=C4)C(=C2)C","20":"3.997","21":"5","22":"3","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4904","2":"JZL184","3":"e11","4":"L3500-02","5":"in 10mM DMSO","6":"Lipase","7":"Metabolism","8":"JZL 184 is the first selective inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 8 nM.","9":"520.49","10":"1101854-58-3","11":"100","12":"192.13","13":"<1","14":"NA","15":"http://selleckchem.com/products/jzl184.html","16":"C27H24N2O9","17":"free base","18":"N/A","19":"OC(C1CCN(CC1)C(=O)OC2=CC=C(C=C2)[N+]([O-])=O)(C3=CC=C4OCOC4=C3)C5=CC=C6OCOC6=C5","20":"4.292","21":"6","22":"0","23":"6","24":"NA","25":"MGLL","26":"1","27":"MGLL"},{"1":"S4907","2":"SC-514","3":"f11","4":"L3500-02","5":"in 10mM DMSO","6":"IÎºB/IKK","7":"NF-ÎºB","8":"SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 Î¼M, blocks NF-ÎºB-dependent gene expression, does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.","9":"224.30","10":"354812-17-2","11":"45","12":"200.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/sc-514.html","16":"C9H8N2OS2","17":"free base","18":"GK 01140","19":"NC(=O)C1=C(N)C=C(S1)C2=CSC=C2","20":"1.510","21":"1","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4926","2":"(R)-Nepicastat HCl","3":"g11","4":"L3500-02","5":"in 10mM DMSO","6":"Hydroxylase","7":"Metabolism","8":"(R)-Nepicastat HCl, the R-enantiomer of Nepicastat HCl, is a potent and selective inhibitor with IC50 of 25.1 nM and 18.3 nM for bovine and human dopamine-Î²-hydroxylase, with negligible affinity for twelve other enzymes and thirteen neurotransmitter receptors.","9":"331.81","10":"195881-94-8","11":"66","12":"198.91","13":"<1","14":"NA","15":"http://selleckchem.com/products/r-nepicastat-hcl.html","16":"C14H16ClF2N3S","17":"Hydrochloride","18":"RS-25560-198 HCl","19":"Cl.NCC1=CNC(=S)N1C2CCC3=C(F)C=C(F)C=C3C2","20":"3.008","21":"0","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4935","2":"Asunaprevir","3":"h11","4":"L3500-02","5":"in 10mM DMSO","6":"HCV Protease","7":"Proteases","8":"Asunaprevir is an orally bioavailable inhibitor of the hepatitis C virus enzyme serine protease NS3 that is necessary for protein processing required for viral replication.","9":"748.29","10":"630420-16-5","11":"100","12":"133.64","13":"<1","14":"NA","15":"http://selleckchem.com/products/asunaprevir.html","16":"C35H46ClN5O9S","17":"free base","18":"BMS-650032","19":"COC1=C2C=CC(=CC2=C(OC3CC(N(C3)C(=O)C(NC(=O)OC(C)(C)C)C(C)(C)C)C(=O)NC4(CC4C=C)C(=O)N[S](=O)(=O)C5CC5)N=C1)Cl","20":"3.565","21":"10","22":"3","23":"14","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5063","2":"Trelagliptin succinate","3":"a2","4":"L3500-03","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Trelagliptin succinate is a dipeptidyl peptidase IV (DPP-4) inhibitor which is used as a new long-acting drug for once-weekly treatment of type 2 diabetes mellitus (DM).","9":"475.47","10":"1029877-94-8","11":"95","12":"199.80","13":"95","14":"199.80","15":"http://selleckchem.com/products/trelagliptin-succinate.html","16":"C22H26FN5O6","17":"succinate","18":"N/A","19":"CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC(=CC=C3C#N)F)C1=O.OC(=O)CCC(O)=O","20":"-1.362","21":"4","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5069","2":"Dabrafenib Mesylate","3":"b2","4":"L3500-03","5":"in 10mM DMSO","6":"Raf","7":"MAPK","8":"Dabrafenib Mesylate is the mesylate salt form of dabrafenib, an orally bioavailable inhibitor of B-raf (BRAF) protein with IC50s of 0.8 nM, 3.2 nM and 5 nM for B-Raf (V600E), B-Raf (WT) and C-Raf, respectively.","9":"615.67","10":"1195768-06-9","11":"100","12":"162.42","13":"<1","14":"NA","15":"http://selleckchem.com/products/dabrafenib-mesylate.html","16":"C24H24F3N5O5S3","17":"mesylate","18":"GSK2118436 Mesylate","19":"CC(C)(C)C1=NC(=C(S1)C2=CC=NC(=N2)N)C3=C(F)C(=CC=C3)N[S](=O)(=O)C4=C(F)C=CC=C4F.C[S](O)(=O)=O","20":"4.963","21":"5","22":"2","23":"6","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S5074","2":"Argatroban Monohydrate","3":"c2","4":"L3500-03","5":"in 10mM DMSO","6":"Thrombin","7":"Others","8":"Argatroban is a direct, selective thrombin inhibitor with anticoagulant effects.","9":"526.65","10":"141396-28-3","11":"100","12":"189.88","13":"<1","14":"NA","15":"http://selleckchem.com/products/argatroban-monohydrate.html","16":"C23H38N6O6S","17":"0","18":"Argatroban hydrate, Argipidine","19":"O.CC1CCN(C(C1)C(O)=O)C(=O)C(CCCNC(N)=N)N[S](=O)(=O)C2=CC=CC3=C2NCC(C)C3","20":"1.059","21":"4","22":"4","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5078","2":"Osimertinib mesylate","3":"d2","4":"L3500-03","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Osimertinib mesylate is the mesylate form of osimertinib, which is an oral, third-generation <b>epidermal growth factor receptor (EGFR)<\/b> tyrosine kinase inhibitor (TKI) drug.","9":"595.71","10":"1421373-66-1","11":"9","12":"15.11","13":"-1","14":"NA","15":"http://www.selleckchem.com/products/osimertinib-mesylate.html","16":"C29H37N7O5S","17":"mesylate","18":"AZD9291 mesylate","19":"COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C.C[S](O)(=O)=O","20":"4.257","21":"4","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5079","2":"Sitagliptin","3":"e2","4":"L3500-03","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Sitagliptin is an oral and highly selective DPP-4 inhibitor with an IC50 of 18 nM. It is used for the treatment of type 2 diabetes.","9":"407.31","10":"486460-32-6","11":"81","12":"198.87","13":"NA","14":"NA","15":"http://selleckchem.com/products/sitagliptin.html","16":"C16H15F6N5O","17":"free base","18":"MK-0431","19":"NC(CC(=O)N1CC[N]2C(=NN=C2C(F)(F)F)C1)CC3=C(F)C=C(F)C(=C3)F","20":"1.930","21":"3","22":"1","23":"5","24":"NA","25":"DPP4","26":"1","27":"NA"},{"1":"S5245","2":"Raltegravir potassium","3":"f2","4":"L3500-03","5":"in 10mM DMSO","6":"Integrase,HIV Protease","7":"Microbiology","8":"Raltegravir Potassium is the orally bioavailable potassium salt of raltegravir, the first approved human immunodeficiency virus type 1 (HIV-1) integrase inhibitor.","9":"482.51","10":"871038-72-1","11":"96","12":"198.96","13":"<1","14":"NA","15":"http://selleckchem.com/products/raltegravir-potassium.html","16":"C20H20FKN6O5","17":"potassium salt","18":"N/A","19":"[K+].CN1C(=O)C(=C(N=C1C(C)(C)NC(=O)C2=NN=C(C)O2)C(=O)NCC3=CC=C(F)C=C3)[O-]","20":"-0.994","21":"7","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5365","2":"Alogliptin","3":"g2","4":"L3500-03","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Alogliptin is a potent, selective inhibitor of the serine protease dipeptidyl peptidase IV (DPP-4) with IC50 values of 2.63 nM and exhibits greater than 10,000 fold selectivity over the closely related serine proteases DPP-8 and DPP-9.","9":"339.39","10":"850649-61-5","11":"67","12":"197.41","13":"18","14":"53.04","15":"http://selleckchem.com/products/alogliptin.html","16":"C18H21N5O2","17":"0","18":"SYR 322","19":"CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC=CC=C3C#N)C1=O","20":"1.271","21":"2","22":"1","23":"3","24":"NA","25":"DPP4","26":"1","27":"DPP4"},{"1":"S5402","2":"Dasabuvir(ABT-333)","3":"h2","4":"L3500-03","5":"in 10mM DMSO","6":"HCV Protease","7":"Proteases","8":"Dasabuvir(ABT-333) is a non-nucleoside inhibitor of NS5B viral RNA-dependent RNA polymerase that inhibits recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates with IC50 values between 2.2 and 10.7 nM. It is at least 7,000-fold selective for the inhibition of HCV genotype 1 polymerases over human/mammalian polymerases.","9":"493.57","10":"1132935-63-7","11":"98","12":"198.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/dasabuvir-abt-333.html","16":"C26H27N3O5S","17":"free base","18":"N/A","19":"COC1=C(C=C(C=C1C2=CC3=CC=C(N[S](C)(=O)=O)C=C3C=C2)N4C=CC(=O)NC4=O)C(C)(C)C","20":"3.492","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5413","2":"Ertugliflozin","3":"a3","4":"L3500-03","5":"in 10mM DMSO","6":"SGLT2","7":"Ion-Channel","8":"PF-04971729 (Ertugliflozin) is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2).","9":"436.88","10":"1210344-57-2","11":"87","12":"199.14","13":"87","14":"199.14","15":"http://selleckchem.com/products/.html","16":"C22H25ClO7","17":"free base","18":"PF-04971729","19":"CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C34OCC(CO)(O3)C(O)C(O)C4O)C=C1","20":"2.103","21":"3","22":"4","23":"6","24":"NA","25":"SLC5A2","26":"1","27":"NA"},{"1":"S5476","2":"Rolapitant","3":"b3","4":"L3500-03","5":"in 10mM DMSO","6":"NK1-receptor","7":"GPCR","8":"Rolapitant is a potent, selective and orally active neurokinin NK1 receptor antagonist.","9":"500.48","10":"552292-08-7","11":"100","12":"199.81","13":"NA","14":"NA","15":"https://www.selleckchem.com/products/rolapitant.html","16":"C25H26F6N2O2","17":"NA","18":"NA","19":"CC(OCC1(CCC2(CCC(=O)N2)CN1)C3=CC=CC=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F","20":"4.761","21":"2","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5566","2":"Dapagliflozin propanediol monohydrate","3":"c3","4":"L3500-03","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.","9":"502.98","10":"960404-48-2","11":"100","12":"198.82","13":"<1","14":"NA","15":"http://selleckchem.com/products/dapagliflozin-propanediol-monohydrate.html","16":"C24H35ClO9","17":"monohydrate","18":"N/A","19":"O.CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)C3OC(CO)C(O)C(O)C3O)C=C1.CC(O)CO","20":"1.682","21":"2","22":"6","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5623","2":"Bedaquiline","3":"d3","4":"L3500-03","5":"in 10mM DMSO","6":"tuberculosis","7":"Immunology","8":"Bedaquiline(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis.","9":"555.50","10":"843663-66-1","11":"12","12":"21.60","13":"<1","14":"NA","15":"http://selleckchem.com/products/.html","16":"C32H31BrN2O2","17":"free base","18":"TMC207; R207910","19":"COC1=NC2=CC=C(Br)C=C2C=C1C(C3=CC=CC=C3)C(O)(CCN(C)C)C4=CC=CC5=CC=CC=C45","20":"6.933","21":"2","22":"0","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5667","2":"Fruquintinib","3":"e3","4":"L3500-03","5":"in 10mM DMSO","6":"VEGFRs","7":"VEGFR","8":"Fruquintinib is a highly potent and selective VEGFR 1/2/3 inhibitor.","9":"393.39","10":"1194506-26-7","11":"6","12":"15.25","13":"<1","14":"NA","15":"https://www.selleckchem.com/products/fruquintinib.html","16":"C21H19N3O5","17":"NA","18":"NA","19":"CNC(=O)C1=C(C)OC2=CC(=CC=C12)OC3=C4C=C(OC)C(=CC4=NC=N3)OC","20":"3.111","21":"7","22":"1","23":"5","24":"NA","25":"KDR","26":"1","27":"NA"},{"1":"S5696","2":"JNJ0966","3":"f3","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"JNJ0966 is a highly selective compound that inhibits activation of <b>MMP-9 zymogen<\/b> and subsequent generation of catalytically active enzyme. It has no effect on MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14 catalytic activity and did not inhibit activation of the highly related MMP-2 zymogen.","9":"360.45","10":"315705-75-0","11":"72","12":"199.75","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/jnj0966.html","16":"C16H16N4O2S2","17":"Free Base","18":"N/A","19":"COC1=CC=CC=C1NC2=NC(=CS2)C3=C(C)N=C(NC(C)=O)S3","20":"2.999","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5701","2":"Alvimopan dihydrate","3":"g3","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"Alvimopan dihydrate is a novel, orally available peripherally restricted opioid antagonist with low systemic absorption. It accelerates the gastrointestinal recovery period with most common side effects in chronic pain patients with OBD were abdominal pai","9":"460.56","10":"170098-38-1","11":"92","12":"199.76","13":"-1","14":"-2.17","15":"http://selleckchem.com/products/.html","16":"C25H36N2O6","17":"free base","18":"NA","19":"O.O.CC1CN(CCC1(C)C2=CC=CC(=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(O)=O","20":"0.096","21":"2","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5795","2":"Rasagiline","3":"h3","4":"L3500-03","5":"in 10mM DMSO","6":"MAO","7":"Metabolism","8":"Rasagiline is a novel selective and irreversible <b>MAO-B<\/b> propargylamine inhibitor with in vitro IC50s of 4.43 nM and 412 nM for MAO-B and MAO-A, respectively.","9":"171.24","10":"136236-51-6","11":"34","12":"198.55","13":"4","14":"23.36","15":"http://www.selleckchem.com/products/rasagiline.html","16":"C12H13N","17":"Free Base","18":"TVP-1012","19":"C#CCNC1CCC2=C1C=CC=C2","20":"3.119","21":"0","22":"1","23":"2","24":"NA","25":"BCL2, MAOB","26":"2","27":"NA"},{"1":"S5818","2":"acalisib (GS-9820)","3":"a4","4":"L3500-03","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"acalisib (GS-9820) is a highly selective and potent <b>p110Î´<\/b> inhibitor (IC50 = 14 nM) with 114- to 400-fold selectivity over the other class I PI3K enzymes and no activity against Class II and III PI3K family members or other PI3K-related proteins including mTOR and DNA-PK.","9":"401.40","10":"870281-34-8","11":"80","12":"199.30","13":"1","14":"2.49","15":"http://www.selleckchem.com/products/acalisib-gs-9820.html","16":"C21H16FN7O","17":"Free Base","18":"CAL-120","19":"CC(NC1=NC=NC2=C1[NH]C=N2)C3=NC4=C(C=C(F)C=C4)C(=O)N3C5=CC=CC=C5","20":"3.097","21":"5","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5819","2":"MRE-269(ACT-333679)","3":"b4","4":"L3500-03","5":"in 10mM DMSO","6":"Immunology & Inflamm","7":"Immunology & Inflammation","8":"MRE-269(ACT-333679) is a <b>prostaglandin I2 (IP) receptor<\/b> agonist with a binding affinity for the human IP receptor that is 130-fold greater than that for other human prostanoid receptor.","9":"419.52","10":"475085-57-5","11":"84","12":"200.23","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/mre-269-act-333679.html","16":"C25H29N3O3","17":"Free Base","18":"N/A","19":"CC(C)N(CCCCOCC(O)=O)C1=NC(=C(N=C1)C2=CC=CC=C2)C3=CC=CC=C3","20":"4.843","21":"4","22":"0","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5837","2":"BRL-50481","3":"c4","4":"L3500-03","5":"in 10mM DMSO","6":"PDE","7":"Metabolism","8":"BRL-50481 is a novel and selective inhibitor of <b>phosphodiesterase (PDE) 7<\/b> with a Ki value, derived from secondary (Dixon) plots, of 180Â±10 nM, being at least 200-fold selective for hrPDE7A1 over all other PDEs.","9":"244.27","10":"433695-36-4","11":"49","12":"200.60","13":"1","14":"4.09","15":"http://www.selleckchem.com/products/brl-50481.html","16":"C9H12N2O4S","17":"Free Base","18":"N/A","19":"CN(C)[S](=O)(=O)C1=CC(=CC=C1C)[N+]([O-])=O","20":"1.327","21":"2","22":"0","23":"3","24":"NA","25":"PDE7A, PDE7B","26":"2","27":"NA"},{"1":"S5901","2":"Canagliflozin hemihydrate","3":"d4","4":"L3500-03","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Canagliflozin hemihydrate is the hemihydrate form of canagliflozin, which is a <b>SGLT2<\/b> inhibitor with IC50 of 2.2 nM for hSGLT2 in a cell-free assay, exhibits 413-fold selectivity over hSGLT1.","9":"907.05","10":"928672-86-0","11":"100","12":"110.25","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/canagliflozin-hemihydrate.html","16":"C48H52F2O11S2","17":"hemihydrate","18":"N/A","19":"O.CC1=C(CC2=CC=C(S2)C3=CC=C(F)C=C3)C=C(C=C1)C4OC(CO)C(O)C(O)C4O.CC5=C(CC6=CC=C(S6)C7=CC=C(F)C=C7)C=C(C=C5)C8OC(CO)C(O)C(O)C8O","20":"6.686","21":"2","22":"8","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5903","2":"JANEX-1","3":"e4","4":"L3500-03","5":"in 10mM DMSO","6":"JAK","7":"JAK/STAT","8":"JANEX-1 is a small molecule inhibitor of <b>JAK3<\/b> that selectively inhibits JAK3 at an IC50 of 78 ÂµM without altering the activity of JAK1 or JAK2, or any other protein tyrosine kinases (IC50 â‰¥ 350 ÂµM).","9":"297.31","10":"202475-60-3","11":"5","12":"16.82","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/janex-1.html","16":"C16H15N3O3","17":"Free Base","18":"WHI-P131","19":"COC1=C(OC)C=C2C(=NC=NC2=C1)NC3=CC=C(O)C=C3","20":"3.202","21":"4","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5909","2":"Anagliptin","3":"f4","4":"L3500-03","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Anagliptin is an orally active and highly selective <b>dipeptidyl peptidase-4 (DPP-4)<\/b> inhibitor and exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-ÎºB activation.","9":"383.45","10":"739366-20-2","11":"77","12":"200.81","13":"20","14":"52.16","15":"http://www.selleckchem.com/products/anagliptin.html","16":"C19H25N7O2","17":"Free Base","18":"N/A","19":"CC1=N[N]2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N","20":"-0.629","21":"4","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5916","2":"GSK 5959","3":"g4","4":"L3500-03","5":"in 10mM DMSO","6":"Epigenetic Reader Do","7":"Epigenetics","8":"GSK5959 is a potent and selective <b>BRPF1 bromodomain<\/b> inhibitor with an IC50 of 80 nM and exhibits >100-fold selectivity for BRPF1 over a panel of 35 other bromodomains, including BRPF2/3 and BET family bromodomains.","9":"394.47","10":"901245-65-6","11":"6","12":"15.21","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/gsk-5959.html","16":"C22H26N4O3","17":"Free Base","18":"N/A","19":"COC1=CC=CC=C1C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCCC4","20":"2.952","21":"3","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5926","2":"Pitolisant hydrochloride","3":"h4","4":"L3500-03","5":"in 10mM DMSO","6":"Histamine Receptor","7":"Neuronal Signaling","8":"Pitolisant acts as a high-affinity competitive antagonist (Ki=0.16 nM) and as an inverse agonist (EC50=1.5 nM) at the <b>human histamine H3 receptor subtype<\/b>.","9":"332.31","10":"903576-44-3","11":"66","12":"198.61","13":"66","14":"198.61","15":"http://www.selleckchem.com/products/pitolisant-hydrochloride.html","16":"C17H27Cl2NO","17":"hydrochloride","18":"Tiprolisant hydrochloride, BF-2649 HCl","19":"Cl.ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1","20":"4.576","21":"1","22":"0","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S5933","2":"K 858","3":"a5","4":"L3500-03","5":"in 10mM DMSO","6":"Kinesin","7":"Cytoskeletal Signaling","8":"K858 is a novel and potent inhibitor of <b>Eg5<\/b> with an IC50 of 1.3 Î¼M for inhibiting the ATPase activity of Eg5, showing at least 150-fold more selective for Eg5 than other members of the kinesin superfamily.","9":"277.34","10":"72926-24-0","11":"55","12":"198.31","13":"1","14":"3.61","15":"http://www.selleckchem.com/products/k858.html","16":"C13H15N3O2S","17":"Free Base","18":"N/A","19":"CC(=O)NC1=NN(C(C)=O)C(C)(S1)C2=CC=CC=C2","20":"1.535","21":"3","22":"1","23":"2","24":"NA","25":"KIF11","26":"1","27":"KIF11"},{"1":"S5935","2":"Alvimopan","3":"b5","4":"L3500-03","5":"in 10mM DMSO","6":"Opioid Receptor","7":"Neuronal Signaling","8":"Alvimopan (LY-246736) is a potent, relatively nonselective <b>opioid<\/b> antagonist with <b>Ki<\/b> values of 0.77, 4.4, and 40 nM for the Î¼, Î´, and Îº opioid receptors, respectively, displaying >100-fold selectivity over other aminergic G-protein-coupled receptors.","9":"424.53","10":"156053-89-3","11":"85","12":"200.22","13":"1","14":"2.36","15":"http://www.selleckchem.com/products/alvimopan.html","16":"C25H32N2O4","17":"Free Base","18":"LY 246736, ADL 8-2698","19":"CC1CN(CCC1(C)C2=CC=CC(=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(O)=O","20":"0.510","21":"2","22":"2","23":"8","24":"NA","25":"OPRD1, OPRK1, OPRM1","26":"3","27":"NA"},{"1":"S6416","2":"JNJ 31020028","3":"c5","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"NA","9":"565.68","10":"1094873-14-9","11":"100","12":"176.78","13":"<1","14":"NA","15":"http://www.selleck.cn/products/.html","16":"C34H36FN5O2","17":"Free Base","18":"N/A","19":"CCN(CC)C(=O)C(N1CCN(CC1)C2=CC=C(NC(=O)C3=CC=CC=C3C4=CC=CN=C4)C=C2F)C5=CC=CC=C5","20":"4.989","21":"3","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6538","2":"B-Raf IN 1","3":"d5","4":"L3500-03","5":"in 10mM DMSO","6":"Raf","7":"MAPK","8":"B-Raf IN 1 is an inhibitor of  Raf  wih IC50 values of 24 nM and 25 nM for B-Raf and C-Raf respectively. It is selective over 13 other kinases, including PKCÎ±, IKKÎ², and PI3KÎ±.","9":"515.53","10":"950736-05-7","11":"100","12":"193.98","13":"<1","14":"NA","15":"http://www.selleck.cn/products/b-rafin-1.html","16":"C29H24F3N5O\\r\\n","17":"free base","18":"N/A","19":"CN(C)CC1=CC=C(C=C1)C2=C3N=CC=C([N]3N=C2)C4=CC(=CC=C4)NC(=O)C5=CC=CC(=C5)C(F)(F)F","20":"5.368","21":"3","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6545","2":"BI-4464","3":"e5","4":"L3500-03","5":"in 10mM DMSO","6":"FAK","7":"Angiogenesis","8":"BI-4464 is a highly selective ATP competitive inhibitor of  PTK2/FAK , with an IC50 of 17 nM.","9":"555.55","10":"1227948-02-8","11":"25","12":"45.00","13":"<1","14":"NA","15":"http://www.selleck.cn/products/bi-4464.html","16":"C28H28F3N5O4\\r\\n","17":"free base","18":"N/A","19":"COC1=CC(=CC=C1NC2=NC(=C(C=N2)C(F)(F)F)OC3=CC=CC4=C3C(=O)CC4)C(=O)NC5CCN(C)CC5","20":"4.531","21":"6","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7006","2":"BAY-61-3606","3":"f5","4":"L3500-03","5":"in 10mM DMSO","6":"Syk","7":"Angiogenesis","8":"BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM).","9":"463.32","10":"648903-57-5","11":"14","12":"30.22","13":"<1","14":"NA","15":"http://selleckchem.com/products/bay-61-3606.html","16":"C20H20Cl2N6O3","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.COC1=CC=C(C=C1OC)C2=CC3=NC=C[N]3C(=N2)NC4=NC=CC=C4C(N)=O","20":"3.082","21":"6","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7008","2":"PP2","3":"g5","4":"L3500-03","5":"in 10mM DMSO","6":"Src","7":"Angiogenesis","8":"PP2, a Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM in cell-free assays, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.","9":"301.77","10":"172889-27-9","11":"60","12":"198.83","13":"<1","14":"NA","15":"http://selleckchem.com/products/pp2.html","16":"C15H16ClN5","17":"free base","18":"AG 1879,AGL 1879","19":"CC(C)(C)[N]1N=C(C2=CC=C(Cl)C=C2)C3=C(N)N=CN=C13","20":"3.435","21":"3","22":"1","23":"2","24":"NA","25":"ABL1, LCK, LYN, RIPK2, SRC","26":"5","27":"SRC"},{"1":"S7024","2":"Stattic","3":"h5","4":"L3500-03","5":"in 10mM DMSO","6":"STAT","7":"JAK/STAT","8":"Stattic, the first nonpeptidic small molecule, potently inhibits STAT3 activation and nuclear translocation with IC50 of 5.1 Î¼M in cell-free assays, highly selectivity over STAT1.","9":"211.19","10":"19983-44-9","11":"42","12":"198.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/stattic.html","16":"C8H5NO4S","17":"free base","18":"N/A","19":"[O-][N+](=O)C1=CC=C2C=C[S](=O)(=O)C2=C1","20":"0.939","21":"2","22":"0","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7033","2":"GSK2656157","3":"a6","4":"L3500-03","5":"in 10mM DMSO","6":"PERK","7":"Apoptosis","8":"GSK2656157 is an ATP-competitive and highly selective inhibitor of PERK with IC50 of 0.9 nM in a cell-free assay, 500-fold greater against a panel of 300 kinases.","9":"416.45","10":"1337532-29-2","11":"32","12":"76.84","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk2656157.html","16":"C23H21FN6O","17":"free base","18":"N/A","19":"C[N]1C=C(C2=C(F)C3=C(C=C2)N(CC3)C(=O)CC4=CC=CC(=N4)C)C5=C(N)N=CN=C15","20":"2.926","21":"4","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7039","2":"PD168393","3":"b6","4":"L3500-03","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"PD168393 is an irreversible EGFR inhibitor with IC50 of 0.70 nM, irreversibly alkylate Cys-773 inactive against insulin, PDGFR, FGFR and PKC.","9":"369.22","10":"194423-15-9","11":"73","12":"197.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/pd168393.html","16":"C17H13BrN4O","17":"free base","18":"N/A","19":"BrC1=CC(=CC=C1)NC2=NC=NC3=CC=C(NC(=O)C=C)C=C23","20":"4.043","21":"3","22":"2","23":"4","24":"NA","25":"EGFR, ERBB2, SRC","26":"3","27":"EGFR"},{"1":"S7051","2":"CGI1746","3":"c6","4":"L3500-03","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"CGI1746 is a potent and highly selective small-molecule inhibitor of the Btk with IC50 of 1.9 nM.","9":"579.69","10":"910232-84-7","11":"100","12":"172.51","13":"<1","14":"NA","15":"http://selleckchem.com/products/cgi1746.html","16":"C34H37N5O4","17":"free base","18":"N/A","19":"CN1C=C(N=C(NC2=CC=C(C=C2)C(=O)N3CCOCC3)C1=O)C4=CC=CC(=C4C)NC(=O)C5=CC=C(C=C5)C(C)(C)C","20":"3.513","21":"5","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7063","2":"LY2090314","3":"d6","4":"L3500-03","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"LY2090314 is a potent GSK-3 inhibitor for GSK-3Î±/Î² with IC50 of 1.5 nM/0.9 nM may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 is highly selective towards GSK3 as demonstrated by its fold selectivity relative to a large panel of kinases.","9":"512.53","10":"603288-22-8","11":"100","12":"195.11","13":"<1","14":"NA","15":"http://selleckchem.com/products/ly2090314.html","16":"C28H25FN6O3","17":"free base","18":"N/A","19":"FC1=CC2=C3[N](CCN(C2)C(=O)N4CCCCC4)C=C(C3=C1)C5=C(C(=O)NC5=O)C6=CN=C7C=CC=C[N]67","20":"2.707","21":"4","22":"1","23":"2","24":"NA","25":"GSK3B","26":"1","27":"GSK3B"},{"1":"S7065","2":"MK-8745","3":"e6","4":"L3500-03","5":"in 10mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more than 450-fold selectivity for Aurora A over Aurora B.","9":"431.91","10":"885325-71-3","11":"86","12":"199.12","13":"<1","14":"NA","15":"http://selleckchem.com/products/mk-8745.html","16":"C20H19ClFN5OS","17":"free base","18":"N/A","19":"FC1=C(C=CC=C1Cl)C(=O)N2CCN(CC2)CC3=CC=CC(=N3)NC4=NC=CS4","20":"3.805","21":"3","22":"1","23":"5","24":"NA","25":"AURKA","26":"1","27":"AURKA"},{"1":"S7067","2":"Tepotinib (EMD 1214063)","3":"f6","4":"L3500-03","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"Tepotinib (EMD 1214063) is a potent and selective c-Met inhibitor with IC50 of 4 nM, >200-fold selective for c-Met than IRAK4, TrkA, Axl, IRAK1, and Mer. Phase 1.","9":"492.57","10":"1100598-32-0","11":"5","12":"10.15","13":"<1","14":"NA","15":"http://selleckchem.com/products/emd-1214063.html","16":"C29H28N6O2","17":"free base","18":"MSC2156119","19":"CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4N=C(C=CC4=O)C5=CC(=CC=C5)C#N","20":"3.629","21":"5","22":"0","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7079","2":"SGC 0946","3":"g6","4":"L3500-03","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"SGC 0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM in a cell-free assay, is inactive against a panel of 12 PMTs and DNMT1.","9":"618.57","10":"1561178-17-3","11":"100","12":"161.66","13":"<1","14":"NA","15":"http://selleckchem.com/products/sgc-0946.html","16":"C28H40BrN7O4","17":"free base","18":"N/A","19":"CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2OC(C(O)C2O)[N]3C=C(Br)C4=C3N=CN=C4N","20":"3.278","21":"4","22":"5","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7087","2":"GSK2334470","3":"h6","4":"L3500-03","5":"in 10mM DMSO","6":"PDK","7":"PI3K/Akt/mTOR","8":"GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay, with no activity at other close related AGC-kinases.","9":"462.59","10":"1227911-45-6","11":"90","12":"194.56","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk2334470.html","16":"C25H34N8O","17":"free base","18":"N/A","19":"CNC1=NC(=CC(=N1)N2CC(CCC2C)C(=O)NC3CCCCC3)C4=CC5=C(C=C4)C(=N[NH]5)N","20":"4.516","21":"4","22":"4","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7093","2":"IPA-3","3":"a7","4":"L3500-03","5":"in 10mM DMSO","6":"PAK","7":"Cytoskeletal Signaling","8":"IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 Î¼M in a cell-free assay, no inhibition to group II PAKs (PAKs 4-6).","9":"350.45","10":"42521-82-4","11":"70","12":"199.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/ipa-3.html","16":"C20H14O2S2","17":"free base","18":"N/A","19":"OC1=CC=C2C=CC=CC2=C1SSC3=C4C=CC=CC4=CC=C3O","20":"5.871","21":"0","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7102","2":"VE-822","3":"b7","4":"L3500-03","5":"in 10mM DMSO","6":"ATM/ATR","7":"PI3K/Akt/mTOR","8":"VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.","9":"463.55","10":"1232416-25-9","11":"36","12":"77.66","13":"<1","14":"NA","15":"http://selleckchem.com/products/ve-822.html","16":"C24H25N5O3S","17":"free base","18":"VX970","19":"CNCC1=CC=C(C=C1)C2=NOC(=C2)C3=C(N)N=CC(=N3)C4=CC=C(C=C4)[S](=O)(=O)C(C)C","20":"3.697","21":"6","22":"2","23":"7","24":"NA","25":"ATM, ATR, MTOR, PIK3CG","26":"4","27":"PIK3CG"},{"1":"S7110","2":"(+)-JQ1","3":"c7","4":"L3500-03","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"(+)-JQ1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for BRD4(1/2) in cell-free assays, binding to all bromodomains of the BET family, but not to bromodomains outside the BET family.","9":"456.99","10":"1268524-70-4","11":"91","12":"199.13","13":"<1","14":"NA","15":"http://selleckchem.com/products/jq1.html","16":"C23H25ClN4O2S","17":"free base","18":"N/A","19":"CC1=C(C)C2=C(S1)[N]3C(=NN=C3C(CC(=O)OC(C)(C)C)N=C2C4=CC=C(Cl)C=C4)C","20":"4.953","21":"5","22":"0","23":"5","24":"NA","25":"BRD4, BRDT","26":"2","27":"BRD4"},{"1":"S7113","2":"Zebularine","3":"d7","4":"L3500-03","5":"in 10mM DMSO","6":"DNA Methyltransferase","7":"Epigenetics","8":"Zebularine is a DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases, also inhibits cytidinedeaminase with Ki of 2 Î¼M in a cell-free assay.","9":"228.20","10":"3690-10-6","11":"46","12":"201.58","13":"46","14":"201.58","15":"http://selleckchem.com/products/zebularine.html","16":"C9H12N2O5","17":"free base","18":"NSC 309132","19":"OCC1OC(C(O)C1O)N2C=CC=NC2=O","20":"-1.747","21":"3","22":"3","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7129","2":"PYR-41","3":"e7","4":"L3500-03","5":"in 10mM DMSO","6":"E1 Activating","7":"Ubiquitin","8":"PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.","9":"371.30","10":"418805-02-4","11":"74","12":"199.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/pyr-41.html","16":"C17H13N3O7","17":"free base","18":"N/A","19":"CCOC(=O)C1=CC=C(C=C1)N2NC(=O)C(=C/C3=CC=C(O3)[N+]([O-])=O)/C2=O","20":"1.870","21":"5","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7140","2":"TCID","3":"f7","4":"L3500-03","5":"in 10mM DMSO","6":"DUB","7":"Ubiquitin","8":"TCID is a DUB inhibitor for ubiquitin C-terminal hydrolase L3 with IC50 of 0.6 Î¼M, 125-fold selective to L1.","9":"283.92","10":"30675-13-9","11":"23","12":"81.01","13":"<1","14":"NA","15":"http://selleckchem.com/products/tcid.html","16":"C9H2Cl4O2","17":"free base","18":"N/A","19":"ClC1=C(Cl)C(=C2C(=O)CC(=O)C2=C1Cl)Cl","20":"3.982","21":"2","22":"0","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7146","2":"DMH1","3":"g7","4":"L3500-03","5":"in 10mM DMSO","6":"TGF-beta/Smad","7":"TGF-beta/Smad","8":"DMH1 is a selective BMP receptor inhibitor with IC50 of 107.9 nM for ALK2, exhibiting no inhibition on AMPK, ALK5, KDR (VEGFR-2) or PDGFR.","9":"380.44","10":"1206711-16-1","11":"22","12":"57.83","13":"<1","14":"NA","15":"http://selleckchem.com/products/dmh1.html","16":"C24H20N4O","17":"free base","18":"N/A","19":"CC(C)OC1=CC=C(C=C1)C2=C[N]3N=CC(=C3N=C2)C4=CC=NC5=C4C=CC=C5","20":"4.036","21":"4","22":"0","23":"4","24":"NA","25":"ACVR1","26":"1","27":"ACVR1"},{"1":"S7148","2":"ML347","3":"h7","4":"L3500-03","5":"in 10mM DMSO","6":"TGF-beta/Smad,ALK","7":"TGF-beta/Smad","8":"ML347 is a selective BMP receptor inhibitor with IC50 of 32 nM for ALK2, >300-fold selectivity over ALK3. Also inhibits ALK1 activity with IC50 of 46 nM.","9":"352.39","10":"1062368-49-3","11":"10","12":"28.38","13":"<1","14":"NA","15":"http://selleckchem.com/products/ml347.html","16":"C22H16N4O","17":"free base","18":"LDN-193719","19":"COC1=CC=C(C=C1)C2=C[N]3N=CC(=C3N=C2)C4=CC=CC5=C4C=CC=N5","20":"3.309","21":"4","22":"0","23":"3","24":"NA","25":"ACVR1, ACVRL1, BMPR1A","26":"3","27":"NA"},{"1":"S7165","2":"UNC1999","3":"a8","4":"L3500-03","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"UNC1999 is a potent, orally bioavailable and selective inhibitor of EZH2 and EZH1 with IC50 of 2 nM and 45 nM in cell-free assays, respectively, showing >1000-fold selectivity over a broad range of epigenetic and non-epigenetic targets.","9":"569.74","10":"1431612-23-5","11":"50","12":"87.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/unc1999.html","16":"C33H43N7O2","17":"free base","18":"N/A","19":"CCCC1=C(CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC=C(N=C4)N5CCN(CC5)C(C)C)C(=O)NC(=C1)C","20":"4.629","21":"4","22":"2","23":"9","24":"NA","25":"EZH2","26":"1","27":"NA"},{"1":"S7167","2":"SSR128129E","3":"b8","4":"L3500-03","5":"in 10mM DMSO","6":"FGFR","7":"Angiogenesis","8":"SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 Î¼M, while not affecting other related RTKs.","9":"346.31","10":"848318-25-2","11":"69","12":"199.24","13":"1","14":"2.89","15":"http://selleckchem.com/products/ssr128129e.html","16":"C18H15N2NaO4","17":"free base","18":"SSR","19":"COC1=C2C=CC=C[N]2C(=C1C)C(=O)C3=CC=C(N)C(=C3)C(=O)O[Na]","20":"2.802","21":"4","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7173","2":"Spebrutinib (CC-292, AVL-292)","3":"c8","4":"L3500-03","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"Spebrutinib (CC-292, AVL-292) is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.","9":"423.44","10":"1202757-89-8","11":"85","12":"200.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/avl-292.html","16":"C22H22FN5O3","17":"free base","18":"CC-292,LMK-435","19":"COCCOC1=CC=C(NC2=NC=C(F)C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)C=C1","20":"4.087","21":"5","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7176","2":"SKI II","3":"d8","4":"L3500-03","5":"in 10mM DMSO","6":"S1P Receptor","7":"GPCR & G Protein","8":"SKI II is a highly selective and non ATP-competitive?sphingosine kinase (SphK)?inhibitor with?IC50?of 0.5 Î¼M, while exhibiting no inhibitory action on other kinases including PI3K, PKCÎ± and ERK2.","9":"302.78","10":"312636-16-1","11":"61","12":"201.47","13":"<1","14":"NA","15":"http://selleckchem.com/products/ski-ii.html","16":"C15H11ClN2OS","17":"free base","18":"SphK-I2","19":"OC1=CC=C(NC2=NC(=CS2)C3=CC=C(Cl)C=C3)C=C1","20":"4.746","21":"1","22":"2","23":"3","24":"NA","25":"SPHK1","26":"1","27":"SPHK1"},{"1":"S7177","2":"PF-543","3":"e8","4":"L3500-03","5":"in 10mM DMSO","6":"S1P Receptor","7":"GPCR & G Protein","8":"PF-543, a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM, exhibits >100-fold selectivity over the SphK2 isoform.","9":"502.07","10":"1415562-82-1(free base)","11":"93","12":"185.23","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf-543.html","16":"C27H31NO4S","17":"free base","18":"N/A","19":"CC1=CC(=CC(=C1)OCC2=CC=C(CN3CCCC3CO)C=C2)C[S](=O)(=O)C4=CC=CC=C4","20":"5.016","21":"3","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7179","2":"BAF312 (Siponimod)","3":"f8","4":"L3500-03","5":"in 10mM DMSO","6":"S1P Receptor","7":"GPCR & G Protein","8":"BAF312 (Siponimod) is a next-generation S1P receptor modulator, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits >1000-fold selectivity over S1P2, S1P3 and S1P4 receptors. Phase 3.","9":"516.60","10":"1230487-00-9","11":"100","12":"193.57","13":"<1","14":"NA","15":"http://selleckchem.com/products/baf312-siponimod.html","16":"C29H35F3N2O3","17":"free base","18":"N/A","19":"CCC1=CC(=CC=C1CN2CC(C2)C(O)=O)\\\\C(C)=N\\\\OCC3=CC=C(C4CCCCC4)C(=C3)C(F)(F)F","20":"3.834","21":"3","22":"0","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7188","2":"CID755673","3":"g8","4":"L3500-03","5":"in 10mM DMSO","6":"Serine/threonin kinase,CaMK","7":"Apoptosis","8":"CID755673 is a cell-active pan-<b>PKD1/2/3<\/b> inhibitor with <b>IC50<\/b> of 180 nM, 280nM, and 227 nM, respectively, about 200-fold selectivity over other CAMKs. \\r\\n","9":"217.22","10":"521937-07-5","11":"43","12":"196.13","13":"<1","14":"NA","15":"http://selleckchem.com/products/cid755673.html","16":"C12H11NO3","17":"free base","18":"N/A","19":"OC1=CC2=C(OC3=C2CCCNC3=O)C=C1","20":"1.922","21":"2","22":"2","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7193","2":"1-Azakenpaullone","3":"h8","4":"L3500-03","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"1-Azakenpaullone is a potent and selective GSK-3Î² inhibitor with IC50 of 18 nM, >100-fold selectivity over CDK1/cyclin B and CDK5/p25.","9":"328.16","10":"676596-65-9","11":"66","12":"201.12","13":"<1","14":"NA","15":"http://selleckchem.com/products/1-azakenpaullone.html","16":"C15H10BrN3O","17":"free base","18":"N/A","19":"BrC1=CC2=C([NH]C3=C2CC(=O)NC4=C3N=CC=C4)C=C1","20":"2.949","21":"2","22":"2","23":"0","24":"NA","25":"CCNB1, CDK1, CDK5, GSK3B","26":"4","27":"GSK3B"},{"1":"S7206","2":"CNX-2006","3":"a9","4":"L3500-03","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"CNX-2006 is a novel irreversible mutant-selective EGFR inhibitor with IC50 of < 20 nM, with very weak inhibition at wild-type EGFR.","9":"545.53","10":"1375465-09-0","11":"100","12":"183.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/cnx-2006.html","16":"C26H27F4N7O2","17":"free base","18":"N/A","19":"COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)NC4CN(CCF)C4","20":"5.150","21":"4","22":"4","23":"12","24":"1","25":"EGFR","26":"1","27":"EGFR"},{"1":"S7208","2":"Bisindolylmaleimide I (GF109203X)","3":"b9","4":"L3500-03","5":"in 10mM DMSO","6":"PKC","7":"TGF-beta/Smad","8":"Bisindolylmaleimide I (GF109203X) is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCÎ±, PKCÎ²I, PKCÎ²II, and PKCÎ³ in cell-free assays, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor.","9":"412.48","10":"133052-90-1","11":"82","12":"198.80","13":"<1","14":"NA","15":"http://selleckchem.com/products/gf109203x.html","16":"C25H24N4O2","17":"free base","18":"GO 6850 , Bisindolylmaleimide I","19":"CN(C)CCC[N]1C=C(C2=CC=CC=C12)C3=C(C(=O)NC3=O)C4=C[NH]C5=CC=CC=C45","20":"3.557","21":"2","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7213","2":"Thiamet G","3":"c9","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"Thiamet G is a potent, selective O-GlcNAcase inhibitor with Kiof 21 nM, while exhibiting 37,000-fold selectivity over human lysosomal â€“hexosaminidase.","9":"248.30","10":"1009816-48-1","11":"50","12":"201.37","13":"50","14":"201.37","15":"http://selleckchem.com/products/thiamet-g.html","16":"C9H16N2O4S","17":"free base","18":"N/A","19":"CCNC1=NC2C(O)C(O)C(CO)OC2S1","20":"-0.613","21":"2","22":"4","23":"3","24":"NA","25":"MGEA5","26":"1","27":"NA"},{"1":"S7218","2":"Alvelestat (AZD9668)","3":"d9","4":"L3500-03","5":"in 10mM DMSO","6":"Serine Protease","7":"Proteases","8":"Alvelestat (AZD9668) is an oral, highly selective inhibitor of neutrophil elastase (NE) with IC50 and Ki of 12 nM and 9.4 nM, at least 600-fold more selective over other serine proteases.   Phase 2.","9":"545.53","10":"848141-11-7","11":"100","12":"183.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/avelestat-azd9668.html","16":"C24H20F3N5O4S","17":"free base","18":"Avelestat","19":"C[N]1N=CC=C1C2=CN(C(=O)C(=C2)C(=O)NCC3=NC=C(C=C3)[S](C)(=O)=O)C4=CC=CC(=C4)C(F)(F)F","20":"2.163","21":"6","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7229","2":"RGFP966","3":"e9","4":"L3500-03","5":"in 10mM DMSO","6":"HDAC","7":"Epigenetics","8":"RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 Î¼M in cell-free assay, exhibits > 200-fold selectivity over other HDAC.","9":"362.40","10":"1396841-57-8","11":"72","12":"198.68","13":"<1","14":"NA","15":"http://selleckchem.com/products/rgfp966.html","16":"C21H19FN4O","17":"free base","18":"N/A","19":"NC1=CC(=CC=C1NC(=O)\\\\C=C\\\\C2=C[N](C\\\\C=C\\\\C3=CC=CC=C3)N=C2)F","20":"3.242","21":"2","22":"2","23":"6","24":"NA","25":"HDAC3","26":"1","27":"HDAC3"},{"1":"S7230","2":"UNC0642","3":"f9","4":"L3500-03","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"UNC0642 is a potent, selective inhibitor of histone methyltransferases G9a/GLP with IC50s less than 2.5 nM for G9a and GLP and shows more than 300-fold selective for G9a and GLP over a broad range of kinases, GPCRs, transporters, and ion channels.","9":"546.70","10":"1481677-78-4","11":"100","12":"182.92","13":"<1","14":"NA","15":"http://selleckchem.com/products/unc0642.html","16":"C29H44F2N6O2","17":"free base","18":"N/A","19":"COC1=CC2=C(C=C1OCCCN3CCCC3)N=C(N=C2NC4CCN(CC4)C(C)C)N5CCC(F)(F)CC5","20":"4.706","21":"4","22":"1","23":"10","24":"NA","25":"EHMT1, EHMT2","26":"2","27":"NA"},{"1":"S7238","2":"NVP-TNKS656","3":"g9","4":"L3500-03","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"NVP-TNKS656 is a highly potent, selective, and orally active tankyrase inhibitor with IC50 of 6 nM for TNKS2, > 300-fold selectivity against PARP1 and PARP2.","9":"494.58","10":"1419949-20-4","11":"100","12":"202.19","13":"<1","14":"NA","15":"http://selleckchem.com/products/nvp-tnks656.html","16":"C27H34N4O5","17":"free base","18":"N/A","19":"COC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)N(CC3CC3)CC4=NC5=C(COCC5)C(=O)N4","20":"1.014","21":"6","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7241","2":"AGI-6780","3":"h9","4":"L3500-03","5":"in 10mM DMSO","6":"Dehydrogenase","7":"Metabolism","8":"AGI-6780 is a potent and selective inhibitor of IDH2 R140Q mutant with IC50 of 23 nM.","9":"481.51","10":"1432660-47-3","11":"96","12":"199.37","13":"<1","14":"NA","15":"http://selleckchem.com/products/agi-6780.html","16":"C21H18F3N3O3S2","17":"free base","18":"N/A","19":"FC(F)(F)C1=CC(=CC=C1)NC(=O)NC2=C(C=CC(=C2)[S](=O)(=O)NC3CC3)C4=CSC=C4","20":"4.046","21":"3","22":"3","23":"7","24":"1","25":"IDH2","26":"1","27":"NA"},{"1":"S7248","2":"Ro3280","3":"a10","4":"L3500-03","5":"in 10mM DMSO","6":"PLK","7":"Cell Cycle","8":"RO3280 is a potent, highly selective inhibitor of  Polo-like kinase 1 (PLK1) with IC50 of 3?nM.","9":"543.61","10":"1062243-51-9","11":"100","12":"183.96","13":"<1","14":"NA","15":"http://selleckchem.com/products/ro3280.html","16":"C27H35F2N7O3","17":"free base","18":"Ro5203280","19":"COC1=C(NC2=NC3=C(C=N2)N(C)C(=O)C(F)(F)CN3C4CCCC4)C=CC(=C1)C(=O)NC5CCN(C)CC5","20":"3.245","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7255","2":"NMS-P937 (NMS1286937)","3":"b10","4":"L3500-03","5":"in 10mM DMSO","6":"PLK","7":"Cell Cycle","8":"NMS-P937 (NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Phase 1.","9":"532.52","10":"1034616-18-6","11":"42","12":"78.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/nms-p937-nms1286937.html","16":"C24H27F3N8O3","17":"free base","18":"N/A","19":"CN1CCN(CC1)C2=CC=C(OC(F)(F)F)C(=C2)NC3=NC4=C(CCC5=C4[N](CCO)N=C5C(N)=O)C=N3","20":"4.742","21":"5","22":"3","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7257","2":"CNX-774","3":"c10","4":"L3500-03","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"CNX-774 is an irreversible, orally active, and highly selective BTK inhibitor with IC50 of <1 nM.","9":"499.50","10":"1202759-32-7","11":"100","12":"200.20","13":"<1","14":"NA","15":"http://selleckchem.com/products/cnx-774.html","16":"C26H22FN7O3","17":"free base","18":"N/A","19":"CNC(=O)C1=CC(=CC=N1)OC2=CC=C(NC3=NC(=C(F)C=N3)NC4=CC=CC(=C4)NC(=O)C=C)C=C2","20":"4.281","21":"6","22":"4","23":"9","24":"NA","25":"BTK","26":"1","27":"BTK"},{"1":"S7263","2":"AZD1981","3":"d10","4":"L3500-03","5":"in 10mM DMSO","6":"GPR","7":"Endocrinology & Hormones","8":"AZD1981 is a potent, selective CRTh2 (DP2) receptor antagonist with IC50 of 4 nM, showing >1000-fold selectivity over more than 340 other enzymes and receptors, including DP1. Phase 2.","9":"388.87","10":"802904-66-1","11":"11","12":"28.29","13":"<1","14":"NA","15":"http://selleckchem.com/products/azd1981.html","16":"C19H17ClN2O3S","17":"free base","18":"N/A","19":"CC(=O)NC1=C2C(=CC=C1)[N](CC(O)=O)C(=C2SC3=CC=C(Cl)C=C3)C","20":"3.859","21":"2","22":"1","23":"5","24":"NA","25":"PTGDR2","26":"1","27":"NA"},{"1":"S7270","2":"SRPIN340","3":"e10","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"SRPIN340 is a selective SRPK inhibitor with Ki of 0.89 Î¼M for SRPK1, showing no significant inhibitory activity against more than 140 other kinases..","9":"349.35","10":"218156-96-8","11":"70","12":"200.37","13":"<1","14":"NA","15":"http://selleckchem.com/products/srpin340.html","16":"C18H18F3N3O","17":"free base","18":"N/A","19":"FC(F)(F)C1=CC(=C(C=C1)N2CCCCC2)NC(=O)C3=CC=NC=C3","20":"3.485","21":"2","22":"1","23":"4","24":"NA","25":"SRPK1, SRPK2","26":"2","27":"NA"},{"1":"S7272","2":"4Î¼8C","3":"f10","4":"L3500-03","5":"in 10mM DMSO","6":"Others","7":"Others","8":"4Î¼8C is a potent and selective IRE1 Rnase inhibitor with IC50 of 76 nM.","9":"204.18","10":"14003-96-4","11":"19","12":"93.06","13":"<1","14":"NA","15":"http://selleckchem.com/products/4u8c.html","16":"C11H8O4","17":"free base","18":"N/A","19":"CC1=CC(=O)OC2=C(C=O)C(=CC=C12)O","20":"1.863","21":"3","22":"1","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7282","2":"NMS-E973","3":"g10","4":"L3500-03","5":"in 10mM DMSO","6":"HSP (e.g. HSP90)","7":"Cytoskeletal Signaling","8":"NMS-E973 is a potent and selective Hsp90 inhibitor with DC50 of <10 nM for Hsp90 binding, no activiy against a panel of 52 diverse protein kinases.","9":"454.43","10":"1253584-84-7","11":"90","12":"198.05","13":"<1","14":"NA","15":"http://selleckchem.com/products/nms-e973.html","16":"C22H22N4O7","17":"free base","18":"N/A","19":"CN1CCC(CC1)NC(=O)C2=NOC(=C2)C3=C(OC4=CC=C(C=C4)[N+]([O-])=O)C=C(O)C=C3O","20":"2.811","21":"4","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7284","2":"Rociletinib (CO-1686, AVL-301)","3":"h10","4":"L3500-03","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2.","9":"555.55","10":"1374640-70-6","11":"100","12":"180.00","13":"<1","14":"NA","15":"http://selleckchem.com/products/co-1686.html","16":"C27H28F3N7O3","17":"free base","18":"CNX-419","19":"COC1=C(NC2=NC=C(C(=N2)NC3=CC=CC(=C3)NC(=O)C=C)C(F)(F)F)C=CC(=C1)N4CCN(CC4)C(C)=O","20":"4.334","21":"5","22":"3","23":"9","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S7294","2":"PFI-2 HCl","3":"a11","4":"L3500-03","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"PFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM, 1000-fold selectivity over other methyltransferases and other non-epigenetic targets.","9":"535.98","10":"1627607-87-7","11":"99","12":"184.71","13":"4","14":"7.46","15":"http://selleckchem.com/products/pfi-2.html","16":"C23H25F4N3O3S","17":"Hydrochloride","18":"N/A","19":"FC1=CC(=CC2=C1CNCC2)[S](=O)(=O)NC(CC3=CC=CC(=C3)C(F)(F)F)C(=O)N4CCCC4","20":"3.268","21":"3","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7295","2":"Apabetalone (RVX-208)","3":"b11","4":"L3500-03","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"Apabetalone (RVX-208) is a potent BET bromodomain inhibitor with IC50 of 0.510 Î¼M for BD2 in a cell-free assay, about 170-fold selectivity over BD1. Phase 2.","9":"370.40","10":"1044870-39-4","11":"74","12":"199.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/rvx-208.html","16":"C20H22N2O5","17":"free base","18":"RVX-000222","19":"COC1=CC(=C2C(=O)NC(=NC2=C1)C3=CC(=C(OCCO)C(=C3)C)C)OC","20":"2.877","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7297","2":"Osimertinib (AZD9291)","3":"c11","4":"L3500-03","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibitor with IC50 of 12.92, 11.44 and 493.8 nM for Exon 19 deletion EGFR, L858R/T790M EGFR, and WT EGFR in LoVo cells, respectively. Phase 3.","9":"499.61","10":"1421373-65-0","11":"99","12":"198.15","13":"<1","14":"NA","15":"http://selleckchem.com/products/azd9291.html","16":"C28H33N7O2","17":"free base","18":"N/A","19":"COC1=C(NC2=NC=CC(=N2)C3=C[N](C)C4=C3C=CC=C4)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C","20":"4.671","21":"4","22":"2","23":"10","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S7307","2":"GSK2606414","3":"d11","4":"L3500-03","5":"in 10mM DMSO","6":"PERK","7":"Apoptosis","8":"GSK2606414 is an orally available, potent, and selective PERK inhibitor with IC50 of 0.4 nM, displaying at least 100-fold selectivity over the other EIF2AKs assayed.","9":"451.44","10":"1337531-36-8","11":"90","12":"199.36","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk2606414.html","16":"C24H20F3N5O","17":"free base","18":"N/A","19":"C[N]1C=C(C2=CC=C3N(CCC3=C2)C(=O)CC4=CC=CC(=C4)C(F)(F)F)C5=C1N=CN=C5N","20":"4.103","21":"3","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7312","2":"Z-DEVD-FMK","3":"e11","4":"L3500-03","5":"in 10mM DMSO","6":"Caspase","7":"Apoptosis","8":"Z-DEVD-FMK is a specific, irreversible Caspase-3 inhibitor, and also shows potent inhibition on caspase-6, caspase-7, caspase-8, and caspase-10.","9":"668.66","10":"210344-95-9","11":"100","12":"149.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/z-devd-fmk.html","16":"C31H42FN3O12","17":"free base","18":"Caspase-3 Inhibitor","19":"COC(=O)CCC(CC(=O)C(CC(=O)OC)NC(=O)OCC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CC(=O)OC)C(=O)CF","20":"1.347","21":"12","22":"3","23":"24","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7318","2":"HTH-01-015","3":"f11","4":"L3500-03","5":"in 10mM DMSO","6":"AMPK","7":"PI3K/Akt/mTOR","8":"HTH-01-015 is a potent and selective NUAK1 inhibitor with IC50 of 100 nM, >100-fold selectivity over NUAK2.","9":"468.55","10":"1613724-42-7","11":"58","12":"123.79","13":"<1","14":"NA","15":"http://selleckchem.com/products/hth-01-015.html","16":"C26H28N8O","17":"free base","18":"N/A","19":"CN1C(=O)C2=C(C=C3C=CC=CC3=C2)N(C)C4=NC(=NC(=C14)C)NC5=C[N](N=C5)C6CCNCC6","20":"2.993","21":"4","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7330","2":"6H05","3":"g11","4":"L3500-03","5":"in 10mM DMSO","6":"Rho","7":"Cell Cycle","8":"6H05 is a selective, and allosteric inhibitor of oncogenic K-Ras(G12C).","9":"590.14","10":"2061344-88-3","11":"100","12":"169.45","13":"100","14":"169.45","15":"http://selleckchem.com/products/6h05.html","16":"C22H31ClF3N3O4S3","17":"free base","18":"N/A","19":"CN(C)CCSSCCNC(=O)C1CCN(CC1)C(=O)CSC2=CC=C(Cl)C=C2.OC(=O)C(F)(F)F","20":"1.174","21":"3","22":"1","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7335","2":"IPI-3063","3":"h11","4":"L3500-03","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"IPI-3063 is a potent and selective p110Î´ inhibitor with biochemical IC50 of 2.5?Â±?1.2 nM and IC50 values for the other class I PI3K isoforms (p110Î±, p110Î², p110Î³) are at least 400-fold higher.","9":"455.51","10":"1425043-73-7","11":"91","12":"199.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/ipi-3063.html","16":"C25H25N7O2","17":"free base","18":"N/A","19":"CC(C)N1C(=O)C2=C(C=CC=C2C=C1C(C)NC3=C(C#N)C(=NC=N3)N)C4=CN(C)C(=O)C=C4","20":"1.621","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7352","2":"Bay 11-7085","3":"a2","4":"L3500-04","5":"in 10mM DMSO","6":"IÎºB/IKK","7":"NF-ÎºB","8":"BAY 11-7085 is an irreversible inhibitor of TNFÎ±-induced IÎºBÎ± phosphorylation with IC50 of 10 Î¼M.","9":"249.33","10":"196309-76-9","11":"50","12":"200.54","13":"<1","14":"NA","15":"http://selleckchem.com/products/bay-11-7085.html","16":"C13H15NO2S","17":"free base","18":"Bay 11-7083","19":"CC(C)(C)C1=CC=C(C=C1)[S](=O)(=O)\\\\C=C\\\\C#N","20":"2.635","21":"2","22":"0","23":"3","24":"NA","25":"NFKBIA","26":"1","27":"NFKBIA"},{"1":"S7353","2":"EPZ004777","3":"b2","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"EPZ004777 is a potent, selective DOT1L inhibitor with IC50 of 0.4 nM in a cell-free assay and demonstrates >1,200-fold selectivity for DOT1L over all other tested PMTs.","9":"539.67","10":"1338466-77-5","11":"100","12":"185.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/epz004777.html","16":"C28H41N7O4","17":"free base","18":"N/A","19":"CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2OC(C(O)C2O)[N]3C=CC4=C3N=CN=C4N","20":"2.529","21":"4","22":"5","23":"10","24":"NA","25":"DOT1L","26":"1","27":"NA"},{"1":"S7358","2":"Poziotinib (HM781-36B)","3":"c2","4":"L3500-04","5":"in 10mM DMSO","6":"HER2,EGFR","7":"Protein Tyrosine Kinase","8":"Poziotinib (HM781-36B) is an irreversible pan-HER inhibitor with IC50 of 3.2 nM, 5.3 nM and 23.5 nM for HER1, HER2, and HER4, respectively. Phase 2.","9":"491.34","10":"1092364-38-9","11":"98","12":"199.45","13":"<1","14":"NA","15":"http://selleckchem.com/products/poziotinib-hm781-36b.html","16":"C23H21Cl2FN4O3","17":"free base","18":"NOV120101","19":"COC1=CC2=C(C=C1OC3CCN(CC3)C(=O)C=C)C(=NC=N2)NC4=CC=C(Cl)C(=C4F)Cl","20":"5.046","21":"5","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7364","2":"Atglistatin","3":"d2","4":"L3500-04","5":"in 10mM DMSO","6":"Lipase","7":"Metabolism","8":"Atglistatin is a highly potent, and selective inhibitor of adipose triglyceride lipase (ATGL) with IC50 of 0.7 Î¼M, high selectivity over other key metabolic lipases.","9":"283.37","10":"1469924-27-3","11":"56","12":"197.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/atglistatin.html","16":"C17H21N3O","17":"free base","18":"N/A","19":"CN(C)C(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)N(C)C","20":"2.832","21":"1","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7378","2":"AEBSF HCl","3":"e2","4":"L3500-04","5":"in 10mM DMSO","6":"Serine Protease","7":"Proteases","8":"AEBSF HCl is a broad spectrum, irreversible serine protease inhibitor.","9":"239.69","10":"30827-99-7","11":"47","12":"196.09","13":"20","14":"83.44","15":"http://selleckchem.com/products/aebsf-hcl.html","16":"C8H11ClFNO2S","17":"Hydrochloride","18":"N/A","19":"Cl.NCCC1=CC=C(C=C1)[S](F)(=O)=O","20":"1.261","21":"2","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7391","2":"Z-FA-FMK","3":"f2","4":"L3500-04","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"Z-FA-FMK is an irreversible cysteine protease inhibitor, and also inhibits effector caspases.","9":"386.42","10":"197855-65-5","11":"77","12":"199.27","13":"<1","14":"NA","15":"http://selleckchem.com/products/z-fa-fmk.html","16":"C21H23FN2O4","17":"free base","18":"N/A","19":"CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2)C(=O)CF","20":"3.034","21":"4","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7392","2":"Loxistatin Acid (E-64C)","3":"g2","4":"L3500-04","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"Loxistatin Acid (E-64C), a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor.","9":"314.38","10":"76684-89-4","11":"62","12":"197.21","13":"2","14":"6.36","15":"http://selleckchem.com/products/loxistatin-acid-e-64c.html","16":"C15H26N2O5","17":"free base","18":"NSC 694279, EP 475","19":"CC(C)CCNC(=O)C(CC(C)C)NC(=O)C1OC1C(O)=O","20":"1.037","21":"4","22":"2","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7393","2":"Aloxistatin","3":"h2","4":"L3500-04","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"Aloxistatin is an irreversible and membrane-permeable cysteine protease inhibitor with blood platelet aggregation inhibiting activity.","9":"342.43","10":"88321-09-9","11":"68","12":"198.58","13":"<1","14":"NA","15":"http://selleckchem.com/products/Aloxistatin.html","16":"C17H30N2O5","17":"free base","18":"E-64d","19":"CCOC(=O)C1OC1C(=O)NC(CC(C)C)C(=O)NCCC(C)C","20":"1.611","21":"5","22":"2","23":"11","24":"NA","25":"CTSG","26":"1","27":"NA"},{"1":"S7420","2":"CA-074 methyl ester (CA-074 Me)","3":"a3","4":"L3500-04","5":"in 10mM DMSO","6":"Cysteine Protease","7":"Proteases","8":"CA-074 Me is a membrane-permeable derivative of CA-074 and acts as an irreversible cathepsin B inhibitor.","9":"397.47","10":"147859-80-1","11":"79","12":"198.76","13":"79","14":"198.76","15":"http://selleckchem.com/products/ca-074-methyl-ester.html","16":"C19H31N3O6","17":"free base","18":"Cathepsin B Inhibitor IV","19":"CCCNC(=O)C1OC1C(=O)NC(C(C)CC)C(=O)N2CCCC2C(=O)OC","20":"0.484","21":"6","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7421","2":"CGP 57380","3":"b3","4":"L3500-04","5":"in 10mM DMSO","6":"MNK","7":"MAPK","8":"CGP 57380 is a potent MNK1 inhibitor with IC50 of 2.2 Î¼M, exhibiting no inhibitory activity on p38, JNK1, ERK1 and -2, PKC, or c-Src-like kinases.","9":"244.23","10":"522629-08-9","11":"48","12":"196.54","13":"<1","14":"NA","15":"http://selleckchem.com/products/cgp57380.html","16":"C11H9FN6","17":"free base","18":"N/A","19":"NC1=C2C(=NC=N1)[NH]N=C2NC3=CC=C(F)C=C3","20":"1.981","21":"3","22":"3","23":"2","24":"NA","25":"AURKB, LCK, MKNK1, MKNK2, SGK1","26":"5","27":"NA"},{"1":"S7429","2":"MI-2 (MALT1 inhibitor)","3":"c3","4":"L3500-04","5":"in 10mM DMSO","6":"MALT","7":"Immunology & Inflammation","8":"MI-2 (MALT1 inhibitor) is an irreversible MALT1 inhibitor with IC50 of 5.84 Î¼M.","9":"455.72","10":"1047953-91-2","11":"91","12":"199.68","13":"<1","14":"NA","15":"http://selleckchem.com/products/mi-2-malt1-inhibitor.html","16":"C19H17Cl3N4O3","17":"free base","18":"N/A","19":"COCCOC1=N[N](C2=CC=C(NC(=O)CCl)C=C2)C(=N1)C3=CC(=C(Cl)C=C3)Cl","20":"4.653","21":"5","22":"1","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7430","2":"SB-3CT","3":"d3","4":"L3500-04","5":"in 10mM DMSO","6":"MMP","7":"Proteases","8":"SB-3CT is an effective and selective gelatinase inhibitor with Ki of 13.9 nM and 600 nM for MMP-2 and MMP-9, respectively.","9":"306.40","10":"292605-14-2","11":"61","12":"199.09","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb-3ct.html","16":"C15H14O3S2","17":"free base","18":"N/A","19":"O=[S](=O)(CC1CS1)C2=CC=C(OC3=CC=CC=C3)C=C2","20":"3.377","21":"3","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7435","2":"AR-A014418","3":"e3","4":"L3500-04","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"AR-A014418 is an ATP-competitive, and selective GSK3Î² inhibitor with IC50 and Ki of 104 nM and 38 nM in cell-free assays, without significant inhibition on 26 other kinases tested.","9":"308.31","10":"487021-52-3","11":"61","12":"197.85","13":"<1","14":"NA","15":"http://selleckchem.com/products/A014418.html","16":"C12H12N4O4S","17":"free base","18":"GSK-3Î² Inhibitor VIII","19":"COC1=CC=C(CNC(=O)NC2=NC=C(S2)[N+]([O-])=O)C=C1","20":"1.529","21":"3","22":"2","23":"5","24":"NA","25":"GSK3B","26":"1","27":"NA"},{"1":"S7436","2":"NH125","3":"f3","4":"L3500-04","5":"in 10mM DMSO","6":"CaMK","7":"Neuronal Signaling","8":"NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor.","9":"524.56","10":"278603-08-0","11":"100","12":"190.64","13":"<1","14":"NA","15":"http://selleckchem.com/products/nh125.html","16":"C27H45IN2","17":"iodide","18":"N/A","19":"[I-].CCCCCCCCCCCCCCCC[N+]1=C(C)[N](CC2=CC=CC=C2)C=C1","20":"6.032","21":"0","22":"0","23":"17","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7457","2":"XEN445","3":"g3","4":"L3500-04","5":"in 10mM DMSO","6":"Lipase","7":"Metabolism","8":"XEN445 is a potent and selective endothelial lipase inhibitor with IC50 of 0.237 Î¼M.","9":"366.33","10":"1515856-92-4","11":"80","12":"218.38","13":"<1","14":"NA","15":"http://selleckchem.com/products/xen445.html","16":"C18H17F3N2O3R","17":"free base","18":"N/A","19":"OC(=O)C1=CC(=CC=C1N2CCC(C2)OCC3=NC=CC=C3)C(F)(F)F","20":"3.725","21":"3","22":"0","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7461","2":"LDC000067","3":"h3","4":"L3500-04","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"LDC000067 is a highly selective CDK9 inhibitor with IC50 of 44 nM, 55/125/210/ >227/ >227-fold selectivity over CDK2/1/4/6/7.","9":"370.43","10":"1073485-20-7","11":"74","12":"199.77","13":"<1","14":"NA","15":"http://selleckchem.com/products/ldc000067.html","16":"C18H18N4O3S","17":"free base","18":"LDC067","19":"COC1=CC=CC=C1C2=NC=NC(=C2)NC3=CC(=CC=C3)C[S](N)(=O)=O","20":"2.783","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7462","2":"PI-1840","3":"a4","4":"L3500-04","5":"in 10mM DMSO","6":"Proteasome","7":"Proteases","8":"PI-1840 is a reversible and selective chymotrypsin-like (CT-L) inhibitor with IC50 of 27 nM with little effects on the other two major proteasome proteolytic activities, trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L).","9":"394.47","10":"1401223-22-0","11":"78","12":"197.73","13":"<1","14":"NA","15":"http://selleckchem.com/products/pi-1840.html","16":"C22H26N4O3","17":"free base","18":"N/A","19":"CCCC1=CC=C(OCC(=O)N(CC2=NC(=NO2)C3=CC=CN=C3)C(C)C)C=C1","20":"3.220","21":"6","22":"0","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7465","2":"FTI 277 HCl","3":"b4","4":"L3500-04","5":"in 10mM DMSO","6":"Transferase","7":"Metabolism","8":"FTI 277 HCl is the methyl ester of FTI 277, which is a potent and selective farnesyltransferase (FTase) inhibitor with IC50 of 500 pM, about 100-fold selectivity over the closely related GGTase I.","9":"484.07","10":"180977-34-8","11":"96","12":"198.32","13":"17","14":"35.12","15":"http://selleckchem.com/products/fti-277-hcl.html","16":"C22H30ClN3O3S2","17":"hydrochloride salt","18":"N/A","19":"Cl.COC(=O)C(CCSC)NC(=O)C1=C(C=C(NCC(N)CS)C=C1)C2=CC=CC=C2","20":"2.897","21":"3","22":"3","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7473","2":"Nexturastat A","3":"c4","4":"L3500-04","5":"in 10mM DMSO","6":"HDAC","7":"DNA Damage","8":"Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM, >190-fold selectivity over other HDACs.","9":"341.40","10":"1403783-31-2","11":"68","12":"199.18","13":"<1","14":"NA","15":"http://selleckchem.com/products/nexturastat-a.html","16":"C19H23N3O3","17":"free base","18":"N/A","19":"CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2","20":"3.079","21":"2","22":"2","23":"7","24":"NA","25":"HDAC1, HDAC6","26":"2","27":"HDAC1"},{"1":"S7499","2":"ESI-09","3":"d4","4":"L3500-04","5":"in 10mM DMSO","6":"cAMP","7":"GPCR & G Protein","8":"ESI-09 is a specific exchange protein directly activated by cAMP (EPAC) inhibitor with IC50 of 3.2 Î¼M and 1.4 Î¼M for EPAC1 and EPAC2, respectively, >100-fold selectivity over PKA.","9":"330.77","10":"263707-16-0","11":"66","12":"199.53","13":"<1","14":"NA","15":"http://selleckchem.com/products/esi-09.html","16":"C16H15ClN4O2","17":"free base","18":"N/A","19":"CC(C)(C)C1=CC(=NO1)C(=O)/C(=N/NC2=CC=CC(=C2)Cl)C#N","20":"4.569","21":"4","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7500","2":"HJC0350","3":"e4","4":"L3500-04","5":"in 10mM DMSO","6":"cAMP","7":"GPCR & G Protein","8":"HJC0350 is a potent and selective EPAC2 inhibitor with IC50 of 0.3 Î¼M, exhibiting no inhibition on Epac1.","9":"277.38","10":"885434-70-8","11":"52","12":"187.47","13":"<1","14":"NA","15":"http://selleckchem.com/products/hjc0350.html","16":"C15H19NO2S","17":"free base","18":"N/A","19":"CC1=C[N](C(=C1)C)[S](=O)(=O)C2=C(C)C=C(C)C=C2C","20":"4.371","21":"2","22":"0","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7501","2":"HO-3867","3":"f4","4":"L3500-04","5":"in 10mM DMSO","6":"STAT","7":"JAK/STAT","8":"HO-3867, an analog of curcumin, is a selective STAT3 inhibitor that inhibits its phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.","9":"464.55","10":"1172133-28-6","11":"13","12":"27.98","13":"<1","14":"NA","15":"http://selleckchem.com/products/ho-3867.html","16":"C28H30F2N2O2","17":"free base","18":"N/A","19":"CC1(C)C=C(CN2C\\\\C(=C/C3=CC=C(F)C=C3)C(=O)C(/C2)=C/C4=CC=C(F)C=C4)C(C)(C)N1O","20":"5.209","21":"1","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7508","2":"JNK Inhibitor IX","3":"g4","4":"L3500-04","5":"in 10mM DMSO","6":"JNK","7":"MAPK","8":"JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6.7 for JNK2 and JNK3, respectively.","9":"332.42","10":"312917-14-9","11":"20","12":"60.16","13":"<1","14":"NA","15":"http://selleckchem.com/products/jnk-inhibitor-ix.html","16":"C20H16N2OS","17":"free base","18":"TCS JNK 5a","19":"O=C(NC1=C(C#N)C2=C(CCCC2)S1)C3=CC=CC4=C3C=CC=C4","20":"4.571","21":"1","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7513","2":"Trelagliptin","3":"h4","4":"L3500-04","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Trelagliptin is a highly selective, long-acting DPP-4 inhibitor. Phase 3.","9":"357.38","10":"865759-25-7","11":"71","12":"198.67","13":"<1","14":"NA","15":"http://selleckchem.com/products/trelagliptin.html","16":"C18H20FN5O2","17":"free base","18":"SYR-472","19":"CN1C(=O)C=C(N2CCCC(N)C2)N(CC3=CC(=CC=C3C#N)F)C1=O","20":"1.476","21":"2","22":"1","23":"3","24":"NA","25":"DPP4","26":"1","27":"NA"},{"1":"S7520","2":"Darapladib (SB-480848)","3":"a5","4":"L3500-04","5":"in 10mM DMSO","6":"Phospholipase (e.g. PLA)","7":"Metabolism","8":"Darapladib (SB-480848) is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM. Phase 3.","9":"666.77","10":"356057-34-6","11":"100","12":"149.98","13":"<1","14":"NA","15":"http://selleckchem.com/products/darapladib-sb-480848.html","16":"C36H38F4N4O2S","17":"free base","18":"N/A","19":"CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(F)C=C5","20":"7.707","21":"3","22":"0","23":"14","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7525","2":"XMD8-92","3":"b5","4":"L3500-04","5":"in 10mM DMSO","6":"ERK","7":"MAPK","8":"XMD8-92 is a potent and selective BMK1/ERK5 inhibitor with Kd of 80 nM.","9":"474.55","10":"1234480-50-2","11":"73","12":"153.83","13":"<1","14":"NA","15":"http://selleckchem.com/products/xmd8-92.html","16":"C26H30N6O3","17":"free base","18":"N/A","19":"CCOC1=CC(=CC=C1NC2=NC3=C(C=N2)N(C)C(=O)C4=C(C=CC=C4)N3C)N5CCC(O)CC5","20":"3.505","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7539","2":"PTC-209 HBr","3":"c5","4":"L3500-04","5":"in 10mM DMSO","6":"BMI-1","7":"Cell Cycle","8":"PTC-209 HBr is the hydrobromide salt of PTC-209, which is a potent and selective BMI-1 inhibitor with IC50 of 0.5 Î¼M, and results in irreversible reduction of cancer-initiating cells (CICs).","9":"576.10","10":"1217022-63-3","11":"100","12":"173.58","13":"<1","14":"NA","15":"http://selleckchem.com/products/ptc-209-hbr.html","16":"C17H14Br3N5OS","17":"free base","18":"N/A","19":"Br.COC1=CC(=C(NC2=NC(=CS2)C3=C(C)N=C4N=CC=C[N]34)C(=C1)Br)Br","20":"5.362","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7549","2":"THZ1 2HCl","3":"d5","4":"L3500-04","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"THZ1 is a covalent CDK7 inhibitor which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7.","9":"638.97","10":"1604810-83-4(free base)","11":"100","12":"156.50","13":"<1","14":"NA","15":"http://selleckchem.com/products/thz1.html","16":"C31H30Cl3N7O2","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(Cl)C(=N3)C4=C[NH]C5=C4C=CC=C5","20":"6.383","21":"4","22":"4","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7557","2":"CL-387785 (EKI-785)","3":"e5","4":"L3500-04","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"CL-387785 (EKI-785) is an irreversible, and selective EGFR inhibitor with IC50 of 370 pM.","9":"381.23","10":"194423-06-8","11":"63","12":"165.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/cl-387785-eki-785.html","16":"C18H13BrN4O","17":"free base","18":"N/A","19":"CC#CC(=O)NC1=CC2=C(NC3=CC=CC(=C3)Br)N=CN=C2C=C1","20":"4.568","21":"3","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7564","2":"SAR125844","3":"f5","4":"L3500-04","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"SAR125844 is a potent intravenously active and highly selective <b>MET<\/b> kinase inhibitor, displaying nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and H1094Y, Y1235D, M1250T, L1195V, and D1228H kinase domain mutants (IC50 values of 0.22, 1.7, 6.5, 65, and 81 nmol/L, respectively).","9":"550.63","10":"1116743-46-4","11":"11","12":"19.98","13":"<1","14":"NA","15":"http://www.selleck.cn/products/sar125844.html","16":"C25H23FN8O2S2\\r\\n","17":"free base","18":"N/A","19":"FC1=CC=C(C=C1)C2=N[N]3C(=NN=C3C=C2)SC4=CC=C5N=C(NC(=O)NCCN6CCOCC6)SC5=C4","20":"4.518","21":"6","22":"2","23":"7","24":"both 1 and 2","25":"NA","26":"1","27":"NA"},{"1":"S7572","2":"A-366","3":"g5","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"A-366 is a potent and selective G9a/GLP histone lysine methyltransferase inhibitor with IC50 of 3.3nM, exhibiting >1000-fold selectivity for G9a/GLP over 21 other methyltransferases.","9":"329.44","10":"1527503-11-2","11":"65","12":"197.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/a-366.html","16":"C19H27N3O2","17":"free base","18":"N/A","19":"COC1=C(OCCCN2CCCC2)C=C3N=C(N)C4(CCC4)C3=C1","20":"2.467","21":"3","22":"1","23":"6","24":"NA","25":"EHMT1, EHMT2","26":"2","27":"NA"},{"1":"S7574","2":"GSK-LSD1 2HCl","3":"h5","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).","9":"289.24","10":"1431368-48-7(free base)","11":"57","12":"197.07","13":"57","14":"197.07","15":"http://selleckchem.com/products/gsk-lsd1-2hcl.html","16":"C14H22Cl2N2","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.C1CC(CCN1)NC2CC2C3=CC=CC=C3","20":"1.964","21":"0","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7575","2":"LLY-507","3":"a6","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltransferase SMYD2.","9":"574.76","10":"1793053-37-8","11":"100","12":"173.99","13":"<1","14":"NA","15":"http://selleckchem.com/products/lly-507.html","16":"C36H42N6O","17":"free base","18":"N/A","19":"CC1=C[N](CCN2CCN(CC2)C3=CC=CC=C3C4=CC(=CC(=C4)C(=O)NCCCN5CCCC5)C#N)C6=C1C=CC=C6","20":"5.851","21":"1","22":"1","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7595","2":"Santacruzamate A (CAY10683)","3":"b6","4":"L3500-04","5":"in 10mM DMSO","6":"HDAC","7":"DNA Damage","8":"Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor with IC50 of 119 pM for HDAC2, >3600-fold selectivity over other HDACs.","9":"278.35","10":"1477949-42-0","11":"55","12":"197.59","13":"<1","14":"NA","15":"http://selleckchem.com/products/santacruzamate-a-cay10683.html","16":"C15H22N2O3","17":"free base","18":"N/A","19":"CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1","20":"1.899","21":"3","22":"2","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7596","2":"CAY10603","3":"c6","4":"L3500-04","5":"in 10mM DMSO","6":"HDAC","7":"DNA Damage","8":"CAY10603 is a potent and selective HDAC6 inhibitor with IC50 of 2 pM, >200-fold selectivity over other HDACs.","9":"446.50","10":"1045792-66-2","11":"89","12":"199.33","13":"<1","14":"NA","15":"http://selleckchem.com/products/cay10603.html","16":"C22H30N4O6","17":"free base","18":"N/A","19":"CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO","20":"3.230","21":"6","22":"3","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7620","2":"GSK1324726A (I-BET726)","3":"d6","4":"L3500-04","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.","9":"434.91","10":"1300031-52-0","11":"86","12":"197.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk1324726a-i-bet726.html","16":"C25H23ClN2O3","17":"free base","18":"N/A","19":"CC1CC(NC2=CC=C(Cl)C=C2)C3=C(C=CC(=C3)C4=CC=C(C=C4)C(O)=O)N1C(C)=O","20":"4.648","21":"2","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7624","2":"SD-208","3":"e6","4":"L3500-04","5":"in 10mM DMSO","6":"TGF-beta/Smad","7":"TGF-beta/Smad","8":"SD-208 is a selective TGF-Î²RI (ALK5) inhibitor with IC50 of 48 nM, >100-fold selectivity over TGF-Î²RII.","9":"352.75","10":"627536-09-8","11":"9","12":"25.51","13":"<1","14":"NA","15":"http://selleckchem.com/products/sd-208.html","16":"C17H10ClFN6","17":"free base","18":"N/A","19":"FC1=CC=C(Cl)C=C1C2=NC3=NC=CN=C3C(=N2)NC4=CC=NC=C4","20":"3.139","21":"5","22":"1","23":"3","24":"NA","25":"TGFBR1","26":"1","27":"NA"},{"1":"S7632","2":"TH588","3":"f6","4":"L3500-04","5":"in 10mM DMSO","6":"MTH1","7":"DNA Damage","8":"TH588 is a potent and selective MTH1 (NUDT1) inhibitor with IC50 of 5 nM. It has no relevant inhibition of any of the other tested proteins at 100?Î¼M, although TH588 showed reasonable selectivity when tested on a much larger panel of 87 enzymes, GPCRs, kinases, ion channels and transporters at 10?Î¼M.","9":"295.17","10":"1609960-31-7","11":"20","12":"67.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/th588.html","16":"C13H12Cl2N4","17":"free base","18":"N/A","19":"NC1=NC(=CC(=N1)NC2CC2)C3=C(Cl)C(=CC=C3)Cl","20":"3.938","21":"2","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7651","2":"SB225002","3":"g6","4":"L3500-04","5":"in 10mM DMSO","6":"CXCR","7":"GPCR & G Protein","8":"SB225002 is a potent, and selective CXCR2 antagonist with IC50 of 22 nM for inhibiting interleukin IL-8 binding to CXCR2, > 150-fold selectivity over the other 7-TMRs tested.","9":"352.14","10":"182498-32-4","11":"70","12":"198.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb225002.html","16":"C13H10BrN3O4","17":"free base","18":"N/A","19":"OC1=CC(=CC=C1NC(=O)NC2=C(Br)C=CC=C2)[N+]([O-])=O","20":"2.923","21":"1","22":"3","23":"3","24":"NA","25":"CXCR2","26":"1","27":"CXCR2"},{"1":"S7656","2":"CPI-360","3":"h6","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"CPI-360 is a potent, selective,and SAM-competitive EZH1 inhibitor with IC50 of 102.3 nM, >100-fold selectivity over other methyltransferases.","9":"437.53","10":"1802175-06-9","11":"20","12":"45.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/cpi-360.html","16":"C25H31N3O4","17":"free base","18":"N/A","19":"COC1=C(CNC(=O)C2=C(C)[N](C(C)C3CCOCC3)C4=C2C=CC=C4)C(=O)NC(=C1)C","20":"2.071","21":"4","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7668","2":"Picropodophyllin (PPP)","3":"a7","4":"L3500-04","5":"in 10mM DMSO","6":"IGF-1R","7":"Protein Tyrosine Kinase","8":"Picropodophyllin (PPP) is a IGF-1R inhibitor with IC50 of 1 nM. It displays selectivity for IGF-1R and does not coinhibit tyrosine phosphorylation the IR, or of a selected panel of receptors less related to IGF-IR(FGF-R, PDGF-R, OR EGF-R).","9":"414.41","10":"477-47-4","11":"82","12":"197.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/picropodophyllin-ppp.html","16":"C22H22O8","17":"free base","18":"AXL1717","19":"COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(O)C4=CC5=C(OCO5)C=C24","20":"2.111","21":"7","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7674","2":"Savolitinib(AZD6094, HMPL-504)","3":"b7","4":"L3500-04","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"Savolitinib (volitinib, AZD6094, HMPL-504) is a novel, potent, and selective MET inhibitor currently in clinical development in various indications, including PRCC. The IC50 values of this compound for c-Met and p-Met are 5 nM and 3 nM, respectively. It shows exquisite selectivity for c-Met over 274 kinase.","9":"345.36","10":"1313725-88-0","11":"16","12":"46.33","13":"<1","14":"NA","15":"http://selleckchem.com/products/hmpl-504-azd6094-volitinib.html","16":"C17H15N9","17":"free base","18":"Volitinib","19":"CC([N]1N=NC2=NC=C(N=C12)C3=C[N](C)N=C3)C4=C[N]5C=CN=C5C=C4","20":"1.032","21":"6","22":"0","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7680","2":"SP2509","3":"c7","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"SP2509 is a selective histone demethylase LSD1 inhibitor with IC50 of  13?nM, showing no activity against MAO-A, MAO-B, lactate dehydrogenase and glucose oxidase.","9":"437.90","10":"1423715-09-6","11":"38","12":"86.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/sp2509.html","16":"C19H20ClN3O5S","17":"free base","18":"HCI-2509","19":"CC(=N\\\\NC(=O)C1=CC=CC(=C1)[S](=O)(=O)N2CCOCC2)/C3=CC(=CC=C3O)Cl","20":"1.891","21":"5","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7709","2":"VX-11e","3":"d7","4":"L3500-04","5":"in 10mM DMSO","6":"ERK","7":"MAPK","8":"VX-11e is a potent, selective, and orally bioavailable ERK2 inhibitor with Ki of <2 nM, over 200-fold selective over other kinases tested.","9":"500.35","10":"896720-20-0","11":"100","12":"199.86","13":"<1","14":"NA","15":"http://selleckchem.com/products/vx-11e.html","16":"C24H20Cl2FN5O2","17":"free base","18":"VTX-11e, Vertex-11e","19":"CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=C[NH]C(=C3)C(=O)NC(CO)C4=CC=CC(=C4)Cl","20":"5.755","21":"3","22":"4","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7714","2":"FIIN-2","3":"e7","4":"L3500-04","5":"in 10mM DMSO","6":"FGFR","7":"Protein Tyrosine Kinase","8":"FIIN-2 is an irreversible, pan-FGFR inhibitor with IC50 of 3.09 nM, 4.3 nM, 27 nM and 45.3 nM for FGFR1/2/3/4, respectively.","9":"634.73","10":"1633044-56-0","11":"69","12":"108.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/fiin-2.html","16":"C35H38N8O4","17":"free base","18":"N/A","19":"COC1=CC(=CC(=C1)OC)N2CC3=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N=C3N(CC6=CC=C(NC(=O)C=C)C=C6)C2=O","20":"5.007","21":"6","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7720","2":"SBE 13 HCl","3":"f7","4":"L3500-04","5":"in 10mM DMSO","6":"PLK","7":"Cell Cycle","8":"SBE 13 HCl is a potent and selective PLK1 inhibitor with IC50 of 200 pM, >4000-fold selectivity over Aurora A kinase, Plk2 and Plk3.","9":"479.40","10":"1052532-15-6","11":"95","12":"198.16","13":"<1","14":"NA","15":"http://selleckchem.com/products/sbe-13-hcl.html","16":"C24H28Cl2N2O4","17":"hydrochloride","18":"N/A","19":"Cl.COC1=CC=C(CCNCC2=CC=C(OCC3=CN=C(Cl)C=C3)C(=C2)OC)C=C1OC","20":"4.895","21":"5","22":"1","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7725","2":"BLZ945","3":"g7","4":"L3500-04","5":"in 10mM DMSO","6":"CSF-1R","7":"Protein Tyrosine Kinase","8":"BLZ945 is an orally active, potent and selective CSF-1R inhibitor with IC50 of 1 nM, >1000-fold selective against its closest receptor tyrosine kinase homologs.","9":"398.48","10":"953769-46-5","11":"79","12":"198.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/blz945.html","16":"C20H22N4O3S","17":"free base","18":"N/A","19":"CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(NC4CCCCC4O)S3","20":"3.201","21":"4","22":"3","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7734","2":"LFM-A13","3":"h7","4":"L3500-04","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"LFM-A13 is a specific Bruton's tyrosine kinase (BTK) inhibitor with IC50 of 2.5 Î¼M, >100-fold selectivity over other protein kinases including JAK1, JAK2, HCK, EGFR,and IRK.","9":"360.00","10":"244240-24-2","11":"72","12":"200.00","13":"<1","14":"NA","15":"http://selleckchem.com/products/lfm-a13.html","16":"C11H8Br2N2O2","17":"free base","18":"N/A","19":"C/C(O)=C(C#N)/C(=O)NC1=C(Br)C=CC(=C1)Br","20":"2.645","21":"1","22":"2","23":"2","24":"NA","25":"BTK","26":"1","27":"NA"},{"1":"S7748","2":"EPZ015666(GSK3235025)","3":"a8","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"EPZ015666(GSK3235025) is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki of 5 nM, >20,000-fold selectivity over other PMTs.","9":"383.44","10":"1616391-65-1","11":"60","12":"156.48","13":"<1","14":"NA","15":"http://selleckchem.com/products/epz015666.html","16":"C20H25N5O3","17":"free base","18":"GSK3235025","19":"OC(CNC(=O)C1=CC(=NC=N1)NC2COC2)CN3CCC4=C(C3)C=CC=C4","20":"1.038","21":"4","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7751","2":"VER155008","3":"b8","4":"L3500-04","5":"in 10mM DMSO","6":"HSP (e.g. HSP90)","7":"Cytoskeletal Signaling","8":"VER-155008 is a potent Hsp70 family inhibitor with IC50 of 0.5 Î¼M, 2.6 Î¼M, and 2.6 Î¼M in cell-free assays for HSP70, HSC70, and GRP78, respectively, >100-fold selectivity over HSP90.","9":"556.40","10":"1134156-31-2","11":"100","12":"179.73","13":"<1","14":"NA","15":"http://selleckchem.com/products/ver155008.html","16":"C25H23Cl2N7O4","17":"free base","18":"C07","19":"NC1=C2N=C(NCC3=CC=C(Cl)C(=C3)Cl)[N](C4OC(COCC5=CC=C(C=C5)C#N)C(O)C4O)C2=NC=N1","20":"3.253","21":"5","22":"4","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7753","2":"BPTES","3":"c8","4":"L3500-04","5":"in 10mM DMSO","6":"Glutaminase","7":"Proteases","8":"BPTES is a potent and selective Glutaminase GLS1 (KGA) inhibitor with IC50 of 0.16 Î¼M. It has no effect on glutamate dehydrogenase activity and causes only a very slight inhibition of Î³-glutamyl transpeptidase activity.","9":"524.68","10":"314045-39-1","11":"100","12":"190.59","13":"<1","14":"NA","15":"http://selleckchem.com/products/bptes.html","16":"C24H24N6O2S3","17":"free base","18":"N/A","19":"O=C(CC1=CC=CC=C1)NC2=NN=C(CCSCCC3=NN=C(NC(=O)CC4=CC=CC=C4)S3)S2","20":"3.432","21":"6","22":"2","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7767","2":"AZ6102","3":"d8","4":"L3500-04","5":"in 10mM DMSO","6":"PPAR","7":"DNA Damage","8":"AZ6102 is a potent TNKS1/2  inhibitor that has 100-fold selectivity against other PARP family enzymes and shows IC50 of 5 nM for Wnt pathway inhibition in DLD-1 cells.","9":"428.53","10":"1645286-75-4","11":"85","12":"198.35","13":"<1","14":"NA","15":"http://selleckchem.com/products/az6102.html","16":"C25H28N6O","17":"free base","18":"AZ-6102","19":"CC1CN(CC(C)N1)C2=NC=C(C(=C2)C)C3=CC=C(C=C3)C4=NC5=C(C=C[N]5C)C(=O)N4","20":"3.649","21":"3","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7775","2":"Emricasan","3":"e8","4":"L3500-04","5":"in 10mM DMSO","6":"Caspase","7":"Apoptosis","8":"Emricasan is a potent irreversible pan-caspase inhibitor.","9":"569.50","10":"254750-02-2","11":"100","12":"175.59","13":"<1","14":"NA","15":"http://selleckchem.com/products/emricasan-idn-6556-pf-03491390.html","16":"C26H27F4N3O7","17":"free base","18":"IDN-6556, PF 03491390, PF-03491390","19":"CC(NC(=O)C(=O)NC1=C(C=CC=C1)C(C)(C)C)C(=O)NC(CC(O)=O)C(=O)COC2=C(F)C(=CC(=C2F)F)F","20":"3.017","21":"6","22":"3","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7784","2":"Fumagillin","3":"f8","4":"L3500-04","5":"in 10mM DMSO","6":"Anti-infection","7":"Microbiology","8":"Fumagillin is a selective and potent irreversible inhibitor of Methionine aminopeptidase 2 (MetAP2), used as an antibiotic to treat microsporidiosis.","9":"458.54","10":"23110-15-8","11":"92","12":"200.64","13":"<1","14":"NA","15":"http://selleckchem.com/products/fumagillin.html","16":"C26H34O7","17":"free base","18":"N/A","19":"COC1C(CCC2(CO2)C1C3(C)OC3CC=C(C)C)OC(=O)\\\\C=C\\\\C=C\\\\C=C\\\\C=C\\\\C(O)=O","20":"3.421","21":"6","22":"0","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7786","2":"Erlotinib","3":"g8","4":"L3500-04","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Erlotinib is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl.","9":"393.44","10":"183321-74-6","11":"78","12":"198.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/erlotinib.html","16":"C22H23N3O4","17":"free base","18":"CP358774, NSC 718781","19":"COCCOC1=C(OCCOC)C=C2C(=NC=NC2=C1)NC3=CC=CC(=C3)C#C","20":"4.309","21":"6","22":"1","23":"10","24":"NA","25":"EGFR, NR1I2","26":"2","27":"EGFR"},{"1":"S7795","2":"ORY-1001 (RG-6016) 2HCl","3":"h8","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"ORY-1001 (RG-6016) 2HCl is an orally active and selective lysine-specific demethylase LSD1/KDM1A inhibitor with IC50 of <20 nM, with high selectivity against related FAD dependent aminoxidases. Phase 1.","9":"303.27","10":"1431326-61-2","11":"5","12":"16.49","13":"61","14":"201.14","15":"http://selleckchem.com/products/ory-1001-rg-6016.html","16":"C15H24Cl2N2","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.NC1CCC(CC1)NC2CC2C3=CC=CC=C3","20":"2.721","21":"0","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7796","2":"GSK2879552 2HCl","3":"a9","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"GSK2879552 2HCl is a potent, selective, orally bioavailable, irreversible LSD1 inhibitor with Kiapp of 1.7 Î¼M. Phase 1.","9":"437.40","10":"1401966-69-5 (free base)","11":"29","12":"66.30","13":"44","14":"100.59","15":"http://selleckchem.com/products/gsk2879552-2hcl.html","16":"C23H30Cl2N2O2","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.OC(=O)C1=CC=C(CN2CCC(CC2)CNC3CC3C4=CC=CC=C4)C=C1","20":"1.586","21":"1","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7810","2":"Afatinib (BIBW2992) Dimaleate","3":"b9","4":"L3500-04","5":"in 10mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"Afatinib (BIBW2992) Dimaleate irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively 100-fold more active against Gefitinib-resistant L858R-T790M EGFR mutant.","9":"717.18","10":"850140-73-7","11":"100","12":"139.44","13":"<1","14":"NA","15":"http://selleckchem.com/products/afatinib-bibw2992-dimaleate.html","16":"C32H33ClFN5O11","17":"Dimaleate","18":"N/A","19":"CN(C)C/C=C/C(=O)NC1=C(OC2CCOC2)C=C3N=CN=C(NC4=CC=C(F)C(=C4)Cl)C3=C1.OC(=O)\\\\C=C/C(O)=O.OC(=O)\\\\C=C/C(O)=O","20":"0.960","21":"9","22":"2","23":"12","24":"both 1 and 2","25":"NA","26":"1","27":"NA"},{"1":"S7820","2":"EPZ020411 2HCl","3":"c9","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"EPZ020411 is a potent and selective small molecule PRMT6 inhibitor with an IC50 of 10 nM.","9":"515.52","10":"1700663-41-7(free base)","11":"100","12":"193.98","13":"81","14":"157.12","15":"http://selleckchem.com/products/epz020411.html","16":"C25H40Cl2N4O3","17":"dihydrochloride","18":"N/A","19":"Cl.Cl.CNCCN(C)CC1=C[NH]N=C1C2=CC=C(OC3CC(C3)OCCC4CCOCC4)C=C2","20":"3.322","21":"4","22":"2","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7824","2":"Nazartinib (EGF816, NVS-816)","3":"d9","4":"L3500-04","5":"in 10mM DMSO","6":"EGFR","7":"Angiogenesis","8":"Nazartinib (EGF816, NVS-816) is a covalent, irreversible, mutant-selective EGFR inhibitor that has nanomolar inhibitory potency against activating mt (L858R, ex19del) and T790M mt, with up to 60-fold selectivity over wild type (wt) EGFR in vitro.","9":"495.02","10":"1508250-71-2","11":"99","12":"199.99","13":"<1","14":"NA","15":"http://selleckchem.com/products/nazartinib-egf816-nvs-816.html","16":"C26H31ClN6O2","17":"free base","18":"N/A","19":"CN(C)C/C=C/C(=O)N1CCCCC(C1)[N]2C(=NC3=CC=CC(=C23)Cl)NC(=O)C4=CC(=NC=C4)C","20":"3.705","21":"4","22":"1","23":"6","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S7835","2":"I-BRD9","3":"e9","4":"L3500-04","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"I-BRD9 (GSK602) is a potent and selective BRD9 inhibitor with pIC50 of 7.3, while it displayed a pIC50 of 5.3 against BRD4.","9":"497.55","10":"1714146-59-4","11":"99","12":"198.97","13":"<1","14":"NA","15":"http://selleckchem.com/products/i-brd9-gsk602.html","16":"C22H22F3N3O3S2","17":"free base","18":"GSK602","19":"CCN1C=C(C2=CC(=CC=C2)C(F)(F)F)C3=C(C=C(S3)C(=N)NC4CC[S](=O)(=O)CC4)C1=O","20":"2.779","21":"3","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7845","2":"SirReal2","3":"f9","4":"L3500-04","5":"in 10mM DMSO","6":"Sirtuin","7":"Epigenetics","8":"SirReal2 is a potent and selective Sirt2 inhibitor with IC50 of 140 nM.","9":"420.55","10":"709002-46-0","11":"84","12":"199.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/sirreal2.html","16":"C22H20N4OS2","17":"free base","18":"N/A","19":"CC1=NC(=NC(=C1)C)SCC(=O)NC2=NC=C(CC3=CC=CC4=CC=CC=C34)S2","20":"4.065","21":"4","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7849","2":"BDA-366","3":"g9","4":"L3500-04","5":"in 10mM DMSO","6":"Bcl-2","7":"Apoptosis","8":"BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affinity and selectivity. It directly binds to Bcl2 with high binding affinity (Ki =3.3 Â± 0.73 nM).","9":"423.50","10":"1909226-00-1","11":"84","12":"198.35","13":"<1","14":"NA","15":"http://selleckchem.com/products/bda-366.html","16":"C24H29N3O4","17":"free base","18":"N/A","19":"CCN(CC)CC(O)CNC1=CC=C(NCC2CO2)C3=C1C(=O)C4=CC=CC=C4C3=O","20":"2.467","21":"3","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7875","2":"NVP-CGM097","3":"h9","4":"L3500-04","5":"in 10mM DMSO","6":"Mdm2","7":"Apoptosis","8":"NVP-CGM097 is a highly potent and selective MDM2 inhibitor with Ki value of 1.3 nM for hMDM2 in TR-FRET assay. It binds to the p53 binding-site of the Mdm2 protein, disrupting the interaction between both proteins, leading to an activation of the p53 pathway.","9":"659.26","10":"1313363-54-0","11":"65","12":"98.60","13":"<1","14":"NA","15":"http://selleckchem.com/products/nvp-cgm097.html","16":"C38H47ClN4O4","17":"free base","18":"CGM-097, CGM 097, CGM 097, NVP CGM097","19":"COC1=CC2=C(C=C1OC(C)C)C(N(C(=O)C2)C3=CC=C(C=C3)N(C)CC4CCC(CC4)N5CCN(C)C(=O)C5)C6=CC=C(Cl)C=C6","20":"6.455","21":"4","22":"0","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7886","2":"CC-223","3":"a10","4":"L3500-04","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"CC-223 is a potent, selective, and orally bioavailable mTOR inhibitor with IC50 of 16 nM, >200-fold selectivity over the related PI3K-Î±. Phase 1/2.","9":"397.47","10":"1228013-30-6","11":"79","12":"198.76","13":"<1","14":"NA","15":"http://selleckchem.com/products/cc-223.html","16":"C21H27N5O3","17":"free base","18":"N/A","19":"COC1CCC(CC1)N2C(=O)CNC3=NC=C(N=C23)C4=CN=C(C=C4)C(C)(C)O","20":"1.660","21":"5","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7906","2":"PFI-4","3":"b10","4":"L3500-04","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"PFI-4 is a potent and selective BRPF1 bromodomain inhibitor with IC50 of 80 nM.","9":"380.44","10":"900305-37-5","11":"17","12":"44.69","13":"<1","14":"NA","15":"http://selleckchem.com/products/pfi-4.html","16":"C21H24N4O3","17":"free base","18":"N/A","19":"COC1=C(C=CC=C1)C(=O)NC2=C(C=C3N(C)C(=O)N(C)C3=C2)N4CCCC4","20":"2.496","21":"3","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7915","2":"BIO-acetoxime","3":"c10","4":"L3500-04","5":"in 10mM DMSO","6":"GSK-3","7":"PI3K/Akt/mTOR","8":"BIO-acetoxime is a potent dual GSK3Î±/Î² inhibitor with IC50 of 10 nM, >240-fold selectivity over CDK5/p25, CDK2/cyclin A and CDK1/cyclin B.","9":"398.21","10":"667463-85-6","11":"19","12":"47.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/bio-acetoxime.html","16":"C18H12BrN3O3","17":"free base","18":"GSK-3 Inhibitor X","19":"CC(=O)O\\\\N=C/1\\\\C(NC2=CC=CC=C12)=C3\\\\C(=O)NC4=C3C=CC(=C4)Br","20":"2.515","21":"4","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7938","2":"GSK2292767","3":"d10","4":"L3500-04","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"GSK2292767 is a potent and selective PI3KÎ´ inhibitor.","9":"512.58","10":"1254036-66-2","11":"100","12":"195.09","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk2292767.html","16":"C24H28N6O5S","17":"free base","18":"N/A","19":"COC1=C(N[S](C)(=O)=O)C=C(C=N1)C2=CC3=C(C=N[NH]3)C(=C2)C4=NC=C(CN5CC(C)OC(C)C5)O4","20":"1.692","21":"8","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7959","2":"SIS3 HCl","3":"e10","4":"L3500-04","5":"in 10mM DMSO","6":"TGF-beta/Smad","7":"TGF-beta/Smad","8":"SIS3, a novel specific inhibitor of Smad3, inhibits TGF-Î² and activin signaling by suppressing Smad3 phosphorylation without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.","9":"489.99","10":"521984-48-5","11":"97","12":"197.96","13":"<1","14":"NA","15":"http://selleckchem.com/products/sis3.html","16":"C28H28ClN3O3","17":"hydrochloride","18":"N/A","19":"Cl.COC1=CC2=C(CN(CC2)C(=O)/C=C/C3=C([N](C)C4=NC=CC=C34)C5=CC=CC=C5)C=C1OC","20":"5.076","21":"4","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7960","2":"Larotrectinib (LOXO-101) sulfate","3":"f10","4":"L3500-04","5":"in 10mM DMSO","6":"Trk receptor","7":"Protein Tyrosine Kinase","8":"Larotrectinib (LOXO-101) sulfate is an oral potent and selective ATP-competitive inhibitor of tropomyosin receptor kinases (TRK).","9":"526.51","10":"1223405-08-0","11":"100","12":"189.93","13":"<1","14":"NA","15":"http://selleckchem.com/products/loxo-101.html","16":"C21H24F2N6O6S","17":"sulfate","18":"ARRY-470, Larotrectinib","19":"OC1CCN(C1)C(=O)NC2=C3N=C(C=C[N]3N=C2)N4CCCC4C5=CC(=CC=C5F)F.O[S](O)(=O)=O","20":"1.374","21":"3","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7964","2":"PLX7904","3":"g10","4":"L3500-04","5":"in 10mM DMSO","6":"Raf","7":"MAPK","8":"PLX7904, also known as PB04, is a potent and selective paradox-breaker RAF inhibitor. It is able to efficiently inhibit activation of ERK1/2 in mutant BRAF melanoma cells but does not hyperactivate ERK1/2 in mutant RAS-expressing cells.","9":"512.53","10":"1393465-84-3","11":"100","12":"195.11","13":"<1","14":"NA","15":"http://selleckchem.com/products/plx7904.html","16":"C24H22F2N6O3S","17":"free base","18":"PB04","19":"CCN(C)[S](=O)(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(C=C23)C4=CN=C(N=C4)C5CC5","20":"2.291","21":"6","22":"2","23":"8","24":"maybe 1","25":"NA","26":"1","27":"NA"},{"1":"S7980","2":"VPS34-IN1","3":"h10","4":"L3500-04","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"Vps34-IN1 is a potent and highly selective Vps34 inhibitor with IC50 of 25 nM invitro,which does not significantly inhibit the isoforms of class I as well as class II PI3Ks.","9":"425.91","10":"1383716-33-3","11":"85","12":"199.57","13":"<1","14":"NA","15":"http://selleckchem.com/products/vps34-in1.html","16":"C21H24ClN7O","17":"free base","18":"Vps34-IN-1","19":"CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC(=C4)Cl","20":"3.672","21":"5","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7983","2":"A-196","3":"a11","4":"L3500-04","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"A-196 is a potent and selective inhibitor of SUV420H1 and SUV420H2 with IC50 values of 0.025 and 0.144 Î¼M, respectively more than 100-fold selective over other histone methyltransferases and non-epigenetic targets.","9":"359.25","10":"1982372-88-2","11":"15","12":"41.75","13":"<1","14":"NA","15":"http://selleckchem.com/products/a-196.html","16":"C18H16Cl2N4","17":"free base","18":"N/A","19":"ClC1=C(Cl)C=C2C(=C1)C(=NN=C2C3=CC=NC=C3)NC4CCCC4","20":"4.995","21":"3","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7992","2":"LDC4297 (LDC044297)","3":"b11","4":"L3500-04","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"LDC4297 is a novel CDK7 inhibitor (IC50=0.13Â±0.06 nM for CDK7 versus IC50s between 10 nM and 10,000 nM for all other analyzed CDKs).","9":"432.52","10":"1453834-21-3","11":"86","12":"198.83","13":"27","14":"62.42","15":"http://selleckchem.com/products/ldc4297-ldc044297.html","16":"C23H28N8O","17":"free base","18":"N/A","19":"CC(C)C1=C2N=C(OC3CCCNC3)N=C(NCC4=CC=CC=C4[N]5C=CC=N5)[N]2N=C1","20":"3.928","21":"5","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8005","2":"SMI-4a","3":"c11","4":"L3500-04","5":"in 10mM DMSO","6":"Pim","7":"JAK/STAT","8":"SMI-4a is a potent inhibitor of?Pim1?with?IC50?of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.","9":"273.23","10":"438190-29-5","11":"55","12":"201.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/smi-4a.html","16":"C11H6F3NO2S","17":"free base","18":"TCS PIM-1 4a","19":"FC(F)(F)C1=CC(=CC=C1)\\\\C=C2/SC(=O)NC2=O","20":"2.884","21":"2","22":"1","23":"2","24":"NA","25":"PIM1","26":"1","27":"PIM1"},{"1":"S8014","2":"GW9508","3":"d11","4":"L3500-04","5":"in 10mM DMSO","6":"GPR","7":"Endocrinology & Hormones","8":"GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, stimulates insulin secretion in a glucose-sensitive manner.","9":"347.41","10":"885101-89-3","11":"69","12":"198.61","13":"<1","14":"NA","15":"http://selleckchem.com/products/gw9508.html","16":"C22H21NO3","17":"free base","18":"N/A","19":"OC(=O)CCC1=CC=C(NCC2=CC=CC(=C2)OC3=CC=CC=C3)C=C1","20":"4.903","21":"2","22":"1","23":"8","24":"NA","25":"FFAR1, FFAR4","26":"2","27":"NA"},{"1":"S8020","2":"GW0742","3":"e11","4":"L3500-04","5":"in 10mM DMSO","6":"PPAR","7":"Metabolism","8":"GW0742 is a potent and highly selective PPARÎ²/Î´ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARÎ± and hPPARÎ³.","9":"471.49","10":"317318-84-6","11":"94","12":"199.37","13":"<1","14":"NA","15":"http://selleckchem.com/products/gw0742.html","16":"C21H17F4NO3S2","17":"free base","18":"N/A","19":"CC1=CC(=CC=C1OCC(O)=O)SCC2=C(C)N=C(S2)C3=CC=C(C(=C3)F)C(F)(F)F","20":"5.795","21":"3","22":"0","23":"8","24":"NA","25":"PPARD","26":"1","27":"NA"},{"1":"S8022","2":"Empagliflozin (BI 10773)","3":"f11","4":"L3500-04","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.","9":"450.91","10":"864070-44-0","11":"90","12":"199.60","13":"<1","14":"NA","15":"http://selleckchem.com/products/empagliflozin-bi10773.html","16":"C23H27ClO7","17":"free base","18":"N/A","19":"OCC1OC(C(O)C(O)C1O)C2=CC(=C(Cl)C=C2)CC3=CC=C(OC4CCOC4)C=C3","20":"1.839","21":"3","22":"4","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8023","2":"TCS 359","3":"g11","4":"L3500-04","5":"in 10mM DMSO","6":"FLT3","7":"Angiogenesis","8":"TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.","9":"360.43","10":"301305-73-7","11":"15","12":"41.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/tcs-359.html","16":"C18H20N2O4S","17":"free base","18":"N/A","19":"COC1=CC=C(C=C1OC)C(=O)NC2=C(C(N)=O)C3=C(CCCC3)S2","20":"2.753","21":"4","22":"2","23":"5","24":"NA","25":"FLT3","26":"1","27":"NA"},{"1":"S8025","2":"GSK3787","3":"h11","4":"L3500-04","5":"in 10mM DMSO","6":"PPAR","7":"Metabolism","8":"GSK3787 is as a selective and irreversible antagonist of PPARÎ´ with pIC50 of 6.6, with no measurable affinity for hPPARÎ± or hPPARÎ³.","9":"392.78","10":"188591-46-0","11":"79","12":"201.13","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk3787.html","16":"C15H12ClF3N2O3S","17":"free base","18":"N/A","19":"FC(F)(F)C1=CC=C(N=C1)[S](=O)(=O)CCNC(=O)C2=CC=C(Cl)C=C2","20":"3.207","21":"4","22":"1","23":"6","24":"NA","25":"PPARD","26":"1","27":"NA"},{"1":"S8031","2":"NSC 23766","3":"a2","4":"L3500-05","5":"in 10mM DMSO","6":"Rho","7":"Cell Cycle","8":"NSC 23766 is an inhibitor of Rac GTPase targeting Rac activation by guanine nucleotide exchange factors (GEFs) with IC50 of ~50 Î¼M in a cell-free assay does not inhibit the closely related  targets, Cdc42 or RhoA.","9":"530.96","10":"1177865-17-6","11":"100","12":"188.34","13":"100","14":"188.34","15":"http://selleckchem.com/products/nsc-23766.html","16":"C24H38Cl3N7","17":"HCl","18":"N/A","19":"Cl.Cl.Cl.CCN(CC)CCCC(C)NC1=NC(=CC(=N1)NC2=CC3=C(N)C=C(C)N=C3C=C2)C","20":"5.477","21":"3","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8040","2":"GDC-0349","3":"b2","4":"L3500-05","5":"in 10mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3KÎ± and other 266 kinases. Phase 1.","9":"452.55","10":"1207360-89-1","11":"91","12":"201.08","13":"<1","14":"NA","15":"http://selleckchem.com/products/gdc-0349.html","16":"C24H32N6O3","17":"free base","18":"RG-7603","19":"CCNC(=O)NC1=CC=C(C=C1)C2=NC(=C3CCN(CC3=N2)C4COC4)N5CCOCC5C","20":"1.982","21":"5","22":"2","23":"5","24":"NA","25":"PIK3CA","26":"1","27":"PIK3CA"},{"1":"S8041","2":"Cobimetinib (GDC-0973, RG7420)","3":"c2","4":"L3500-05","5":"in 10mM DMSO","6":"MEK","7":"MAPK","8":"Cobimetinib (GDC-0973, RG7420) is a potent and highly selective MEK1 inhibitor with IC50 of 4.2 nM, showing more than 100-fold selectively for MEK1 over MEK2 and showed no significant inhibition when tested against a panel of more than 100 of serine-threonine and tyrosine kinases. Phase 3.","9":"531.31","10":"934660-93-2","11":"100","12":"188.21","13":"<1","14":"NA","15":"http://selleckchem.com/products/cobimetinib-gdc-0973-rg7420.html","16":"C21H21F3IN3O2","17":"free base","18":"XL518","19":"OC1(CN(C1)C(=O)C2=C(NC3=CC=C(I)C=C3F)C(=C(F)C=C2)F)C4CCCCN4","20":"3.701","21":"1","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8042","2":"GW2580","3":"d2","4":"L3500-05","5":"in 10mM DMSO","6":"CSF-1R","7":"Protein Tyrosine Kinase","8":"GW2580 is a selective CSF-1R inhibitor for c-FMS with IC50 of 30 nM, 150- to 500-fold selective compared to b-Raf, CDK4, c-KIT, c-SRC, EGFR, ERBB2/4, ERK2, FLT-3, GSK3, ITK, JAK2 etc.","9":"366.41","10":"870483-87-7","11":"48","12":"131.00","13":"<1","14":"NA","15":"http://selleckchem.com/products/gw2580.html","16":"C20H22N4O3","17":"free base","18":"SC-203877","19":"COC1=CC=C(COC2=CC=C(CC3=C(N)N=C(N)N=C3)C=C2OC)C=C1","20":"3.127","21":"5","22":"2","23":"7","24":"NA","25":"CSF1R","26":"1","27":"NA"},{"1":"S8044","2":"BMS-345541","3":"e2","4":"L3500-05","5":"in 10mM DMSO","6":"IÎºB/IKK","7":"NF-ÎºB","8":"BMS-345541 is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 Î¼M and 4 Î¼M in cell-free assays, respectively.","9":"255.32","10":"445430-58-0","11":"9","12":"35.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/bms-345541.html","16":"C14H17N5","17":"free base","18":"N/A","19":"CC1=CC=C2N=C(NCCN)C3=NC=C(C)[N]3C2=C1","20":"1.472","21":"2","22":"2","23":"3","24":"NA","25":"CHUK, IKBKB","26":"2","27":"IKBKB"},{"1":"S8047","2":"Dynasore","3":"f2","4":"L3500-05","5":"in 10mM DMSO","6":"Dynamin","7":"Cytoskeletal Signaling","8":"Dynasore is a cell-permeable, reversible non-competitive dynamin inhibitor of GTPase activity of dynamin 1/2, with IC50 of 15 Î¼M in a cell-free assay, also inhibits the mitochondrial dynamin Drp1, with no effect against other small GTPase.","9":"322.31","10":"304448-55-3","11":"64","12":"198.57","13":"<1","14":"NA","15":"http://selleckchem.com/products/dynasore.html","16":"C18H14N2O4","17":"free base","18":"N/A","19":"OC1=C(O)C=C(C=C1)\\\\C=N\\\\NC(=O)C2=C(O)C=C3C=CC=CC3=C2","20":"2.865","21":"2","22":"4","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8048","2":"Venetoclax (ABT-199, GDC-0199)","3":"g2","4":"L3500-05","5":"in 10mM DMSO","6":"Bcl-2","7":"Apoptosis","8":"Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays, >4800-fold more selective versus Bcl-xL and Bcl-w, and no activity to Mcl-1. Phase 3.","9":"868.44","10":"1257044-40-8","11":"100","12":"115.15","13":"<1","14":"NA","15":"http://selleckchem.com/products/abt-199.html","16":"C45H50ClN7O7S","17":"free base","18":"N/A","19":"CC1(C)CCC(=C(C1)C2=CC=C(Cl)C=C2)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)N[S](=O)(=O)C5=CC=C(NCC6CCOCC6)C(=C5)[N+]([O-])=O)OC7=CN=C8[NH]C=CC8=C7","20":"7.940","21":"6","22":"3","23":"13","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8049","2":"Tubastatin A","3":"h2","4":"L3500-05","5":"in 10mM DMSO","6":"others","7":"HDAC","8":"Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).","9":"335.40","10":"1252003-15-8","11":"67","12":"199.76","13":"<1","14":"NA","15":"https://www.selleckchem.com/products/tubastatin-a.html","16":"C20H21N3O2","17":"NA","18":"NA","19":"CN1CCC2=C(C1)C3=C(C=CC=C3)[N]2CC4=CC=C(C=C4)C(=O)NO","20":"3.081","21":"1","22":"1","23":"3","24":"NA","25":"HDAC6","26":"1","27":"NA"},{"1":"S8102","2":"Z-VAD(OH)-FMK (Caspase Inhibitor VI)","3":"a3","4":"L3500-05","5":"in 10mM DMSO","6":"Caspase","7":"Apoptosis","8":"Z-VAD-FMK (Caspase Inhibitor VI) is an irreversible pan-caspase inhibitor.","9":"453.46","10":"161401-82-7","11":"90","12":"198.47","13":"<1","14":"NA","15":"http://selleckchem.com/products/z-vad(oh)-fmk.html","16":"C21H28FN3O7","17":"free base","18":"N/A","19":"CC(C)C(NC(=O)OCC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC(O)=O)C(=O)CF","20":"1.246","21":"6","22":"3","23":"13","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8116","2":"Acalabrutinib (ACP-196)","3":"b3","4":"L3500-05","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"Acalabrutinib(ACP-196) is a selective second-generation Bruton's tyrosine kinase (BTK) inhibitor with an IC50 of 3 nM, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. ACP-196 has improved target specificity over ibrutinib with 323-, 94-, 19- and 9-fold selectivity over the other TEC kinase family members (ITK, TXK, BMX, and TEC, respectively) and no activity against EGFR.","9":"465.51","10":"1420477-60-6","11":"93","12":"199.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/acalabrutinib.html","16":"C26H23N7O2","17":"free base","18":"N/A","19":"CC#CC(=O)N1CCCC1C2=NC(=C3[N]2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=NC=CC=C5","20":"2.699","21":"5","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8141","2":"Cl-amidine","3":"c3","4":"L3500-05","5":"in 10mM DMSO","6":"Immunology & Inflammation related","7":"Immunology & Inflammation","8":"Cl-amidine is an irreversible pan-peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 Â± 0.3 Î¼M, 0.8 Â± 0.3 Î¼M, 6.2 Â± 1.0 Î¼M for PAD4, PAD1 and PAD3, respectively.","9":"424.80","10":"1043444-18-3","11":"84","12":"197.74","13":"70","14":"164.78","15":"http://selleckchem.com/products/cl-amidine.html","16":"C16H20ClF3N4O4","17":"trifluoroacetate","18":"N/A","19":"NC(=O)C(CCCNC(=N)CCl)NC(=O)C1=CC=CC=C1.OC(=O)C(F)(F)F","20":"1.333","21":"3","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8156","2":"ARS-853 (ARS853)","3":"d3","4":"L3500-05","5":"in 10mM DMSO","6":"Rho","7":"Cell Cycle","8":"ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation.","9":"432.94","10":"1629268-00-3","11":"86","12":"198.64","13":"<1","14":"NA","15":"http://selleckchem.com/products/ars-853.html","16":"C22H29ClN4O3","17":"free base","18":"N/A","19":"CC1(CC1)C2=C(Cl)C=C(O)C(=C2)NCC(=O)N3CCN(CC3)C4CN(C4)C(=O)C=C","20":"2.256","21":"2","22":"2","23":"6","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S8166","2":"ONO-4059 (GS-4059) hydrochloride","3":"e3","4":"L3500-05","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"ONO-4059 (GS-4059) is highly potent and selective BTK inhibitor with an IC50 of 2.2 nM.","9":"490.94","10":"1439901-97-9","11":"98","12":"199.62","13":"<1","14":"NA","15":"http://selleckchem.com/products/ono-4059-gs-4059.html","16":"C25H23ClN6O3","17":"hydrochloride","18":"N/A","19":"Cl.CC#CC(=O)N1CCC(C1)N2C(=O)N(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C25","20":"3.706","21":"5","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8167","2":"AMG 337","3":"f3","4":"L3500-05","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"AMG 337 is an oral, small molecule, ATP-competitive, highly selective inhibitor of the MET receptor with an IC50 of 1 nM.","9":"463.46","10":"1173699-31-4","11":"95","12":"204.98","13":"<1","14":"NA","15":"http://selleckchem.com/products/amg-337.html","16":"C23H22FN7O3","17":"free base","18":"N/A","19":"COCCOC1=CC2=C(C=CN(C(C)C3=NN=C4[N]3C=C(C=C4F)C5=C[N](C)N=C5)C2=O)N=C1","20":"1.188","21":"7","22":"0","23":"7","24":"NA","25":"MET","26":"1","27":"NA"},{"1":"S8180","2":"PF-CBP1 HCl","3":"g3","4":"L3500-05","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"PF-CBP1 HCl is a highly selective inhibitor of the bromodomain of CREB-binding protein(CREBBP).It inhibits CREBBP and p300 bromodomains with IC50 of 125 and 363 nM respectively.","9":"525.08","10":"2070014-93-4","11":"100","12":"190.45","13":"100","14":"190.45","15":"http://selleckchem.com/products/pf-cbp1.html","16":"C29H37ClN4O3","17":"Hydrochloride","18":"N/A","19":"Cl.CCCOC1=CC=C(CCC2=NC3=CC(=CC=C3[N]2CCN4CCOCC4)C5=C(C)ON=C5C)C=C1","20":"5.432","21":"5","22":"0","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8190","2":"CPI-637","3":"h3","4":"L3500-05","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 Î¼M and 0.051Î¼M for CBP and EP300 respectively in TR-FRET assay. It is highly selective against other bromodomains, displaying substantial biochemical activity only against BRD9.","9":"386.45","10":"1884712-47-3","11":"27","12":"69.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/cpi-637.html","16":"C22H22N6O","17":"free base","18":"N/A","19":"CC1CC(=O)NC2=C(N1)C(=CC=C2)C3=CC4=C(C=C3)[N](C)N=C4C5=C[N](C)N=C5","20":"3.035","21":"3","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8201","2":"BI-78D3","3":"a4","4":"L3500-05","5":"in 10mM DMSO","6":"JNK","7":"MAPK","8":"BI-78D3 is a competitive JNK inhibitor with IC50 of 280 nM that displays > 100 fold selectivity over p38Î± and no activity at mTOR and PI-3K.","9":"379.37","10":"883065-90-5","11":"100","12":"263.59","13":"<1","14":"NA","15":"http://selleckchem.com/products/bi-78d3.html","16":"C13H9N5O5S2","17":"free base","18":"N/A","19":"OC1=NN=C(SC2=NC=C(S2)[N+]([O-])=O)[N]1C3=CC=C4OCCOC4=C3","20":"2.738","21":"5","22":"1","23":"4","24":"NA","25":"MAPK8","26":"1","27":"MAPK8"},{"1":"S8238","2":"SB366791","3":"b4","4":"L3500-05","5":"in 10mM DMSO","6":"TRPV","7":"Transmembrane Transporters","8":"SB-366791 is a novel, potent, and selective, cinnamide TRPV1 antagonist with an IC50 of 5.7 nM.","9":"287.74","10":"472981-92-3","11":"57","12":"198.10","13":"<1","14":"NA","15":"http://selleckchem.com/products/sb366791.html","16":"C16H14ClNO2","17":"free base","18":"N/A","19":"COC1=CC=CC(=C1)NC(=O)/C=C/C2=CC=C(Cl)C=C2","20":"3.730","21":"2","22":"1","23":"4","24":"NA","25":"TRPV1","26":"1","27":"TRPV1"},{"1":"S8244","2":"Etomoxir (Na salt)","3":"c4","4":"L3500-05","5":"in 10mM DMSO","6":"Transferase","7":"Metabolism","8":"Etomoxir is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1) on the outer face of the inner mitochondrial membrane.","9":"320.74","10":"828934-41-4","11":"64","12":"199.54","13":"64","14":"199.54","15":"http://selleckchem.com/products/etomoxir-na-salt.html","16":"C15H18ClNaO4","17":"sodium salt","18":"N/A","19":"[Na]OC(=O)C1(CCCCCCOC2=CC=C(Cl)C=C2)CO1","20":"3.847","21":"4","22":"0","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8245","2":"Thiomyristoyl","3":"d4","4":"L3500-05","5":"in 10mM DMSO","6":"Sirtuin","7":"DNA Damage","8":"Thiomyristoyl is a potent and specific SIRT2 inhibitor with an IC50 of 28 nM. It inhibits SIRT1 with an IC50 value of 98 Î¼M and does not inhibit SIRT3 even at 200 Î¼M.","9":"581.85","10":"1429749-41-6","11":"100","12":"171.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/thiomyristoyl.html","16":"C34H51N3O3S","17":"free base","18":"TM","19":"CCCCCCCCCCCCCC(=S)NCCCCC(NC(=O)OCC1=CC=CC=C1)C(=O)NC2=CC=CC=C2","20":"9.441","21":"3","22":"3","23":"24","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8253","2":"CCT245737","3":"e4","4":"L3500-05","5":"in 10mM DMSO","6":"Chk","7":"Cell Cycle","8":"CCT245737 is an orally active CHK1 inhibitor with The IC50 of 1.4 nM. It exhibits >1,000-fold selectivity against CHK2 and CDK1.","9":"379.34","10":"1489389-18-5","11":"75","12":"197.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/cct245737.html","16":"C16H16F3N7O","17":"free base","18":"N/A,SRA737","19":"FC(F)(F)C1=CN=C(NC2=CN=C(C=N2)C#N)C=C1NCC3CNCCO3","20":"1.460","21":"4","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8265","2":"GSK6853","3":"f4","4":"L3500-05","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"GSK6853 is a selective benzimidazolone BRPF1 inhibitor with pIC50 of 8.1(TR-FRET) showing greater than 1600-fold selectivity over all other bromodomains tested.","9":"409.48","10":"1910124-24-1","11":"81","12":"197.81","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk6853.html","16":"C22H27N5O3","17":"free base","18":"N/A","19":"COC1=CC=CC=C1C(=O)NC2=CC3=C(C=C2N4CCNCC4C)N(C)C(=O)N3C","20":"1.834","21":"3","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8278","2":"SHP099 HCl","3":"g4","4":"L3500-05","5":"in 10mM DMSO","6":"phosphatase","7":"Others","8":"SHP099 is a highly potent, selective and orally bioavailable small-molecule <b>SHP2<\/b> inhibitor with an IC50â€‰value ofâ€‰0.071â€‰Î¼M and shows no activity against SHP1.","9":"388.72","10":"2200214-93-1","11":"77","12":"181.10","13":"2","14":"4.70","15":"http://selleckchem.com/products/shp099-dihydrochloride.html","16":"C16H21Cl4N5","17":"Dihydrochloride","18":"N/A","19":"Cl.CC1(N)CCN(CC1)C2=CN=C(C(=N2)N)C3=CC=CC(=C3Cl)Cl","20":"3.410","21":"2","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8292","2":"Selonsertib (GS-4997)","3":"h4","4":"L3500-05","5":"in 10mM DMSO","6":"ASK","7":"Apoptosis","8":"GS-4997 is a highly selective and potent once-daily oral ASK1 inhibitor with potential anti-inflammatory, antineoplastic and anti-fibrotic activities.","9":"445.49","10":"1448428-04-3","11":"36","12":"80.81","13":"<1","14":"NA","15":"http://selleckchem.com/products/selonsertib-gs-4997.html","16":"C24H24FN7O","17":"free base","18":"N/A","19":"CC(C)[N]1C=NN=C1C2=CC=CC(=N2)NC(=O)C3=CC(=C(C)C=C3F)[N]4C=NC(=C4)C5CC5","20":"4.054","21":"5","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8296","2":"dBET1","3":"a5","4":"L3500-05","5":"in 10mM DMSO","6":"Epigenetic Reader Do","7":"Epigenetics","8":"dBET1 is a CRBN-based <b>BET<\/b> degrader with an IC50 of 20 nM, showing highly selectivity. Out of 7,429 proteins, only the expression of the oncoproteins MYC and PIM1, as well as BRD2, BRD3 and BRD4 are significantly downregulated by dBET1 treatment.","9":"785.27","10":"1799711-21-9","11":"100","12":"127.34","13":"<1","14":"NA","15":"http://www.selleck.cn/products/bet1.html","16":"C38H37ClN8O7S\\r\\n","17":"free base","18":"N/A","19":"CC1=C(C)C2=C(S1)[N]3C(=NN=C3C(CC(=O)NCCCCNC(=O)COC4=CC=CC5=C4C(=O)N(C6CCC(=O)NC6=O)C5=O)N=C2C7=CC=C(Cl)C=C7)C","20":"2.976","21":"10","22":"3","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8327","2":"KYA1797K","3":"b5","4":"L3500-05","5":"in 10mM DMSO","6":"Wnt/beta-catenin","7":"Stem Cells &  Wnt","8":"KYA1797K is a highly potent and selective Wnt/Î²-catenin inhibitor with IC50 of 0.75 ?M (TOPflash assay).","9":"442.51","10":"1956356-56-1","11":"29","12":"65.54","13":"29","14":"65.54","15":"http://selleckchem.com/products/kya1797k.html","16":"C17H11KN2O6S2","17":"potassium salt","18":"N/A","19":"[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)\\\\C=C3/SC(=S)N(CCC(=O)O[K])C3=O","20":"3.967","21":"4","22":"0","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8330","2":"IPI-549","3":"c5","4":"L3500-05","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"IPI-549 is a potent inhibitor of PI3K-Î³ with >100-fold selectivity over other lipid and protein kinases. The biochemical IC50 for PI3K-Î³ is 16 nM.","9":"528.56","10":"1693758-51-8","11":"100","12":"189.19","13":"<1","14":"NA","15":"http://selleckchem.com/products/ipi-549.html","16":"C30H24N8O2","17":"free base","18":"N/A","19":"CC(NC(=O)C1=C2N=CC=C[N]2N=C1N)C3=CC4=CC=CC(=C4C(=O)N3C5=CC=CC=C5)C#CC6=C[N](C)N=C6","20":"2.732","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8337","2":"1400W 2HCl","3":"d5","4":"L3500-05","5":"in 10mM DMSO","6":"NOS","7":"Immunology & Inflammation","8":"1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase(iNOS).","9":"250.17","10":"214358-33-5","11":"35","12":"139.90","13":"35","14":"139.90","15":"http://selleckchem.com/products/1400w.html","16":"C10H17Cl2N3","17":"dihydrochloride","18":"N-(3-(Aminomethyl)benzyl)acetamidine","19":"Cl.Cl.CC(=N)NCC1=CC=CC(=C1)CN","20":"0.881","21":"0","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8340","2":"SGC2085","3":"e5","4":"L3500-05","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"SGC2085 is a potent and selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) inhibitor with an IC50 value of 50 nM and >100-fold selective over other PRMTs.","9":"312.41","10":"1821908-48-8","11":"62","12":"198.46","13":"<1","14":"NA","15":"http://selleckchem.com/products/sgc2085.html","16":"C19H24N2O2","17":"free base","18":"N/A","19":"CC(N)C(=O)NCC1=CC=C(OC2=CC(=CC(=C2)C)C)C(=C1)C","20":"3.498","21":"2","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8362","2":"Irbinitinib (ARRY-380, ONT-380)","3":"f5","4":"L3500-05","5":"in 10mM DMSO","6":"HER2","7":"Protein Tyrosine Kinase","8":"ARRY-380 (ONT-380) is an oral, potent, selective, reversible and ATP-competitive small-molecule inhibitor of ErbB-2 (also called HER2) with IC50s of 8 nM and 7 nM for ErbB-2 and p95 HER2, respectively in cell-based assays, showing ~500-fold selective for HER2 vs EGFR. It has potential antineoplastic activity.","9":"480.52","10":"937263-43-9","11":"96","12":"199.78","13":"<1","14":"NA","15":"http://selleckchem.com/products/arry-380-ont-380.html","16":"C26H24N8O2","17":"free base","18":"Tucatinib","19":"CC1=CC(=CC=C1OC2=CC3=NC=N[N]3C=C2)NC4=NC=NC5=CC=C(NC6=NC(C)(C)CO6)C=C45","20":"4.744","21":"7","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8363","2":"NMS-P118","3":"g5","4":"L3500-05","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"NMS-P118 is a potent, orally available, and highly selective PARP-1 inhibitor endowed with excellent ADME and pharmacokinetic profiles, showing 150-fold selectivity for PARP-1 over PARP-2 (Kd 0.009 Î¼M vs 1.39 Î¼M, respectively).","9":"395.42","10":"1262417-51-5","11":"24","12":"60.69","13":"<1","14":"NA","15":"http://selleckchem.com/products/nms-p118.html","16":"C20H24F3N3O2","17":"free base","18":"N/A","19":"NC(=O)C1=CC(=CC2=C1C(=O)N(C2)C3CCN(CC3)C4CCC(F)(F)CC4)F","20":"1.422","21":"2","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8412","2":"Naquotinib(ASP8273)","3":"h5","4":"L3500-05","5":"in 10mM DMSO","6":"EGFR","7":"Angiogenesis","8":"Naquotinib(ASP8273) is an orally available, irreversible, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity.","9":"562.71","10":"1448232-80-1","11":"52","12":"92.41","13":"<1","14":"NA","15":"http://selleckchem.com/products/naquotinib-asp8273.html","16":"C30H42N8O3","17":"free base","18":"N/A","19":"CCC1=NC(=C(NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(C)CC4)N=C1OC5CCN(C5)C(=O)C=C)C(N)=O","20":"2.756","21":"5","22":"2","23":"9","24":"1","25":"NA","26":"1","27":"NA"},{"1":"S8438","2":"T-3775440 HCl","3":"a6","4":"L3500-05","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"T-3775440 HCl is an irreversible  LSD1  inhibitor that is highly selective for LSD1 relative to other monoamine oxidases (e.g., MAO-A and MAO-B), with an IC50 value of 2.1 nmol/L.","9":"346.85","10":"1422535-52-1","11":"69","12":"198.93","13":"22","14":"63.43","15":"http://www.selleck.cn/products/t-3775440-hcl.html","16":"C18H23ClN4O\\r\\n","17":"HCl","18":"N/A","19":"Cl.C[N]1C=C(C=N1)C(=O)NC2=CC=C(C=C2)C3CC3NCC4CC4","20":"2.262","21":"2","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8447","2":"8-OH-DPAT (8-Hydroxy-DPAT)","3":"b6","4":"L3500-05","5":"in 10mM DMSO","6":"5-HT Receptor","7":"Neuronal Signaling","8":"8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic 5-HT1A agonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site Its biological half-life is 1.5 hous.","9":"247.38","10":"78950-78-4","11":"49","12":"198.08","13":"<1","14":"NA","15":"http://selleckchem.com/products/8-oh-dpat-8-hydroxy-dpat.html","16":"C16H25NO","17":"free base","18":"N/A","19":"CCCN(CCC)C1CCC2=CC=CC(=C2C1)O","20":"4.287","21":"0","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8452","2":"BAY-876","3":"c6","4":"L3500-05","5":"in 10mM DMSO","6":"GLUT","7":"Metabolism","8":"BAY-876 is a potent and selective GLUT1 inhibitor (IC50=0.002 Î¼M) with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4.","9":"496.42","10":"1799753-84-6","11":"99","12":"199.43","13":"<1","14":"NA","15":"http://selleckchem.com/products/bay-876.html","16":"C24H16F4N6O2","17":"free base","18":"N/A","19":"CC1=C(NC(=O)C2=CC(=NC3=CC(=CC=C23)F)C(N)=O)C(=N[N]1CC4=CC=C(C=C4)C#N)C(F)(F)F","20":"4.065","21":"4","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8456","2":"VPS34 inhibitor 1 (Compound 19, PIK-III analogue)","3":"d6","4":"L3500-05","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.","9":"391.47","10":"1383716-46-8","11":"78","12":"199.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/vps34-inhibitor-1.html","16":"C21H25N7O","17":"free base","18":"N/A","19":"CC(C)(O)CNC1=NC=C(C(=N1)CC2CC2)C3=CC=NC(=N3)NC4=CC=NC=C4","20":"2.798","21":"5","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8457","2":"UK-371804 HCl","3":"e6","4":"L3500-05","5":"in 10mM DMSO","6":"Serine Protease","7":"Proteases","8":"UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor with excellent enzyme potency (Ki=10 nM) and selectivity profile (4000-fold versus tPA and 2700-fold versus plasmin).","9":"422.29","10":"256476-36-5","11":"30","12":"71.04","13":"<1","14":"NA","15":"http://selleckchem.com/products/uk-371804-hcl.html","16":"C14H17Cl2N5O4S","17":"hydrochloride","18":"UK-371804 HCl","19":"Cl.CC(C)(N[S](=O)(=O)C1=CC2=C(C=C1)C(=CN=C2NC(N)=N)Cl)C(O)=O","20":"1.326","21":"4","22":"3","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8465","2":"GSK'872 (GSK2399872A)","3":"f6","4":"L3500-05","5":"in 10mM DMSO","6":"Serine/threonin kinase","7":"Apoptosis","8":"GSK'872 (GSK2399872A) is a potent and selective RIP3 kinase inhibitor which binds RIP3 kinase domain with high affinity (IC50=1.8 nM) and inhibits kinase activity with IC50 of 1.3 nM. It has minimal cross-reactivity.","9":"383.49","10":"1346546-69-7","11":"76","12":"198.18","13":"<1","14":"NA","15":"http://selleckchem.com/products/GSK872-GSK2399872A.html","16":"C19H17N3O2S2","17":"free base","18":"N/A","19":"CC(C)[S](=O)(=O)C1=CC=C2N=CC=C(NC3=CC4=C(SC=N4)C=C3)C2=C1","20":"3.902","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8479","2":"LLY-284","3":"g6","4":"L3500-05","5":"in 10mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"LLY-284 is the diastereomer of LLY-283, which is a potent and selective SAM-competitive chemical probe for PRMT5. LLY-284 is much less active than LLY-283 and can be used as a negative control for LLY-283.","9":"342.35","10":"2226515-75-7","11":"68","12":"198.63","13":"<1","14":"NA","15":"https://www.selleckchem.com/products/lly-284.html","16":"C17H18N4O4","17":"free base","18":"N/A","19":"NC1=NC=NC2=C1C=C[N]2C3OC(C(O)C3O)C(O)C4=CC=CC=C4","20":"0.509","21":"3","22":"4","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8489","2":"GSK180736A (GSK180736)","3":"h6","4":"L3500-05","5":"in 10mM DMSO","6":"ROCK","7":"Cell Cycle","8":"GSK180736A, developed as a Rho-associated, coiled-coil-containing protein kinase inhibitor, binds to GRK2(G protein-coupled receptor kinase 2) with logIC50 pf -6.6 (logIC50 -4.0 for GRK5 and >-3 for GRK1) â‰¥400-fold selective for GRK2 over both GRK1 and GRK5.","9":"365.36","10":"817194-38-0","11":"73","12":"199.80","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk180736a.html","16":"C19H16FN5O2","17":"free base","18":"N/A","19":"CC1=C(C(NC(=O)N1)C2=CC=C(F)C=C2)C(=O)NC3=CC4=C([NH]N=C4)C=C3","20":"1.843","21":"3","22":"4","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8493","2":"PD-166866 (PD166866)","3":"a7","4":"L3500-05","5":"in 10mM DMSO","6":"FGFR","7":"Angiogenesis","8":"PD-166866 is a synthetic molecule inhibiting the tyrosin kinase action of FGFR1, shows a very high selectivity towards FGFR1 and inhibits the auto-phosphorylation activity of FGRF1.","9":"396.44","10":"192705-79-6","11":"14","12":"35.31","13":"<1","14":"NA","15":"http://selleckchem.com/products/pd-166866.html","16":"C20H24N6O3","17":"free base","18":"N/A","19":"COC1=CC(=CC(=C1)C2=CC3=C(N=C(N)N=C3)N=C2NC(=O)NC(C)(C)C)OC","20":"2.279","21":"6","22":"3","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8495","2":"WT161","3":"b7","4":"L3500-05","5":"in 10mM DMSO","6":"HDAC","7":"Epigenetics","8":"WT161 is a potent, selective, and bioavailable HDAC6 inhibitor with IC50 values of 0.4 nM, 8.35 nM and 15.4 nM for HDAC6, HDAC1 and HDAC2, respectively shown to have >100-fold selectivity over other HDACs.","9":"458.55","10":"1206731-57-8","11":"86","12":"187.55","13":"<1","14":"NA","15":"http://selleckchem.com/products/wt161.html","16":"C27H30N4O3","17":"free base","18":"N/A","19":"ONC(=O)CCCCCCC(=O)N/N=C/C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3","20":"5.406","21":"3","22":"2","23":"12","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8503","2":"BLU-554 (BLU554)","3":"c7","4":"L3500-05","5":"in 10mM DMSO","6":"FGFR","7":"Angiogenesis","8":"BLU-554 is a potent, highly-selective, oral FGFR4 inhibitor with an IC50 value of 5 nM. The IC50s for FGFR1-3 is 624-2203 nM.","9":"503.38","10":"1707289-21-1","11":"100","12":"198.66","13":"<1","14":"NA","15":"http://selleckchem.com/products/blu-554.html","16":"C24H24Cl2N4O4","17":"free base","18":"N/A","19":"COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=C(C=C2)N=C(NC4COCCC4NC(=O)C=C)N=C3)OC","20":"4.229","21":"6","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8534","2":"LY3214996","3":"d7","4":"L3500-05","5":"in 10mM DMSO","6":"ERK","7":"MAPK","8":"LY3214996 is a selective and novel ERK1/2 inhibitor with IC50 of 5 nM for both enzymes in biochemical assays. It potently inhibits cellular phospho-RSK1 in BRAF and RAS mutant cancer cell lines.","9":"453.56","10":"1951483-29-6","11":"27","12":"59.53","13":"<1","14":"NA","15":"http://selleckchem.com/products/ly3214996.html","16":"C22H27N7O2S","17":"free base","18":"N/A","19":"C[N]1N=CC=C1NC2=NC(=CC=N2)C3=CC4=C(S3)C(C)(C)N(CCN5CCOCC5)C4=O","20":"2.664","21":"5","22":"1","23":"6","24":"maybe 1","25":"NA","26":"1","27":"NA"},{"1":"S8538","2":"PF-06651600","3":"e7","4":"L3500-05","5":"in 10mM DMSO","6":"JAK","7":"JAK/STAT","8":"PF-06651600 is a potent and irreversible JAK3-selective inhibitor with an IC50 of 33.1 nM but without activity (IC50 > 10 000 nM) against JAK1, JAK2, and TYK2.","9":"285.34","10":"1792180-81-4","11":"57","12":"199.76","13":"NA","14":"NA","15":"http://selleckchem.com/products/pf-06651600.html","16":"C15H19N5O","17":"free base","18":"N/A","19":"CC1CCC(CN1C(=O)C=C)NC2=C3C=C[NH]C3=NC=N2","20":"1.854","21":"3","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8541","2":"FM-381","3":"f7","4":"L3500-05","5":"in 10mM DMSO","6":"JAK","7":"JAK/STAT","8":"FM-381 is a JAK3 specific reversible covalent inhibitor with IC50 of 127 pM for JAK3 and demonstrates 400-, 2,700- and 3,600-fold selectivity over JAK1, JAK2, and TYK2, respectively.","9":"428.49","10":"no CAS","11":"20","12":"46.68","13":"<1","14":"NA","15":"http://selleckchem.com/products/fm-381.html","16":"C24H24N6O2","17":"free base","18":"N/A","19":"CN(C)C(=O)/C(=C/C1=CC=C(O1)C2=NC3=CN=C4[NH]C=CC4=C3[N]2C5CCCCC5)C#N","20":"4.084","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8556","2":"AZ31","3":"g7","4":"L3500-05","5":"in 10mM DMSO","6":"ATM/ATR","7":"DNA Damage","8":"AZ31 is a selective and novel <b>ATM<\/b> inhibitor with an IC50 of <0.0012 Î¼M. It shows excellent selectivity over closely related enzymes (>500 fold selective over DNA-PK and PI3KÎ± and >1000 fold selective over mTOR, PI3KÎ² and PI3KÎ³).","9":"420.50","10":"2088113-98-6","11":"53","12":"126.04","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/az31.html","16":"C24H28N4O3","17":"Free Base","18":"N/A","19":"COCC1=NC=C(C=C1)C2=CC=C3N=CC(=C(NC(C)C4CCOCC4)C3=C2)C(N)=O","20":"2.010","21":"5","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8558","2":"Tofogliflozin(CSG 452)","3":"h7","4":"L3500-05","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Tofogliflozin is a novel sodium-glucose co-transporter 2(SGLT2) inhibitor with IC50 values of 2.9 nM and 8444 nM for hSGLT2 and hSGLT1, respectively.","9":"404.45","10":"1201913-82-7","11":"84","12":"207.69","13":"4","14":"9.89","15":"http://selleckchem.com/products/tofogliflozin-csg-452.html","16":"C22H28O7","17":"hydrate","18":"N/A","19":"O.CCC1=CC=C(CC2=CC3=C(COC34OC(CO)C(O)C(O)C4O)C=C2)C=C1","20":"1.920","21":"2","22":"4","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8559","2":"INF39","3":"a8","4":"L3500-05","5":"in 10mM DMSO","6":"Immunology & Inflammation related","7":"Immunology & Inflammation","8":"INF39 is a nontoxic, irreversible NLRP3 inhibitor that counteracts NLRP3 activation through direct irreversible interaction with NLRP3 and partial inhibition of LPS-driven pro-inflammatory gene expression.","9":"224.68","10":"866028-26-4","11":"The physical form of the compound is liquid, which can be dissolved in any proportion.","12":"NA","13":"NA","14":"NA","15":"http://selleckchem.com/products/inf39.html","16":"C12H13ClO2","17":"free base","18":"N/A","19":"CCOC(=O)C(=C)CC1=C(Cl)C=CC=C1","20":"3.666","21":"2","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8565","2":"Omarigliptin (MK-3102)","3":"b8","4":"L3500-05","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Omarigliptin (MK-3102) is a competitive, reversible inhibitor of DPP-4 (IC50 = 1.6 nM, Ki = 0.8 nM). It is highly selective over all proteases tested (IC50 > 67 Î¼M), including QPP, FAP, PEP, DPP8, and DPP9 and has weak ion channel activity (IC50 > 30 Î¼M at IKr, CaÎ³1.2, and NaÎ³1.5).","9":"398.43","10":"1226781-44-7","11":"79","12":"198.28","13":"<1","14":"NA","15":"http://selleckchem.com/products/omarigliptin-mk-3102.html","16":"C17H20F2N4O3S","17":"free base","18":"N/A","19":"C[S](=O)(=O)[N]1C=C2CN(CC2=N1)C3COC(C(N)C3)C4=C(F)C=CC(=C4)F","20":"1.098","21":"4","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8578","2":"PRN1371","3":"c8","4":"L3500-05","5":"in 10mM DMSO","6":"FGFR","7":"Angiogenesis","8":"PRN1371 is an irreversible covalent FGFR1-4 kinase inhibitor, with IC50s of 0.6, 1.3, 4.1, 19.3 and 8.1 nM for FGFR1, 2, 3, 4 and CSF1R, respectively.","9":"561.46","10":"1802929-43-6","11":"100","12":"178.11","13":"<1","14":"NA","15":"http://selleckchem.com/products/prn1371.html","16":"C26H30Cl2N6O4","17":"free base","18":"N/A","19":"CNC1=NC=C2C=C(C(=O)N(CCCN3CCN(CC3)C(=O)C=C)C2=N1)C4=C(Cl)C(=CC(=C4Cl)OC)OC","20":"3.438","21":"6","22":"1","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8581","2":"Serabelisib (INK-1117,MLN-1117,TAK-117)","3":"d8","4":"L3500-05","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"Serabelisib (INK-1117,MLN-1117,TAK-117) is a potent and selective oral PI3KÎ± isoform inhibitor (IC50 of 21 nmol/L against PI3KÎ±) that has demonstrated > 100-fold selectivity relative to other class I PI3K family members (PI3KÎ²/Î³/Î´) and mTOR, and a high degree of selectivity against many other kinase.","9":"363.37","10":"1268454-23-4","11":"16","12":"44.03","13":"<1","14":"NA","15":"http://selleckchem.com/products/tak-117-ink-1117-mln-1117.html","16":"C19H17N5O3","17":"free base","18":"N/A","19":"NC1=NC2=C(O1)C=CC(=C2)C3=C[N]4C(=NC=C4C(=O)N5CCOCC5)C=C3","20":"0.939","21":"5","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8591","2":"FX1","3":"e8","4":"L3500-05","5":"in 10mM DMSO","6":"Bcl-6","7":"Apoptosis","8":"FX1 is a selective BCL6 BTB inhibitor with an IC50 value of 35 Î¼M in reporter assays. FX1 shows great selectivity against a panel of 50 different kinases. 10 Î¼M FX1 fails to significantly inhibit of any of these kinases.","9":"368.82","10":"1426138-42-2","11":"73","12":"197.93","13":"<1","14":"NA","15":"http://selleckchem.com/products/fx1.html","16":"C14H9ClN2O4S2","17":"free base","18":"N/A","19":"OC(=O)CCN1C(=S)SC(/C1=O)=C/2C(=O)NC3=C2C=C(Cl)C=C3","20":"2.356","21":"3","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8592","2":"Pamiparib (BGB-290)","3":"f8","4":"L3500-05","5":"in 10mM DMSO","6":"PARP","7":"DNA Damage","8":"Pamiparib (BGB-290) is a potent and selective inhibitor of <b>PARP1<\/b> and <b>PARP2<\/b> with IC50 values of 0.83 and 0.11 nM, respectively in biochemical assays. It shows high selectivity over other PARP enzymes.","9":"298.31","10":"1446261-44-4","11":"59","12":"197.78","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/bgb-290.html","16":"C16H15FN4O","17":"Free Base","18":"N/A","19":"CC12CCCN1CC3=NNC(=O)C4=CC(=CC5=C4C3=C2[NH]5)F","20":"2.078","21":"2","22":"2","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8619","2":"NCT-503","3":"g8","4":"L3500-05","5":"in 10mM DMSO","6":"Dehydrogenase","7":"Metabolism","8":"NCT-503 is a phosphoglycerate dehydrogenase (PHGDH) inhibitor with the IC50 value of 2.5 Î¼M. It is inactive against a panel of other dehydrogenases and shows minimal cross-reactivity in a panel of 168 GPCRs.","9":"408.48","10":"1916571-90-8","11":"81","12":"198.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/nct-503.html","16":"C20H23F3N4S","17":"free base","18":"N/A","19":"CC1=CC(=NC(=C1)C)NC(=S)N2CCN(CC2)CC3=CC=C(C=C3)C(F)(F)F","20":"5.688","21":"1","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8629","2":"BMS-986205","3":"h8","4":"L3500-05","5":"in 10mM DMSO","6":"IDO1","7":"others","8":"BMS-986205 is a selectiveÂ indoleamine 2,3-dioxygenase 1Â (IDO1) inhibitor.","9":"410.91","10":"1923833-60-6","11":"82","12":"199.56","13":"<1","14":"NA","15":"http://selleckchem.com/products/.html","16":"C24H24ClFN2O","17":"free base","18":"N/A","19":"CC(C1CCC(CC1)C2=CC=NC3=C2C=C(F)C=C3)C(=O)NC4=CC=C(Cl)C=C4","20":"6.125","21":"2","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8632","2":"Chk2 Inhibitor II (BML-277)","3":"a9","4":"L3500-05","5":"in 10mM DMSO","6":"Chk","7":"Cell Cycle","8":"Chk2 Inhibitor II (BML-277) is an ATP-competitive inhibitor of Chk2 with IC50 of 15 nM.  It is 1000-fold more selective toward Chk2 serine/threonine kinase than for Chk1 and Cdk1/B kinases.","9":"363.80","10":"516480-79-8","11":"72","12":"197.91","13":"<1","14":"NA","15":"http://selleckchem.com/products/chk2-inhibitor-2-bml-277.html","16":"C20H14ClN3O2","17":"free base","18":"N/A","19":"NC(=O)C1=CC=C2[NH]C(=NC2=C1)C3=CC=C(OC4=CC=C(Cl)C=C4)C=C3","20":"4.497","21":"3","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8637","2":"Ipragliflozin (ASP1941)","3":"b9","4":"L3500-05","5":"in 10mM DMSO","6":"SGLT","7":"GPCR & G Protein","8":"Ipragliflozin (ASP1941) is a highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor with an IC50 value of 7.4 nM for hSGLT2 and a 254-fold selectivity versus SGLT1.","9":"404.45","10":"761423-87-4","11":"80","12":"197.80","13":"<1","14":"NA","15":"http://selleckchem.com/products/ipragliflozin-asp-1941.html","16":"C21H21FO5S","17":"free base","18":"N/A","19":"OCC1OC(C(O)C(O)C1O)C2=CC(=C(F)C=C2)CC3=CC4=C(S3)C=CC=C4","20":"2.350","21":"1","22":"4","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8639","2":"Diphenyleneiodonium chloride (DPI)","3":"c9","4":"L3500-05","5":"in 10mM DMSO","6":"NADPH-oxidase","7":"Immunology & Inflammation","8":"Diphenyleneiodonium chloride (DPI) is an inhibitor of NADPH oxidase and also a potent, irreversible, and time-, temperature-dependent iNOS/eNOS inhibitor.","9":"314.55","10":"4673-26-1","11":"13","12":"41.33","13":"<1","14":"NA","15":"http://selleckchem.com/products/diphenyleneiodonium-chloride-dpi.html","16":"C12H8ClI","17":"chloride","18":"N/A","19":"[Cl-].[I+]1C2=CC=CC=C2C3=C1C=CC=C3","20":"1.101","21":"0","22":"0","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8641","2":"Nec-1s (7-Cl-O-Nec1)","3":"d9","4":"L3500-05","5":"in 10mM DMSO","6":"TNF-alpha","7":"Apoptosis","8":"Nec-1s is a stable variant of Necrostatin-1. It is a more specific <b>RIPK1<\/b> inhibitor lacking the IDO-targeting effect, with >1000-fold more selective for RIPK1 than for any other kinase out of 485 human kinases.","9":"277.71","10":"852391-15-2","11":"56","12":"201.65","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/nec-1s-7-cl-o-nec1.html","16":"C13H12ClN3O2","17":"Free Base","18":"Necrostatin-1 stable","19":"CN1C(=O)NC(CC2=C[NH]C3=C(Cl)C=CC=C23)C1=O","20":"2.043","21":"2","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8642","2":"GSK'963","3":"e9","4":"L3500-05","5":"in 10mM DMSO","6":"NF-ÎºB,TNF-alpha","7":"NF-ÎºB","8":"GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase with an IC50 of 29 nM in FP binding assays. It is >10â€‰000-fold selective for RIP1 over 339 other kinases.","9":"230.31","10":"2049868-46-2","11":"46","12":"199.73","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk963.html","16":"C14H18N2O","17":"free base","18":"N/A","19":"CC(C)(C)C(=O)N1N=CCC1C2=CC=CC=C2","20":"2.545","21":"2","22":"0","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8644","2":"GNF-6231","3":"f9","4":"L3500-05","5":"in 10mM DMSO","6":"Wnt/beta-catenin","7":"Stem Cells &  Wnt","8":"GNF-6231 is a potent, orally active and selective Porcupine inhibitor with IC50 of 0.8 nM.","9":"448.49","10":"1243245-18-2","11":"89","12":"198.44","13":"<1","14":"NA","15":"http://selleckchem.com/products/gnf-6231.html","16":"C24H25FN6O2","17":"free base","18":"N/A","19":"CC(=O)N1CCN(CC1)C2=CC=C(NC(=O)CC3=CC(=C(N=C3)C4=CC(=NC=C4)F)C)N=C2","20":"2.135","21":"5","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8648","2":"ACY-738","3":"g9","4":"L3500-05","5":"in 10mM DMSO","6":"HDAC","7":"Epigenetics","8":"ACY-738 inhibits HDAC6 with low nanomolar potency (IC50=1.7 nM) and a selectivity of 60- to 1500-fold over class I HDACs.","9":"270.29","10":"1375465-91-0","11":"54","12":"199.79","13":"<1","14":"NA","15":"http://selleckchem.com/products/acy-738.html","16":"C14H14N4O2","17":"free base","18":"N/A","19":"ONC(=O)C1=CN=C(NC2(CC2)C3=CC=CC=C3)N=C1","20":"1.325","21":"3","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8652","2":"Skp2 inhibitor C1 (SKPin C1)","3":"h9","4":"L3500-05","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"Skp2 inhibitor C1 (SKPin C1) is a specific and selective small-molecule inhibitor of Skp2-mediated p27 degradation by reducing p27 binding through key compound-receptor contacts.","9":"465.34","10":"432001-69-9","11":"93","12":"199.85","13":"<1","14":"NA","15":"http://selleckchem.com/products/skp2-inhibitor-c1-skpin-c1.html","16":"C18H13BrN2O4S2","17":"0","18":"N/A","19":"OC(=O)COC1=C(C=C(Br)C=C1)\\\\C=C2/SC(=S)N(CC3=CN=CC=C3)C2=O","20":"3.693","21":"4","22":"0","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8657","2":"PF-06840003","3":"a10","4":"L3500-05","5":"in 10mM DMSO","6":"IDO","7":"Metabolism","8":"PF-06840003 is a highly selective orally bioavailable IDO-1 inhibitor. Although it has moderate hIDO1 enzyme inhibition (IC50 0.41 Î¼M), it is a highly efficient compound (LE 0.53, LipE 5.1), driven by its tight packing within the enzyme, as well as the high density of hydrogen bonds it forms with hIDO-1 despite its small size.","9":"232.21","10":"198474-05-4","11":"46","12":"198.10","13":"<1","14":"NA","15":"http://selleckchem.com/products/pf-06840003.html","16":"C12H9FN2O2","17":"free base","18":"EOS200271","19":"FC1=CC=C2[NH]C=C(C3CC(=O)NC3=O)C2=C1","20":"1.201","21":"2","22":"2","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8660","2":"GI254023X","3":"b10","4":"L3500-05","5":"in 10mM DMSO","6":"Immunology & Inflammation related","7":"Immunology & Inflammation","8":"GI254023X is a selective inhibitor of ADAM10 with 100-fold selectivity for ADAM10 over ADAM17. The IC50 values for recombinant ADAM10 amd ADAM17 are 5.3 nM and 541 nM, respectively.","9":"391.50","10":"260264-93-5","11":"78","12":"199.23","13":"<1","14":"NA","15":"http://selleckchem.com/products/gi254023x.html","16":"C21H33N3O4","17":"free base","18":"GI 4023","19":"CNC(=O)C(NC(=O)C(CCCC1=CC=CC=C1)C(C)N(O)C=O)C(C)(C)C","20":"2.517","21":"3","22":"2","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8666","2":"BAY 1895344 (BAY-1895344)","3":"c10","4":"L3500-05","5":"in 10mM DMSO","6":"ATM/ATR","7":"DNA Damage","8":"BAY 1895344 is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM.","9":"411.89","10":"1876467-74-1(free base)","11":"82","12":"199.08","13":"82","14":"199.08","15":"http://selleckchem.com/products/bay-1895344.html","16":"C20H22ClN7O","17":"hydrochloride","18":"N/A","19":"Cl.CC1COCCN1C2=CC(=C3C=CN=C(C4=CC=N[NH]4)C3=N2)C5=CC=N[N]5C","20":"3.156","21":"5","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8672","2":"Tenalisib (RP6530)","3":"d10","4":"L3500-05","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"Tenalisib (RP6530) is a potent and selective dual PI3KÎ´/Î³ inhibitor with IC50 values of 24.5 nM and 33.2 nM for PI3KÎ´ and PI3KÎ³, respectively. Its selectivity over Î± and Î² isoforms are more than 300-fold and 100-fold, respectively.","9":"415.42","10":"1639417-53-0","11":"75","12":"180.54","13":"<1","14":"NA","15":"http://selleckchem.com/products/tenalisib-rp6530.html","16":"C23H18FN5O2","17":"free base","18":"N/A","19":"CCC(NC1=C2N=C[NH]C2=NC=N1)C3=C(C(=O)C4=CC=CC=C4O3)C5=CC=CC(=C5)F","20":"4.070","21":"5","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8675","2":"H3B-6527","3":"e10","4":"L3500-05","5":"in 10mM DMSO","6":"FGFR","7":"Protein Tyrosine Kinase","8":"H3B-6527 is a highly selective covalent FGFR4 inhibitor with an IC50 value of <1.2 nM and at least 250-fold selectivity over FGFR1-3 (IC50 values of 320, 1,290 and 1,060 nM respectively).","9":"629.54","10":"1702259-66-2","11":"50","12":"79.42","13":"<1","14":"NA","15":"http://selleckchem.com/products/h3b-6527.html","16":"C29H34Cl2N8O4","17":"free base","18":"N/A","19":"CCN1CCN(CC1)C2=CC(=C(NC3=CC(=NC=N3)N(C)C(=O)NC4=C(Cl)C(=CC(=C4Cl)OC)OC)C=C2)NC(=O)C=C","20":"5.160","21":"6","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8676","2":"Glumetinib","3":"f10","4":"L3500-05","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"Glumetinib (SCC244) is a potent and highly selective  c-Met  inhibitor with an IC50 of 0.42 Â± 0.02 nmol/L. Glumetinib has greater than 2,400-fold selectivity for c-Met over those 312 kinases evaluated, including the c-Met family member RON and highly homologous kinases Axl, Mer, and TyrO3.","9":"459.48","10":"1642581-63-2","11":"11","12":"23.94","13":"<1","14":"NA","15":"http://www.selleck.cn/products/glumetinib.html","16":"C21H17N9O2S\\r\\n","17":"free base","18":"N/A","19":"C[N]1C=C(C=N1)C2=C[N]3C(=NC=C3[S](=O)(=O)[N]4N=CC5=NC=C(C=C45)C6=C[N](C)N=C6)C=C2","20":"1.725","21":"7","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8677","2":"Cu-CPT22","3":"g10","4":"L3500-05","5":"in 10mM DMSO","6":"TLR","7":"Immunology & Inflammation","8":"CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 Â± 0.09 ÂµM while no significant inhibition to TLR2/6. It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-Î³, CAMK1, and PLK4).","9":"362.37","10":"1416324-85-0","11":"72","12":"198.69","13":"<1","14":"NA","15":"http://selleckchem.com/products/cu-cpt22.html","16":"C19H22O7","17":"free base","18":"N/A","19":"CCCCCCOC(=O)C1=CC2=C(C(=C(O)C(=C2)OC)O)C(=O)C(=C1)O","20":"3.358","21":"4","22":"3","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8680","2":"AZD1390","3":"h10","4":"L3500-05","5":"in 10mM DMSO","6":"ATM/ATR","7":"PI3K/Akt/mTOR","8":"AZD1390 is a first-in-class orally available and CNS penetrant ATM inhibitor with an IC50 of 0.78 nM in cells and >10,000-fold selectivity over closely related members of the PIKK family of enzymes and excellent selectivity across a broad panel of kinases.","9":"477.57","10":"2089288-03-7","11":"14","12":"29.32","13":"<1","14":"NA","15":"http://selleckchem.com/products/azd1390.html","16":"C27H32FN5O2","17":"free base","18":"N/A","19":"CC(C)N1C(=O)N(C)C2=C1C3=CC(=C(F)C=C3N=C2)C4=CC=C(OCCCN5CCCCC5)N=C4","20":"4.231","21":"4","22":"0","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8684","2":"Selective JAK3 inhibitor 1","3":"a11","4":"L3500-05","5":"in 10mM DMSO","6":"JAK","7":"JAK/STAT","8":"Selective JAK3 inhibitor 1 is an irreversible <b>JAK3<\/b> inhibitor with Ki values of 0.07 nM, 320 nM, 740 nM for JAK3, JAK1 and JAK2 respectively. It is also selective over the other kinases possessing a cysteine in the same region as JAK3, such as BMX, EGFR, ITK, and BTK.","9":"350.37","10":"1443235-95-7","11":"70","12":"199.79","13":"<1","14":"NA","15":"http://www.selleck.cn/products/selective-jak3-inhibitor-1.html","16":"C19H18N4O3\\r\\n","17":"Free Base","18":"N/A","19":"CCOC(=O)C1=C[NH]C2=C1C(=NC=N2)C3=CC(=CC=C3)NC(=O)C(C)=C","20":"2.959","21":"5","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8693","2":"Selective PI3KÎ´ Inhibitor 1 (compound 7n)","3":"b11","4":"L3500-05","5":"in 10mM DMSO","6":"PI3K","7":"PI3K/Akt/mTOR","8":"Selective PI3KÎ´ Inhibitor 1 (compound 7n) is an inhibitor of <b>PI3KÎ´<\/b> with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K Î±/Î³/Î²=3670/1460/21300 nM].","9":"429.45","10":"2088525-31-7","11":"43","12":"100.13","13":"<1","14":"NA","15":"http://www.selleck.cn/products/selective-pi3k-inhibitor-1.html","16":"C23H20FN7O\\r\\n","17":"Free Base","18":"N/A","19":"C[N]1N=C(N=C1C2(CC2)C3=CC=CC=C3)C4=CN=C(N)C(=N4)C5=CC(=C(C=C5)C(N)=O)F","20":"2.957","21":"5","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8727","2":"Atuveciclib (BAY-1143572)","3":"c11","4":"L3500-05","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"Atuveciclib (BAY-1143572) is potent and highly selective <b>PTEFb/CDK9<\/b> inhibitor with <b>IC50<\/b> values of 13 nM for CDK9/CycT and the ratio of IC50 values for CDK2/CDK9 is about 100. Outside the CDK family, It inhibits GSK3 kinase with IC50 values of 45 nM and 87 nM for GSK3Î± and GSK3Î² respectively.","9":"387.43","10":"1414943-88-6","11":"77","12":"198.75","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/atuveciclib-bay-1143572.html","16":"C18H18FN5O2S","17":"Free Base","18":"N/A","19":"COC1=CC(=CC=C1C2=NC(=NC=N2)NC3=CC(=CC=C3)C[S](C)(=N)=O)F","20":"3.699","21":"5","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8741","2":"Avitinib (AC0010)","3":"d11","4":"L3500-05","5":"in 10mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Avitinib (AC0010) is a pyrrolopyrimidine-based irreversible <b>EGFR<\/b> inhibitor that is mutation-selective with IC50 value of 0.18 nM against EGFR L858R/T790M double mutations, nearly 43-fold greater potency over wild-type EGFR (IC50 value, 7.68 nM). It has comparable anti-tumor activity and tolerated toxicity.","9":"487.53","10":"1557267-42-1","11":"97","12":"198.96","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/avitinib-ac0010.html","16":"C26H26FN7O2","17":"Free Base","18":"N/A","19":"CN1CCN(CC1)C2=C(F)C=C(NC3=NC4=C(C=C[NH]4)C(=N3)OC5=CC(=CC=C5)NC(=O)C=C)C=C2","20":"4.857","21":"4","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8745","2":"LXH254","3":"e11","4":"L3500-05","5":"in 10mM DMSO","6":"Raf","7":"MAPK","8":"LXH254 is a type II ATP-competitive inhibitor that inhibits both <b>B- and CRAF kinase<\/b> activities at picomolar concentrations with a high degree of selectivity against a panel of 456 human kinases and in cell-based assays.","9":"502.49","10":"1800398-38-2","11":"100","12":"199.01","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/lxh254.html","16":"C25H25F3N4O4","17":"Free Base","18":"N/A","19":"CC1=CC=C(NC(=O)C2=CC(=NC=C2)C(F)(F)F)C=C1C3=CC(=NC(=C3)OCCO)N4CCOCC4","20":"4.061","21":"5","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8746","2":"H3B-5942","3":"f11","4":"L3500-05","5":"in 10mM DMSO","6":"Estrogen/progestogen","7":"Endocrinology & Hormones","8":"H3B-5942 is a selective and irreversible  estrogen receptor  covalent antagonist, inactivates both ERÎ± WT and ERÎ± mutation. The Ki values are 1 nM and 0.41 nM, respectively.","9":"494.63","10":"2052128-15-9","11":"99","12":"200.15","13":"<1","14":"NA","15":"http://www.selleck.cn/products/h3b-5942.html","16":"C31H34N4O2\\r\\n","17":"free base","18":"N/A","19":"CC\\\\C(C1=CC=CC=C1)=C(C2=CC=C(OCCNC\\\\C=C\\\\C(=O)N(C)C)C=C2)/C3=CC4=C([NH]N=C4)C=C3","20":"5.374","21":"3","22":"2","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8759","2":"S55746 (S 055746,BCL201)","3":"g11","4":"L3500-05","5":"in 10mM DMSO","6":"Bcl-2","7":"Apoptosis","8":"S55746 (S 055746,BCL201) is a novel, orally active <b>BCL-2<\/b> specific inhibitor (Ki = 1.3 nM) with poor affinity for BCL-XL and no significant binding to MCL-1, BFL-1 (BCL2A1/A1). The selectivity of S55746 for BCL-2 versus BCL-XL ranges from ~70 to 400 folds.","9":"710.82","10":"1448584-12-0","11":"100","12":"140.68","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/s55746-s055746-bcl201.html","16":"C43H42N4O6","17":"Free Base","18":"N/A","19":"OC1=CC=C(C=C1)N(C(=O)C2=C3CCCC[N]3C(=C2)C4=C(C=C5OCOC5=C4)C(=O)N6CC7=C(CC6CN8CCOCC8)C=CC=C7)C9=CC=CC=C9","20":"6.817","21":"5","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8776","2":"WM-1119","3":"h11","4":"L3500-05","5":"in 10mM DMSO","6":"Histone Acetyltransf","7":"Epigenetics","8":"WM-1119 is a highly potent, selective inhibitor of <b>lysine acetyltransferase KAT6A<\/b> with <b>IC50<\/b> of 0.25 Î¼M. It is 1,100-fold and 250-fold more active against KAT6A than against KAT5 or KAT7, respectively.","9":"389.38","10":"2055397-28-7","11":"78","12":"200.32","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/wm-1119.html","16":"C18H13F2N3O3S","17":"Free Base","18":"N/A","19":"FC1=CC(=CC(=C1)C(=O)NN[S](=O)(=O)C2=CC=CC=C2F)C3=NC=CC=C3","20":"2.781","21":"4","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8777","2":"Evobrutinib","3":"a2","4":"L3500-06","5":"in 10mM DMSO","6":"BTK","7":"Protein Tyrosine Kinase","8":"Evobrutinib is a highly selective <b>BTK<\/b> inhibitor with an IC50 of 37.9 nM. It has potential anti-neoplastic activity.","9":"429.51","10":"1415823-73-2","11":"86","12":"200.23","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/evobrutinib.html","16":"C25H27N5O2","17":"Free Base","18":"M-2951, MSC-2364447C","19":"NC1=C(C(=NC=N1)NCC2CCN(CC2)C(=O)C=C)C3=CC=C(OC4=CC=CC=C4)C=C3","20":"3.916","21":"4","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8787","2":"GSK'547","3":"b2","4":"L3500-06","5":"in 10mM DMSO","6":"TNF-alpha","7":"Apoptosis","8":"GSK'547 is a highly selective and potent inhibitor of <b>RIP1<\/b> exhibiting a 400-fold improvement in mouse pharmacokinetic oral exposure compared with GSK'963","9":"396.39","10":"2226735-55-1","11":"29","12":"73.16","13":"<1","14":"NA","15":"http://www.selleck.cn/products/gsk547.html","16":"C20H18F2N6O\\r\\n","17":"free base","18":"N/A","19":"FC1=CC(=CC(=C1)F)C2CC=NN2C(=O)C3CCN(CC3)C4=NC=NC(=C4)C#N","20":"2.776","21":"4","22":"0","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8791","2":"Zanubrutinib (BGB-3111)","3":"c2","4":"L3500-06","5":"in 10mM DMSO","6":"BTK","7":"Protein Tyrosine Kinase","8":"Zanubrutinib (BGB-3111) is a potent, specific and irreversible <b>BTK<\/b> inhibitor that has been shown to have a lower off-target inhibitory activity on other kinases, including ITK, JAK3 and EGFR.","9":"471.55","10":"1691249-45-2","11":"94","12":"199.34","13":"<1","14":"NA","15":"http://www.selleck.cn/products/zanubrutini-bgb-3111.html","16":"C27H29N5O3\\r\\n","17":"Free Base","18":"N/A","19":"NC(=O)C1=C2NCCC(C3CCN(CC3)C(=O)C=C)[N]2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4","20":"3.478","21":"4","22":"2","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8801","2":"CC-90003","3":"d2","4":"L3500-06","5":"in 10mM DMSO","6":"ERK","7":"MAPK","8":"CC-90003 is an irreversible inhibitor of <b>ERK1/2<\/b> with IC50s in the 10-20 nM range and shows good kinase selectivity in a 258-kinase biochemical assay.","9":"458.44","10":"1621999-82-3","11":"92","12":"200.68","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/cc-90003.html","16":"C22H21F3N6O2","17":"Free Base","18":"N/A","19":"COC1=CC(=C(C)C=N1)NC2=NC(=C(C=N2)C(F)(F)F)NC3=C(NC(=O)C=C)C=C(C)C=C3","20":"5.316","21":"5","22":"3","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8813","2":"LIT-927","3":"e2","4":"L3500-06","5":"in 10mM DMSO","6":"CXCR","7":"Immunology & Inflammation","8":"LIT-927 is a novel neutraligand of <b>CXCL12<\/b> with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.","9":"328.75","10":"2172879-52-4","11":"66","12":"200.76","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/lit-927.html","16":"C17H13ClN2O3","17":"Free Base","18":"N/A","19":"COC1=CC(=CC=C1O)C2=CC(=NC(=O)N2)C3=CC=C(Cl)C=C3","20":"3.599","21":"3","22":"2","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8822","2":"Ligandrol (LGD-4033, VK-5211)","3":"f2","4":"L3500-06","5":"in 10mM DMSO","6":"Androgen Receptor","7":"Endocrinology & Hormones","8":"Ligandrol (LGD-4033, VK-5211) is a novel nonsteroidal, oral selective <b>androgen receptor<\/b> modulator with high affinity (Ki of âˆ¼1 nM) and selectivity.","9":"338.25","10":"1165910-22-4","11":"68","12":"201.03","13":"<1","14":"NA","15":"http://www.selleck.cn/products/lgd-4033-vk-5211.html","16":"C14H12F6N2O\\r\\n","17":"Free Base","18":"N/A","19":"OC(C1CCCN1C2=CC(=C(C=C2)C#N)C(F)(F)F)C(F)(F)F","20":"3.799","21":"0","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8854","2":"JNJ-38877618(OMO-1)","3":"g2","4":"L3500-06","5":"in 10mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"JNJ-38877618 (OMO-1) is a potent, highly selective, orally bioavailable  MET kinase  inhibitor with binding affinity (Kd) of 1.4 nM and enzyme inhibitory activity against wt and M1268T mutant MET (2 and 3 nM IC50).","9":"374.35","10":"943540-74-7","11":"10","12":"26.71","13":"<1","14":"NA","15":"http://www.selleck.cn/products/jnj-38877618.html","16":"C20H12F2N6\\r\\n","17":"free base","18":"N/A","19":"FC(F)(C1=CC2=C(C=C1)N=CC=C2)C3=NN=C4C=CC(=N[N]34)C5=CC=NC=C5","20":"3.252","21":"5","22":"0","23":"3","24":"2","25":"NA","26":"1","27":"NA"},{"1":"S8864","2":"ZT-12-037-01","3":"h2","4":"L3500-06","5":"in 10mM DMSO","6":"Serine/threonin kina","7":"Apoptosis","8":"ZT-12-037-01 is a specific and ATP-competitive  STK19  inhibitor with IC50s of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N), respectively. It displays extremely high kinase selectivity using KINOMEscan against a panel of 468 diverse kinases using an in vitro ATP-site competition binding assay at 1 Î¼M.","9":"385.50","10":"2328073-61-4","11":"41","12":"106.36","13":"<1","14":"NA","15":"http://www.selleck.cn/products/zt-12-037-01.html","16":"C21H31N5O2\\r\\n","17":"free base","18":"N/A","19":"COC1=CC2=NC(=NC(=C2C=C1OC)NC3CCN(CC3)C(C)C)NC4CC4","20":"3.359","21":"4","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8872","2":"GSK8612","3":"a3","4":"L3500-06","5":"in 10mM DMSO","6":"Serine/threonin kina","7":"Apoptosis","8":"GSK8612 is a highly potent and selective inhibitor for  TBK1 (Tank-binding Kinase-1)  with pKd of 8.0. Within 10-fold affinity with respect to TBK1, no off-targets of GSK8612 could be identified.","9":"520.33","10":"2361659-62-1","11":"100","12":"192.19","13":"<1","14":"NA","15":"http://www.selleck.cn/products/gsk8612.html","16":"C17H17BrF3N7O2S\\r\\n","17":"free base","18":"N/A","19":"CC1=N[N](CC(F)(F)F)C=C1NC2=NC=C(Br)C(=N2)NCC3=CC=C(C=C3)[S](N)(=O)=O","20":"3.447","21":"5","22":"3","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9360","2":"4-Hydroxyquinazoline","3":"b3","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"antiplatelet","8":"Some 4-quinazolinone derivatives have antiplatelet activity.","9":"146.15","10":"491-36-1","11":"29","12":"198.43","13":"NA","14":"NA","15":"NA","16":"C8H6N2O","17":"free base","18":"NA","19":"O=C1NC=NC2=CC=CC=C12","20":"0.750","21":"2","22":"1","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9500","2":"Valbenazine tosylate","3":"c3","4":"L3500-06","5":"in 10mM DMSO","6":"VMAT2","7":"Others","8":"vesicular monoamine transporter 2 (VMAT2) inhibitor","9":"762.97","10":"1639208-54-0","11":"100","12":"131.07","13":"-1","14":"-1.31","15":"http://selleckchem.com/products/.html","16":"C38H54N2O10S2","17":"free base","18":"NA","19":"COC1=C(OC)C=C2C3CC(OC(=O)C(N)C(C)C)C(CC(C)C)CN3CCC2=C1.CC4=CC=C(C=C4)[S](O)(=O)=O.CC5=CC=C(C=C5)[S](O)(=O)=O","20":"7.062","21":"4","22":"1","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6558","2":"Irosustat (STX64, BN83495)","3":"d3","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"Irosustat (STX64, BN83495), a tricyclic coumarin sulfamate, is an orally active, nonsteroid-based, irreversible <b>steroid sulfatase<\/b> inhibitor with an IC50 of 8 nM.","9":"309.34","10":"288628-05-7","11":"62","12":"200.43","13":"<1","14":"NA","15":"http://www.selleck.cn/products/irosustat.html","16":"C14H15NO5S\\r\\n","17":"Free Base","18":"N/A","19":"N[S](=O)(=O)OC1=CC=C2C3=C(CCCCC3)C(=O)OC2=C1","20":"2.527","21":"3","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6622","2":"BMS309403","3":"e3","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"BMS309403 is a small-molecule <b>FABP4<\/b> inhibitor with nM affinity (Kd=4 nM for FABP4) and >100-fold selectivity against FABP5 as well as the heart isoform FABP3.","9":"474.55","10":"300657-03-8","11":"95","12":"200.19","13":"<1","14":"NA","15":"http://www.selleck.cn/products/bms309403.html","16":"C31H26N2O3\\r\\n","17":"Free Base","18":"N/A","19":"CCC1=C(C2=CC=CC=C2)C(=N[N]1C3=CC=CC=C3C4=CC=CC(=C4)OCC(O)=O)C5=CC=CC=C5","20":"7.317","21":"3","22":"0","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6638","2":"AMG-333","3":"f3","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"AMG-333 is a potent and highly selective antagonist of <b>TRPM8<\/b> with IC50 values of 13 nM and 30 nM for human TRPM8 and rat TRPM8.","9":"453.32","10":"1416799-28-4","11":"91","12":"200.74","13":"<1","14":"NA","15":"http://www.selleck.cn/products/amg-333.html","16":"C20H12F5N3O4\\r\\n","17":"Free Base","18":"N/A","19":"OC(=O)C1=CN=C(C=C1)C(=O)NC(C2=CC(=C(OC(F)(F)F)C=C2)F)C3=C(F)C=CC=N3","20":"4.843","21":"5","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6648","2":"PF-06282999","3":"g3","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"PF-06282999 is an orally bioavailable, irreversible inactivator of <b>myeloperoxidase enzyme<\/b> and is currently in clinical trials for the potential treatment of cardiovascular diseases.","9":"325.77","10":"1435467-37-0","11":"65","12":"199.53","13":"<1","14":"NA","15":"http://www.selleck.cn/products/pf-06282999.html","16":"C13H12ClN3O3S","17":"Free Base","18":"N/A","19":"COC1=C(C=C(Cl)C=C1)C2=CC(=O)NC(=S)N2CC(N)=O","20":"1.868","21":"3","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6717","2":"TCS-OX2-29","3":"h3","4":"L3500-06","5":"in 10mM DMSO","6":"OX Receptor","7":"GPCR & G Protein","8":"TCX-OX2-29 is a <b>OX2R<\/b> antagonist (pKi = 7.5) that exhibits >250-fold selectivity for hOX2R compared with hOX1R (IC50s = 40 nM and >10,000 nM, respectively).","9":"397.51","10":"372523-75-6","11":"87","12":"218.86","13":"<1","14":"NA","15":"http://www.selleck.cn/products/tcs-ox2-29.html","16":"C23H31N3O3\\r\\n","17":"Free Base","18":"N/A","19":"COC1=CC2=C(CN(CC2)C(=O)C(NCC3=CC=NC=C3)C(C)(C)C)C=C1OC","20":"2.709","21":"4","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6725","2":"PCI 29732","3":"a4","4":"L3500-06","5":"in 10mM DMSO","6":"BTK","7":"Protein Tyrosine Kinase","8":"PCI 29732 is a selective and irreversible <b>Btk<\/b> inhibitor with an IC50 of 0.5 nM.","9":"371.43","10":"330786-25-9","11":"74","12":"199.23","13":"<1","14":"NA","15":"http://www.selleck.cn/products/pci-29732.html","16":"C22H21N5O\\r\\n","17":"Free Base","18":"N/A","19":"NC1=NC=NC2=C1C(=N[N]2C3CCCC3)C4=CC=C(OC5=CC=CC=C5)C=C4","20":"4.801","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8843","2":"AZD7648","3":"b4","4":"L3500-06","5":"in 10mM DMSO","6":"DNA-PK","7":"DNA Damage","8":"AZD7648 is a potent inhibitor of <b>DNA-PK<\/b> with an IC50 of 0.6 nM in biochemical assay and more than 100-fold selective against 396 other kinases.","9":"380.40","10":"2230820-11-6","11":"6","12":"15.77","13":"<1","14":"NA","15":"http://www.selleck.cn/products/azd7648.html","16":"C18H20N8O2\\r\\n","17":"Free Base","18":"N/A","19":"CN1C(=O)N(C2CCOCC2)C3=NC(=NC=C13)NC4=C[N]5N=CN=C5C=C4C","20":"1.059","21":"6","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8862","2":"PDD00017273","3":"c4","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"PDD00017273 is a potent and selective <b>poly (ADP ribose) glycohydrolase (PARG)<\/b> inhibitor with an IC50 of 26 nM. PDD00017273 exhibits >350-fold selectivity for PARG over a panel of ion channels, enzymes and receptors, including PARP1 and ARH3.","9":"514.62","10":"1945950-21-9","11":"100","12":"194.32","13":"<1","14":"NA","15":"http://www.selleck.cn/products/pdd00017273.html","16":"C23H26N6O4S2\\r\\n","17":"Free Base","18":"N/A","19":"C[N]1N=C(C)C=C1CN2C(=O)N(CC3=CN=C(C)S3)C(=O)C4=CC(=CC=C24)[S](=O)(=O)NC5(C)CC5","20":"1.554","21":"6","22":"1","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8899","2":"FF-10101","3":"d4","4":"L3500-06","5":"in 10mM DMSO","6":"FLT3","7":"Angiogenesis","8":"FF-10101 is a novel irreversible <b>FLT3<\/b> inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively.","9":"530.66","10":"1472797-69-5","11":"100","12":"188.44","13":"<1","14":"NA","15":"http://www.selleck.cn/products/ff-10101.html","16":"C29H38N8O2\\r\\n","17":"Free Base","18":"N/A","19":"CCCNC1=NC(=NC=C1C#CCCCNC(=O)C(C)N(C)C(=O)\\\\C=C\\\\CN(C)C)NC2=CC=C(C=C2)C#N","20":"4.153","21":"4","22":"3","23":"15","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2643","2":"4-IPP","3":"e4","4":"L3500-06","5":"in 10mM DMSO","6":"Immunology & Inflammation related","7":"Immunology & Inflammation","8":"4-IPP is an irreversible inhibitor of <b>macrophage migration inhibitory factor (MIF)<\/b> and a specific suicide substrate for MIF. 4-IPP can inhibit receptor activator of NF-ÎºB ligand (RANKL)-induced osteoclastogenesis and potentiate osteoblast-mediated mineralization and bone nodule formation in vitro.","9":"282.08","10":"41270-96-6","11":"56","12":"198.53","13":"<1","14":"NA","15":"http://www.selleck.cn/products/4-ipp.html","16":"C10H7IN2\\r\\n","17":"Free Base","18":"4-Iodo-6-phenylpyrimidine","19":"IC1=CC(=NC=N1)C2=CC=CC=C2","20":"3.103","21":"2","22":"0","23":"1","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2645","2":"SIB 1757","3":"f4","4":"L3500-06","5":"in 10mM DMSO","6":"GluR","7":"Neuronal Signaling","8":"SIB 1757 is a highly selective, noncompetitive antagonist of <b>metabotropic glutamate receptor type 5 (mGluR5)<\/b> with IC50 of 0.4 Î¼M at hmGluR5 compared with >30 ÂµM at hmGluR1b, hmGluR2, hmGluR4, hmGluR6, hmGluR7 and hmGluR8.","9":"213.24","10":"31993-01-8","11":"22","12":"103.17","13":"<1","14":"NA","15":"http://www.selleck.cn/products/sib-1757.html","16":"C12H11N3O\\r\\n","17":"Free Base","18":"N/A","19":"CC1=NC(=C(O)C=C1)N=NC2=CC=CC=C2","20":"3.628","21":"3","22":"1","23":"2","24":"NA","25":"GRM5","26":"1","27":"GRM5"},{"1":"S6658","2":"ETC-206 (AUM 001)","3":"g4","4":"L3500-06","5":"in 10mM DMSO","6":"MNK","7":"MAPK","8":"ETC-206 is an orally available highly selective small-molecule <b>MNK 1/2<\/b> inhibitor with IC50s of 64 nM and 86 nM, respectively.","9":"408.45","10":"1464151-33-4","11":"82","12":"200.76","13":"<1","14":"NA","15":"http://www.selleck.cn/products/etc-206.html","16":"C25H20N4O2\\r\\n","17":"Free Base","18":"ETC-1907206","19":"O=C(N1CCOCC1)C2=CC=C(C=C2)C3=C[N]4C(=NC=C4C5=CC=C(C=C5)C#N)C=C3","20":"3.016","21":"3","22":"0","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8944","2":"G150","3":"h4","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"G150 is a potent and highly selective <b>human cyclic GMP-AMP synthase (h-cGAS)<\/b> inhibitor with IC50 of 10.2 nM.","9":"391.25","10":"2369751-30-2","11":"78","12":"199.36","13":"<1","14":"NA","15":"http://www.selleck.cn/products/g150.html","16":"C18H16Cl2N4O2\\r\\n","17":"Free Base","18":"N/A","19":"NC1=NC=C(C=C1)C2=CC(=C(Cl)C3=C2C4=C(CCN(C4)C(=O)CO)[NH]3)Cl","20":"2.353","21":"2","22":"3","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6686","2":"SC-560","3":"a5","4":"L3500-06","5":"in 10mM DMSO","6":"COX","7":"Immunology & Inflammation","8":"SC-560 is a highly selective <b>COX-1<\/b> inhibitor with IC50 of 9 nM, compared with the IC50 of 6.3 Î¼M for COX-2, nearly 1,000-fold higher than with COX-1.","9":"352.74","10":"188817-13-2","11":"70","12":"198.45","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/sc-560.html","16":"C17H12ClF3N2O\\r\\n","17":"Free Base","18":"N/A","19":"COC1=CC=C(C=C1)[N]2N=C(C=C2C3=CC=C(Cl)C=C3)C(F)(F)F","20":"5.885","21":"2","22":"0","23":"4","24":"NA","25":"PTGS1","26":"1","27":"NA"},{"1":"S8951","2":"TED-347","3":"b5","4":"L3500-06","5":"in 10mM DMSO","6":"Hippo pathway","7":"Stem Cells &  Wnt","8":"TED-347 is a potent, irreversible, covalent and allosteric inhibitor of <b>the TEADâ‹…Yap protein-protein interaction<\/b>. TED-347 inhibits TEAD4â‹…Yap1 protein-protein interaction with an apparent EC50 of 5.9 Î¼M.","9":"313.70","10":"2378626-29-8","11":"69","12":"219.96","13":"Ë‚1","14":"NA","15":"http://www.selleckchem.com/products/ted-347.html","16":"C15H11ClF3NO","17":"Free Base","18":"N/A","19":"FC(F)(F)C1=CC=CC(=C1)NC2=CC=CC=C2C(=O)CCl","20":"4.594","21":"1","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S0018","2":"Verdiperstat","3":"c5","4":"L3500-06","5":"in 10mM DMSO","6":"Peroxidases","7":"Metabolism","8":"Verdiperstat (AZD3241) is a selective, orally active and irreversible inhibitor of myeloperoxidase (MPO) with IC50 of 630 nM. Verdiperstat (AZD3241) can be used in the research of neurodegenerative brain disorders.","9":"253.32","10":"890655-80-8","11":"51","12":"201.33","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/verdiperstat.html","16":"C11H15N3O2S\\r\\n","17":"free base","18":"AZD-3241, BHV-3241","19":"CC(C)OCCN1C(=S)NC(=O)C2=C1C=C[NH]2","20":"2.270","21":"2","22":"2","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S0709","2":"Tubastatin A TFA","3":"d5","4":"L3500-06","5":"in 10mM DMSO","6":"HDAC","7":"Epigenetics","8":"Tubastatin A TFA (Tubastatin A trifluoroacetate salt) is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). Tubastatin A promotes autophagy and increases apoptosis.","9":"449.42","10":"1239262-52-2","11":"40","12":"89.00","13":"5","14":"11.13","15":"http://www.selleckchem.com/products/tubastatin-a-tfa.html","16":"C22H22F3N3O4\\r\\n","17":"trifluoroacetate","18":"Tubastatin A trifluoroacetate salt","19":"CN1CCC2=C(C1)C3=CC=CC=C3[N]2CC4=CC=C(C=C4)C(=O)NO.OC(=O)C(F)(F)F","20":"0.930","21":"2","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8574","2":"BI 894999","3":"e5","4":"L3500-06","5":"in 10mM DMSO","6":"Epigenetic Reader Domain","7":"Epigenetics","8":"BI 894999 is a potent and selective BET inhibitor with IC50 of 5 nM and 41 nM for the binding of BRD4-BD1 and BRD4-BD2 to acetylated histones, respectively. BI 894999 is highly selective for BRD2/3/4 and BRDT (Kd of 0.49-1.6â€‰nM), with at least a 200-fold selectivity vs. BRD4-BD1.","9":"429.51","10":"1660117-38-3","11":"86","12":"200.23","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/bi894999.html","16":"C25H27N5O2\\r\\n","17":"free base","18":"N/A","19":"CC([N]1C2=CC(=NC=C2N=C1C3=NN(C)C(=O)C(=C3)C)C4CCOCC4)C5=CC=CC=C5","20":"3.677","21":"5","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8783","2":"JSH-150","3":"f5","4":"L3500-06","5":"in 10mM DMSO","6":"CDK","7":"Cell Cycle","8":"JSH-150 is a highly selective and potent inhibitor of CDK9 with IC50 of 1 nM.","9":"505.08","10":"2247481-21-4","11":"100","12":"197.99","13":"100","14":"197.99","15":"http://www.selleckchem.com/products/jsh-150.html","16":"C24H33ClN6O2S\\r\\n","17":"free base","18":"N/A","19":"COCCNC1CCC(CC1)NC2=NC=C(Cl)C(=C2)C3=CSC(=N3)NCC4(CCOCC4)C#N","20":"3.162","21":"4","22":"3","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9600","2":"Orelabrutinib","3":"g5","4":"L3500-06","5":"in 10mM DMSO","6":"BTK","7":"Angiogenesis","8":"Orelabrutinib is a potent, orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK). Orelabrutinib has potential antineoplastic activity.","9":"427.49","10":"1655504-04-3","11":"86","12":"201.17","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/orelabrutinib.html","16":"C26H25N3O3\\r\\n","17":"free base","18":"ICP-022","19":"NC(=O)C1=C(N=C(C=C1)C2CCN(CC2)C(=O)C=C)C3=CC=C(OC4=CC=CC=C4)C=C3","20":"4.055","21":"4","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9694","2":"MLi-2","3":"h5","4":"L3500-06","5":"in 10mM DMSO","6":"LRRK2","7":"Autophagy","8":"MLi-2 is an orally active and highly selective inhibitor of LRRK2. MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro with IC50 of 0.76 nM, a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 with IC50 of 1.4 nM, and a radioligand competition binding assay with IC50 of 3.4 nM.","9":"379.46","10":"1627091-47-7","11":"76","12":"200.28","13":"76","14":"200.28","15":"http://www.selleckchem.com/products/mli-2.html","16":"C21H25N5O2\\r\\n","17":"free base","18":"N/A","19":"CC1CN(CC(C)O1)C2=CC(=NC=N2)C3=N[NH]C4=CC=C(OC5(C)CC5)C=C34","20":"3.892","21":"5","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S0008","2":"IRAK4-IN-1","3":"a6","4":"L3500-06","5":"in 10mM DMSO","6":"IRAK","7":"Immunology & Inflammation","8":"IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with IC50 of 7 nM.","9":"337.42","10":"1820787-94-7","11":"4","12":"11.85","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/irak4-in-1.html","16":"C19H23N5O\\r\\n","17":"Free Base","18":"Compound 23","19":"N#CC1=CC2=C(C=C1)N=CN=C2NC3CCC(CC3)N4CCOCC4","20":"2.600","21":"3","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S0050","2":"ML277","3":"b6","4":"L3500-06","5":"in 10mM DMSO","6":"Potassium Channel","7":"Transmembrane Transporters","8":"ML277 (CID-53347902) is a potent activator of KCNQ1 channels with an EC50 of 260 nM and shows >100-fold selectivity over KCNQ2 and KCNQ4.","9":"471.59","10":"1401242-74-7","11":"94","12":"199.33","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/ml277.html","16":"C23H25N3O4S2\\r\\n","17":"Free Base","18":"CID-53347902","19":"COC1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3CCCCN3[S](=O)(=O)C4=CC=C(C)C=C4","20":"4.050","21":"5","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1335","2":"VX-150","3":"c6","4":"L3500-06","5":"in 10mM DMSO","6":"Sodium Channel","7":"Transmembrane Transporters","8":"VX-150 (EOS-62073) is an orally bioavailable pro-drug that rapidly converts into its active moiety, which is a highly selective inhibitor of NaV1.8 relative to the other sodium channel subtypes (>400-fold).","9":"516.34","10":"1793080-72-4","11":"100","12":"193.67","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/vx-150.html","16":"C21H17F4N2O7P\\r\\n","17":"Free Base","18":"EOS-62073","19":"CC1=C(OC2=C(C=CC(=C2)C(F)(F)F)C(=O)NC3=CC(=O)N(CO[P](O)(O)=O)C=C3)C=CC(=C1)F","20":"2.940","21":"4","22":"1","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4462","2":"CYM-5520","3":"d6","4":"L3500-06","5":"in 10mM DMSO","6":"S1P Receptor","7":"GPCR & G Protein","8":"CYM-5520 is a highly selective sphingosine-1-phosphate receptor 2 (S1PR2) agonist with an EC50 of 0.48 ÂµM and does not activate other S1P receptors.","9":"345.39","10":"1449747-00-5","11":"69","12":"199.77","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/cym-5520.html","16":"C21H19N3O2\\r\\n","17":"Free Base","18":"N/A","19":"CC1=CC(=C(C)[N]1CC2=CC=CC=C2)C(=O)CN3C=C(C=CC3=O)C#N","20":"2.150","21":"2","22":"0","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6070","2":"CBA (TRPM4-IN-5)","3":"e6","4":"L3500-06","5":"in 10mM DMSO","6":"TRP Channel","7":"Transmembrane Transporters","8":"CBA (TRPM4-IN-5, Compound 5) is a highly selective blocker of the TRPM4 ion channel with an IC50 of 1.5Î¼M.","9":"340.16","10":"351424-20-9","11":"68","12":"199.91","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/cba-trpm4-in-1.html","16":"C15H11Cl2NO4\\r\\n","17":"Free Base","18":"Compound 5, TRPM4 inhibitor 5","19":"OC(=O)C1=C(NC(=O)COC2=CC=CC=C2Cl)C=C(Cl)C=C1","20":"3.410","21":"3","22":"1","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6389","2":"CPI-455","3":"f6","4":"L3500-06","5":"in 10mM DMSO","6":"Histone Demethylase","7":"Epigenetics","8":"CPI-455 is a specific KDM5 inhibitor with an IC50 of 10 nM for full-length KDM5A in enzymatic assays. CPI-455 shows over 200-fold selectivity for KDM5 relative to KDM2, 3, 4, 6, and 7 enzymes.\\r\\n","9":"278.31","10":"1628208-23-0","11":"56","12":"201.21","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/cpi-455.html","16":"C16H14N4O\\r\\n","17":"Free Base","18":"N/A","19":"CC(C)C1=C(NC2=C(C=N[N]2C1=O)C#N)C3=CC=CC=C3","20":"2.810","21":"2","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6943","2":"IU1-47","3":"g6","4":"L3500-06","5":"in 10mM DMSO","6":"DUB","7":"Ubiquitin","8":"IU1-47 is a potent and specific inhibitor of USP14 with an IC50 of 0.6 Î¼M. IU1-47 shows âˆ¼33-fold selectivity for USP14 over USP5 (IsoT).","9":"330.85","10":"670270-31-2","11":"8","12":"24.18","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/iu1-47.html","16":"C19H23ClN2O\\r\\n","17":"Free Base","18":"N/A","19":"CC1=CC(=C(C)[N]1C2=CC=C(Cl)C=C2)C(=O)CN3CCCCC3","20":"4.320","21":"1","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9782","2":"Sulfopin","3":"h6","4":"L3500-06","5":"in 10mM DMSO","6":"Others","7":"Others","8":"Sulfopin (PIN1-3) is a highly selective covalent inhibitor of Pin1 with a Ki of 17 nM in the FP assay. Sulfopin blocks Myc-driven tumor initiation and growth in vivo.\\r\\n","9":"281.80","10":"2451481-08-4","11":"56","12":"198.72","13":"3","14":"10.65","15":"http://www.selleckchem.com/products/sulfopin.html","16":"C11H20ClNO3S\\r\\n","17":"Free Base","18":"PIN1-3","19":"CC(C)(C)CN(C1CC[S](=O)(=O)C1)C(=O)CCl","20":"1.090","21":"3","22":"0","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S9914","2":"CITCO","3":"a7","4":"L3500-06","5":"in 10mM DMSO","6":"CAR","7":"Metabolism","8":"CITCO is a potent and selective constitutive androstane receptor (CAR) agonist with EC50 of 49&thinsp;nM. CITCO displays &gt;50-fold selectivity for CAR over PXR in the transient transfection assay.\\r\\n","9":"436.74","10":"338404-52-7","11":"87","12":"199.20","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/citco.html","16":"C19H12Cl3N3OS\\r\\n","17":"Free Base","18":"N/A","19":"ClC1=CC=C(C=C1)C2=C(\\\\C=N\\\\OCC3=CC=C(Cl)C(=C3)Cl)[N]4C=CSC4=N2","20":"6.120","21":"3","22":"0","23":"5","24":"NA","25":"NR1I3","26":"1","27":"NA"},{"1":"E0049","2":"Pizuglanstat (TAS-205)","3":"b7","4":"L3500-06","5":"in 10mM DMSO","6":"PGDS","7":"Metabolism","8":"Pizuglanstat (TAS-205) is a highly selective hematopoietic prostaglandin D synthase (HPGDS) inhibitor with an IC50 of 55.8 nM.","9":"508.61","10":"1244967-98-3","11":"100","12":"196.61","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/pizuglanstat.html","16":"Câ‚‚â‚‡Hâ‚ƒâ‚†Nâ‚†Oâ‚„\\r\\n","17":"Free Base","18":"N/A","19":"C[N]1C=CC=C1C(=O)N2CCN(CC2)C(=O)NC3=CC=C(C=C3)N4CCC(CC4)C(=O)N5CCOCC5","20":"1.360","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"E0054","2":"Tegoprazan","3":"c7","4":"L3500-06","5":"in 10mM DMSO","6":"ATPase","7":"Transmembrane Transporters","8":"Tegoprazan (CJ-12420, IN-A001, K-CAB, LXI-15028, RQ-00000004) is a novel potent and highly selective inhibitor of gastric H+/K+-ATPase with IC50s ranging from 0.29 Î¼M to 0.52 Î¼M for  porcine, canine, and human H+/K+-ATPases in vitro, respectively.","9":"387.38","10":"942195-55-3","11":"77","12":"198.77","13":"<1","14":"NA","15":"http://www.selleckchem.com/products/tegoprazan.html","16":"C20H19F2N3O3\\r\\n","17":"Free Base","18":"CJ-12420, IN-A001, K-CAB, LXI-15028, RQ-00000004","19":"CN(C)C(=O)C1=CC2=C(N=C(C)[NH]2)C(=C1)OC3CCOC4=C3C(=CC(=C4)F)F","20":"2.890","21":"4","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"E0122","2":"Gemigliptin","3":"d7","4":"L3500-06","5":"in 10mM DMSO","6":"DPP-4","7":"Proteases","8":"Gemigliptin (Zemiglo, LC15-0444) is a potent, selective and long-acting dipeptidyl peptidase 4 (DPP 4) inhibitor with a Ki of 7.25 nM. Gemigliptin shows at least &gt;23,000-fold selectivity for DPP-4 over various proteases and peptidases, including DPP-8, DPP-9, and fibroblast activation protein (FAP)-&alpha;.\\r\\n","9":"489.36","10":"911637-19-9","11":"98","12":"200.26","13":"12","14":"24.52","15":"http://www.selleckchem.com/products/gemigliptin.html","16":"C18H19F8N5O2\\r\\n","17":"Free Base","18":"Zemiglo, LC15-0444","19":"NC(CN1CC(F)(F)CCC1=O)CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F","20":"1.290","21":"4","22":"1","23":"6","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1116","2":"Palbociclib (PD-0332991) HCl","3":"a2","4":"L3500-07","5":"in 10mM Water","6":"CDK","7":"Cell Cycle","8":"Palbociclib (PD-0332991) HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays, respectively. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 3.","9":"483.99","10":"827022-32-2","11":"3","12":"6.20","13":"30","14":"61.98","15":"http://selleckchem.com/products/PD-0332991.html","16":"C24H30ClN7O2","17":"Hydrochloride","18":"N/A","19":"Cl.CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2N(C5CCCC5)C1=O","20":"3.183","21":"5","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1579","2":"Palbociclib (PD0332991) Isethionate","3":"b2","4":"L3500-07","5":"in 10mM Water","6":"CDK","7":"Cell Cycle","8":"Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 3.","9":"573.66","10":"827022-33-3","11":"<1","12":"NA","13":"10","14":"17.43","15":"http://selleckchem.com/products/pd-0332991-palbociclib-isethionate.html","16":"C26H35N7O6S","17":"Isethionate","18":"N/A","19":"CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N4CCNCC4)N=C2N(C5CCCC5)C1=O.OCC[S](O)(=O)=O","20":"1.847","21":"5","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S4013","2":"Sodium Monofluorophosphate","3":"c2","4":"L3500-07","5":"in 10mM Water","6":"phosphatase","7":"Others","8":"Sodium Monofluorophosphateis a competitive inhibitor of pyruvate kinase and alkaline phosphatase with Ki of 3.4 mM and 69 Î¼M, respectively, which also irreversibly inhibits phosphorylase phosphatase with Ki of 0.5 mM.","9":"143.95","10":"10163-15-2","11":"<1","12":"NA","13":"29","14":"201.46","15":"http://selleckchem.com/products/sodium-monofluorophosphate.html","16":"FNa2O3P","17":"Disodium salt","18":"NSC248","19":"[Na+].[Na+].[O-][P]([O-])(F)=O","20":"-2.357","21":"0","22":"0","23":"0","24":"NA","25":"PYGM","26":"1","27":"NA"},{"1":"S4582","2":"Eflornithine hydrochloride hydrate","3":"d2","4":"L3500-07","5":"in 10mM Water","6":"Decarboxylase","7":"Metabolism","8":"Eflornithine(Difluoromethylornithine) inhibits polyamine biosynthesis by the selective, irreversible inhibition of ornithine decarboxylase (ODC). A chemoprotective agent that blocks angiogenesis. Its biological half-life is 8 hours.","9":"236.64","10":"96020-91-6","11":"<1","12":"NA","13":"47","14":"198.61","15":"http://selleckchem.com/products/eflornithine-hydrochloride-hydrate.html","16":"C6H15ClF2N2O3","17":"hydrochloride hydrate","18":"Difluoromethylornithine hydrochloride hydrate","19":"O.Cl.NCCCC(N)(C(F)F)C(O)=O","20":"-3.046","21":"1","22":"2","23":"5","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7507","2":"LDN-193189 2HCl","3":"e2","4":"L3500-07","5":"in 10mM Water","6":"TGF-beta/Smad","7":"TGF-beta/Smad","8":"LDN193189 HCl is the hydrochloride salt of LDN193189, which is a selective BMP signaling inhibitor, and inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM in C2C12 cell lines, respectively, 200-fold selectivity for BMP versus TGF-Î².","9":"479.40","10":"1435934-00-1","11":"<1","12":"NA","13":"52","14":"108.47","15":"http://selleckchem.com/products/ldn-193189-2hcl.html","16":"C25H23ClN6","17":"Hydrochloride","18":"N/A","19":"Cl.C1CN(CCN1)C2=CC=C(C=C2)C3=C[N]4N=CC(=C4N=C3)C5=CC=NC6=C5C=CC=C6","20":"3.291","21":"3","22":"1","23":"3","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7809","2":"MCC950(CP-456773)","3":"f2","4":"L3500-07","5":"in 10mM Water","6":"Immunology & Inflammation related","7":"Immunology & Inflammation","8":"MCC950 sodium salt is a potent, selective inhibitor of NLRP3 with IC50 of 7.5 nM in BMDMs but not the AIM2, NLRC4 or NLRP1 inflammasomes.","9":"426.46","10":"256373-96-3","11":"<1","12":"NA","13":"85","14":"199.32","15":"http://selleckchem.com/products/mcc950-sodium-salt.html","16":"C20H23N2NaO5S","17":"free base","18":"CP-456773","19":"CC(C)(O)C1=COC(=C1)[S](=O)(=O)N([Na])C(=O)NC2=C3CCCC3=CC4=C2CCC4","20":"3.521","21":"4","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8651","2":"bpV (HOpic)","3":"g2","4":"L3500-07","5":"in 10mM Water","6":"PTEN","7":"Others","8":"bpV (HOpic) is a potent inhibitor of PTEN with an IC50 of 14 nM. The IC50s for PTP-Î² and PTP-1B are about 350- and 1800-fold higher than the IC50 for PTEN, respectively.","9":"347.24","10":"722494-26-0","11":"<1","12":"NA","13":"69","14":"198.71","15":"http://selleckchem.com/products/bpv-hopic.html","16":"C6H4K2NO8V","17":"potassium","18":"Bisperoxovanadium(HOpic)","19":"[K+].[K+].OC1=CC=C2N(=C1)|[V+3]|3|4(|[O-][O-]|3)(|[O-][O-]|4)(|[O-]C2=O)=O","20":"-1.876","21":"0","22":"1","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1023","2":"Erlotinib HCl (OSI-744)","3":"a2","4":"L3500-08","5":"in 2mM DMSO","6":"Autophagy,EGFR","7":"Protein Tyrosine Kinase","8":"Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM in cell-free assays, >1000-fold more sensitive for EGFR than human c-Src or v-Abl.","9":"429.90","10":"183319-69-9","11":"4","12":"9.30","13":"<1","14":"NA","15":"http://selleckchem.com/products/Erlotinib-Hydrochloride.html","16":"C22H24ClN3O4","17":"Hydrochloride","18":"(CP358774, NSC 718781) HCl","19":"Cl.COCCOC1=C(OCCOC)C=C2C(=NC=NC2=C1)NC3=CC=CC(=C3)C#C","20":"4.691","21":"6","22":"1","23":"10","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1108","2":"TAE684 (NVP-TAE684)","3":"b2","4":"L3500-08","5":"in 2mM DMSO","6":"ALK","7":"Protein Tyrosine Kinase","8":"TAE684 (NVP-TAE684) is a potent and selective ALK inhibitor with IC50 of 3 nM in a cell-free assay, 100-fold more sensitive for ALK than InsR.","9":"614.20","10":"761439-42-3","11":"3","12":"4.88","13":"<1","14":"NA","15":"http://selleckchem.com/products/NVP-TAE684.html","16":"C30H40ClN7O3S","17":"Free Base","18":"N/A","19":"COC1=C(NC2=NC=C(Cl)C(=N2)NC3=C(C=CC=C3)[S](=O)(=O)C(C)C)C=CC(=C1)N4CCC(CC4)N5CCN(C)CC5","20":"5.342","21":"5","22":"2","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S1112","2":"SGX-523","3":"c2","4":"L3500-08","5":"in 2mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"SGX-523 is a selective Met inhibitor with IC50 of 4 nM, no activity to BRAFV599E, c-Raf, Abl and p38Î±. Phase 1.","9":"359.41","10":"1022150-57-7","11":"3","12":"8.35","13":"<1","14":"NA","15":"http://selleckchem.com/products/SGX-523.html","16":"C18H13N7S","17":"free base","18":"N/A","19":"C[N]1C=C(C=N1)C2=N[N]3C(=NN=C3C=C2)SC4=CC=C5N=CC=CC5=C4","20":"3.580","21":"5","22":"0","23":"3","24":"NA","25":"MET","26":"1","27":"NA"},{"1":"S2150","2":"Neratinib (HKI-272)","3":"d2","4":"L3500-08","5":"in 2mM DMSO","6":"EGFR,HER2","7":"Protein Tyrosine Kinase","8":"Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM in cell-free assays weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.","9":"557.04","10":"698387-09-6","11":"5","12":"8.98","13":"<1","14":"NA","15":"http://selleckchem.com/products/Neratinib(HKI-272).html","16":"C30H29ClN6O3","17":"free base","18":"N/A","19":"CCOC1=C(NC(=O)\\\\C=C\\\\CN(C)C)C=C2C(=C1)N=CC(=C2NC3=CC=C(OCC4=NC=CC=C4)C(=C3)Cl)C#N","20":"4.881","21":"5","22":"2","23":"11","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2251","2":"(-)-Huperzine A (HupA)","3":"e2","4":"L3500-08","5":"in 2mM DMSO","6":"GluR,AChR","7":"Neuronal Signaling","8":"(-)-Huperzine A is a potent, highly specific and reversible inhibitor of acetylcholinesterase (AChE) with Ki of 7 nM, exhibiting 200-fold more selectivity for G4 AChE over G1 AChE. Also acts as an NMDA receptor antagonist. Phase 4.","9":"242.32","10":"102518-79-6","11":"0.66","12":"2.72","13":"<1","14":"NA","15":"http://selleckchem.com/products/(-)-Huperzine-A.html","16":"C15H18N2O","17":"Free Base","18":"N/A","19":"C\\\\C=C/1C2CC3=C(C=CC(=O)N3)C1(N)CC(=C2)C","20":"1.056","21":"1","22":"2","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2684","2":"CX-5461","3":"f2","4":"L3500-08","5":"in 2mM DMSO","6":"DNA/RNA Synthesis","7":"DNA Damage","8":"CX-5461 is an inhibitor of <b>rRNA synthesis<\/b>, selectively inhibits Pol I-driven transcription of rRNA with <b>IC50<\/b> of 142 nM in HCT-116, A375, and MIA PaCa-2 cells, has no effect on Pol II, and possesses 250- to 300-fold selectivity for inhibition of rRNA transcription versus DNA replication and protein translation.","9":"513.61","10":"1138549-36-6","11":"2","12":"3.89","13":"<1","14":"NA","15":"http://www.selleck.cn/products/cx-5461.html","16":"C27H27N7O2S","17":"Free Base","18":"N/A","19":"CN1CCCN(CC1)C2=CC=C3C(=O)C(=C4SC5=C(C=CC=C5)N4C3=N2)C(=O)NCC6=CN=C(C)C=N6","20":"3.188","21":"5","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2735","2":"MK-8776 (SCH 900776)","3":"g2","4":"L3500-08","5":"in 2mM DMSO","6":"CDK,Chk","7":"Cell Cycle","8":"MK-8776 (SCH 900776) is a selective Chk1 inhibitor with IC50 of 3 nM in a cell-free assay. It shows 500-fold selectivity against Chk2. Phase 2.","9":"376.25","10":"891494-63-6","11":"3","12":"7.97","13":"<1","14":"NA","15":"http://selleckchem.com/products/sch-900776.html","16":"C15H18BrN7","17":"Free Base","18":"N/A","19":"C[N]1C=C(C=N1)C2=C3N=C(C4CCCNC4)C(=C(N)[N]3N=C2)Br","20":"1.320","21":"3","22":"2","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2744","2":"CCT137690","3":"h2","4":"L3500-08","5":"in 2mM DMSO","6":"Aurora Kinase","7":"Cell Cycle","8":"CCT137690 is a highly selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 15 nM, 25 nM and 19 nM. It has little effect on hERG ion-channel.","9":"551.48","10":"1095382-05-0","11":"4","12":"7.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/cct137690.html","16":"C26H31BrN8O","17":"Free Base","18":"N/A","19":"CN1CCN(CC1)C2=CC=C(C=C2)C3=NC4=C(N5CCN(CC5)CC6=NOC(=C6)C)C(=CN=C4[NH]3)Br","20":"3.704","21":"4","22":"1","23":"5","24":"NA","25":"AURKA, AURKB, AURKC","26":"3","27":"AURKC"},{"1":"S2788","2":"Capmatinib (INCB28060)","3":"a3","4":"L3500-08","5":"in 2mM DMSO","6":"c-Met","7":"Protein Tyrosine Kinase","8":"Capmatinib (INCB28060) is a novel, ATP-competitive inhibitor of c-MET with IC50 of 0.13 nM in a cell-free assay, inactive against RONÎ², as well as EGFR and HER-3. Phase 1.","9":"412.42","10":"1029712-80-8","11":"2","12":"4.85","13":"<1","14":"NA","15":"http://selleckchem.com/products/incb28060.html","16":"C23H17FN6O","17":"Free Base","18":"INC280, NVP-INC280","19":"CNC(=O)C1=CC=C(C=C1F)C2=N[N]3C(=CN=C3N=C2)CC4=CC=C5N=CC=CC5=C4","20":"3.246","21":"5","22":"1","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S2827","2":"Torin 1","3":"b3","4":"L3500-08","5":"in 2mM DMSO","6":"Autophagy,mTOR","7":"PI3K/Akt/mTOR","8":"Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays exhibits 1000-fold selectivity for mTOR than PI3K.","9":"607.62","10":"1222998-36-8","11":"2","12":"3.29","13":"<1","14":"NA","15":"http://selleckchem.com/products/torin-1.html","16":"C35H28F3N5O2","17":"Free Base","18":"N/A","19":"CCC(=O)N1CCN(CC1)C2=CC=C(C=C2C(F)(F)F)N3C(=O)C=CC4=C3C5=CC(=CC=C5N=C4)C6=CC7=CC=CC=C7N=C6","20":"5.914","21":"4","22":"0","23":"5","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S6001","2":"pomaglumetad (LY404039)","3":"c3","4":"L3500-08","5":"in 2mM DMSO","6":"GluR","7":"Neuronal Signaling","8":"LY404039 is a potent agonist of recombinant human mGlu2/mGlu3 receptors with Ki of 149 nM/92 nM, shows >100-fold selectivity over ionotropic glutamate receptors, glutamate transporters, and other receptors. Phase 3.","9":"235.22","10":"635318-11-5","11":"1","12":"4.25","13":"<1","14":"NA","15":"http://selleckchem.com/products/LY2140023(LY404039).html","16":"C7H9NO6S","17":"Free Base","18":"N/A","19":"NC1(C[S](=O)(=O)C2C(C12)C(O)=O)C(O)=O","20":"-4.682","21":"4","22":"1","23":"2","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S6642","2":"Branaplam (LMI070)","3":"d3","4":"L3500-08","5":"in 2mM DMSO","6":"Others","7":"Others","8":"Branaplam (LMI070) is a highly selective, small-molecule splicing modulators of <b>survival motor neuronâ€‘2 (SMN2)<\/b> with an EC50 of 0.02 Î¼M.","9":"393.48","10":"1562338-42-4","11":"3","12":"7.62","13":"<1","14":"NA","15":"http://www.selleck.cn/products/branaplam-lmi070.html","16":"C22H27N5O2","17":"Free Base","18":"N/A","19":"CC1(C)CC(CC(C)(C)N1)OC2=NN=C(C=C2)C3=C(O)C=C(C=C3)C4=C[NH]N=C4","20":"3.141","21":"4","22":"3","23":"4","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7004","2":"EPZ005687","3":"e3","4":"L3500-08","5":"in 2mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM in a cell-free assay, 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.","9":"539.67","10":"1396772-26-1","11":"2","12":"3.71","13":"<1","14":"NA","15":"http://selleckchem.com/products/epz005687.html","16":"C32H37N5O3","17":"Free Base","18":"N/A","19":"CC1=CC(=C(CNC(=O)C2=CC(=CC3=C2C=N[N]3C4CCCC4)C5=CC=C(CN6CCOCC6)C=C5)C(=O)N1)C","20":"3.919","21":"4","22":"2","23":"7","24":"NA","25":"EZH2","26":"1","27":"NA"},{"1":"S7035","2":"XL388","3":"f3","4":"L3500-08","5":"in 2mM DMSO","6":"mTOR","7":"PI3K/Akt/mTOR","8":"XL388 is a highly potent, selective, ATP-competitive inhibitor ofmTOR with IC50 of 9.9 nM, 1000-fold selectivity over the closely related PI3K kinases.","9":"455.50","10":"1251156-08-7","11":"1.25","12":"2.74","13":"<1","14":"NA","15":"http://selleckchem.com/products/xl388.html","16":"C23H22FN3O4S","17":"free base","18":"N/A","19":"CC1=C(F)C(=CC=C1C(=O)N2CCOC3=CC=C(C=C3C2)C4=CN=C(N)C=C4)[S](C)(=O)=O","20":"3.007","21":"5","22":"1","23":"3","24":"NA","25":"MTOR","26":"1","27":"MTOR"},{"1":"S7061","2":"GSK126","3":"g3","4":"L3500-08","5":"in 2mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 of 9.9 nM, >1000-fold selective for EZH2 over 20 other human methyltransferases.","9":"526.67","10":"1346574-57-9","11":"3","12":"5.70","13":"<1","14":"NA","15":"http://selleckchem.com/products/gsk126.html","16":"C31H38N6O2","17":"Free Base","18":"N/A","19":"CCC(C)[N]1C=C(C)C2=C(C=C(C=C12)C3=CC=C(N=C3)N4CCNCC4)C(=O)NCC5=C(C)C=C(C)NC5=O","20":"4.114","21":"3","22":"3","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7128","2":"Tazemetostat (EPZ-6438)","3":"h3","4":"L3500-08","5":"in 2mM DMSO","6":"Histone Methyltransferase","7":"Epigenetics","8":"Tazemetostat (EPZ-6438) is a potent, and selective EZH2 inhibitor with Ki and IC50 of 2.5 nM and 11 nM in cell-free assays, exhibiting a 35-fold selectivity versus EZH1 and >4,500-fold selectivity relative to 14 other HMTs.","9":"572.74","10":"1403254-99-8","11":"5","12":"8.73","13":"<1","14":"NA","15":"http://selleckchem.com/products/epz-6438.html","16":"C34H44N4O4","17":"free base","18":"E7438","19":"CCN(C1CCOCC1)C2=C(C)C(=CC(=C2)C3=CC=C(CN4CCOCC4)C=C3)C(=O)NCC5=C(C)C=C(C)NC5=O","20":"3.506","21":"4","22":"2","23":"9","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7164","2":"GSK343","3":"a4","4":"L3500-08","5":"in 2mM DMSO","6":"Histone Methyltransf","7":"Epigenetics","8":"GSK343 is a potent and selective <b>EZH2<\/b> inhibitor with <b>IC50<\/b> of 4 nM in a cell-free assay, showing 60 fold selectivity against EZH1, and >1000 fold selectivity against other histone methyltransferases.","9":"541.69","10":"1346704-33-3","11":"2","12":"3.69","13":"<1","14":"NA","15":"http://www.selleck.cn/products/gsk343.html","16":"C31H39N7O2","17":"Free Base","18":"N/A","19":"CCCC1=C(CNC(=O)C2=CC(=CC3=C2C=N[N]3C(C)C)C4=CC(=NC=C4)N5CCN(C)CC5)C(=O)NC(=C1)C","20":"3.902","21":"4","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7400","2":"ISRIB (trans-isomer)","3":"b4","4":"L3500-08","5":"in 2mM DMSO","6":"PERK","7":"Apoptosis","8":"ISRIB (trans-isomer), the trans-isomer of ISRIB, is a potent and selective PERK inhibitor with IC50 of 5 nM and does not have global effects on translation, transcription, or mRNA stability in non-stressed cells.","9":"451.34","10":"1597403-47-8","11":"4","12":"8.86","13":"<1","14":"NA","15":"http://selleckchem.com/products/isrib-trans-isomer.html","16":"C22H24Cl2N2O4","17":"Free Base","18":"N/A","19":"ClC1=CC=C(OCC(=O)NC2CCC(CC2)NC(=O)COC3=CC=C(Cl)C=C3)C=C1","20":"4.055","21":"4","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7790","2":"A-1210477","3":"c4","4":"L3500-08","5":"in 2mM DMSO","6":"Bcl-2","7":"Apoptosis","8":"A-1210477 is a potent and selective MCL-1 inhibitor with Ki and IC50 of 0.454 nM and 26.2 nM, respectively, >100-fold selectivity over other Bcl-2 family members.","9":"850.04","10":"1668553-26-1","11":"3","12":"3.53","13":"<1","14":"NA","15":"http://selleckchem.com/products/a-1210477.html","16":"C46H55N7O7S","17":"Free Base","18":"N/A","19":"CN(C)[S](=O)(=O)N1CCN(CC1)C2=CC=C(OCC3=C(C(=N[N]3C)C)C4=C5[N](CCN6CCOCC6)C(=C(CCCOC7=C8C=CC=CC8=CC=C7)C5=CC=C4)C(O)=O)C=C2","20":"3.151","21":"7","22":"0","23":"16","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S7819","2":"BLU9931","3":"d4","4":"L3500-08","5":"in 2mM DMSO","6":"FGFR","7":"Angiogenesis","8":"BLU9931 is a potent, selective, and irreversible FGFR4 inhibitor with IC50 of 3 nM, about 297-, 184-, and 50-fold selectivity over FGFR1/2/3, respectively.","9":"509.38","10":"1538604-68-0","11":"4","12":"7.85","13":"<1","14":"NA","15":"http://selleckchem.com/products/blu9931.html","16":"C26H22Cl2N4O3","17":"Free Base","18":"N/A","19":"COC1=CC(=C(Cl)C(=C1Cl)C2=CC3=CN=C(NC4=C(NC(=O)C=C)C=CC=C4C)N=C3C=C2)OC","20":"6.577","21":"5","22":"2","23":"7","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8012","2":"Otenabant (CP-945598) HCl","3":"e4","4":"L3500-08","5":"in 2mM DMSO","6":"Cannabinoid Receptor","7":"GPCR & G Protein","8":"Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. Phase 1.","9":"546.88","10":"686347-12-6","11":"5","12":"9.14","13":"<1","14":"NA","15":"http://selleckchem.com/products/cp-945598-hcl.html","16":"C25H26Cl3N7O","17":"Hydrochloride","18":"Otenabant","19":"Cl.CCNC1(CCN(CC1)C2=NC=NC3=C2N=C([N]3C4=CC=C(Cl)C=C4)C5=CC=CC=C5Cl)C(N)=O","20":"0.000","21":"0","22":"0","23":"0","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8548","2":"FGF401","3":"f4","4":"L3500-08","5":"in 2mM DMSO","6":"FGFR","7":"Protein Tyrosine Kinase","8":"FGF401 is an FGFR4-selective inhibitor with an IC50 of 1.1 nM. It binds in a reversible covalent manner to the FGFR4 kinase domain and shows at least 1,000 fold selectivity against of panel of 65 kinases in biochemical assays.","9":"506.56","10":"1708971-55-4","11":"5","12":"9.87","13":"<1","14":"NA","15":"http://selleckchem.com/products/fgf401.html","16":"C25H30N8O4","17":"free base","18":"N/A","19":"COCCNC1=C(C=NC(=C1)NC(=O)N2CCCC3=C2N=C(C=O)C(=C3)CN4CCN(C)CC4=O)C#N","20":"0.939","21":"6","22":"2","23":"8","24":"NA","25":"NA","26":"1","27":"NA"},{"1":"S8724","2":"Lazertinib (YH25448,GNS-1480)","3":"g4","4":"L3500-08","5":"in 2mM DMSO","6":"EGFR","7":"Protein Tyrosine Kinase","8":"Lazertinib (YH25448,GNS-1480) is a potent, highly mutant-selective and irreversible EGFR-TKI with IC50 values of 1.7 nM, 2 nM, 5 nM, 20.6 nM and 76 nM for Del19/T790M, L858R/T790M, Del19, L85R and Wild type EGFR respectively, showing much higher IC50 values aganist ErbB2 and ErbB4.","9":"554.64","10":"1903008-80-9","11":"4","12":"7.21","13":"<1","14":"NA","15":"http://selleckchem.com/products/lazertinib-yh25448-gns-1480.html","16":"C30H34N8O3","17":"free base","18":"N/A","19":"COC1=CC(=C(NC(=O)C=C)C=C1NC2=NC=CC(=N2)[N]3C=C(CN(C)C)C(=N3)C4=CC=CC=C4)N5CCOCC5","20":"4.560","21":"6","22":"2","23":"10","24":"1","25":"NA","26":"1","27":"NA"}],"options":{"columns":{"min":{},"max":[10],"total":[27]},"rows":{"min":[10],"max":[10],"total":[474]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>seedNumber=1; numberOfTargets_Thr=30
cond1=highly_selective_inhibitor$count_target&lt;numberOfTargets_Thr
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(highly_selective_inhibitor$known_target_single)[which(cond1)],
  Chemical.Name=as.character(highly_selective_inhibitor$Name)[which(cond1)]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c(&#39;Negative&#39;, &#39;Positive&#39;))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match_stripall(Complete_Set$Chemical.Name, onTarget$drugCategory$name)]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset8=data.frame(Complete_Set, Source=&#39;oncoKB approved&#39;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->

<div id="rmd-source-code">---
title: "Preprocess and Curate the 11 Gold-Standard Datasets; Also give DeepTarget's Score for each hit"
output: html_notebook
---

<!-- Here, we will Curate and preprocess 11 gold-standard datasets -->
<!-- Validation of Step 1: Primary target identification -->
<!-- Set the working Directory -->
```{r, setup, include=FALSE}
working_directory='/Users/sinhas8/Project_TrueTarget/'
knitr::opts_knit$set(root.dir = working_directory)
```

<!-- Uncomment this chunk to run this script independently -->
```{r}
# knitr::knit('Step0B_Data_and_Libraries.Rmd')
# knitr::knit('Step0_Write_Functions.Rmd')
```

<!-- Dataset 1: Drug-Target pairs with multiple independent reports (>3) as per BioGrid (Biogrid Highly Cited, N=28).We Curate this from BioGrid Chemical Interaction database. -->
```{r echo = F, results = 'hide', message=FALSE, warning=FALSE}
set.seed(1)
biogrid=read.csv('Data/BIOGRID-CHEMICALS-3.5.182.chemtab.txt',sep='\t')
KnownTarget_predictions$drugName_stripall=stripall2match(KnownTarget_predictions$drugName)
biogrid$Chemical.Name_stripall = stripall2match(biogrid$Chemical.Name)
biogrid_matched=biogrid[!is.na(match(biogrid$Chemical.Name_stripall,
                         KnownTarget_predictions$drugName_stripall)),]
# Available small molecules
small_molecules_available=unique(biogrid_matched$Chemical.Name_stripall)
KnownTarget_predictions_matched=KnownTarget_predictions[
  !is.na(match(KnownTarget_predictions$drugName_stripall,
         small_molecules_available )),]
biogrid_matched$Chemical.Name= factor(as.character(biogrid_matched$Chemical.Name))
biogrid_matched_Subsetlist=split(biogrid_matched[,c('Official.Symbol', 'Chemical.Name',
                                                    'Interaction.Type', 'Action')],
                                 biogrid_matched$Chemical.Name)
biogrid_matched_Subsetlist_reformat=lapply(biogrid_matched_Subsetlist, function(x)
  dcast(x, Official.Symbol + Chemical.Name + Action ~  Interaction.Type))
biogrid_matched_Subsetlist_withScore=do.call(rbind, biogrid_matched_Subsetlist_reformat)
colnames(biogrid_matched_Subsetlist_withScore)[4]='Score'
biogrid_matched_Subsetlist_withScore$Score=as.numeric(biogrid_matched_Subsetlist_withScore$Score)
biogrid_matched_Subsetlist_withScore$Score[is.na(biogrid_matched_Subsetlist_withScore$Score)]=1
biogrid_matched_Subsetlist_withScore=biogrid_matched_Subsetlist_withScore[
  order(biogrid_matched_Subsetlist_withScore$Score, decreasing = T),]

biogrid_matched_Subsetlist_withScore$Chemical.Name_stripall=stripall2match(biogrid_matched_Subsetlist_withScore$Chemical.Name)
DrugBankScore_vsOurScore=data.frame(biogrid_matched_Subsetlist_withScore, 
                                    KnownTarget_predictions_matched[match(
                                      biogrid_matched_Subsetlist_withScore$Chemical.Name_stripall,
                                      KnownTarget_predictions_matched$drugName_stripall),])
onTarget$drugCategory$name_stripall=stripall2match(onTarget$drugCategory$name)

DrugBankScore_vsOurScore$drugCategory=onTarget$drugCategory$drug_category[
  match(DrugBankScore_vsOurScore$drugName_stripall,
        onTarget$drugCategory$name_stripall
        )]

colnames(DrugBankScore_vsOurScore)[c(1)]='Drugbank_Gene'
colnames(DrugBankScore_vsOurScore)[c(4)]='Citations_Count'

df2plot=as.data.frame(DrugBankScore_vsOurScore)

df2plot$KnownTarget=onTarget$drugCategory$target[
  match(df2plot$drugName_stripall,
        onTarget$drugCategory$name_stripall
        )]
df2plot$Count_KnownTarget=sapply(df2plot$KnownTarget,
                                 function(x) length(strsplit(as.character(x), '\\,')[[1]])) 
# Seed for creating shuffled Negative labels
seedNumber=1

#Filtering Criteria and conditions; 
Citations_Count_thr=4;  Count_KnownTarget_thr=3
cond1 = df2plot$Action %in% c('inhibitor', 'inhibitor, competitive',
                              'antagonist', 'negative modulator')
cond2 = df2plot$drugCategory %in% 'targeted cancer'
cond3=df2plot$Citations_Count>Citations_Count_thr
cond4=df2plot$Count_KnownTarget<Count_KnownTarget_thr
sum(cond1 & cond2 & cond3 & cond4)
drugs_forPR_try1=df2plot[cond1 & cond2 & cond3 & cond4,]
Positive_Set_DrugGene_Pairs=drugs_forPR_try1[,1:2]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[
    as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Gold_Standard_Dataset1=data.frame(Complete_Set, Source='Biogrid Highly Cited')
```
<!-- Dataset 2: Drug-Target pairs, where drugs are inhibitors & target have a pharmacologically active status from DrugBank-->
```{r}
load('Data/drugs2targets.RData')
numberOfTargets=table(drugs2targets$drug.name)
drugs2targets$numberOfTargets=numberOfTargets[match(drugs2targets$drug.name, names(numberOfTargets))]
active_drugs2targets=drugs2targets[which(drugs2targets$pharmaco.active=='yes' & 
                                           drugs2targets$action.simp.strict=='inhibition'),]
numberOfActiveTargets=table(as.character(active_drugs2targets$drug.name))
active_drugs2targets$numberOfActiveTargets=numberOfActiveTargets[match(active_drugs2targets$drug.name, names(numberOfActiveTargets))]
matched_gs3=active_drugs2targets[stripall2match(active_drugs2targets$drug.name) %in%
                                    KnownTarget_predictions$drugName_stripall,]
matched_gs3=na.omit(matched_gs3)
# Seed for creating shuffled Negative labels
seedNumber=1
#Filtering Criteria and conditions;
numberOfActiveTargets_Thr=2;numberOfTargets_Thr=2; drug_type='inhibitor'
cond1=matched_gs3$numberOfActiveTargets<numberOfActiveTargets_Thr
cond2=matched_gs3$numberOfTargets<numberOfTargets_Thr
cond3=matched_gs3$action==drug_type
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=matched_gs3$protein.gene.symbol[cond1 & cond2 & cond3], 
                                               Chemical.Name=matched_gs3$drug.name[cond1 & cond2 & cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)

Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))

Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset2=data.frame(Complete_Set, Source='DrugBank Active Inhibitors')
```
<!-- Dataset 3: Repeating the above but focusing on Antagonists instead of Inhibitors-->
```{r}
seedNumber=1
#Filtering Criteria and conditions;
numberOfActiveTargets_Thr=2;numberOfTargets_Thr=3; drug_type='antagonist'
cond1=matched_gs3$numberOfActiveTargets<numberOfActiveTargets_Thr
cond2=matched_gs3$numberOfTargets<numberOfTargets_Thr
cond3=matched_gs3$action==drug_type
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=matched_gs3$protein.gene.symbol[cond1 & cond2 & cond3], 
                                               Chemical.Name=matched_gs3$drug.name[cond1 & cond2 & cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)

Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))

Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset3=data.frame(Complete_Set, Source='DrugBank Active antagonists')
```
<!-- Dataset 4: Drug-Target pairs from ChemicalProbes.org Scientific Advisory Board recommendation score   -->
<!-- Note: if we increase our stringency, our prediction power increases -->
```{r}
sab_score=readxl::read_xlsx('Data/SAB_Score_chemical_Probes.xlsx')
sab_score$`Probe Name`=tolower(sab_score$`Probe Name`)
sab_score[grep('EGFR',sab_score$`Protein target`),]
sab_score_matched=sab_score[!is.na(match(stripall2match(sab_score$`Probe Name`),
                                         KnownTarget_predictions$drugName_stripall )),]
sab_score_matched$CountTargets=sapply(sab_score_matched$`Protein target`,
                                      function(x) length(strsplit(x, ', ')[[1]]))
sab_score_matched_trimmed=data.frame(ProbeName=rep(sab_score_matched$`Probe Name`, sab_score_matched$CountTargets),
                                     Targets=unlist(sapply(sab_score_matched$`Protein target`, function(x) strsplit(x, ', ')[[1]])))
sab_score_matched_trimmed$Targets=as.character(sab_score_matched_trimmed$Targets)
sab_score_matched_trimmed$Targets[grep('BRAF',sab_score_matched_trimmed$Targets)]='BRAF'
CountTargets=table(sab_score_matched_trimmed$ProbeName)
sab_score_matched_trimmed$CountTargets=CountTargets[match(sab_score_matched_trimmed$ProbeName,
                                                          names(CountTargets))]
# Seed for creating shuffled Negative labels
seedNumber=1
#Filtering Criteria and conditions;
numberOfTargets_Thr=2; Avg_Rating_thr=3
cond1=sab_score_matched_trimmed$CountTargets<numberOfTargets_Thr
Positive_Set_DrugGene_Pairs=na.omit(data.frame(Drugbank_Gene=sab_score_matched_trimmed$Targets[cond1], 
                                               Chemical.Name=sab_score_matched_trimmed$ProbeName[cond1]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
Positive_Set_DrugGene_Pairs$Avg_Rating=sab_score_matched$`Avg Rating (in cells)`[match(Positive_Set_DrugGene_Pairs$Chemical.Name, sab_score_matched$`Probe Name`)]
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Avg_Rating>Avg_Rating_thr,1:2]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs_V2(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]

Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset4=data.frame(Complete_Set, Source='SAB')
```
<!-- Dataset 5: Drug Target pairs where, a mutation in the target gene causes clinical resistance to the drug; from COSMIC (COSMIC resistance, N=16) (COSMICv91 Drug Resistance file) -->
<!-- Note: if we increase our stringency, our prediction power increases -->
```{r echo = F, results = 'hide', message=FALSE, warning=FALSE}
CosmicResistanceMutations=read.table('Data/CosmicResistanceMutations.tsv', sep='\t')
colnames(CosmicResistanceMutations)=as.character(unlist(CosmicResistanceMutations[1,]))
CosmicResistanceMutations=CosmicResistanceMutations[-1,]
CosmicResistanceMutations=CosmicResistanceMutations[-1,]
CosmicResistanceMutations[CosmicResistanceMutations$`Drug Name`=='Ibrutinib',]
CosmicResistanceMutations$trimmed_geneName= sapply(CosmicResistanceMutations$`Gene Name`,function(x) strsplit(as.character(x), '_')[[1]][1])
DrugTargetPair= data.frame(drugname=CosmicResistanceMutations$`Drug Name`, GeneName=CosmicResistanceMutations$trimmed_geneName)
Evidence_Strength=table(paste(DrugTargetPair$drugname, DrugTargetPair$GeneName))
DrugTargetPair=unique(DrugTargetPair)
DrugTargetPair$drugName_geneName=paste(DrugTargetPair$drugname, DrugTargetPair$GeneName)
DrugTargetPair=cbind(DrugTargetPair,
                     Evidence_Strength=as.numeric(Evidence_Strength[
                       match(DrugTargetPair$drugName_geneName, names(Evidence_Strength))]))
numberofTargets=table(DrugTargetPair$drugname)
DrugTargetPair$numberofTargets=numberofTargets[match(DrugTargetPair$drugname, names(numberofTargets))]

DrugTargetPair$known_target=onTarget$drugCategory$target[
  match(stripall2match(DrugTargetPair$drugname),
        stripall2match(onTarget$drugCategory$name))]
DrugTargetPair$is.target=apply(DrugTargetPair, 1, function(x) grepl(x[2], x[6]) )
# Filter criteria
seedNumber=1; numberOfTargets_Thr=5; Evidence_Strength_thr=50
cond1=DrugTargetPair$numberofTargets<numberOfTargets_Thr
cond2=DrugTargetPair$Evidence_Strength> Evidence_Strength_thr
cond3=DrugTargetPair$is.target
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(DrugTargetPair$GeneName)[cond1 & cond2 & cond3],
  Chemical.Name=as.character(DrugTargetPair$drugname)[cond1 & cond2 & cond3]))

Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[tolower(Positive_Set_DrugGene_Pairs$Chemical.Name)  %in%
                                                          tolower(onTarget$drugCategory$name),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs_V2(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset5=data.frame(Complete_Set, Source='COSMIC resistance')
# Area under the curve: 0.9375 #size=8
# Area under the curve: 0.8 #size=14
```
<!-- Dataset 6: Drug Target pairs where, a mutation in the target gene causes clinical resistance to the drug; from onkoKB -->
```{r}
oncokb_resistance=read.csv('Data/oncokb_biomarker_drug_associations_resistance.tsv', sep='\t')
# Preprocessing
split_drugnames=strsplit(oncokb_resistance$Drugs..for.therapeutic.implications.only., ', ')
oncokb_resistance_expanded=lapply(1:nrow(oncokb_resistance), function(x)
  cbind(oncokb_resistance[x,],split_drugnames=split_drugnames[[x]]) )
oncokb_resistance_expanded=do.call(rbind, oncokb_resistance_expanded)
# remove Amplification
oncokb_resistance_expanded=oncokb_resistance_expanded[-grep('Amp',oncokb_resistance_expanded$Alterations),]
oncokb_resistance_expanded$known_target=onTarget$drugCategory$target[match_stripall(oncokb_resistance_expanded$split_drugnames, onTarget$drugCategory$name)]
oncokb_resistance_expanded$count_target=sapply(strsplit(as.character(oncokb_resistance_expanded$known_target), ', '), length)
oncokb_resistance_expanded$is.target=apply(oncokb_resistance_expanded, 1, function(x) grepl(x[2], x[7]))
# Filtering Criteria
seedNumber=1; numberOfTargets_Thr=10; which_level = c('R1', 'R2')
cond1=oncokb_resistance_expanded$count_target<numberOfTargets_Thr
cond2=oncokb_resistance_expanded$is.target
cond3= oncokb_resistance_expanded$Level %in% which_level
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(oncokb_resistance_expanded$Gene)[cond1 & cond2 & cond3],
  Chemical.Name=as.character(oncokb_resistance_expanded$split_drugnames)[cond1 & cond2 & cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]

Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[tolower(Positive_Set_DrugGene_Pairs$Chemical.Name)  %in%
                                                          tolower(onTarget$drugCategory$name),]
print(dim(Positive_Set_DrugGene_Pairs))
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset6=data.frame(Complete_Set, Source='oncoKB resistance')
```
<!-- Dataset 7: Drug Target pairs where, there is an FDA approval for treatment in patients with a mutation in target gene; from onkoKB -->
```{r echo = F, results = 'hide', message=FALSE, warning=FALSE}
oncokb_approved=read.csv('Data/oncokb_biomarker_drug_associations_approved.tsv', sep='\t')
# Preprocessing
split_drugnames=strsplit(oncokb_approved$Drugs..for.therapeutic.implications.only., ', ')
oncokb_approved_expanded=lapply(1:nrow(oncokb_approved), function(x)
  cbind(oncokb_approved[x,],split_drugnames=split_drugnames[[x]]) )
oncokb_approved_expanded=do.call(rbind, oncokb_approved_expanded)

# remove ceratin biomarker types are are not application
to_remove_categories=c('Amp', 'Wildtype','High', 'Deletion', 'Duplication')
maybe_categories=c('Fusion', 'Truncating',  'Oncogenic Mutations')
to_remove_categories_id=unique(unlist(sapply(to_remove_categories, function(x) 
  grep(x,oncokb_approved_expanded$Alterations) )))
oncokb_approved_expanded=oncokb_approved_expanded[-to_remove_categories_id,]
#remove combinations
oncokb_approved_expanded=oncokb_approved_expanded[
  -grep('\\+',oncokb_approved_expanded$split_drugnames),]
oncokb_approved_expanded=oncokb_approved_expanded[!is.na(match_stripall(oncokb_approved_expanded$split_drugnames, onTarget$drugCategory$name)),]

oncokb_approved_expanded$known_target=onTarget$drugCategory$target[match_stripall(oncokb_approved_expanded$split_drugnames, onTarget$drugCategory$name)]
oncokb_approved_expanded$count_target=sapply(strsplit(as.character(oncokb_approved_expanded$known_target), ', '), length)
#whether the biomarker is a target or not
oncokb_approved_expanded$is.target=apply(oncokb_approved_expanded, 1, function(x) grepl(x[2], x[7]))
#Filtering Criteria
seedNumber=1; numberOfTargets_Thr=10; which_level = c(1:4)
cond1=oncokb_approved_expanded$count_target<numberOfTargets_Thr
cond2=oncokb_approved_expanded$is.target
cond3= oncokb_approved_expanded$Level %in% which_level
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(oncokb_approved_expanded$Gene)[cond1 & cond2 & cond3],
  Chemical.Name=as.character(oncokb_approved_expanded$split_drugnames)[cond1 & cond2 & cond3]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[
  Positive_Set_DrugGene_Pairs$Drugbank_Gene %in% rownames(corrMat),]
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
print(dim(Positive_Set_DrugGene_Pairs))
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match(tolower(Complete_Set$Chemical.Name), tolower(onTarget$drugCategory$name))]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset7=data.frame(Complete_Set, Source='oncoKB resistance')
```
<!-- Dataset 8: Hihgly Selective inhibitors based on their binding profile; SelleckChem -->
```{r}
# Preprocessing
highly_selective_inhibitor=readxl::read_xlsx('Data/Updated_20220419-L3500-Highly-Selective-Inhibitor-Library-96-well.xlsx', sheet = 2)
highly_selective_inhibitor$known_target=onTarget$drugCategory$target[
  match_stripall(highly_selective_inhibitor$Name, onTarget$drugCategory$name)]
highly_selective_inhibitor$count_target=sapply(strsplit(as.character(highly_selective_inhibitor$known_target), ', '), length)
highly_selective_inhibitor$known_target_single=KnownTarget_predictions$MaxTargetName[
  match_stripall(highly_selective_inhibitor$Name, KnownTarget_predictions$drugName)]
highly_selective_inhibitor
seedNumber=1; numberOfTargets_Thr=30
cond1=highly_selective_inhibitor$count_target<numberOfTargets_Thr
Positive_Set_DrugGene_Pairs=na.omit(data.frame(
  Drugbank_Gene=as.character(highly_selective_inhibitor$known_target_single)[which(cond1)],
  Chemical.Name=as.character(highly_selective_inhibitor$Name)[which(cond1)]))
Positive_Set_DrugGene_Pairs=unique(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs=Positive_Set_DrugGene_Pairs[Positive_Set_DrugGene_Pairs$Drugbank_Gene %in%
                                                          rownames(corrMat),]
set.seed(seedNumber)
Negative_Set_DrugGene_Pairs=randomize_DF_with_unique_Pairs(Positive_Set_DrugGene_Pairs)
Positive_Set_DrugGene_Pairs$Label=1
Negative_Set_DrugGene_Pairs$Label=0
Complete_Set=rbind(Positive_Set_DrugGene_Pairs, Negative_Set_DrugGene_Pairs)
Complete_Set$Label= factor(Complete_Set$Label, labels = c('Negative', 'Positive'))
Complete_Set$drug_BroadID=onTarget$drugCategory$broad_id_trimmed[
  match_stripall(Complete_Set$Chemical.Name, onTarget$drugCategory$name)]
Complete_Set$crispr_corr=sapply(1:nrow(Complete_Set), function(x)
  err_handle(corrMat[as.character(Complete_Set$Drugbank_Gene)[x], as.character(Complete_Set$drug_BroadID)[x]]))
Complete_Set=na.omit(Complete_Set)
Gold_Standard_Dataset8=data.frame(Complete_Set, Source='oncoKB approved')
```

<!-- Intergarte the above 8 datasets for testing the performance of DeepTarget for primary Target prediction  -->
```{r}
Comp_Gold_Standard=rbind(Gold_Standard_Dataset3)
```
</div>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});

$(document).ready(function () {
  $('.knitsql-table').addClass('kable-table');
  var container = $('.kable-table');
  container.each(function() {

    // move the caption out of the table
    var table = $(this).children('table');
    var caption = table.children('caption').detach();
    caption.insertBefore($(this)).css('display', 'inherit');
  });
});

</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->
<script>
$(document).ready(function () {
  window.initializeSourceEmbed("Step6_Preprocess_GoldStandards.Rmd");
  window.initializeCodeFolding("show" === "show");
});
</script>


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
